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Summary 
Cystic fibrosis (CF) is the most common lethal inherited disease among Caucasians and arises due 
to mutations in a chloride channel, called cystic fibrosis transmembrane conductance regulator. 
A hallmark of this disease is the chronic bacterial infection of the airways, which is usually, 
associated with pathogens such as Pseudomonas aeruginosa, S. aureus and recently becoming 
more prominent, B. cepacia. The excessive inflammatory response, which leads to irreversible 
lung damage, will in the long term lead to mortality of the patient at around the age of 40 years.  
Understanding the pathogenesis of CF currently relies on animal models, such as those 
employing genetically-modified mice, and on single cell culture models, which are grown either 
as polarised or non-polarised epithelium in vitro. Whilst these approaches partially enable the 
study of disease progression in CF, both types of models have inherent limitations.  
The overall aim of this thesis was to establish a multicellular co-culture model of normal and CF 
human airways in vitro, which helps to partially overcome these limitations and permits analysis 
of cell-to-cell communication in the airways. These models could then be used to examine the 
co-ordinated response of the airways to infection with relevant pathogens in order to validate 
this approach over animals/single cell models. Therefore epithelial cell lines of non-CF and CF 
background were employed in a co-culture model together with human pulmonary fibroblasts. 
Co-cultures were grown on collagen-coated permeable supports at air-liquid interface to 
promote epithelial cell differentiation. The models were characterised and essential features for 
investigating CF infections and inflammatory responses were investigated and analysed. A 
pseudostratified like epithelial cell layer was established at air liquid interface (ALI) of mono-and 
co-cultures and cell layer integrity was verified by tight junction (TJ) staining and transepithelial 
resistance measurements (TER). Mono- and co-cultures were also found to secrete the airway 
mucin MUC5AC. Influence of bacterial infections was found to be most challenging when intact 
S. aureus, B. cepacia and P. aeruginosa were used. CF mono- and co-cultures were found to 
mimic the hyperinflammatory state found in CF, which was confirmed by analysing IL-8 
secretions of these models. 
These co-culture models will help to elucidate the role fibroblasts play in the inflammatory 
response to bacteria and will provide a useful testing platform to further investigate the 
dysregulated airway responses seen in CF. 
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1 Chapter 1 Introduction 
1.1 The human respiratory system 
The human respiratory system consists of two regions, the upper and the lower airways. 
The upper airways consist of nose, oral cavity, pharynx and larynx (figure 1.1) and the main 
functions of the upper airways are to humidify, warm and filter inhaled air to mostly prevent 
foreign particles, including viruses and bacteria, from entering the tracheobronchial tree.  
The lower airways or tracheobronchial tree consist of a series of branching airways, called 
generations or orders. The right lung has three lobes, whereas the left lung only has two lobes. 
The trachea bifurcates into right and left main bronchi, which branch into secondary (lobar) 
bronchi, then divide again into tertiary (segmental) bronchi before finally branching into 
bronchioles, which are the smallest airways without alveoli. This part of the lower airways is 
called the conducting airway region, which leads inspired air to the gas exchanging regions 
downstream, the alveolar ducts. The alveolar ducts are lined with alveolar sacs (alveoli).The 
entire respiratory system is lined with epithelial cells containing several different cell types, 
which all have specific structure and function. 
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Figure 1.1 The anatomy of human airways (Anon, 2011) 
 
1.1.1 The structure of the airway epithelium 
The respiratory tract is composed of several different epithelial cell types and each fulfils certain 
functions to maintain lung homeostasis (Breeze and Wheeldon, 1977). Different epithelial cell 
types have been described and can be classified into the following three major categories: basal, 
ciliated columnar and non-ciliated secretory columnar cells. Other cells that can be found in the 
respiratory system are immune and inflammatory cells, which can migrate to the airways 
through the basement membrane to support epithelial cell function (Knight and Holgate, 2003). 
The cross section of the airway wall shows the different epithelial cell types and their position on 
top of the underlying basement membrane. The bronchial epithelium is organised as a 
pseudostratified cell layer comprised of basal, ciliated and secretory cells (goblet). The basal cell 
population helps to build up the pseudostratified appearance as they are strongly attached to 
the basement membrane through hemidesmosomes, which are specialized cell-extra cellular 
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matrix junctions (Green and Jones 1996). Additionally desmosomes, which are intercellular 
adhesion molecules create trans-cellular networks and give the tissue a high resistance to 
mechanical stress (Knight and Holgate, 2003). Furthermore there are tight junctions, who ensure 
columnar-columnar interactions and also they form a tight but selective barrier in the 
paracellular space between epithelial cells, separating the lumen of the airways from the 
underlying tissue. Tight junctions are located closest to the lumen and form a belt like 
appearance where adjoining cells are connected to each other’s membrane (Farquhar and 
Palade, 1963). 
 
1.1.1.1 Cells of the airway epithelium 
Basal cells are abundant in the conducting airways although their number decreases according 
to the size of the region. There are much more numerous in the trachea and extrapulmonary 
bronchi (Jeffery and Reid, 1975). Basal cells are important for attaching other epithelial cells to 
the basement membrane (BM) via hemidesmosomes. They have pyramidal or ovoid shape 
containing a large nucleus, which is surrounded by low amount of cytoplasm. Historically, basal 
cells were thought to be the origin of stem cells in the airway epithelium, giving rise to ciliated 
and secretory columnar cells in larger airways (Breeze and Wheeldon, 1977). In addition to their 
possible progenitor role and attachment of superficial cells to the basement membrane, basal 
cells also secrete a number of active molecules including cytokines, chemokines, and growth 
factors. In the pseudostratified epithelium all cells rest on the basement membrane but basal 
cells do not reach the lumen and do not contribute to the apical epithelial surface.  
Secretory cells, such as goblet cells and serous cell, contribute to the secretion of airway mucus 
and they are present in the apical surface of the epithelial cell layer. Goblet cells are most 
numerous and the main source of airway mucus. They are characterised by the electron-lucent 
appearance of secretory granules and morphologically show microvilli expression on the cell 
surface. Additionally they take part in the inflammatory response by rapidly increasing mucus 
secretion after exposure to bacterial infection, for example (Gail and Lenfant, 1983, Jeffery and 
Li, 1997). A thin mucus layer lines the epithelium as an innate defence mechanism, which 
entraps any inhaled particles, other foreign molecules, bacteria and viruses. This is part of the 
mucociliary escalator, which will be discussed further on. Serous cells are another type of 
secretory cell, resembling mucus goblet cells with a difference in granule content where it is 
seen to be electron-dense. These cells have only been found in rodent airways, but two 
populations of these rare cells have been observed in small airways of human lung (Rogers et al., 
1993). 
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Columnar ciliated cells, found in the pseudostratified epithelium, reach the lumen but still attach 
to the basement membrane and they form tight junctions with other columnar cells but also 
form desmosomes to attach to adjacent cells and basal cells (Breeze and Wheeldon, 1977, 
Farquhar and Palade, 1963). Furthermore they directly take part in the mucociliary escalator, 
which was just mentioned above as these cells, which make up 50 % of all epithelial cells in the 
airways (Knight and Holgate, 2003), are responsible for moving the mucus blanket towards the 
pharynx. All entrapped bacteria and particles are eliminated in this way in healthy airways.  
 
1.1.2 Pulmonay Fibroblasts 
Pulmonary fibroblasts were long thought to only be an inert structural supporting cell but 
growing evidence has been reported and confirmed that these cells can actively contribute 
directly to pulmonary inflammation and they are also responsible for deposition of the ECM 
within the lung (McAnulty et al., 1995, Mutsaers et al., 1997). Interstitial fibroblasts in the lungs 
account for about 40 % of all lung cells (Dunsmore and Rannels, 1996). In the conducting airways 
there are subepithelial fibroblasts, which are in close proximity to the epithelium, which allows 
direct close interaction between these two cell types and the ECM (Brewster et al., 1990). These 
mesenchymal cells were termed attenuated fibroblasts and together with the epithelium, the 
ECM and neural tissue this unit has been termed mesenchymal trophic unit (Evans et al., 1999). 
This complex has been shown to be important during airway growth and airway branching 
(Minoo and King, 1994). For asthma it has been shown that reactivation of this unit leads to 
fibrosis (Holgate et al., 2000). In CF it is thought that anti-fibrotic factors (Interferon-γ), which 
have been found to be increased in CF, lead to normal repair without fibrosis. CF tissue has been 
found to show normal histological appearance, even in the presence of infection (Shute et al., 
2003). 
 
1.1.3 The extracellular matrix (ECM) and basement membrane 
The extracellular matrix (ECM) includes the interstitial matrix, which is present between the 
different cells in the intercellular spaces, and BM, which is a sheet-like deposition of ECM. The 
complex composition of the ECM is crucial in terms of displaying a highly organised part of 
connective tissue. It serves several different functions, such as support and anchorage for cells, 
segregating different tissues from one another and regulating intercellular communication. In 
the airways the ECM has to maintain normal lung functions by maintaining functional and 
structural integrity.  
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A constant balancing act is kept between synthesis and degradation of the different components 
of ECM. Three controlling mechanisms are responsible for this balance. One is de novo sythesis 
and deposition of ECM components, the second is proteolytic degradation of existing ECM by 
Matrix-Metalloproteinases (MMPs) and the last one is the inhibition of MMP activity by specific 
endogenous antiproteases, the tissue inhibitors of MMPs (TIMPs)(Eickelberg et al., 1999). The 
ECM consists mainly of fibrous proteins and glycosaminoglycans (GAGs) including proteoglycans, 
collagens, elastins, laminin and fibronectin, which are mostly produced by fibroblasts (Diaz et al., 
1989, Eickelberg et al., 1999, Miyazaki et al., 1990).  
The basement membrane (BM) also called basal lamina, is a thin sheet-like membrane (40-
120nm), on which epithelial cells adhere. The BM mainly consists of type IV collagen, laminin, 
fibronectin, proteoglycans, including perlecan and provides structural support and it is presented 
in every tissue of the human body, where epithelial cells are always linked to it. The BM 
separates these epithelial cells from the underlying connective tissue but it also plays a role in 
epithelial-mesenchyme interactions and it has been found to be tissue specific. In addition the 
BM facilitates epithelial cell adhesion and migration through ECM interactions, plus it can also 
serve as a growth factor reservoir. Furthermore it plays a role in establishing epithelial cell 
polarity (LeBleu et al., 2007, Howat et al., 2001).  
 
1.1.4 Function of the airway epithelium 
The main function of the complex airway epithelium is to protect the airways and the underlying 
tissue from inhaled airborne particles, noxious substances and pathogens. As earlier mentioned 
the airway epithelium is the first line of contact with the outside environment and it is therefore 
responsible to entrap the inhaled foreign particles in the luminal mucus layer, which covers the 
bronchial epithelium, and that way the mixture will be removed from the lung by coordinated 
directional ciliary beating (mucociliary escalator) moving the mucus and trapped particles 
towards the pharynx. This defence mechanism is responsible for keeping the airway mostly 
sterile. If this mechanism fails and a particle or pathogen is recognised by the host immune 
system, a pro-inflammatory signalling pathway is activated, upon which the epithelial cells 
produce and release inflammatory cytokines, such as IL-8 (Kim et al., 1997, Abdullah and Davis, 
2007, Livraghi and Randell, 2007, Mills et al., 1999, Atsuta et al., 1997) 
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1.1.4.1 Mucociliary clearance (MCC, or mucociliary escalator) 
MCC of the respiratory tract is an important innate defence mechanism against inhaled particles 
and pathogens. Cilia lining the upper and lower airways are covered by a thin mucus layer and 
beat rapidly in a coordinated direction propelling mucus and trapped particles towards the 
pharynx (Gail and Lenfant, 1983). The air-surface liquid (ASL) is crucial for effective mucus 
clearance, which consists of a periciliary liquid (PCL) layer and a mucus layer overlying the PCL. 
The PCL keeps the mucus the right distance away from the underlying epithelia, this is usually 
about 7µm, the same length as the cilia, whereas the mucus layer can vary in height from 7 µm - 
70 µm (Tarran, 2004). The PCL provides a low viscosity solution that lubricates the cilia, which 
then can beat rapidly and continuously. The mucus layer, as described above, is responsible for 
entrapping any inhaled particles and substances to protect the lung from infection and 
inflammation. The viscoelastic mucus layer consists of a mixture of water, ions and mainly of two 
of the oligomeric glycoprotein mucins, MUC5AC and MUC5B (Thornton and Sheehan, 2004, 
Breeze and Wheeldon, 1977, Boucher, 2007). Moreover, the airway epithelium serves as a rich 
source of anti-oxidants and anti-bacterial agents including lactoferrin, lysozyme, and opsonins 
(Velden and Versnel 1998). It also produces anti-proteases such as tissue inhibitors of 
metalloproteinases (Velden and Versnel 1998). 
 
Figure 1.2 Schematic of the airway epithelium in normal (left side) and CF (right side) airways 
On the left side the normal human epithelium contains goblet cells, which secrete mucus and ciliated cells, 
which are responsible for propelling the thin layer of mucus towards the pharynx. 
On the right side the situation as found in CF is shown. Goblet cells hypersecrete mucus, which is 
additionally dehydrated based on the CFTR mutation. This leads to depletion of the PCL and cilia get 
entrapped in the vast amount of mucus, which can then not be moved anymore by the cilia. This CF lung 
environment invites bacteria to colonise, leading eventually to chronic infection of CF lungs. 
 
Airway Epithelium
Non-CF airway CF airways
Decreased depth 
Periciliary liquid
Poorer mucociliary clearance
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1.1.4.2 Airway Mucus 
Airway mucus is a heterogeneous mixture of mucins (0.5-1 %), which are highly glycosylated 
glycoproteins, salts and dialyzable components (0.5-1 %), secreted polypeptides, water (95-98%), 
lipids, cells and cellular debris that appear in the airways (Clunes and Boucher, 2007). 
Additionally mucus also contains soluble antimicrobial substances, such as lactoferrin, which is 
an abundant substance of the ASL, proteases, antiproteases, oxidants and antioxidants and 
antibodies (Singh et al., 2002, Wine, 1999). Mucins can have very different physiologic roles and 
mature mucins are subdivided into two groups: membrane bound and secreted. The secreted 
mucins are responsible for the viscoelasticity of the extracellular mucus layer in the lumen of the 
airways. Three mucins are expressed in the airways: MUC2, MUC5AC and MUC5B. MUC5AC is 
predominantly synthesised by goblet cells in the airway epithelium and MUC5B is synthesised in 
submucosal glands, whereas MUC2 is barely detectable but can be produced in goblet cells. 
Furthermore mucins show an extraordinary diversity through the carbohydrate side chains, so 
that they can literally bind any particle that they contact to protect the airways (Thornton et al., 
1996, Thornton and Sheehan, 2004, Houtmeyers et al., 1999).  
1.2 Cystic Fibrosis 
Cystic Fibrosis (CF) is the most common lethal inherited disease among the Caucasian population 
and currently affects approximately 9000 individuals (CF Trust, UK). It is an autosomal recessive 
disease caused by a mutation of the cystic fibrosis transmembrane conductance regulator (CFTR) 
gene and affects multiple organs, such as the sweat glands, conducting airways and the nasal 
epithelium, for example. “Cystic Fibrosis of the pancreas” was first described by Anderson in 
1938 as pancreatic lesions and later on Di Sant’Agnese et al. (1953) found that children with CF 
show very high levels of sodium and chloride in their sweat (Di Sant'Agnese et al., 1953). Gibson 
and Cooke used this finding to develop a diagnostic test based on the measurement of high 
levels of electrolytes in sweat, which is still used nowadays (Gibson and Cooke, 1959). 
1.2.1 CFTR mutation and its consequences 
The mutation of the CFTR gene can cause either malfunction or absence of the CFTR, which is a 
cAMP-regulated chloride (Cl
-
) ion channel. About 1700 individual mutations 
(www.genet.sickkids.on.ca/cftr) have been identified and reported in the cystic fibrosis mutation 
database with Δ-F508 mutation (deletion of phenylalanine at position 508) being responsible for 
about 66% of all mutations in the CFTR worldwide (Donaldson et al., 2006). The consequence of 
any of these mutations are multi-organ disorders as they affect the functioning of lungs, 
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pancreas, gastrointestinal tract, liver, sweat glands and male reproductive ducts (Wine, 1995) 
but the severities differ from mild to very serious. 
The CFTR ion channel provides a pathway for Cl
-
-ion movement across epithelium and regulates 
the Cl
-
-ion flow, thus it is essential for salt transport, fluid flow and maintaining the essential 
ionic homeostasis needed for regular functionality, especially in the airways. In normal airways 
there is a balance between Na
+
 ion absorption and Cl- secretion. This balance is regulated by 
CFTR, which is located in apical membrane of epithelial cells and by another ion channel called 
ENaC, which is also located in the apical membrane, and which is normally downregulated by 
CFTR (Boucher, 2007). This transport balance is crucial for the homeostasis of air-surface liquid, 
which consists of two layers, a mucus layer and a periciliary liquid layer (PCL) as described above 
(Gail and Lenfant, 1983).  
In cystic fibrosis, however, this is a different picture. The mutation of CFTR and therefore 
absence or malfunction of the Cl
-
 ion channel leads to uncontrolled Na
+
 hyperabsorption as ENaC 
is not regulated anymore as well as to decreased Cl
-
 secretion across the apical cell membrane 
into the cells. Consequently water follows into the cells, which leads to dehydration of ASL and 
depletion of PCL, which in turn leads to direct interactions of the mucus layer with epithelial cell 
surfaces (Knowles and Boucher, 2002). The mucus layer contains two major gel-forming mucins 
in the airways, which are called MUC5AC and MUC5B (Thornton et al., 1996) and which upon 
PCL depletion are able to interact with other membrane-associated mucins, such as MUC1 and 
MUC4 (Voynow and Rubin, 2009). Furthermore epithelial cilia get trapped and are not able to 
propel the mucus and all entrapped particles and especially bacteria towards the pharynx 
anymore. This exposes the lung to a vast amount of potentially harmful agents and bacteria but 
it does not stop here, as in CF it has been reported that mucins are hypersecreted (Welsh and 
Smith, 1995), as for example the MUC5AC gene is upregulated by bacterial byproducts, such as 
LPS (Bautista et al., 2009). All together this invites bacteria to colonise the airways and finally 
leads to chronic bacterial infections of CF lungs. This chronic bacterial infection and host 
inflammatory responses eventually lead to lung obstruction and eventually to patient morbidity.  
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1.3 Bacterial infections in CF 
Lungs of babies that have CF have been found to be structurally normal at birth but following 
bacterial infections, high levels of mucus are secreted (Girod et al., 1992). Pulmonary infections 
in CF have been reported to involve relatively few species of bacteria, which have been isolated 
from CF patients. In early stages of CF Staphylococcus aureus (S. aureus), for example, is the 
most common pathogen in children and in early adolescents. Later on S. aureus is replaced or at 
least dominated by P. aeruginosa, which is the most common pathogen (80%) isolated from 
adult CF lungs. Another bacterium, which has gained a lot of attention throughout the last 20 
years in accordance with it being isolated more often, is B. cepacia , which is known to be 
transmissible between patients and usually leads to a rapid decline in lung function (Burns et al., 
1998, Govan et al., 1993).  
Most bacterial infections are localised in the larger and smaller airways rather than in the alveoli. 
In general all bacterial infections start with the adherence of the pathogen to the host cell 
surfaces, to the mucus layer provided in CF airways or to extracellular matrix (ECM) using 
different adhesins (Ulrich et al., 1998). S. aureus is known to cause chronic endobronchial 
infections in CF lungs and has been shown to preferably adhere to mucus in the airways, for 
example (Ulrich et al., 1998). The focus in the second part of this study will be directed towards 
S. aureus, B. cepacia and P. aeruginosa.  
 
1.3.1 Staphylococcus aureus (S. aureus) 
S. aureus is a gram-positive bacterium that is consistently isolated from CF patients but 
considering the high prevalence, S. aureus infections in the airways are still ill defined in terms of 
how this bacterium successfully initiates and establishes infection in CF. Before there were 
antibiotic treatments available for this organism S. aureus was regarded as one of the main 
colonising bacteria in CF and was considered lethal for children with CF and contributes to 
patients poor prognosis and mortality in adults. Nowadays there are quite successful 
antistaphylococcal and prophylactic antibiotics available (Flucloxacillin), which keep this 
organism at bay and S. aureus is not usually considered to be the common cause for morbidity 
and mortality in CF anymore. Prophylactic antibiotics have been considered to lead to early 
acquisition with P. aeruginosa though (Elborn, 1999). S. aureus and other bacteria cause an 
inflammatory response, which can lead to irreversible lung damage in CF (Armstrong et al., 
1995). The repertoire of virulence factors is big and numerous components of S. aureus cell 
membrane, such as lipoteichoic acid (LTA), peptidoglycan and other lipoproteins have been 
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shown to induce an inflammatory response in epithelial cells (Fournier and Philpott, 2005). In 
case of the pattern-associated molecular pattern (PAMP) LTA, it has been show that the pattern 
recognition receptor (PRR) toll-like receptor (TLR) 2 is necessary for successful induction of a pro-
inflammatory response and cytokine/chemokine secretion, for example (Greene et al., 2005b). 
Additionally there are other receptors presented on epithelial cells that can interact with S. 
aureus, such as asialoGM1, which leads to IL-8 expression and leading to recruitment of 
neutrophils (Normark et al., 2004). Protein A is another important adhesin and 
immunostimmulatory component of S. aureus that is able to directly interact with tumor 
necrosis factor α (TNF-α) receptor 1 (TNFR1) presented on most airway cells and induce 
inflammation (Gomez et al., 2004). Furthermore S. aureus secretes different virulence factors 
but the exact roles they play in CF have not been fully determined yet. 
1.3.2 Burkholderia cenocepacia (B. cepacia) 
Another bacterium that has become more prevalent in CF is the gram-negative and motile B. 
cenocepacia (in this work referred to as B. cepacia), which was first described by Burkholder 
(1949) as a phytopathogen causing soft rot of onion bulb.  
As for S. aureus the first step in infection is adhesion to the airway lumen. It has been shown 
that this bacterium adheres through proteins and glycolipid (asialoGM1) receptors but also to 
secretory mucins (Sajjan and Forstner, 1992). Binding to mucins has been shown to occur only 
when the bacterium expresses the cable pilus and it has recently been reported that through this 
the bacterium can bind to epithelial cells and induce inflammation (Sajjan et al., 2000a). B. 
cepacia is also able to bind to TNFR1, similar to S. aureus and induce a pro-inflammatory 
response via this receptor (Sajjan et al., 2008). Furthermore there are also secreted virulence 
factors and cell wall components, such as LPS. This virulence factor plays a dual role in case of B. 
cepacia as this contributes to the high bacterial resistance to antimicrobial peptides and it is a 
potent inducer of pro-inflammatory responses (Bamford et al., 2007). In CF it has been reported 
that B. cepacia causes infections in only 3.5 % of CF patients in the world but B. cepacia 
infections are usually accompanied by a rapid decline of lung function and poor prognosis 
(Courtney et al., 2004). Furthermore this bacterium has been shown to be transmissible (LiPuma, 
2003)and cause the “cepacia syndrome” (fever, pneumonia, bacteraemia) in about 20 % of 
infected CF patients (Isles et al., 1984). B. cepacia also secretes various other virulence factors 
that can cause enhancement of the pro-inflammatory response of the host but many details of 
B. cepacia pathogenesis are not known yet and further research is needed to elucidate the 
dynamic interactions between the bacteria and the host to develop new strategies and therapies 
to enhance the quality of life with CF. 
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1.3.3 Pseudomonas aeruginosa (P. aeruginosa) 
Even though P. aeruginosa is non-pathogenic to the normal respiratory tract it is the most 
common pathogen found in CF, which has been reported to appear in about 80 % of CF patients 
at the age of 18 and older (CF Trust UK). Chronic infection is now responsible for the large 
majority of excess morbidity and mortality in these patients, since once infected, it is almost 
impossible to eradicate this organism, which often displays multi-drug resistances from the 
respiratory tract (Nguyen et al., 2007). Like for the other two bacteria it has been shown that 
many P. aeruginosa products, including lipoproteins, LPS, flagella and other secreted virulence 
factors contribute to the pathogenesis of these bacteria. The strong inflammatory response 
produced as result of P. aeruginosa infection leads to irreversible lung damage and a decline in 
lung function eventually leading to morbidity and mortality of the patient (Ratjen and Doring, 
2003). P. aeruginosa adherence to the airways has also been shown to involve interactions with 
mucins (Ramphal et al., 1991). CF patients are highly susceptible to these infections and even 
though extensive research has been dedicated to this organism it is still not understood in detail 
how P. aeruginosa persists in CF airways (de Bentzmann et al., 1996c). Again different receptors 
have been identified that take part in delivering the inflammatory response and lead to the 
production of chemokines and cytokines, for example. As earlier mentioned TLR-2 recognises 
gram-positive bacteria via LTA and TLR-4 recognises gram-negative via LPS. TLR induced 
responses usually lead to an activation of NF-κB and the secretion of IL-8 and other cytokines 
depending on the signalling pathway (Greene et al., 2005b, Hauber et al., 2005). P. aeruginosa 
also has an additional repertoire of virulence factors that support this persistent infection in CF 
patients, such as elastase for example. This virulence factor has been shown to rapidly decrease 
epithelial cell layer integrity and traverse the epithelium, leaving tissue damage (Azghani, 1996). 
These are only a few ways of P. aeruginosa’s virulence and ability to evoke a pro-inflammatory 
response but points out the importance of understanding the pathogen-host interaction to be 
able to develop new therapies and to increase the quality of life for CF patients. 
 
1.4 Lipopolysaccharide (LPS) 
LPS was discovered at the end of the nineteenth century by Richard Pfeiffer (Westphal, 1977) 
and was later described as a heat stable and cell-associated macromolecule, which is found on 
the outer membrane of gram-negative bacteria. LPS can be shed by bacteria during growth, 
exposure to antibiotics and death. LPS is composed of three distinct structural components. The 
O-antigen, the core region, which is subdivided into inner and outer core and the Lipid A region, 
which is the endotoxic unit of LPS (Galanos and Freudenberg, 1993). The O-specific chain enables 
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bacteria to survive in vivo as it makes the bacteria resistant to phagocytosis and killing by 
complement of the host’s immune system (Poxton, 1995)(figure 1.3). 
 
Figure 1.3 Schematic of LPS structure (Anon, 2011); LPS is the major cell wall component of Gram negative 
bacteria and is composed of three main subunits. The first subunit is a repeating sugar unit (green 
hexamers) called the O-antigen, the second unit is the core oligosaccharide (inner and outer core) and the 
last unit, which anchors LPS in the cell wall and makes it immunostimulatory is a region called Lipid A. 
 
LPS of gram-negative bacteria has been shown to be able to induce an inflammatory host 
response and is continuously present in chronic infected CF lungs. This host response is initiated 
with LPS binding to a glycoprotein called LPS-binding protein, which is synthesized in the liver 
and present in plasma. LBP binds LPS, upon which this complex is transferred to CD14. This 
glycoprotein accelerates the transfer but it is not necessary for the binding to CD14 (Hailman et 
al., 1994). CD14 is located on host cells, such as monocytes, and it does not have an intracellular 
domain. This is the reason that another receptor (PRR) is involved it transmitting the signal to 
the inside of the cell. This receptor is TLR-4, which builds a complex with MD-2 and therefore 
plays a crucial role in innate immunity as this causes a rapid inflammatory response including the 
secretion of IL-8 (Greene et al., 2005b). TLR-4 has an intracellular domain that then recruits 
other proteins involved in this pathway to translocate NF-κB from the cytoplasm to the nucleus, 
where this complex then can activate the transcription of target genes, such as IL-8 (Kim et al., 
2005a). 
1.5 Available therapies for CF patients 
Several treatments for CF patients are available that all aim to increase the quality of life and 
expand the life expectancies. The age given for the median predicted life survival for someone 
with CF is about 35 but it needs to be always kept in mind that different people with different 
mutations are differently affected by this multi-organ disease.  
Helping patients to loosen the mucus is one major objective of several everyday routines that 
are carried out by patients, which sometimes require help. There are airway clearing techniques, 
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such as chest physical therapies and postural drainage. Furthermore there are devices that help 
removing mucus in different ways, such as through oscillation of the airways. There is oscillating 
positive expiratory pressure, for example, where the patient breathes out through a device, 
which causes the large and the small airways to vibrate and therefore partially loosens the 
mucus, which can eventually be coughed up. There are other breathing techniques, which all 
help to get the mucus moving and these can all be adjusted to the patients needs. Furthermore 
there are more commonly known little helpers, such as Ibuprofen and hypertonic saline and in 
addition there are certain recommendations for patients in terms of nutrition but these are all 
add-on therapies and usually other therapies are required (http://www.cff.org/treatments).  
There are several antibiotics commonly used in CF but the therapeutic management of chronic 
infections with P. aeruginosa for example remains challenging. One macrolide antibiotic that was 
originally used in patients with panbronchiolitis infected with P. aeruginosa looked like a 
potential therapy for CF and a randomised controlled trial was carried out at the beginning of 
this century. Patients that were included were six years and older and had to have a P. 
aeruginosa infection for one year or longer. After the trial it was reported that Azithromycin 
treatment was associated with improvement of lung function (FEV1), less exacerbations and 
weight was gained by the patients compared to the placebo group. Patients of the azithromycin 
group also reported that they noticed improvements in physical functioning. (Saiman et al., 
2003). After this trial azithromycin was observed for its anti-virulence effects and it was shown 
that there is a correlation between in vitro anti-virulence effects (P. aeruginosa isolates) and the 
improvement of CF patients (Nguyen et al., 2007). Azithromycin has antibacterial effects but is 
not bactericidal or bacteriostatic against P. aeruginosa at the concentrations realistically 
achievable in sputum (Baumann et al., 2004) but it has been shown that macrolides can 
decrease the production of virulence factors, such as elastase (Kita et al., 1991). This decrease in 
virulence factors possibly has a direct influence on the pro-inflammatory effects of P. 
aeruginosa. 
A new antibiotic has been launched in 2010 in the USA, called Cayston (Aztreonam Lysine), 
which is an antibiotic to inhale and is the first new developed one of this kind in more than a 
decade. Cayston is an aerolised formulation of the monobactam antibiotic aztreonam and lysine 
(Gibson et al., 2006). This antibiotic acts against aerobic gram-negative bacteria and was shown 
to improve lung function of CF patients and reduce the bacterial density in sputum in clinical 
trials (McCoy et al., 2008, Plosker, 2010). These outcomes show that this antibiotic is an addition 
to the therapies available for chronic infections in CF. These are just a couple of examples of 
what is available and usually these conventional therapies are used in combination or alteration 
with others to achieve the most beneficial outcome for every patient. The maintenance and care 
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is one side of the story and then there is the situation, where a patient has got severe lung 
disease and all other conventional treatments do not help anymore that is when a lung 
transplantation is considered. Roughly 120-150 transplants are carried out each year in the USA 
but the general problem of organ shortage is also present here. In 2003, 368 CF patients were 
accepted for lung transplant but 524 applied. An issue that was raised in terms of organ shortage 
for transplantation is the low number of living donors, who are willing to give one of their lobes. 
If two people do this one CF patient can have a new lung. This whole process is obviously more 
complex in the way that donors must match the recipient in biological features, such as blood 
type (www.cff.org).  
Despite all these and other treatment options 90 % of CF patients will eventually die of 
respiratory failure.  
 
1.6 Gene therapy for CF 
The main aim of gene therapy for CF is to deliver the CFTR gene efficiently to target cells to cure 
or slow down the progression of disease. The excitement about gene therapy was big once the 
CFTR gene was discovered in 1989 and it still is but it has been trial and error for the last 20 
years. More than 20 clinical trials were carried out so far using viral and non-viral gene transfer 
agents. There are some problems that were encountered on the way and which lead to a 
reasonable slow progress in this field of research (Davies and Alton, 2010).  
Problems that were encountered in different trials include efficiency of delivery, host immune 
responses, the determination of efficacy itself and it is uncertain what degree of delivery need to 
be reached for clinical benefits. Soon after the discovery of the CFTR gene researchers isolated 
CF cells from a patients and successfully delivered wild-type CFTR DNA (Drumm et al., 1990), 
which was also repeated in CF mice using liposome-mediated gene delivery (Alton et al., 1993). 
These initial attempts were soon followed by studies in humans using either viral or non-viral 
gene-transfer.  
The viral delivery systems that were used to date include engineered adenovirus or adeno-
associated viruses but again problems were emerging, including absence of receptors expressed 
on epithelial cell surfaces (Walters et al., 1999), the induction of inflammatory responses (Crystal 
et al., 1994) and in case of repeated application the immune response decreased the expression 
rate dramatically, probably by neutralizing antibodies synthesised in the host (Zabner et al., 
1996). Non-viral delivery systems include cationic lipids (Caplen et al., 1995), compacted DNA 
nanoparticles (Konstan et al., 2004) and naked DNA (Zabner et al., 1997, Ruiz et al., 2001). The 
main advantage that has been shown for these non-viral systems is the possibility of repeated 
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administration but some of these also elicit side effects in CF patients. Side effects have not been 
reported for every trial and if present they can vary from very mild flu like symptoms 
(Zuckerman et al., 1999) to unacceptable toxicity (Crystal et al., 1994). In one trial initial 
assessment of an adeno-associated virus transfer and functional CFTR expression was found 
quite successful as lung function improved in accordance with higher levels of IL-10 and lower 
levels of IL-8 (Moss et al., 2004) and therefore a larger scale trial was carried out, in which these 
clinical improvements were not observed (Moss et al., 2007). Non-viral systems were used 
mainly in the form of lipid-based gene-transfer and also resulted in variable outcomes. The 
efficacy has generally been found variable but one trial has reported success in terms of 
repeated administration to the nasal epithelium and no loss of efficacy (Hyde et al., 2000). 
However, delivery of CFTR to the nose as indicator of safety has been criticised as in another trial 
it was also found that in case of cationic-lipid mediated CFTR delivery to the nose, no symptoms 
were seen but when delivered to the lung there were CF patients experiencing mild-influenza 
like symptoms (Alton et al., 1999). 
It has been shown over the years that CFTR can safely be delivered to the airways and even 
repeatedly when non-viral systems are used. Repeated delivery to the airways is an essential 
feature as the there is a constant turnover of the epithelium present. In contrast the expression 
level of CFTR declined quickly and side effects were observed for both delivery systems, plus it is 
not known how efficacy will correlate with clinical benefit. The main focus of the UK Cystic 
Fibrosis Gene Therapy consortium is directed to develop a non-viral delivery system that can be 
administered repeatedly and that leads to clinical benefits for the patient. Alongside the aim is 
to increase the period of expression of CFTR. One system was assessed and found to meet 
certain criteria, such as nebulizable, repeatable and to have a good preclinical toxicity profile. 
The cationic lipid GL67, which was used in the trial reported by Alton et al. (1999), was identified 
to fulfil these requirements and is currently being modified to reduce the side effects found after 
delivery to the airways and to improve gene expression duration (Davies and Alton, 2010). Gene 
therapy needs further improvements to verify safety and efficacy but also further understanding 
of correlation between changes of the CFTR expression in patients and what they identify as 
clinical improvements to lead to a successful treatment that can either slow down, halt or cure 
CF lung disease. 
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1.7 Modelling the disease 
1.7.1 Animal models  
Animal models have been used in research for several different approaches, not just CF but also 
COPD, asthma and for other non respiratory research fields. For CF several animal models have 
been developed throughout the years and the main organisms that have been used are mice. 
Although there are many other animal models, including rat, guineapig and the novel pig and 
ferret models, these are all in vivo systems that have mostly been genetically modified in the 
attempt to create an animal that shows CF pathogenesis in several, ideally all CF affected organs. 
This overall aim has yet to be achieved though. Next to in vivo models there are several in vitro 
models employing usually one cell line or primary cells. A couple of co-culture in vitro models 
have been developed and some will be discussed here further on. Here it is the aim to give a 
short insight into the in vivo and in vitro models that are available for CF airway research.  
 
1.7.1.1 Rodent models for CF research 
Several mouse models have been developed up until today for further investigation of the 
development of CF lung disease and a quick look at the history of these models will point out 
where they stand today. 
At the beginning the models were not always genetically modified, such as models for chronic 
lung infection, which is also a hallmark of CF. One of the first models for chronic 
bronchopulmonary infection was a rat model, which was infected with P. aeruginosa bacteria, 
which were embedded in agar beads to retain the bacteria in the airways and mimic a chronic 
infection (Cash et al., 1979). There were similar models to this using agarose beads instead 
(Klinger et al., 1983)and these beads changed further down the line to alginate in the attempt to 
closer mimic CF P. aeruginosa infection, where these bacteria grow in a alginate biofilm (Wu et 
al., 2001). This rat model was then adapted to mice to study chronic mucoid P. aeruginosa 
infection and to study bacterial pathogenesis in CF (Starke et al., 1987). The genetically modified 
mouse models where CFTR gene in the mouse DNA has been disrupted by homologous 
recombination in embryonic stem cells, which enables researchers to target a mutation to a 
specific site in the chromosome (Dorin et al., 1992, Snouwaert et al., 1992, Thomas and 
Capecchi, 1987). Furthermore in other mice the human known ΔF508 mutation (and others) was 
introduced into the homologous mouse gene loci to generate CF mice (Zeiher et al., 1995). One 
problem with these animal models that became obvious quite quickly was the predominant 
intestinal pathogenesis and in contrast these mice did not show any sign of lung disease, which is 
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the main cause of morbidity and mortality in humans. Additionally recombinant CF mouse 
models were developed with clinically relevant mutations, which were introduced to the mouse 
gene, such as earlier mentioned ΔF508 (Zeiher et al., 1995) or G551D mutation (Delaney et al., 
1996). After all generating all these mouse models, which have been fundamental for CF 
research, transgenic KO mice were developed, which allowed preclinical testing of mutation-
specific treatment approaches (Du et al., 2002). However, for all these generated models it 
important to keep in mind how they were generated and that this could have an effect on 
possible phenotypes and therefore analysis results, which need to be taken into account.  
So what about lung disease? The phenotypes of the previously mentioned mice models did not 
show any signs of spontaneous lung disease and also there were ground breaking differences in 
the phenotypes. In CFTR KO mice, whether a complete KO or with some residual CFTR, the 
intestinal disease is the most prominent feature in accordance with decreased body weight and 
mucus plugging of intestine leading to death without showing a development of lung disease 
because of chronic inflammation and bacterial infections as it is seen in human CF. Even though 
some models were reported to be less able to fight infection and then showed increased 
inflammation, especially after repeated bacterial challenges, lung disease as seen in humans was 
not observed (Davidson et al., 1995). There are several things to be aware of using animal 
models and to interpret findings in certain phenotypes in the attempt to understand the human 
disease as mouse models show different CF severities in phenotypes depending on the 
background of the mouse, the mutation and the expression levels of CFTR. In terms of lung 
pathology there was little evidence of changes, which has been suggested to be due to the 
sterile facilities most mice are kept in and that the changes that are seen in human lungs occur 
over years and not weeks (Kukavica-Ibrulj and Levesque, 2008). Then finally in 2004 Mall et al. 
(2004) presented the first mouse models that actually displayed lung pathology similar to what is 
found in humans. In this mouse model not CFTR was modified but the sodium channel β-ENaC 
was overexpressed and caused hyperabsorption of sodium ions, leading to depletion of ASL, 
dehydrated mucus and these mice showed characteristics of lung disease. This early disease 
state was followed by neutrophillic inflammation and increase in pro-inflammatory cytokines in 
airway liquids. Upon bacterial challenges these mice were unable to clear the infection. The 
outcome here showed that ion flow directly influences the height of the periciliary liquid (PCL), 
that ion flow alteration can lead to CF pathogenesis in the small airways and that inflammatory 
response is initiated by dysfunction of ion flow and PCL depletion (Mall et al., 2004).  
In addition to these mouse models there are others but only two recent once will be introduced 
here. After the development of gene targeting other animal models were generated, such as pigs 
and ferrets. On one hand these animal models have the advantage of being bigger and easier to 
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analyse and on the other hand lung anatomy is more similar than mouse lungs compared to 
what is seen in humans.  
 
1.7.1.2 The new pig model for CF research 
In 2008 Rogers et al. (2008) reported the first time about the “successful” development of CF 
piglets. 
The researchers disrupted the CFTR gene in fibroblasts of normal pigs by homologous 
recombination and somatic cell nuclear transfer to generate mixed (CFTR
-/-
,CFTR
-/+
 and CFTR 
+/+
) 
litters of pigs. At birth CFTR
-/-
 piglets appeared normal and apart from genetic analysis could not 
be identified to be different from the other litter mates but whereas meconiul ileus in humans 
only appears at a rate of 16 – 20 % (Dorfman et al., 2009) it was 100 % for the CF pigs, which had 
to be surgically solved for survival of the pigs. Other CF symptoms found included pancreatic 
destruction, abnormalities of gallbladder and the normal appearance of lungs at birth but again 
the disease pathological appearance in detail is different (Rogers et al., 2008). In these CF piglets 
the lungs at birth were normal compared to the non-CF litter mates and did not show increased 
inflammation. BAL was analysed only 6-12 hours after birth and no increase neutrophil count or 
other signals of inflammation were found but x-ray tomography revealed progressive thickening 
of airway walls and scattered infiltrates, similar to humans. Further analysis of BAL showed that 
CF pigs more often had bacteria present in the airways and at higher concentrations, including S. 
aureus. It was also reported that CF piglets were unable to efficiently eradicate bacteria and 
were less frequently sterile when compared to the non-CF piglets (Stoltz et al., 2010). This model 
provides new insights into the development of lung disease, especially straight after birth but 
researching these pigs takes time as pigs have a much longer life cycle compared to mice. 
 
1.7.1.3 The new ferret model for CF research  
Another model that has recently been developed using gene targeting is the CF ferret model and 
the idea of this being a good CF model was driven by the higher similarity (compared to mouse) 
of lung anatomy and biology between ferrets and humans and a fast reproduction time of 
ferrets. After a long struggle to actually get any CF ferrets to survive after birth it was shown that 
CF ferrets showed pathologies like they are seen in humans. Meconium ileus was observed in 75 
% of CF ferrets and a wide variability in intestinal obstruction was seen. Pancreatic disease was 
reported to be similar as it is in humans. However, the most striking difference of ferrets and 
humans is the intestinal tract, which lacks a cecum (assists in digestion of plant material). 
Therefore the weight gain in newborn ferrets was the biggest hurdle and it was suggested that 
 45 
 
intestinal CFTR is crucial for absorption of nutrients. Once ferrets survived, a BAL analysis 
revealed increased bacterial counts one week after birth, which were not accounted for death in 
these ferrets. More publications are to be awaited and the first conclusion drawn by these 
researchers was that this model maybe useful for dissecting the pathophysiology found in CF 
(Sun et al., 2010). 
 
All these animal models assist in dissecting the effects of CFTR mutations on the whole organism, 
however as mentioned above there are species specific differences, which need to be taken into 
account and care has to be taken to relate results of animal experiments to a human disease like 
CF. Although animal models have assisted in learning about CF and pathophysiology of infections 
the limitations of these models must be recognized and great caution must be taken when trying 
to transfer results to patients.  
1.7.2 In vitro cell culture models for CF research 
Next to all these in vivo models there are cell culture based in vitro models for CF research, 
which usually employ either primary epithelial cells or epithelial cell lines that were generated 
from isolated epithelial cells of healthy or of CF airways. One advantage of these in vitro cultures 
is that they have human origin and therefore species specific differences do not need to be 
taken into account and therefore in vitro cell cultures have been extensively used to investigate 
airway biology, disease pathophysiology and even the use of novel therapies. 
 
1.7.2.1 Submerged cell culture 
The simplest version of cell culture is under submerged conditions in plastic dishes and other 
tissue culture ware. Submerged cell culture has been used in airway related research but it has 
been pointed out that these cells do not closely mimic the in vivo physiology and morphology. 
This technique is used to maintain and expand immortalized cell lines in flasks but also it is used 
for primary cells in terms of maintenance after dissociation of the freshly excised specimen, 
which can then be expanded before being used for further experiments (Randell et al., 2011). As 
already mentioned, submerged cultures do not necessarily show close similarity to in vivo 
morphology and physiology. One cell line that has been investigated for exactly these 
differences is Calu-3 and it was shown that under submerged conditions (on a transwell insert 
rather than plastic) a less suitable model of the tracheobronchial epithelium was established 
compared to cultures grown at air-liquid interface (ALI) (Grainger et al., 2006). There are other 
reports that compare submerged cultures to ALI cell cultures and they have reported similar 
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findings in that responses of the two cultures are often different, such as cytokine expression by 
NHBE cells (Kikuchi et al., 2004), or the suscepitibility of primary human nasal cells to P. 
aeruginosa infections (Fleiszig et al., 1997). Furthermore it has been emphasised that ALI 
cultures also show polarized secretion of IL-6 and IL-8 in 16HBE140-, for example (Chow et al., 
2010). However, some general and very useful laboratory techniques, such as flow cytometry 
cannot be used for cell cultures grown at ALI because disrupting the differentiated cell layer 
would possibly cause cell damage and lead to false interpretation of results. They can be used 
for submerged cell cultures though but whether these results are valuable for comparison to in 
vivo is questionable. There is a need to develop further techniques for characterising and 
analysing ALI cell cultures. The closest in vitro cell culture mimicking the in vivo one is achieved 
using primary cell culture at ALI. 
1.7.2.2 Air-liquid interface cell culture of primary cells and transformed cell lines 
Primary human airway epithelial cell models have been around for over twenty years (Lechner et 
al., 1982) and they provide the closest representation of airway epithelium in vitro as they have 
not been transformed and should have the same genotype and phenotype as cells in vivo when 
cultured at air-liquid interface (Whitcutt et al., 1988), which recreates the natural surroundings 
of these cells. The human lung is lined by epithelial cells, which face the lumen where air is 
coming in on one side and subepithelial tissue on the other side (Breeze and Wheeldon, 1977). 
Primary cells that have been freshly isolated from a specimen are first cultured in plastic dishes, 
in which they are only poorly differentiated and show a squamous phenotype but this step is 
necessary for expanding and passaging these valuable epithelial cells. As already mentioned 
culture of airway epithelial cells at ALI (on porous membranes) allows mucociliary 
differentiation, which is a complex process and has been shown to involve cell-matrix and cell-
cell interactions, differentiation of serous cells and the establishment of correct ion flow 
properties has not been fully elucidated yet. It has been shown though that there is a 
differentiation-dependant mucin upregulation (MUC5AC, MUC5B) present in primary nasal and 
bronchial epithelial cells (Bernacki et al., 1999). Furthermore retinoic acid has been shown to 
suppress or reverse squamous metaplasia in culture (Yoon et al., 1999). Even though this first 
steps in this direction were made in the eighties (Wu et al., 1985, Yankaskas et al., 1985, Wiesel 
et al., 1983) and was constantly improved (Wu et al., 1997) there is still much unknown about 
detailed regulation of this complex process.  
Even though primary cells are a good and relevant model for CF research they are not readily 
available for many laboratories and depending on the research field not many diseased tissue 
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samples might be available. Furthermore primary cells have a limited replicative lifespan, which 
makes the use of primary cells expensive (Randell et al., 2011).  
Other types of cells that have been extensively used are cell lines and they have been proven to 
be a valuable complement to primary epithelial cell culture. There are different ways of 
generating cell lines, including transformation to immortalize these with the Simian Virus 40 
(SV40) (Zeitlin et al., 1991b) but also cancerous cells, which are already immortal, have been 
used for airway research (Shen et al., 1994). Transformation of primary cells to generate cell 
lines has not always led to success though as many cells do not survive crisis (Buchanan et al., 
1990, Reddel et al., 1988, Gruenert et al., 1988), lose the ability to polarize (Gruenert et al., 
1988) and therefore do not recapitulate the in vivo phenotype and even when they do polarize 
they sometimes lose certain essential epithelial features, such ion flow (Cozens et al., 1994). 
However there are cell lines with typical epithelial cell features that have been successfully used 
in CF research, as the cell lines used throughout this project (C38, IB3-1 and Calu-3) and many 
others (Wan et al., 2000, Ehrhardt et al., 2006, Greene et al., 2005b). Additionally cell lines are 
often more readily available either commercially or through collaborations of different 
laboratories. As already described above culturing airway cells at ALI is the preferred technique 
to generate airway related research models that closely mimic the in vivo appearance of the 
epithelium. 
 
1.7.2.3 Mono- and co-culture systems for airway related research 
ALI cultures of primary cells and transformed cell lines for airway related research mimic, as 
described above, the in vivo morphology and physiology of airway epithelial cells closer than 
submerged cell cultures. Mono-cultures have been extensively used in many areas of research 
focussing on the airways. For CF research there are many cell mono-culture models that all focus 
on broadening the understanding of CF lung pathophysiology with different objectives, such as 
inflammatory responses to the infection with bacteria (Kube et al., 2001)or bacterial products 
(LPS) , bacterial adherence to CF and non CF cells and general characterisation studies looking at 
tight junction properties and paracellular integrity (Nilsson et al., 2010), just to name a few. 
The initial stages of establishing mono-cultures of primary human bronchial epithelial (HBE) cells 
at ALI for airway related research were not straight forward. Even though much attention has 
been directed towards cell growth medium and growth supports, such as collagen IV (Fiedler et 
al., 1991), to establish in vivo like culture models, the establishment of ALI using a porous 
membrane as growth support, has been reported to be a very important inducer of cell 
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differentiation, of which the complex mechanisms are still not fully elucidated (Gruenert et al., 
1995, Randell et al., 2011) but these mono-culture systems have made a huge difference to 
research and the collected knowledge of the airways, the function of different cell types in the 
airways and enabled to further investigate diseases, such as CF. These models made it possible 
to study biochemical and genetic mechanisms of differentiated epithelial cells of healthy and 
diseased origin.  
One of the driving forces behind developing models is the ability to study ex vivo cell cultures in 
a simplified setting compared to in vivo, to reduce and partially replace animal models. Like the 
ALI culture models display a simplified version of the airways (epithelium) and are nowadays 
routinely used in the attempt to answer basic research question, discover molecular mechanism 
and in terms of CF identify the link between CFTR mutations and lung pathogenesis.  
However, in vivo there is not only one cell type present, it has long been known that the airways 
consist of different cells that all play their role in tissue homeostasis through direct cell-cell 
interactions as well as through autocrine and paracrine communication via secreted growth 
factors and cytokines, for example (Breeze and Wheeldon, 1977, Burgel and Nadel, 2004, Knight, 
2001). Epithelial cell interactions with subepithelial fibroblasts have been reported to be 
important as this modulates cell behaviour, proliferation and differentiation of the epithelium 
and vice versa (Minoo and King, 1994). For example it is known that epithelial wound repair is 
dependent on their own actions, their interactions with the ECM and on the cytokine milieu, 
which is established by themselves but also other surrounding cells in the airways, such as 
bronchial wall fibroblasts, which secrete cytokines and modulate epithelial cell function 
(Thompson et al., 1995). Compared to CF research more attention has been paid to subepithelial 
fibroblasts in asthma research and certain growth factors and interleukins (IL) have been 
detected in airways, epithelial cells as well as fibroblasts, including IL-8, IL-6, hepatocyte growth 
factor (HGF) and several members of fibroblast growth factors (FGF) (Holgate et al., 2000, 
Knight, 2001, Sacco et al., 2004).  
Even though more information has been gathered about factors that modulate epithelial cell 
proliferation and differentiation, the mechanisms are not completely known yet. To further 
elucidate underlying mechanisms of these interactions between epithelial cells and fibroblasts, 
possible growth factors and cytokines, for example, a few co-culture systems have been 
developed so far. Understanding the mechanisms of communication may lead to novel targets 
for therapies for respiratory diseases. 
One of these co-culture models was established by Skibinski et al. (2007) to look at the role of 
HGF in terms of bronchial epithelial growth regulation. In this study as well as in most others 
fibroblasts were used as feeder layers, which have been treated with mitomycin C to inhibit 
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proliferation and inhibit possible overgrowth of fibroblasts, which were grown in the bottom of a 
24-well plate, not allowing direct cell contact to epithelial cells grown on TWs. This group 
showed that HGF has growth promoting effects on bronchial epithelial cells, which is in 
accordance with other reports (Thompson et al., 1995, Skibinski et al., 2007). Additionally it was 
pointed out that HGF is important but not the only stimulating compound secreted by 
fibroblasts, as the inhibition of HGF did not lead to complete proliferation inhibition of bronchial 
epithelial cells. Furthermore it was shown that the inhibition of TNF-α and IL-6 using specific 
antibodies reduced the co-culture HGF production and therefore epithelial cell proliferation. 
These findings emphasize that there is a whole communication network to be discovered for 
epithelial cells and subepithelial fibroblasts. An additional study further emphasises this as 
Myerburg et al. (2007) have shown that subepithelial fibroblasts establish a suitable 
environment for human bronchial epithelial cell differentiation. It has been shown here that 
subepithelial fibroblasts, which were actively proliferating on the undersurface of the TWs, 
increased ciliogenesis, for example (Myerburg et al., 2007).  
These are two examples of epithelial cell and subepithelial fibroblast co-cultures that clearly 
show and emphasise that these intercellular interactions and communications via secreted 
factors are important and further investigation is needed to elucidate the role of subepithelial 
fibroblasts and direct cell-cell interactions in CF lung disease. 
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2 Chapter 2 Material and Methods 
2.1 General consumables 
All reagents were purchased from Sigma (Poole, UK) unless stated otherwise. Cell culture 
consumables were purchased from Appleton Woods and Greiner Bio-One (Birmingham, UK). 
Normocin (100 µg/ml end concentration) was bought from InvivoGen, San Diego. Fetal bovine 
serum gold (FBS), Dulbecco’s modified eagle medium: Nutrient mixture 12- HAM (DMEM/F12) 
growth medium, Phosphate saline Buffer (1x, PBS), L-glutamine and Trypsin-EDTA were 
purchased from PAA Laboratories Ltd (Sommerset, UK). BD Falcon Transwell
®
 inserts and 
companion plates were purchased from VWR (Leicestershire, UK). Normal human pulmonary 
fibroblasts, fibroblast growth medium 2 (HPFM), airway epithelial cell growth medium (AEM) 
were purchased from Promocell (Heidelberg, Germany). Vectashield hard set mounting medium 
containing 4’-6-diamidino-2-phenylindole (DAPI) was purchased from Vector Laboratories 
(Peterborough, UK). Immobilon

 Western Enhanced Chemiluminescent substrate (ECL) was 
purchased from Millipore (Watford, UK), X-ray film and DeStreak solution was purchased from 
Amersham Biosciences (Buckinghamshire, UK). Mueller-Hinton broth and Mueller-Hinton agar 
were purchased from OXOID LTD. (Basingstoke, UK). Calu-3 cells were purchased from American 
Type Culture Collection (ATCC). 4 well microscope slides were purchased from C.A. Hendley 
(Essex) LTD. (Essex, UK). Phenol, Kodak GBX developer and Kodak GBX fixer and replenisher were 
purchased from Sigma (Poole, UK). Nunc Maxisorb ELISA plates, Microscope slides (1.0-1.2mm 
thick) and coverslips (0.13-0.17mm thick) were purchased from Fisher Scientific (Loughborough, 
UK). Immersol™ Immersion oil was purchased from Carl Zeiss Ltd (Hertfordshire, UK). Petri 
dishes were purchased from Sarstedt Ltd. (Leicester, UK). 
 
2.2 Antibodies 
Mouse monoclonal antibody to fibroblast surface protein (1B10; ab11333, 0.2 mg/ml), mouse 
monoclonal anti-cytokeratin 8 antibody (0.5 mg/ml, ab9023), mouse monoclonal anti-basal cell 
cytokeratin (CK5) antibody (1 mg/ml ab9272) and mouse monoclonal anti-mucin 5AC (ab3649, 
0.2 mg/ml) antibody were purchased from Abcam (Cambridge, USA). Mouse IgG kappa (Mopc 
21, 5 mg, m-7894), and goat anti-mouse fluorescein isothio-cyanate (FITC; F0257) antibodies 
were purchased from Sigma. The mouse monoclonal anti-vimentin [V9] antibody was purchased 
from Gene Tex (GTX76575) and mouse monoclonal anti-Zonulae occludens protein 1(ZO-1; 0.5 
mg/ml) antibody was purchased from Invitrogen. 
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2.3 Cell types 
There are different cell types available for research use. If cells are taken directly from a living 
organism (e.g. biopsy) these cells are called primary cells and some primary cells are also 
commercially available, in this case human pulmonary fibroblasts. When a cell line is established 
primary cells are manipulated in terms of transformation to alter their properties to an immortal 
cell line. The third category of cell lines available is cancerous cell lines, which are already 
immortal due to their cancerous properties. Cell lines do differ slightly to the cells of their origin, 
as through transformations and long-term in vitro culturing gene expression can change. 
 
2.3.1 Primary cells 
The only primary cells that were used throughout this project were human pulmonary 
fibroblasts (HPF), which originated from normal lung tissue and are commercially available from 
Promocell. As primary cells are taken directly from a living organism (biopsies) without being 
transformed they should represent the same geno- and phenotype as the same cells in vivo, 
which is an advantage as they will possess the same morphological and biochemical 
characteristics as in vivo but primary cells are in general short lived as they can only be used for a 
small number of passages, in this case from P2-P7, as recommended by the manufacturer 
(Promocell). 
 
2.3.2 Transformed and cancerous cell lines 
Transformed cell lines originate usually from a specific tissue of a specific species and through 
transformation they are immortalised, which means they do not die after a couple of passages 
but keep dividing and growing in cell cultures, potentially giving unlimited supply of these cells. 
IB3-1 is a bronchial epithelial cell line that originates from a cystic fibrosis patient. This cell line 
was immortalized in 1992 by transformation with a hybrid virus, adeno-12-SV40 and all cells are 
deficient in cyclic-AMP-medicated protein kinase A activation of chloride conductance, which is 
diagnostic of CF. IB3-1 are heterozygote for the delta F508 mutation and a non-sense mutation 
(W1282X) In C38 cells, which originate from IB3-1, the CF phenotype was corrected by 
transfection with wild-type adeno-associated viral CFTR (AAVCFTR) and the cells stably express 
wild-type CFTR (Zeitlin et al., 1991a, Flotte et al., 1993) 
Calu-3 is a cancerous cell line and originated from a lung adenocarcinoma. 12 different cell lines 
from carcinomas were screened and only 3 of these showed a measurable TER, plus Calu-3 were 
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the only cells expressing CFTR. Compared to transformed cell lines Calu-3 did not undergo crisis 
and will contain the same properties over repeated passages, resembling serous gland cells 
(Shen et al., 1994) 
 
2.4 Cell culture 
2.4.1 Human placental collagen type IV as growth substrate 
Human placental collagen type IV (Sigma, collagen IV) is acid soluble and was dissolved in 3 % 
sterile filtered acetic acid, as per manufacturer’s instructions. All cell culture materials such as 
cell culture flasks, Transwell
®
inserts and 4-well slides were coated with collagen type IV. The 
volume of human placental collagen type IV used for each device is dependent on the surface 
area as the final concentration to be worked with is 10 µg/cm
2
. Once the collagen was applied all 
devices were incubated at room temperature for 1 hour before the excess human placental 
collagen type IV was aspirated and devices were washed three times with 1 x PBS. Human type 
IV collagen acts as a substitute basement membrane for cells in vitro and encourages them to 
proliferate and spread. This mimics the in vivo physiology closer than using plastic tissue culture 
devices (Fiedler et al., 1991). Collagen coated devices were stored at 4° C for up to one month if 
not used immediately for culturing cells and experiments. 
 
2.4.2 Culturing cells from frozen 
Frozen vials of cells were removed from liquid nitrogen and defrosted quickly in a water bath at 
37 °C. Once thawed, the 1 ml cell suspension was transferred to 5ml warm cell specific culture 
medium placed in a 15 ml Falcon tube. The cell suspension was then spun down at 250 x g for 5 
min. The resulting cell pellet was resuspended in 10 ml of cell culture medium and directly 
transferred into a collagen type IV-coated 75 cm
2
 tissue culture flasks. The cells were then placed 
in an incubator at 37°C, 5 % CO2 atmosphere after labelling the 75 cm
2
 tissue culture flasks with 
name of user, cell type, and date and passage number. 
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2.4.3 Cryopreservation of cells  
Cell growth was monitored using a light microscope and at 80-90 % confluency, cells were 
washed with PBS to remove FBS, which would inhibit the activity of trypsin. For 75 cm
2
 culture 
flasks, 2.5 ml of trypsin/EDTA (0.25 %) was used to lift the adherent cells off the culture device. 
Once trypsin-EDTA was added to the culture flasks these were returned to the cell culture 
incubator at 37 
°
C, as this is the optimum temperature for enzyme activity of trypsin. Once the 
cells were detached from the flask, cell culture medium was added (5 ml) to inhibit the activity 
of trypsin and then cells were transferred to a falcon tube to be spun down at 250 x g for 5 min. 
Supernatant was discarded and the cell pellet was resuspended in freezing solution, which 
contains 10 % (v/v) dimethyl sulphoxide (DMSO), 40 % (v/v) cell specific culture medium and 50 
% (v/v) (FBS). Cells from one 75 cm
2
 culture flasks were resuspended in 3 ml freezing solution 
and then 1ml was transferred to each of three labelled cryotubes. The vial was then put into a 
“Mr Frosty” freezing container containing 250 ml isopropanol that allows cell to cool at a rate of 
-1°C/min. The freezing container was placed in a -80 °C freezer for 24 h before the vials were 
transferred into the liquid Nitrogen cell bank. 
 
2.4.4 Submerged cell culture 
Human pulmonary fibroblasts (HPF) were maintained in fibroblast growth medium 2 containing 
12 % FBS (unless otherwise stated), normocin (50mg/ml), 2mM L-glutamine and the 
manufacturer’s supplement (full HPFM). The supplement consisted of FBS (0.02 ml/ml), basic 
fibroblast growth factor (recombinant human, 1 ng/ml) and insulin (recombinant human, 5 
µg/ml). 
C38 and IB3-1 cells were maintained in full medium comprising Promocell
®
 airway epithelial 
growth medium (AEM) supplemented with 5 % FBS (unless otherwise stated), normocin (50 
mg/ml) and the manufacturer’s supplement (full AEM). This consisted of bovine pituitary extract 
(0.004 µl/ml), epidermal growth factor (recombinant human, 10 ng/ml), insulin (recombinant 
human, 5 µg/ml), Hydrocortisone (0.5 µg/ml), epinephrine (0.5 µg/ml), triiodo-L-thyronine (6.7 
ng/ml), transferrin, holo (human, 10 µg/ml) and retinoic acid (0.1 ng/ml). 
Calu-3 cells were maintained in DMEM/Ham’s F12, which was supplemented with 15 % FBS 
(unless otherwise stated), normocin (50 mg/ml) and 2 mM L-glutamine.  
All cells were cultured in collagen IV coated (10 µg/cm
2
) 75 cm
2
 tissue culture flasks under 
standard cell culture conditions at 37 °C and 5 % CO2 until 90-95 % confluent. Cells morphology, 
growth, the degree of confluence and confirmation of absence of any bacterial or fungal 
 55 
 
contamination was assessed using an inverted microscope. When cells were 90 % confluent the 
medium was removed and cells were washed and trypsinised as described in 2.4.3. Cells were 
then counted and seeded for further experiments or for expansion into more 75 cm
2
 tissue 
culture flasks. 
2.4.5 Determination of cell counts 
Cell counts were carried out prior to every experiment in order to seed the correct number of 
cells required for each experiment. After the cells have been trypsinised, spun down and 
resuspended in fresh cell culture medium, a volume of 10 µl cell suspension was applied to an 
improved Neubauers haemocytometer. Cells in the four quadrants were counted and the 
average calculated to obtain the final number of cells per ml multiplied by 10
4
.  
2.4.6 Cell culture on Transwell® Inserts (TWs) 
The cell culture TWs used had a polyethylene terephthalate (PET) track-etched membrane with a 
pore size of 0.4 μm, pore density of 2 ± 0.2 x 10
6
/cm
2
 and an effective growth area of 0.33cm
2
. 
These inserts were aseptically handled with sterile forceps and 12 TWs were placed into a 24-
well cell culture insert companion plate before collagen IV was applied to the inserts as 
described in 2.4.1 
For mono-cultures of HPF, C38, IB3-1 and Calu-3, cells were seeded apically onto human 
placental type IV collagen coated TWs at a cell density of 3 x10
4
 cells/well. HPF cells were seeded 
in HPFM, C38 and IB3-1 cells were seeded in AEM, whilst Calu-3 cells were seeded in full 
DMEM/F12. Initially all cells were cultured under submerged conditions with 300 µl medium in 
the apical compartment and 600 µl medium was added to the basolateral compartment. 
Four days after seeding cells, the apical medium on the epithelial cells was removed (the 
epithelial cells were now said to be at air-liquid interface- ALI) and the apical medium on HPF 
was refreshed. Basolateral medium was refreshed on those same days for all cells. The 
established air-liquid interface (ALI) induces mucociliary epithelial differentiation. The 
basolateral medium and any apical liquid from epithelial cultures were then collected every 3 - 4 
days and fresh medium was added to the basolateral compartment, whereas for HPF the 
medium in the apical compartment was also refreshed. All medium collected was frozen at - 80 
°
C until further analysis.  
For co-cultures HPF cells were seeded exactly as described above and were cultured under 
submerged conditions for 4 days prior to removal of the apical HPFM, which was then replaced 
with epithelial cell suspension. C38 and IB3-1 cells were seeded on top of the HPF cells at the 
same density as Calu-3 (5 x 10
4
 cells/well) but each in their specific medium, either AEM or 
 56 
 
DMEM/F12. At this point the basolateral medium was changed to the appropriate epithelial 
medium for the epithelial cells used in the co-culture. These cultures were then kept under 
submerged conditions for another four days to allow the epithelial cells to form a confluent and 
adherent layer on top of the HPF-populated collagen IV basement membrane. Afterwards the 
medium was aspirated to establish an ALI and induce differentiation of the epithelial cells. Again 
the basolateral medium and any apical medium were collected every 3 - 4 days and fresh 
medium was added to the basolateral compartment. This procedure was repeated every 3 - 4 
days for a period of at least 14 days. Alongside with the medium change the Transepithelial 
electrical resistance (TER) was measured as described in 2.9. All samples collected, were frozen 
at -80 
°
C until further analysis. 
 
2.5 Cell viability assay - Cell Titer Blue
™
 (Promega) 
Cell Titer Blue (CTB)
 
is an endpoint assay that provides a homogeneous, fluorometric method to 
monitor cell viability. Viable cells, which are metabolically active, can convert resazurin (blue 
with little intrinsic fluorescence activity) into its highly fluorescent product, called resorufin 
(pink). CTB was directly applied to the cell surface, in the cell medium and required an 
incubation of 2 h at 37 °C prior to analysis (as per the manufacturer’s instructions). The 
fluorescent intensity was measured on a standard multiwell fluorescent plate reader 
(Spectramax Gemini XS, Molecular Devices, Berkshire UK) with a 560 nm excitation, and 590 nm 
emission wavelength. CTB was used in different experimental layouts, which will be discussed 
individually in the chapters affected. 
 
2.6 Flowcytometry 
Flow cytometric analysis was performed on an EPICS XL-MCL flow cytometer (Beckman-Coulter, 
Miami, USA). This excitation source was an air cooled argon laser emitting a 488 nm beam at 15 
mW.  
 
2.6.1 Cell cycle analysis using flow cytometry 
The method used for Cell cycle analysis to distinguish cells in different phases of the cell cycle 
was first described by Nicoletti et al. (Nicoletti et al., 1991) and was proven to be rapid, easy and 
reproducible method for monitoring cell cycle changes under certain conditions with special 
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focus on apoptosis, a controlled mechanism of cell death. Apoptotic cells show distinct 
morphological changes and physical properties (cell shrinkage and condensation of chromatin 
for example).  
Cellular DNA can be stained using propidium iodide (PI), which intercalates with DNA and emits 
fluorescence which correlates with the amount of DNA in each cell.  
Cells were seeded in their specific growth medium on 24-well cell culture plates at a density of 1 
x 10
5
 cells/well and incubated overnight at 37 °C, before their own specific medium was 
refreshed, kept, (this is referred to as conditioned medium) or replaced with fresh or 
conditioned medium of the other cell types. After a further incubation period of 24 h the cells 
were harvested as follows. Before cell cycle analysis, cells were washed with 500 µl PBS and 
lifted off the well with 300 µl Trypsin-EDTA. Each well was treated separately and all washes and 
the trypsinized cells for each different condition were pooled in one tube and centrifuged at 300 
x g for 5 minutes. The supernatant was aspirated and the resulting cell pellet resuspended in 1 
ml hypotonic fluorochrome solution (50 mg/ml propidium iodide in 0.1 % sodium citrate and 0.1 
% Triton X-100). Samples were incubated in the dark at 4 °C until flow cytometric analysis 
(Nicoletti et al., 1991), which was carried out within 24 hours.  
2.6.2 Immunofluorescence staining of cells for flow cytometry 
2.6.2.1 Indirect Immunofluorescence staining (flow cytometry) 
2 x10
5
 cells were washed and incubated with 100µl of primary antibody for 30mins on ice. Cell 
surface CD14 expression was detected with undiluted 63D3 or the IgG1 isotype control MOPC 
21. Following incubation cells were washed twice before incubated with 100µl secondary-
conjugated antibody (goat anti-mouse PE (1:50) or goat anti-rabbit FITC (1:50) for at least 
30mins on ice. Cells were either analysed straight afterwards on the flow cytometer.  
 
2.6.2.2 Direct Immunofluorescence staining (flow cytometry) 
Cell surface TLR4 was determined using direct immunofluorescence staining with TLR4 (HTA 125) 
PE or IgG2a/Κ-isotype control. 2 x 10
5
 cells were washed and incubated with 2 µL of HTA 125 or 
the isotype control for 30mins on ice. Following incubation cells are washed twice and analysed 
straight away using flow cytometry. 
  
 2.7 Immunocytochemical characterisation
Immunocytochemistry is a widely used method for identifying proteins, receptors or other 
macromolecules in cells or tissue samples by using a specific primary antibody against the 
immunogen of interest. If the primary antibody is not already conjugated to 
dye-labelled antibody (e.g. fluorescent) was used in a second staining step to visualize the 
expression and/or distribution of the immunogen of interest. 
 
2.7.1 Determination of optimal antibody titer 
The definition of an optimum antibody tite
maximum specific staining with the least amount of background under specific experimental 
conditions. Often there will be advice from the manufacturer about dilutions, incubation times 
and temperatures. The 
because if in the rare case of having a too high concentration of primary antibody, the reaction 
with the antigen is poor due to steric hindrance. When the primary antibody concentrat
low, there is not enough antibody to react with all the antigens presented 
Figure 2.1 Optimising 1B10, an antibody against a fibroblast surface antigen
HPF cells were seeded on human placental collagen type IV coated (10 µg/cm
density of 3.5 x 10
4
 cells/ml in 
applied as primary antibody in the following concentrations: 1:250, 1:500, 1:750 and 1:1000 before the 
secondary goat anti-mouse FITC conjugated
antibody dilution is 1:250. 
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r is the highest dilution of antibody that gives 
quality of staining will be directly influenced by the antibody dilution 
 
200 µl medium, incubated for 2 days and after fixing and blocking, 1B10 was 
 antibody was applied. For this antibody the optimum primary 
dye, a secondary 
ion is too 
(Dako, 2006). 
 
2
) 4 well slides at a cell 
 The protocol that has previously been established in our lab for staining epithelial cells for the 
epithelial cell markers, the cytokeratins (CK),
1B10 and is described in detail in 
ratio of the more concentrated stock solution to the total volume of the desired dilution. 1:10 
means that we put one part of stock solution of antibody into nine parts of diluent. For 1B10 the 
optimal dilution determined is 1:250, as this gives a minimal background s
signal-to-noise-ratio, whereas for 1:500 the antibody was diluted too high, meaning insufficient 
primary antibody is present to react with all antigen presented in the sample. With any higher 
dilutions no staining of immunogen is ach
Figure 2.2 Optimising the antibody titer of Vimentin for HPF on 4
HPF cells were seeded on human placental collagen type IV coated (10 µg/cm
density of 3.5 x 10
4
 cells/ml in 
Vimentin was applied as primary antibody in the following concentrations: 1:100, 1:250 and 1:500 before 
the secondary goat anti-mouse FITC conjugated
dilution is 1:100 for optimal staining results.
 
For the anti-vimentin antibody the same 
titer to be used was determined at 1:100 to get sufficient staining of the immunogen.
 
2.7.2 Immunocytochemical characterisation 
4 well-slides 
Calu-3, IB3-1, C38 and HPF were seeded onto collagen 
cell density of 3.5 x 10
4
 cells/ml in 
2 days and unless stated
20 minutes. Fixed cells were rinsed three times with 110
with 110 µl of 0.1 % (v/v) 
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 was also adapted and followed for this titration of 
2.7.2. Dilutions of antibodies are in general expressed as the 
ieved at all.  
-well slides 
200 µl medium, incubated for 2 days and after after fixing and blocking, 
 antibody was applied. For this antibody the optimum 
 
method as for 1B10 was performed and the antibody 
of submerged cell culture on
IV coated (10 µg/cm
200 µl medium. Cells were incubated at 37
 otherwise, fixed with 110 µl of 100 % pre-cooled methanol at 
 µl PBS/ well prior to permeabilising 
Triton X-100 in PBS for 30 minutes at room t
taining with a maximal 
 
2
) 4 well slides at a cell 
 
 
2
) 4 well slides at a 
 
°
C with 5 % CO2 for 
-20 
°
C for 
emperature. Cells were 
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rinsed with PBS as before and blocked with 110 µl of 1 % (v/v) normal sheep serum in PBS 
containing 1 % (w/v) BSA for 1 h at room temperature. After a further 3 washes with PBS, cells 
were incubated with primary antibodies. All antibodies used were mouse monoclonal antibodies 
and were directed against cytokeratin 5 (CK5), cytokeratin 8 (CK8), a fibroblast surface protein 
(1B10), Zonulae occludens 1 (ZO-1) or were isotype-matched control antibody in the form of 
IgG1, which was used as negative control. The antibodies were diluted to optimal working 
concentrations in 1 % (w/v) BSA in PBS and again 110 µl were applied to each well. The slides 
were then incubated overnight at 4 
°
C. Cells were washed 3 times with PBS, prior to incubation 
with goat anti-mouse FITC conjugated secondary antibody (1:100), which was applied in 1% BSA 
in PBS for 1 h at 4 
°
C in the same total volume as for the primary antibody. Cells were then 
washed three times with PBS and left to air-dry in the dark prior to mounting with hard set 
mounting medium containing DAPI. Images were taken on a Zeiss Axiovert 200M fluorescent 
microscope using objective with 63 x magnification with a DAPI filter (exposures were between 
5-20 ms) and a FITC filter (exposures were between 50-200 ms). 
 
2.7.3 Immunocytochemical characterisation of cells cultured on TWs 
Cells were grown as described in 2.4.6 and were fixed with 200 µl 100 % pre-cooled methanol at 
-20 
°
C for 20 minutes. TWs were washed 3 times with 200 µl PBS before being excised and each 
membrane was placed, with cells uppermost, in individual wells of a 24 well tissue culture plate. 
Cells were permeabilised with 100 µl 0.1 % (v/v) Triton X-100 in PBS for 30 minutes at RT and 
subsequently washed 3 times with 200 µl PBS. Cells were blocked with 100 µl of 1 % (v/v) normal 
sheep serum in PBS for 1 h at RT. After a further 3 washes with 200 µl PBS, cells were incubated 
with specific antibodies (as described in 2.7.2). Cells were then washed 3 times with 200 µl PBS 
before incubation with 100 µl goat anti-mouse FITC conjugated secondary antibody diluted 
1:100 in 1 % (w/v) BSA in PBS for 1 h at 4 
°
C. Cells were further washed with 200 µl PBS and left 
to air-dry in the dark before mounting with hard set mounting medium containing DAPI. Images 
were taken on a Zeiss Axiovert 200M fluorescent microscope using objective 63 with a DAPI filter 
(exposures of 5 - 20 ms) and a FITC filter (exposures of 50-150 ms). 
 
2.8 Histology 
The following techniques were performed at Birmingham University in collaboration with Gary 
Reynolds CSci FIBMS (Institute for Biomedical Research). 
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2.8.1 Processing of transwells through to paraffin wax 
The TWs were formalin fixed by addition of 10% (v/v) formaldehyde to the culture medium at 
Aston University and directly transferred to Mr Reynolds, who then performed the processing 
and cutting and staining of sections. Following fixation the TW membranes were carefully cut 
out of the TWs and bisected. After placing onto biopsy pads and into cassettes, the TW were 
hand processed through to paraffin wax, comprising of 3 changes in IMS (totalling 2 hours), 3 
changes in isopropanol (totalling 3 hours) and impregnation in wax under vacuum (2 hours). The 
TW were then blocked out and 3µm sections cut, placed onto charged slides and heated for 1 
hour at 65
°
C. 
2.8.2 Staining of tissue sections 
A standard haematoxylin and eosin stain was performed on sections. 
2.8.3 Immunohistochemistry for sections 
After dewaxing, rehydration and a peroxidase block, sections underwent a low temperature 
epitope retrieval technique (ALTER) as previously described (Reynolds et al, 2002). 
Immunostaining was performed on a Dako Autostainer, briefly comprising a 10 minute block in 
2% (w/v) casein solution, incubation in optimally diluted primary antibody for 1 hour, Vector 
ImmPRESS universal secondary for 30 minutes (MP-7500, Vector, UK) and then visualisation with 
ImmPACT NovaRED chromagen (SK-4805, Vector, UK) for 10 minutes. Following dehydration and 
clearing sections were mounted with glass coverslips in DPX mount. 
 
2.9 Transepithelial electrical resistance (TER) measurements 
TER is a measure of the resistance to ion flux across the epithelial cell layer, which reflects the 
degree of confluence and the tightness of the cell barrier (Foster et al., 2000). TER is commonly 
used in airway related research working with cell cultures at ALI as it is convenient, reliable and 
non-destructive to the cell layer. It allows monitoring of the growth of epithelial tissue cultures 
in vitro and to monitor the formation of epithelial cell layer integrity, which also indicates the 
presence of TJs. 
TER of mono- and co-cultures on TWs was measured using an Epithelial Voltohmeter with STX2 
chopstick electrodes (World Precision Instruments) to monitor confluence and barrier formation 
of the epithelial cell layer. As the resistance must be measured between a liquid to liquid 
interface, 300 µl of medium was added to the apical side of the TW before introducing the 
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shorter chopstick electrode into the apical compartment and the second and longer electrode 
into the basal compartment. During initial cell culture of each cell type on TWs the TER was 
measured on day 0, which is the day ALI was established (apart from HPF, which were always 
cultured under submerged conditions), day 4, day 7, day 11 and day 14 to generate a TER 
development profile. This was repeated for each cell type three times. Three individual 
companion plates, each holding 8 TWs were monitored over 14 days at ALI and each reading was 
carried out in triplicate. The TER profiles generated were found to be reproducible. Afterwards 
TER was only measured on day 14 or just before an experiment in order to determine epithelial 
cell confluence, an intact epithelial cell layer and TJ formation. 
TER values reported in this work take into account the area of the cell layer (area of TWs = 
0.33cm
2
) and are expressed as Ω x cm
2
. Triplicate measurements were taken for TW and the 
background resistance, which was typically between 100-120 Ω x cm
2
 (cell-free collagen IV 
coated TW) was subtracted from the average of a triplicate measurement.  
 
Figure 2.3 Picture of the voltohmmeter and chopstick electrode that was used throughout this project in 
order to measure TER as an indicator of an intact, functional cell barrier.  
 
2.10 Dot Blot analysis of Mucin secretion - MUC5AC 
Apical air surface liquid (ASL) secretions of mono- and co-cultures, as well as basolateral 
medium, were collected on day 0, 10 and 14 to be analysed for the presence of mucin. The 
apical sides of mono- and co-cultures were washed with 200 µl sterile PBS (1X), which was 
transferred from one to the next Transwell
® 
insert (8TWs) to concentrate the mucin present and 
increase the chances of detection.  
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Figure 2.4 Preparation of dot blot samples: wash apical compartment with 200µl sterile PBS and pass this 
volume from one to the next Transwell
® 
insert to concentrate mucin. Usually eight TWs were used to 
collect one sample.  
The samples were collected, spun down and frozen at -80 °C till analysis. Preparation of the dot 
blotter included cutting a nitrocellulose membrane to target size and soaking it in distilled water 
before it was fitted into the dot blotter. A vacuum pump was connected and switched on once 
all samples had been applied. HPF, C38 and IB3-1 samples were applied in neat and also in a 1:2 
dilution, whereas Calu-3 samples were applied in neat, in 1:2 dilution, in 1:5 dilution as well as in 
a 1:10 dilution to the target wells on the dot blotter with day 10 always leading and day 14 
following. In addition to the samples, negative controls were apllied to the blot as well in the 
following order: PBS, 1 % (w/v) BSA, and the culture medium AEM and DMEM/F12. 
After sample application, the membrane was blocked in Tris-buffered saline containing 0.1 % 
(v/v) Tween-20 (TTBS) with 3 % (w/v) BSA for 1h at RT. TTBS was then used to wash the 
membrane three times for 15 min prior to overnight incubation at RT on a shaker with primary 
mouse monoclonal anti-muc5AC antibody at 1:500. The following day the membrane was 
washed three times for 20 min with TTBS. The secondary antibody used was a horseradish 
peroxidise linked sheep anti-mouse antibody 1:5000 for 90min at RT on the shaker. Excess 
secondary antibody was washed off with TTBS (4 x 20 min) before the membrane was treated 
with enhanced chemiluminescence (ECL) for 5 min to make the visualization of MUC5AC on the 
membrane possible by detection of the exposed light on a photographic film. 
 
  
200µl sterile PBS
Freeze sample
at -80 or use
immediatley for
dot blot
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2.11 Zymography 
Gelatin zymography is a common method for analysing the expression of matrix 
metalloproteinase-2 (MMP-2) in cells and media samples. After collecting the samples (carried 
out in the same manner as for the dot blot) these were either frozen at -80°C or directly 
prepared for zymography. The 10% gelatin zymograms were bought from Invitrogen (Novex®) 
and were used as recommended by the manufacturer.  
After the gels were mounted in the running chamber and tris-glycine SDS running buffer was 
added the samples were loaded in non-reducing sample buffer (Novex®) as well as recombinant 
MMP-2 standard (Peprotech; 62kDa).  
After sufficient running time the gel was washed with 2.5% Triton X-100 to remove SDS and 
renature the MMP-2 species in the gels (4 x 15 min). After preparing the incubation buffer 
(50mM Tris-HCL, 10mM CaCl2, 1mM ZnCl2 , pH 7.6), 2.5% Triton X-100 was poured off and the gel 
was placed into incubation buffer for at least 72 hours at 37°C. This induced gelatin lysis by 
renatured MMP-2. On day two, after the incubation buffer has been removed, the gel was 
incubated in staining solution (1 % (w/v) Coomassie Blue G in, 40 % (v/v) methanol and 10 % 
(v/v) acetic acid) for 20 minutes, before de-staining in 40 % (v/v) methanol and 10 % (v/v) acetic 
acid until the gelatinolytic activity was apparent as clear bands on a blue background. 
 
2.12 Electron microscopy 
2.12.1 Scanning Electron Microscopy (SEM) 
SEM was conducted at The University of Birmingham with the help of Paul Stanley (Manager of 
the centre for electron microscopy). TWs with either mono- or co-cultures were grown for two 
weeks at ALI before being fixed with glutaraldehyde (2.5%) for at least one hour. After fixation, 
the TWs were taken to Birmingham University for further processing. An optional step involving 
chemical fixation with osmium tetroxide (1 %, 1 h) followed after which the same dehydration 
steps as for TEM were followed but applying dried ethanol at the last step for dehydration. 
The next step, termed critical point drying, involved soaking the specimen in liquid CO2 for 1 
hour and passing through the critical point which is 1170psi/31.1 
o
C. Afterwards the samples 
were mounted on stubs using rapid araldite or double-sided adhesive tape before they are 
coated with 10 nm gold. Samples were then examined using a SEM and micrographs taken. 
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2.12.2 Transmission electron microscopy (TEM) 
TEM was conducted at The University of Birmingham with the help of Paul Stanley. Transwell
® 
inserts with either mono- or co-cultures were grown for two weeks at ALI before being fixed 
with glutaraldehyde (2.5 %) for between one hour and several days. During this period, the 
Transwell
® 
inserts were taken to Birmingham University for further processing. The second step 
of the chemical fixation involved osmium tetroxide (1 %) for one hour. The fixation process was 
followed by several dehydration steps using 50 %, 70 %, 90 %, and 100 % alcohol for 2 x 15 
minutes at each concentration. Following this 100 % dried alcohol was used for 2 x 15 minutes 
followed by 2 x 15 minutes with propylene oxide. The embedding process was started on a rotar 
in a fume cupboard using a mix of propylene oxide/resin (1:1) for 45 minutes and then resin for 1 
hour. The TWs membranes were placed just under the surface of fresh resin in embedding 
moulds. Samples are exposed to a vacuum for 30 minutes before allowing these to return to 
normal atmospheric pressure. If necessary the samples were orientated in the right way before 
the resin was polymerised at 60°C for ~ 24 hours. Following this period the sample blocks were 
trimmed and cut with a glass blade in a microtome to ~1µm sections for light microscope 
examination. Areas for ultra thin sections were selected and electron microscope grids were 
prepared (Formvar film/carbon coat). Using a diamond knife 50 -150 nm sections were cut, 
collected on the grids and stained with uranyl acetate and lead citrate. Examination with TEM 
followed and micrographs were taken. 
 
2.13 Phenol extraction of LPS 
LPS was isolated from Pseudomonas aeruginosa 50DR (P. aeruginosa) and Burkholderia 
cenocepacia J2315 (B. cepacia), which are both CF relevant bacterial strains. These bacteria were 
obtained from the microbiological culture collection in Aston University’s microbiology 
laboratory. P. aeruginosa 50DR was cultured overnight on Mueller-Hinton agar (MHA, Oxoid Ltd) 
plates at 37 
°
C. The next day, one colony was picked to be used to inoculate another overnight 
culture (100ml) in sterile Mueller-Hinton broth (MHB, Oxoid Ltd) at 37 
°
C at 150 rpm on a shaker. 
The same procedure was followed for B. cenocepacia J2315 except that this strain has to be 
grown for about 36 h at each step taken. To make sure that the bacterial cultures were pure and 
clean of contamination, samples were streaked out on a MHA plate. After checking for purity, 
sterile MHB (50ml) was inoculated and then transferred into 2 conical flasks containing 2 litres of 
sterile MHB. These were then incubated on a shaker at 37 
°
C and 150 rpm for 48 h. Another test 
for purity of the bacterial cultures was carried out (as described above) before each culture was 
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centrifuged to pellet the bacteria (7871 x g) for 10 min. (Avante JE centrifuge containing using a 
JA14 rotor). Bacterial pellets were washed with sterile water, centrifuged again and the pellets 
were re-suspended in 100 ml sterile water. 100 ml of freshly-prepared aqueous phenol (80 %, 
w/v) at 80 
°
C was added and the suspensions were stirred at 80 
°
C for 30 min followed by 
centrifugation 12298 x g for 20 minutes, using the same centrifuge and rotor as above. 
Centrifugation yielded 2 distinct phases, the upper phase (containing the LPS) was recovered and 
transferred into a cellulose acetate dialysis membrane tubing (Sigma), which was sealed and 
dialysed against running water for 4 days to remove the phenol. After collection of the dialysate, 
magnesium sulphate was added to a final concentration of 10 mM to encourage LPS micelle 
formation. After ultracentrifugation (109,564 x g in a Beckmann-Coulter ultracentrifuge for 4 h at 
4
°
C, 70Ti-rotor) the deposited pellet of LPS was re-suspended in 10 ml sterile H2O and frozen in 
liquid nitrogen. The LPS was freeze dried, weighed and a stock solution prepared, sterilised by 
filtration, this was further diluted in sterile AEM (serum free) to make a stock solution of 1 
mg/ml which was stored at -20 
°
C until required.  
 
2.14 Bacterial growth conditions 
P. aeruginosa 50DR, B. cenocepacia J2315 and S. aureus ATCC 6538 were grown in MHB at 37°C 
and in a shaker at 150rpm or on MHA plates in a 37°C incubator. Bacteria were also stored on 
MicroBank beads (Pro-Lab Diagnostics, Cheshire, UK) at -70 °C until required.  
Bacteria were either grown to an optical density of 1, which equals a bacterial density of 
approximately 1 x 10
9
 CFU/ml at 600nm or the bacterial suspension was diluted down to it. 
 
2.15 Antibiotic susceptibility test 
In order to determine the susceptibility of P. aeruginosa 50DR, B. cenocepacia J2315 and S. 
aureus (ATCC 6538) to the antibiotic gentamicin and normocin a disc diffusion test was used. 
Small filter paper discs containing gentamicin (200 µg/ml) were placed onto MHA plates, which 
were covered with bacterial suspension using a swab to generate a bacterial lawn. If the bacteria 
applied were sensitive to gentamicin, a clear zone of growth inhibition was seen around the 
antibiotic containing filter. The same experiment was carried out with Normocin, which was 
routinely used in cell culture media to make sure this antibiotic will not inhibit bacterial growth 
in its working concentration.  
 2.15.1 Gentamicin susceptibility
Figure 2.5 Disc diffusion test of gentamicin susceptibility for 
S. aureus, B. cepacia and P. aeruginosa
generate a bacterial lawn of each bacterium. The gentamic
contained 200 µg/ml gentamicin and MHA plates were incubated over night at 37°C before the 
susceptibility was assessed. All three bacteria show susceptibility as a clear area around each gentamicin 
disk was shown, where no bacterial growth was identified. 
 
In figure 2.5 it is shown that bacterial cell growth of 
inhibited and clear zones were formed around the Gentamicin disc, which contained 200 µg/ml 
of gentamicin. This experiment showed that gentamicin can be employed after challenges with 
live bacteria to kill the extracellular bacteria in the mono
2.15.2 Normocin susceptibility
Figure 2.6 Susceptibility of 
50mg/ml 
Each bacterium was spread out on a MHA plate using a swab to create a bacterial lawn before holes were 
cut into the agar using a Pasteur pipette. These holes were then filled with 50µl Normicin. After overnight 
incubation at 37°C the plates were assessed. For all three bacteria clear areas around the antibiotic filled 
hole were observed and they are all susceptible to this antibiotic. 
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S. aureus, B. cepacia
 cell suspensions were plated out on MHA plates by using a swab to 
in disc was dispensed onto the agar. The discs 
 
S. aureus, B. cepacia
- and co-cultures.
 
S. aureus, B. cepacia and P. aeruginosa to Normicin at a concentration 
 
 
 and P. aeruginosa 
 and P. aeruginosa was 
 
 
 Figure 2.7 Sensitivity of S. aureus
of 100µg/ml 
At this working concentration none of the bacteria showed clear areas around the holes filled with one of 
the three media containing Normocin at the working concentration. These bacteria are therefore not 
susceptible to this antibiotic at this concentration.
In figure 2.6 and 2.7 the inhibitory effects on bacterial growth of 
aeruginosa using the antibiotic normocin are shown. In figure 2.
mg/ml, which is the stock 
shown that the antibiotic concentration (100 µg/ml) of normocin at working concentration does 
not inhibit bacterial cell growth of these three bacteria.
 
2.16 Heat inactivation of bacteria
Colonies of P. aeruginosa
cultivated MHA plate and grown in 50 ml MHB at 37
next day cultures were split into equal parts (one half was kept for 
cell cultures with live bacteria) and one half was put into a waterbath maintained at 80
least 1 h. To be sure bacteria were alive prior to heat
inactivation; samples were taken before and
waterbath. Every 15 mins 
point the bacteria were all killed.
cultures were spun down at 3500 x g
 
68 
, B. cepacia and P. aeruginosa to Normocin at its w
 
S. aureus
6 normocin was employed at 50 
solution before it is added to cell growth medium. In figure 2.7 it is 
 
 
 50DR, B. cenocepacia J2315 and S. aureus were picked from a fresh
 °C overnight in a shaker at 150
experimental 
-inactivation and dead post heat
 after placing the bacterial suspension into the 
a sample was taken from the waterbath to determine at which time 
 After successful heat inactivation the heat
 for 15 min and washed in 10 ml PBS. This was repeated 
 
orking concentration 
, B. cepacia and P. 
ly 
 rpm. On the 
treatment of 
 °C for at 
-
-inactivated bacterial 
 three times before the culture’s optical density (OD) was measured at 470 nm. The OD was then 
adjusted to an OD470nm of 1.0, which corresponds to a bacterial cell number of approxim
10
9
 cfu/ml for S. aureus, 
diluted 1:10 to make a stock solution of 1 x 10
experiments under submerged conditions or at ALI was 1
Figure 2.8 Heat inactivation of 
S. aureus was cultured over night in MHB before 20ml of the bacterial suspension was heat inactivated in 
a waterbath, which was maintained at 80°C for 75 min to evaluate at which time point all ba
dead. Samples were taken before heat inactivation and then every 15 min. Samples were plated out on 
MHA plates and incubated over night at 37°C before these were observed. After 15 min of heat 
inactivation all bacteria were dead and no colonies
Figure 2.9 Heat inactivation of 
B. cepacia was cultured over night in MHB. 20ml of the bacterial suspension was heat inactivated in an 
80°C hot waterbath for 75 min to evaluate at which time point all bacteria were
before heat inactivation and then every 15 min. Samples were plated out on MHA plates and incubated 
over night at 37°C before these were observed. Agar plates of 
were covered in a thick bacterial lawn, whereas after 15 min of heat inactivation all bacteria were dead 
and no colonies were found on agar plates.
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B. cepacia and P. aeruginosa. These bacterial suspensions were then 
8
 cfu/ml. Final bacterial cell density used in the 
 x 10
7 
cfu/ml.  
 
S. aureus 
 were found on agar plates. 
 
B. cepacia  
 
B. cepacia plated before heat inactivation 
 
ately 1 x 
cteria were 
dead. Samples were taken 
 Figure 2.10 Heat inactivation of 
A 50 ml culture of P. aeruginosa
bacterial suspension was heat inactivated in an 80°C hot waterbath for 75 min to evaluate at which time 
point all bacteria were dead. Before heat inactivation one sample was taken and pla
bacteria were alive beforehand. Samples were then taken every 15 min and plated out on MHA plates. 
After an overnight incubation of the plates at 37°C, plates were visually analysed. before these were 
observed. Agar plates of P. aeruginos
lawn, whereas after 15 min of heat inactivation all bacteria were dead and no colonies were found on agar 
plates. 
 
For all three bacteria, S. aureus
after 15 min at 80°C. For the following experiments employing HIA bacteria, these were in the 
waterbath for at least 30 min before these were adjusted to the final bacterial density for 
experiments.  
 
2.17 LPS treatment of submerged 
cultures at ALI
LPS from P. aeruginosa 
Sigma Aldrich Ltd) were used at 0.1, 1, 10, 100 and 1000ng/ml to treat mono
under submerged or at AL
mg/ml.  
For submerged conditions
cells/well in full growth medium. After 24 hours incubation under standard condit
medium was replaced with serum
insulin from bovine pancreas
Sigma), normocin (50mg/ml
supplement is added in addition to ITS, as suggested by manufacturer. After another 24 h the 
 
70 
 
P. aeruginosa  
 was incubated over night in MHB and placed on a shaker. 20ml of the 
a plated before heat inactivation were covered in a thick bacterial 
, B. cepacia and P. aeruginosa heat inac
mono-cultures and of mono
 
50DR, B. cenocepacia and P. aeruginosa serotype 10 
I conditions. The concentration of all stock solutions of LPS types was 1 
, cells were seeded onto 24-well plates at a cell density of 1 x 10
-free (SF) medium containing ITS supplement (
, 0.55 mg/ml human transferrin and 0.5 μg/ml sodium selenite
) and 2mM L-glutamine. For AEM and HPFM, the manufacturer’s 
ted out to verify 
tivation was successful 
- and co-
(obtained from 
- and co-cultures 
5
 
ions the full 
1.0 mg/ml 
; ITS, 
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ITS-medium is replaced with ITS-medium containing different concentrations of LPS. Four wells 
were set up for each concentration of LPS and samples were collected 24 h after LPS exposure 
for analysis. Cell viability was assessed using CTB as described in 2.4 and Interleukin-8 (IL-8) 
concentration was measured by ELISA (Peprotech EC Ltd). 
The same experimental outline was used for mono- and co-cultures grown at ALI but, based on 
the results of LPS stimulation of submerged cultures, only the highest concentration of LPS 
(1000ng/ml) was applied. 
 
2.18 Treatment of submerged mono- cultures and mono- and co-cultures 
grown at ALI with heat inactivated (HIA) or live bacteria 
Submerged mono-cultures were set up exactly the same way as described in 2.17. On the third 
day ITS-medium was replaced with ITS-medium containing 1 x 10
7
 bacteria/ml, either live or HIA 
(produced as described in section 2.16) and samples were incubated for 24 h. After this 
incubation all apical supernatants as well as basal media samples were collected for analysis of 
IL-8 concentrations using an ELISA kit (2.19). For both experimental set ups the cell viability assay 
CTB was performed as well but with the difference that in the case of treatment with live 
bacteria an additional step to this experiment was added. The cultures were incubated with 500 
µl ITS-medium containing 100 µg/ml gentamicin for one hour, in order to kill any bacteria bound 
to the cell surface, which is known to kill gram-negative bacteria as well as the gram-positive 
bacterium S. aureus. After the incubation with gentamicin the medium was removed and ITS-
medium containing CTB
 
was added to assess cell viability. CTB was used as outlined in section 
2.5. 
 
2.19 Detection of Interleukin 8 (IL-8) by ELISA 
For the quantification of human IL-8 in cell culture supernatants of submerged and ALI mono- 
and co-cultures treated with either LPS, heat-inactivated bacteria or viable bacteria, a human IL-
8 ELISA development kit, was purchased from Peprotech EC Ltd. (London, UK). All reagents were 
part of the kit unless otherwise stated and were prepared according to manufacturer’s product 
information. After reconstitution of all reagents as advised in manufacturer’s protocol purified 
anti-human IL-8 capture antibody (0.5 µg/ml) diluted in carbonate bicarbonate coating buffer 
was applied (100 µl/well) onto high affinity binding 96-microtitre plates (Nunc MaxiSorp™) and 
incubated over night at 4°C. Afterwards microtitre plates were subsequently washed three times 
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(300 µl/well) wash buffer (PBS, 0.05 % (v/v) Tween
®
-20). After removing residual wash buffer 300 
µl block buffer (PBS, 1 % (w/v) BSA) was applied to each well and incubated for 1h at RT followed 
by another wash as described above. The standard (0 pg/ml -10000 pg/ml) and samples for 
analysis were applied at a volume of 100µl/well to appropriate wells in triplicate and were 
incubated for 2h at RT. After another wash the detection antibody, anti-human IL-8, was applied 
at 100 µl/well followed by another incubation of 2 h at RT. Excess antibody was then aspirated 
and the microtitre plates washed again. An incubation of 30 min at RT with avidin-HRP enzyme 
solution followed before the microtitre plates were washed five times with wash buffer to make 
sure any excess avidin-HRP will be washed off. SigmaFAST™ OPD solution was prepared to be 
ready and applied straight onto each well at 100 µl/well for 5 min at RT. 50 µl/well of a 1M 
Hydrochloric acid was then added to stop the reaction. A microplate reader at 492nm was used 
to measure the OD/absorbance of each well. The IL-8 content of samples was calculated based 
on the standard curve. 
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3 Chapter 3 - Characterisation of suitable growth substrate and 
cell culture medium 
3.1 Introduction 
The overall aim of this project was to develop a co–culture model of CF- and non-CF human 
airways in vitro. In this co-culture model different cell types were grown together and therefore 
some very important aspects, such as cell growth on a promoting substrate and cell nutrition 
have to be investigated before moving further ahead. The development of the proposed 3D co-
culture model (figure 1.4) using HPF and one of the three epithelial cell lines C38, IB3-1 or Calu-3, 
at the same time, required a suitable substrate and a suitable medium that ensures healthy cell 
growth, cell adherence and proliferation of both cell types. The basement membrane (BM) is 
important for cell adhesion and cell migration (Hinenoya et al., 2008) whereas a suitable 
medium needs to be determined, which supplies all essential nutrients and growth factors for 
both cell types to ensure healthy proliferation and differentiation (Moghal and Neel, 1998) of 
the epithelial cell layer without causing cell cycle changes, such as a drive towards apoptosis.  
 
Airway epithelial cells are supported by the BM, also called basal lamina, in vivo and thus an in 
vitro model will need to take account of this feature and incorporate some sort of growth 
substrate, which is a component of the BM into the model to mimic the in vivo situation as close 
as possible. The BM is a specialised form of extracellular matrix (ECM), which is a complex and 
very important network, which not only determines the structural organisation of a multicellular 
organism and its different tissues but it also supports cellular and tissue specific functions 
(adhesion, migration, proliferation and differentiation) (Teti, 1992, Coraux et al., 2008). The ECM 
is made up of fibrous proteins, such as collagens for structural support, of different adhesion 
molecules, such as fibronectin and laminin, and of a range of different proteoglycans, which 
form a “gel like” ground substance together with glycosaminoglycans (GAG) (Teti, 1992). The 
exact composition of the ECM varies from tissue to tissue. In the respiratory epithelium for 
example, cells are tightly bound together by tight junctions for example, and only leave little 
space for ECM to fill, whereas in connective tissues these spaces are large and the ECM 
abundant. The ECM is not inert, as it was believed, but is constantly being remodelled by cells 
reshaping and degrading it. There are also proteases (e.g. MMPs) present in the ECM that can 
change the matrix composition by converting structural molecules to signalling ones by releasing 
growth factors or other bioactive peptides that have been stored in it (Daley et al., 2008). This 
turnover is quite high during wound repair, in response to infections and in certain diseases, for 
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example in cancer (Daley et al., 2008, Teti, 1992, Coraux et al., 2008). All cells that are in contact 
with the ECM have cell surface receptors, such as integrins. These will recognize ECM proteins, 
such as laminin and collagens, and initiate signal transduction pathways, which makes it possible 
to have a connection between the extracellular space, the cytosol and the cytoskeleton. This 
way cells can react to changes that happen on the outside of the cell and pass on the 
information to the inside through the cytosol to the nucleus, where this information than can be 
used to react to these changes by expression of certain genes for example. This chain reaction 
leads then to translation and at the end a functional protein that is needed to react to the 
changes that occurred (Teti, 1992, Daley et al., 2008). 
The BM is usually found underlying epithelial cells, including respiratory epithelium, and 
separating these from the connective tissue underneath (Stanley et al., 1982, Sage, 1982). One 
of the main components of basement membranes is collagen type IV (Timpl, 1989), which is a 
network forming type collagen that has a molecular filtration function in contrast to the fibril 
forming collagens (Kadler et al., 2007). Collagen type IV has been found mainly in the basal 
lamina of different tissues, including the alveoli in the lungs (Sage, 1982) and has been reported 
to play an important role in epithelial cell attachment and therefore in maintaining functional 
integrity (Sage, 1982, Coraux et al., 2008). Another important finding is that human tracheal 
epithelial cells (HTE) cultured on plastic surfaces lost the ability to produce secretory component 
(SC), an important transport molecule in the airways but were able to produce it when cultured 
on collagen IV (Fiedler et al., 1991), which supports the idea of a promoting growth substrate to 
be used in epithelial cell cultures. 
 
Furthermore it was important to consider the right cell growth medium, which is usually 
purchased from biotech companies, either in a ready to use version or it can be bought in 
separates to mix any additives just before use. There is a whole range of different cell growth 
media available, as different cell types need different nutrients and sometimes special additives 
to provide a perfect environment for cell proliferation. For different cell types, cell lines and 
primary cells there are in general recommendations which medium to use. Several researchers 
have tried in the past to define the exact supplements needed in culture medium to allow 
epithelial cell differentiation. A list of components has been announced that support viability of 
freshly isolated cells and serum has been proven useful as it contains TGF-β and has been shown 
to stop epithelial proliferation and initiate squamous differentiation. Furthermore retinoic acid 
has been mentioned to appear very important for epithelial cell differentiation as have several 
others. Depending on the type of epithelial cell type the needs are different as well but one 
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major factor that seems to work for most cultures to induce differentiation is the establishment 
of an air-liquid – interface. 
 
As the intention was to co-culture two different cell types, fibroblasts and epithelial cells, 
together in one cell-culture system, it was vital to determine a suitable cell growth medium, in 
which both of these cell types can live and proliferate at a normal cell type specific rate without 
showing significant changes in their cell cycle profile or in their morphology. HPF, C38, IB3-1 and 
Calu-3 were therefore cultured in three different types of media and their growth characteristics 
analysed to make sure this important aspect was taken care of.  
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3.2 Aims 
The overall aim of the work in this chapter was to determine a useful substrate and culture 
medium with which to generate the co-culture model. 
In order to achieve this, the first aim was to investigate whether human placental collagen type 
IV is a useful substrate to provide a basement membrane for cell anchorage and migration that 
can be used on all tissue culture devices when looking at HPF, C38, IB3-1 and Calu-3 cells. 
The second aim was to identify the most suitable culture medium that would support growth 
and vitality of both cell types without having a negative impact on one of the applied cell types 
in terms of proliferation, morphology or apoptosis. 
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3.3 Methods 
3.3.1 Cell culture 
3.3.1.1 Submerged cell culture  
Human pulmonary fibroblasts (HPF) were maintained in fibroblast growth medium 2 containing 
11 % FCS (unless otherwise stated), normocin (50mg/ml), 2mM L-glutamine and the 
manufacturer’s supplement (HPFM).  
Calu-3 cells were maintained in DMEM/F12, which was supplemented with 15 % FCS (unless 
otherwise stated), normocin (50 mg/ml) and 2 mM L-glutamine.  
IB3-1 and C38 cells were maintained in full medium comprising Promocell
®
 airway epithelial 
growth medium (AEM) supplemented with 5 % FCS (unless otherwise stated), normocin (50 
mg/ml) and the manufacturer’s supplement. All cells were cultured in 75 cm
2
 tissue culture 
flasks under standard cell culture conditions at 37 °C and 5 % CO2 until 90-95 % confluent. Cell 
morphology, growth, the degree of confluency and confirmation of absence of any bacterial or 
fungal contamination was assessed using an inverted microscope. The detailed procedure is 
described in 2.4.4. 
 
3.3.1.2 Cell culture on Transwell inserts 
Briefly (detailed in 2.4.6) for mono-cultures of HPF, C38, IB3-1 and Calu-3, cells were seeded 
apically onto Transwell
®
 Inserts at 3 x10
4
 cells/well. Calu-3 cells were seeded in full DMEM/F12, 
whilst C38 and IB3-1 cells were seeded in AEM. HPF cells were seeded in HPFM. Initially all cells 
were cultured under submerged conditions with 300 µl medium in the apical compartment and 
600 µl medium was added to the basolateral compartment. Four days after seeding cells, the 
apical medium on the epithelial cells was removed and the apical medium on HPF was refreshed. 
Basolateral medium was refreshed on the same days for all cells. The basolateral medium and 
any apical liquid were then collected every 3 - 4 days and fresh medium was added to the 
basolateral compartment and in case of HPF medium in the apical compartment was also 
refreshed.  
For co-cultures HPF cells were seeded exactly as described above and apical HPFM was removed 
after 4 days incubation and was replaced with epithelial cell suspension. C38 and IB3-1 cells 
were seeded on top of the HPF cell layer at the same density (5 x 10
4
 cells/well) as Calu-3 but in 
AEM instead of DMEM/F12. At this point the basolateral medium was changed to the applying 
epithelial medium used in the co-culture. These cultures were then kept under submerged 
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conditions for another four days to allow the epithelial cells to form a confluent and adherent 
layer on top of the HPF. Afterwards the medium was aspirated to establish an ALI and induce 
differentiation of the epithelial cells.  
 
3.3.2 Cell morphology 
Light microscopy was used to monitor cell type specific morphology throughout these 
experiments. 
 
3.3.3 Cell viability assay- Cell Titer Blue 
Cell Titer Blue
 
is a cell viability assay, which is a homogeneous, fluorometric method to monitor 
cell viability and cell metabolic activity. The blue dye used is termed resazurin (little intrinsic 
fluorescence activity) and is converted into its highly fluorescent product, called resorufin (pink) 
in the mitochondria. The fluorescence intensity measured can be correlated directly to the 
number of viable cells and therefore their metabolically active. Cell Titer Blue was directly 
applied to the cell medium and required an incubation of 2 h at 37 °C prior to analysis. The 
fluorescent intensity was measured on a standard multiwell fluorescence spectrophotometer 
(Spectramax Gemini XS, Molecular Devices, Berkshire UK) at 560 nm excitation, and 590 nm 
emission wavelength. This method was used to determine an optimum cell density for 96-well 
plates for a 48 h incubation for each cell line, which was then used for investigating the optimum 
medium to be used for these co-culture models. 
 
3.3.4 Cell cycle analysis using flow cytometry 
Cellular DNA can be stained using propidium iodide (PI), which intercalates with DNA and emits 
fluorescence and the intensity of the signal correlates with the amount of DNA in each cell.  
Cells were seeded in their specific growth medium on 24-well cell culture plates at a density of 1 
x 10
5
 cells/well and incubated overnight at 37 °C, before their own specific medium was either 
refreshed, kept (conditioned) or replaced with fresh or conditioned medium of the other cell 
types. After a further incubation period of 24 h the cells were harvested and the effects of these 
media to the different cell types was analysed by cell cycle analysis. 4 wells of each different 
condition were pooled and suspended in hypotonic fluorochrome solution for DNA staining. 
 Samples were incubated in the dark at 4
which was carried out within 24 hours (further details in 2.6.1).
3.4 Results 
3.4.1 Collagen type IV as 
Human placental collagen type IV was used a
each cell type, HPF, C38, IB3
culture device was visualised after a 24 h incubation on either collagen IV coated tissue culture 
devices or plastic surfaces. L
images indicate that there were substrate
attachment (figure 3.1).  
Figure 3.1 Comparison of HPF, C38, IB3
uncoated plastics. Cells were seeded on to 24 well plates at a density of 3x10
24hours on naked tissue culture devices or collagen IV coated (10µg/cm
types appear to show a much higher confluence after the 24 h incubation on collagen IV, compared to the 
ones grown on naked devices.
µm) 
 
When cells were grown on uncoated
incubation, whereas, in comparison, for cells grown on collagen IV coated devices, all the 
different cell types showed a higher number of cells adhered. Figure 3.1 displays the 
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 °C until flow cytometric analysis 
 
a growth substrate  
s a growth substrate in this cell culture system. For 
-1 and Calu-3, the overall quantity of cells attached to the cell 
ight microscopy was used to analyse the different cultures and these 
-dependent differences 
 
-1 and Calu-3 cell growth when cultured on collagen IV coated or 
5
 cells per well and grown for 
2
) plastic. All four diffe
 Images are representative of three individual experiments (scale bar = 
 plain plastic surfaces, the cells were still sparse after 24 h 
(Nicoletti et al., 1991), 
in cell spreading and 
rent cell 
100 
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representative pictures of each cell type under these growth conditions. Pictures on the left side 
show HPF, C38, IB3-1 and Calu-3 after a 24 h incubation growing on plain plastic surfaces. For all 
different cell types there are only a small number of cells attached to the plastic surface. Pictures 
on the right side show cell under the same conditions but grown on Collagen IV and they reveal a 
clear difference in terms of cell numbers being attached to the collagen IV coated surface. There 
was definitely a higher number of cells attached for each different cell type. 
 
3.4.2 Investigation of a suitable medium for the co-culture model 
The in vitro co-culture model that was developed during this project, applied HPF seeded on 
collagen IV, before one of the epithelial cell lines C38, IB3-1 or Calu-3 were seeded on top. It was 
essential to investigate in which cell culture medium these two different cell types would grow 
normally and healthy. If this is the case their cell cycle profile will look normal without showing 
any dramatic increase in cell proliferation, without showing any morphological changes or 
equally important without increase in cell death (apoptosis). 
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3.4.2.1 Cell morphology of HPF, C38, IB3-1 and Calu-3 after exposure to different cell 
culture medium 
All cell types used were seeded onto collagen IV coated 24 well plates using their cell type 
specific medium for 24 h to allow cell adherence and proliferation. Afterwards the cell type 
specific medium was removed and was either kept (in order to use as “conditioned medium”), or 
was refreshed with the same cell-type specific medium, or replaced with one of the other two 
media (figure 3.2). This meant that each cell type was exposed to fresh and conditioned medium 
of each kind. 24 h incubation followed before the cells were analyzed for morphological changes 
and level of confluence using a light microscope. 
 
 
Figure 3.2 Flow diagram of experimental set up for investigation of a suitable medium for the proposed 
co-culture model The diagram shows that every cell type was exposed to fresh and conditioned human 
pulmonary fibroblast medium (HPFM), airway epithelial medium (AEM) and to Dulbecco’s modified eagle 
medium: nutrient mixture-12 (DMEM/F12).  
  
HPF, C38, 
IB3-1 or 
Calu-3
HPFM
fresh
cond.
AEM
fresh
cond.
DMEM/F12
cond.
fresh
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Fresh Conditioned
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AEM
DMEM/F12
 
Figure 3.3 HPF cell morphology after exposure to different cell growth medium  
HPF were seeded onto collagen IV coated 24 well plates at a density of 1x10
5 
cells/well and incubated for 
24 h before the cell specific medium was replaced with either fresh or conditioned HPFM, AEM or 
DMEM/F12. After further 24 h incubation the pictures were taken. On all pictures HPF cells look 
morphologically the same and the confluency looks even across the different conditions. Images are 
representative of three individual experiments (scale bar = 100 µm) 
 
 
The pictures in figures 3.3 show HPF cell morphology after being cultured in all different media 
applied. The two pictures in the top row show HPF cultured in HPFM in fresh (left side) and in 
conditioned form (right side). HPF on both pictures show the same spindle like morphology and 
the same degree of confluence. In the next two pictures (middle) the morphology and 
confluency of HPF can be seen after they were cultured in fresh (right side) or conditioned (left 
side) AEM. The morphology and confluency looks exactly the same as in the pictures above when 
cultured in HPFM. The same result is shown for culturing HPF in DMEM/F12 again in a fresh (left 
side) and conditioned (right side) form. After analysing all epithelial cells in all different media 
applied, as well, it becomes clear that morphology and confluency are not affected by any of 
these media for any of these cells, when looking at the cell populations using light microscopy 
after 24 h incubation. Cell morphology of C38, IB3-1 and Calu-3 is shown in figure 3.4- 3.6. 
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Figure 3.4 C38 cell morphology after exposure to different cell growth medium  
C38 were seeded onto collagen IV coated 24 well plates at a density of 1x10
5 
cells/well and incubated for 
24 h before the cell specific medium was replaced with either fresh or conditioned AEM, HPFM or 
DMEM/F12. After further 24 h incubation these epithelial cells look morphologically the same on all six 
pictures and the confluency looks even across the different conditions. Images are representative of three 
individual experiments (scale bar = 100 µm) 
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Figure 3.5 IB3-1 cell morphology after exposure to different cell growth medium  
After seeding IB3-1 onto collagen IV coated 24 well plates at a density of 1x10
5 
cells/well, the plates were 
incubated for 24 h before the cell specific medium was replaced with either fresh or conditioned AEM, 
HPFM or DMEM/F12. After 24 h incubation under these conditions IB3-1 look morphologically the same 
on all six pictures and showed a healthy looking confluent layer of cells. Images are representative of three 
individual experiments (scale bar = 100 µm) 
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Figure 3.6 Calu-3 morphology after exposure to different cell growth medium  
Calu-3 were seeded at a density of 1x10
5 
cells/well onto collagen IV coated 24 well plates and incubated 
for 24 h before the cell specific medium was replaced with either fresh or conditioned DMEM/F12, HPFM 
or AEM. After further 24 h incubation the morphology and the degree of confluency was analysed. Under 
all different conditions the same result could be seen: normal morphology and confluency looks even 
across the different conditions. Images are representative of three individual experiments (scale bar = 100 
µm) 
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3.4.3 Cell viability assay – Cell Titer Blue
®
 (CTB) assay 
3.4.3.1 Optimising the cell viability assay for HPF, C38, IB3-1 and Calu-3 
Before setting up 96-well plates for the cell viability experiment, a cell dilution experiment was 
carried out to find the optimum cell densities to seed in each well for each of these cell types. 
The cell density had to be taken into account as cells were to be grown for 48h (in total) in a 96-
well plate. If there are too many cells there will be a decrease of metabolic activity (low 
fluorescent signal) due to the lack of nutrients and that could be interpreted with a wrong result. 
If there are too few cells in each well, e.g. 50 cells and in the next one 100 cells the difference in 
fluorescent intensity is not high enough to be able to monitor little changes in cell metabolic 
activity, even though there is a direct correlation of cell number and fluorescent signal, it is not 
sensitive enough for such small numbers. The optimum cell number needs to be high enough to 
give a fluorescent signal higher than the background reading but also leave enough range to 
detect dramatic increases of metabolic activity. 
 
 
Figure 3.7 Optimising cell densities for optimum cell growth of HPF on 96-well plate 
HPF were seeded onto 96-well plates at the indicated density per well (x-axis) and incubated for 48h to 
find an optimum cell number that can be grown in these wells without showing cell overgrowth and/or 
apoptosis. After the 48h incubation CTB was added and following manufacturer’s guide incubated for 2h 
before reading the 96-well plate on a fluorometer at 560 nm excitation and 590 nm emission (4 separate 
wells per cell density were used for analysis). The optimum cell density for these cells was 5 x 10
3
 
cells/well, which resulted in an average of 4997 ± 1236 FU. Each bar represents the mean ± SD from three 
different experiments. 
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Figure 3.8 Optimising cell densities for optimum cell growth of C38 on 96-well plate 
C38 were seeded onto 96-well plates at different cell densities (x-axis) and incubated for 48h to determine 
an optimum cell number for this experiment without having an effect on cell growth and/or apoptosis. 
After the 48h incubation CTB was added and following manufacturer’s guide incubated for 2h before 
reading the 96-well plate on a fluorometer at 560 nm excitation and 590 nm emission (4 separate wells 
per cell density were used for analysis). 5 x 10
3
 cells/well is the optimum cell density to be seeded with an 
average FU of 2208 ± 65 for C38. Each bar represents the mean ± SD from three different experiments. 
 
 
Figure 3.9 Optimising cell densities for optimum cell growth of IB3-1 on 96-well plate 
A 96-well plate was used to carry out this experiment and IB3-1 were seeded at different cell densities (x-
axis) and incubated for 48h to determine an optimum cell number for this experiment without having an 
effect on cell growth and/or apoptosis. After the 48h incubation CTB was added and following 
manufacturer’s guide incubated for 2h before reading the 96-well plate on a fluorometer at 560 nm 
excitation and 590 nm emission (4 separate wells per cell number were used for analysis). The optimum 
cell density used was 5 x 10
3
 cells/well and gave an average FU of 2162 ± 33 for IB3-1. Each bar represents 
the mean ± SD from three different experiments. 
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Figure 3.10 Optimising cell densities for optimum cell growth of C38 on 96-well plate 
Calu-3 were seeded onto 96-well plates at the indicated cell densities and incubated for 48h to find an 
optimum density of cells that can be grown on this surface area without showing cell overgrowth and 
apoptosis. After the 48h incubation CTB was added and following manufacturer’s guide incubated for 2h 
before reading the plate on a fluorometer at 560nm excitation and 590nm emission (4 wells per cell 
number).The optimum cell density determined was 5 x 10
4
 cells/well resulting in an average FU of 10511 ± 
1048. Each bar represents the mean ± SD from three different experiments. 
 
 
For HPF the optimum cell density determined in this experiment was 5 x 10
3
 cells/well, which 
resulted in an average FU of 4997 ± 1236 (figure 3.7). For the epithelial cell lines C38 and IB3-1 
the optimum cell density determined was 5 x 10
3
 cells/well with an average FU of 2208.225 ± 
65.24 for C38 (figure 3.8) and an average FU of 2162 ± 33 for IB3-1 (figure 3.9).The optimum 
density of cells for Calu-3 was 5x10
4
 cells/well resulting in an average FU of 10511 ± 1048 (figure 
3.10). 
3.4.3.2 Medium investigation using CTB 
After determination of the optimum cell densities (figure 3.7 – 3.10) for using 96-well plates for 
the CTB assay, cells were seeded at the optimum densities and incubated for 24 h each in their 
own cell type specific medium. After this all cell types were challenged with fresh and 
conditioned HPFM, AEM, and DMEM/F12, following the same experimental set up as shown in 
figure 3.2. 
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Figure 3.11 Cell viability of HPF cultured in different fresh and conditioned cell growth medium 
HPF were seeded onto 96-well plates at a density of 5x10
3
 cell/well and incubated in HPFM for 24h before 
challenging cells with either fresh or conditioned HPFM, AEM or DMEM/F12. After further 24 h incubation 
CTB was applied for two hours before the fluorescence was determined using a fluorometer at 560 nm 
excitation and 590 nm emission respectively. HPF cells show a significant increase of metabolic cell activity 
in conditioned HPFM and fresh DMEM/F12, when compared to the positive control, HPF in fresh HPFM. 
Results have been subjected to 1way –ANOVA and Tukey’s test, ***= p < 0.01 compared to positive 
control, where the positive control was HPF grown in their specific fresh HPFM for the duration of the 
experiment. Negative control was fresh HPFM without any cells present. Data are presented as mean + 
standard deviation and results are taken from three independent experiments looking at 8 wells in each 
experiment. 
 
HPF cells were grown in either fresh or conditioned medium of each kind after they were seeded 
onto 96 well plates and incubated for 24h in their own fresh HPFM before they were challenged 
with fresh and conditioned AEM or DMEM/F12. The results for HPF show that there is a 
significant increase from 4522 ± 533 FU in fresh HPFM to 6399 ± 488 FU in conditioned HPFM. 
When HPF were grown in fresh DMEM/F12 there was also a significant increase to 8205 ± 590 
compared to the positive control of HPF cells in HPFM. For fresh and conditioned AEM, as well as 
conditioned DMEM/F12, no significant change in fluorescent intensity could be determined 
compared to HPF in fresh HPFM (figure 3.11). 
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Figure 3.12 Cell viability of C38 cultured in different fresh and conditioned cell growth medium 
C38 were seeded onto 96-well plates at a density of 5x10
3
 cell/well and incubated in AEM for 24h before 
exchanging the medium with either fresh or conditioned AEM, HPFM or DMEM/F12. After a further 24 h 
incubation CTB was applied for two hours before the fluorescence signal was measured using a 
fluorometer at 560 nm excitation and 590 nm emission respectively. C38 cells show a significant increase 
of metabolic cell activity when grown in conditioned HPFM or in fresh or conditioned DMEM/F12. 
Results have been subjected to 1way –ANOVA and Tukey’s test, ***= p < 0.01 significance compared to 
positive control, where the positive control was C38 grown in their specific fresh AEM. Data presented as 
mean + standard deviation and results taken from three independent experiments looking at 8 wells in 
each experiment. 
 
For the epithelial cell line C38 (figure 3.12) no significant differences in the fluorescent intensity 
were measured for conditioned AEM or fresh HPFM, when compared to the positive control, 
which was C38 in fresh AEM. A significant increase of the fluorescent signal measured was seen 
when C38 were grown in conditioned HPFM. Here, the fluorescent signal increased from 1861.25 
± 158.3 FU to 2942.88 ± 104.58 and when C38 were grown in DMEM/F12 a significant increase in 
FU for fresh (3168.8 ± 679.52 FU) and conditioned medium (3266.99 ± 219.64 FU) was detected.  
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Figure 3.13 Cell viability of IB3-1 cultured in different fresh and conditioned cell growth medium 
IB3-1 were seeded onto 96-well plates at a density of 5x10
3
 cells/well and incubated in AEM for 24h 
before exchanging the medium with either fresh or conditioned AEM, HPFM or DMEM/F12. After a further 
24 h incubation CTB was applied for two hours before the fluorescence signal was measured using a 
fluorometer at 560 nm excitation and 590 nm emission respectively. IB3-1 cells show a significant increase 
of metabolic cell activity when grown in fresh or conditioned HPFM or when grown in fresh or conditioned 
DMEM/F12. 
Results have been subjected to 1way –ANOVA and Tukey’s test, ***= p < 0.01 significance compared to 
positive control, where IB3-1 was grown in their specific fresh AEM. The negative control was AEM 
without any cells present. Data presented as mean + standard deviation and results taken from three 
independent experiments looking at 8 wells in each experiment. 
 
The fluorescent signal measured for IB3-1 cultured in fresh AEM is 2029 ± 32 and there is no 
difference when comparing it to cells grown in conditioned AEM. Significant differences were 
found for all the other media tested. When grown in fresh HPFM the fluorescent signal increased 
to 2565 ± 13 and when grown in conditioned HPFM the signal reached 2957 ± 27. A significant 
difference compared to control was also measured for IB3-1 grown either fresh DMEM/F12 
(2808 ± 74 FU) or conditioned DMEM/F12 (2831 ± 84 FU). 
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Figure 3.14 Cell viability of Calu-3 cultured in different fresh and conditioned cell growth medium 
Calu-3 were seeded onto 96-well plates at a density of 5x10
4
 cell/well and incubated in DMEM/F12 for 24h 
before exchanging the medium with either fresh or conditioned DMEM/F12, AEM or HPFM. Cells were 
incubated for another 24h before CTB was applied for two hours. Plates were read on a fluorescent plate 
reader at 560nm excitation and 590nm emission.  
Results have been subjected to 1way –ANOVA and Tukey’s test, ***= p < 0.01 significance compared to 
positive control, which is Calu-3 in DMEM/F12. Data presented as mean + standard deviation and results 
taken from three independent experiments looking at 8 wells in each experiment. 
 
Calu-3 cells were assessed for their ability to grow in the indicated media using CTB as well and 
the results in figure 3.14 show that there was no significant difference in the fluorescent signal 
measured for conditioned DMEM/F12 (11483 ± 774 FU), for fresh (10267 ± 697 FU) or 
conditioned (10385 ± 763 FU) AEM, when compared to fresh DMEM/F12, which resulted in a 
reading of 11395 ± 424 FU. However, when cultured in fresh or conditioned HPFM a significant 
decrease of fluorescence was observed, where the signal went down to 6114 ± 797 FU for the 
fresh medium and down to 5124 ± 212 FU for the conditioned medium.  
  
 Table 3.1 Summary of the viability assay re
conditioned media for 24 h
The table shows the effects that fresh or condioned media had on the different cell types when compared 
to the control, which was each cell typ
activity is indicated by an arrow facing up, whereas decreases of metabolic activity are indicated by a 
down facing arrow and no changes are shown as hyphen.
 
Table 3.1 summarises the result
the effect of different media in either fresh or conditioned form on the cell’s metabolic activity 
after a 24 h incubation in these media. The arrows in the table show when a medium had a 
significant impact on cell metabolic activity either in an increasing or decreasing 
was no significant difference of metabolic activity compared to the control it is indicated by a 
hyphen.  
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3.4.4 Cell cycle analysis using flow cytometry after exposure to different 
culture media 
3.4.4.1 Cell cycle analysis of HPF 
HPF’s specific cell cycle profile was generated after cells were cultured in fresh HPFM, to have a 
baseline cell cycle profile to compare the other profiles with that were generated after HPF were 
cultured in the other applied media, AEM and DMEM/F12. The experimental set up in terms of 
which cell type was grown in what medium is shown in figure 3.2.  
The distribution of HPF cells in the different cell cycle phases shows the typical cell cycle pattern 
with almost no cells in subG0 (table 3.2). When using flow cytometry, the labeled cells that run 
through it and are detected by the fluorescent signal coming off them from the PI-staining of 
DNA as well as by their size and granularity. These cells are then plotted on a dot plot according 
to their size and granularity and can be gated in a certain region, which is usually tightly drawn 
around the main population of cells on that dot plot. The intention of gating the main cell 
population is to discriminate any debris, doublets and cell aggregates, which are scattered 
around this main cell population. A histogram is also produced showing each cells fluorescent 
intensity (proportional to DNA amount in nucleus). The histogram can then be divided into the 
cell cycle phases and the cell counts plus mean fluorescence for each region will be analysed by 
the flow cytometer. 
 
Cell cycle phase Percent of gated cells Std. Dev. 
   subG0 1.30% 0.57 
G0,G1 57.50% 5.05 
S-phase 13.20% 1.65 
M,G2 27.50% 4.37 
 
Table 3.2 Normal distribution of HPF cells across the cell cycle when cultured in fresh HPFM 
 
In table 3.1 the exact distribution of HPF cells (in % of gated cells) for this cell cycle profile is 
given after being cultured in fresh HPFM, whereas in figure 3.15 the cell counts for each cell 
cycle phase of HPF cells in each of the applied media is presented. Every profile generated by 
culturing HPF in all the media applied is compared to the original profile, HPF cultured in HPFM, 
(dark green bars). For none of the applied media, whether in fresh or conditioned form, a 
significant difference was observed.  
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Figure 3.15 Cell cycle analysis of HPF after a 24 h exposure to HPFM, AEM and DMEM/F12 in fresh and 
conditioned form.  
The 24 h exposure of HPF cells to these media does not cause any increase in SubG0 as there is no 
significant difference in the number of cell present in the particular area defined as Sub G0. No cell cycle 
shift can be observed in this graph for any of the media. Each bar represents the mean ± SD from three 
different experiments. 
 
3.4.4.2 Cell cycle analysis of C38 
C38 were investigated for their ability to life and grow in HPFM and DMEM/F12 and results were 
compared to the cell cycle profile produced when grown in AEM as their specific  culture 
medium.  
Cell cycle 
phase Percent of gated cells Std. Dev. 
      
subG0 1.10% 0.32 
G0,G1 65.20% 0.73 
S-phase 13.10% 0.61 
M,G2 19.20% 0.46 
 
Table 3.3 Normal distribution of C38 cells across the cell cycle when cultured in fresh AEM 
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 The distribution for cells in the cell cycle profile for fresh AEM is shown in table3.2. 
percent of the cells were found in subG0, 65.2% in G0/G1 and about one third in S
M/G2 phase taken together.
 
Figure 3.16 Cell cycle analysis of 
conditioned form 
For the epithelial cell line C38 
of the used media apart from C38 being cultured in fresh HPFM. In this medium C38 show a significant 
decreased number of cells present in the G0/G1 p
C38 will therefore be cultured in their own specific AEM for all following experiments. 
the mean ± SD from three different experiments.
 
In figure 3.16 cell counts for C38 in differe
different media. In this case C38 show a significant decrease in the cell number presented in 
G0/G1 phase and additionally a slight increase in S
HPFM (dark green bars) instead of AEM. 
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3.4.4.3 Cell cycle analysis of IB3-1 
As for the other two cell types HPF and C38, IB3-1 was used in the same way to identify which 
medium could serve as a suitable one for co-culture conditions. The table below (table 3.3) 
shows the typical cell distribution of IB3-1 when cultured in fresh AEM, which is very similar to 
the distribution of C38.  
Cell cycle 
phase Percent of gated cells Std. Dev. 
      
subG0 1.10% 0.29 
G0,G1 61.40% 0.61 
S-phase 12.80% 0.10 
M,G2 23.20% 0.09 
 
Table 3. 4 Normal distribution of IB3-1 cells across the cell cycle when cultured in fresh AEM 
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Figure 3.17 Cell cycle analysis of IB3-1 after a 24 h exposure to AEM, HPFM and DMEM/F12 in fresh and 
conditioned form 
IB3-1’s cell cycle profiles for all applied media were analysed and these cells do not show any significant 
differences in cell numbers being present in different phases of the cell cycle with the exception of IB3-1 
cultured in fresh HPFM, where a significant lower number of cells is present in G0/G1 phase. In addition to 
this there is a significant increase in S-phase with more cells replicating, which is also reflected by an 
increase in M, G2. In this case the medium chosen for further experiments is AEM. Each bar represents the 
mean ± SD from three different experiments. 
 
 
For IB3-1 the different cell cycle patterns shown in figure 3.17 reveal that culturing IB3-1 in fresh 
HPFM leads to a decrease of cell numbers in G0/G1 and to a significant increase in S-phase plus 
an increase in M/G2.  
 
3.4.4.4 Cell cycle analysis of Calu-3 
A standard cell cycle profile was produced for Calu-3 using fresh DMEM/F12, which is used here 
as their specific cell culture medium. The typical distribution of cells in the different phases of 
the cell cycle is shown in table 3.4.  
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Cell cycle 
phase Percent of gated cells Std. Dev. 
      
subG0 3.80% 0.78 
G0,G1 55.10% 2.98 
S-phase 13.27% 2.39 
M,G2 26.20% 1.98 
 
Table 3.5 Normal distribution of Calu-3 cells across the cell cycle when cultured in fresh DMEM/F12 
 
 
Figure 3.18 Cell cycle analysis of Calu-3 after a 24 h exposure to DMEM/F12, HPFM and AEM in fresh and 
conditioned form 
Cell cycle profiles of Calu-3 cells were generated and analysed after these epithelial cells were grown in 
fresh and conditioned media (DMEM/F12, HPFM and AEM). In this case no significant differences of cell 
counts could be found for the different phases of the cell cycle. These cells will therefore be grown in their 
own specific DMEM/F12 medium for all mono- and co-culture experiments. Each bar represents the mean 
± SD from three different experiments. 
 
Looking at the distribution of Calu-3 cells counted in each of the cell cycle phases after being 
cultured in all the applied fresh and conditioned media (DMEM/F12, HPFM, and AEM), no 
significant increases or decreases could be observed. 
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3.5 Discussion 
Placental human collagen type IV (collagen IV) was chosen as a suitable substrate for mono-
culture and co-culture systems of human CF- and non-CF airways in vitro applying HPF, C38, IB3-
1 and Calu-3 cells. An experiment was carried out to compare cell adherence on collagen IV to 
cell adherence on plain plastic tissue culture ware. The results clearly show that collagen IV 
supported cell adherence of all four different cell types investigated, as a higher number of cells 
adhered to collagen IV coated tissue culture ware in 24 h then to a simple uncoated plastic 
surface (figure 3.1). These findings fit together with results of other research groups that have 
been published. First of all it is known that collagen IV is one of the most abundant components 
in BMs, which underlies epithelial cells and so separates these from the stroma that lies 
underneath the BM (Sage, 1982). As epithelial cell interaction with the BM is essential for a 
normal and healthy development, they have receptors, that can be divided into integrins and 
non-integrin (e.g. heparan sulphate proteoglycans) receptors (Khoshnoodi et al., 2008). At least 
two of the integrins are collagen receptors and are constitutively expressed in the human adult 
lung in vivo as well as in cultured primary human airway epithelial cells in vitro (Wang et al., 
1996). Collagen IV is a network forming collagen that not only gives structural support to tissues 
and organs, it also has specific biological functions (Kadler et al., 2007, Stanley et al., 1982). One 
very important aspect that Fiedler et al. (1991) found is that human tracheal epithelial cells 
(HTE) cultured on a plastic surface lost the ability to produce an important protein called 
secretory component (SC), which is an important transport protein for sIgA. sIgA is usually found 
in the mucosal lining after it has been transported by SC across the cell and was released into the 
lumen of the airways, where it exhibits antimicrobial properties to protect the underlying 
epithelium. In addition to human airway epithelial cells and their need for collagen type IV to 
support cell growth, Kavvada et al. (2005) has found that guinea pig gastric epithelial cells need 
collagen IV to form a differentiated and polarized monolayer of cells by promoting tight junction 
(TJ) formation whereas collagen I did not support this to the same extent (Kavvada et al., 2005). 
Furthermore it has been reported that other cell lines such as the Chinese hamster ovary cell line 
(CHO) and human fibrosarcoma cell line (HT-1080) showed distinct adherence to collagen IV 
(Aumailley and Timpl, 1986). Collagen IV sequencing revealed that certain domains in different 
isoforms of collagen IV show a high similarity and suggest that these are responsible for highly 
conserved functions across mammalian and invertebrate species (Than et al., 2002). Collagen IV 
is now routinely used in airway related research to serve as a basement membrane and is 
commercially available from big biotechnological and chemical supplying companies.  
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Cell growth medium for in vitro cell culture supplies cells with defined nutrients and also 
contains essential growth factors, amino acids and vitamins, for example, which is vital for 
healthy cell growth and vitality. Because different cell types and cell lines have different 
nutritional requirements it is not always easy to have one medium to satisfy several different cell 
types. For the development of the co-culture model, however, one medium needed to be 
determined that can be used for a co-culture model that applies two different cell types, which 
are fibroblasts and epithelial cells, in the same system. One medium out of three (HPFM, AEM, 
DMEM/F12) that we routinely use for these cells, needed to serve for different combinations of 
fibroblasts and epithelial cells in the co-culture model. HPFM is the cell specific medium for HPF, 
AEM for C38 and IB3-1 and DMEM/F12 for Calu-3. The cell combinations for the co-culture 
model were HPF-C38, HPF-IB3-1 and HPF-Calu-3. All different cells have a typical morphology, 
which implies being flat, large and adherent for epithelial cells, depending on the origin of the 
cells and its specification as there are also different types of epithelial cells (e.g. serous, ciliated). 
Fibroblasts are, when adherent, long, flat and stretched in a spindle shape with an oval nucleus.  
As described in chapter 1 the lower and upper airways display different cells and in different 
proportions depending on the region of the respiratory tract where they were found in but the 
entire respiratory system is lined by epithelial cells (Gail and Lenfant, 1983).  
 
For the medium investigation all cells were cultured submerged to look for morphological 
changes (e.g. giant cell, multi-nucleated cells, or even ragged cell edges). Each cell type was 
cultured in each of the three media in fresh and conditioned form. To produce conditioned 
media, each cell type was grown in their cell specific medium, which was then collected for this 
experiment. Conditioned medium contains a different mix of leftover nutrients and everything 
that was secreted by the cells that were cultured in it, such as growth factors, cytokines and 
other proteins. These may have an effect on the other cells when cultured in it. The pictures of 
the light microscope of cell morphology (figure 3.3 – 3.6) showed that there was no sign of 
abnormal morphology for any of the cells analysed after they were cultured in one of the fresh 
or conditioned media (HPFM, AEM and DMEM/F12).  
 
To look a bit further and in more detail if these media have an effect on the cells, a cell viability 
assay was performed to investigate if any medium was directly influencing the metabolic activity 
or if they are even cytotoxic to the cells tested. Furthermore a flow cytometric cell cycle analysis 
was carried out to investigate if the media on one hand could drive cells towards cell death or on 
the other hand promote proliferation.  
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The results for HPF showed that there is no significant difference in their metabolic activity when 
these were cultured in fresh or conditioned AEM compared to the metabolic activity when 
cultured in fresh HPFM (figure 3.15). This implies that they can be cultured in AEM as well as 
their specific HPFM, which is also true looking at the cell cycle profiles, as HPF do not show any 
significant shifts of cell numbers in the cell cycle (figure 3.3). However, for conditioned HPFM 
there is a significant increase in cell metabolic activity but again no difference can be observed 
when looking at the cell cycle profiles. For HPF another significant increase in metabolic cell 
activity was seen, when they were cultured in fresh DMEM/F12, compared to HPF cultured in 
fresh HPFM. There is one major difference between these two media. HPFM contains 11% FBS 
and DMEM/F12 contains 15% FBS as fresh media and this could be an explanation for the 
increase of metabolic activity. FBS is the most commonly used serum for tissue culture and the 
concentration usually varies from 5 – 20% (v/v) depending on the cells needs. The addition to 
the medium increases its quality as it contains basic nutrients, hormones, growth factors and 
binding proteins for example but the exact components that enhance cell growth are not known 
yet. Cells cannot survive without serum but too much is equally bad and it needs to be optimised 
for every cell line and primary cells if not already done so. To certain extend cell growth and 
proliferation can be stimulated by a higher concentration of FBS in the medium based on the rich 
supplements that come with it. This increasing metabolic activity was not observed when HPF 
were cultured in conditioned DMEM/F12. The FBS concentration in conditioned media will be 
less than in fresh media as some of its ingredients will have been used by cells grown in it before. 
These results of increasing metabolic activity when grown in conditioned HPFM and fresh 
DMEM/F12 were not exactly reflected in the cell cycle analysis. While the cell viability test is 
based on enzyme activity in the mitochondria and the cytosol to convert resazurin (non-
fluorescent) into resorufin (fluorescent), the flow cytometric cell cycle analysis is based on 
staining the amount of DNA in each cell to be able to locate the stage of cell cycle that these cells 
were in.  
Viable cells need to generate energy not only to enter and complete the cell cycle but also for 
the synthesis of essential components and for maintaining their membrane integrity, for 
example. This means that resazurin will eventually be enzymatically reduced to resorufin in their 
mitochondria or in the cytosol unless the cells are dead. Resting cells have a lower metabolic 
activity than proliferating cell but when cells come out of G0, which is a quiescent phase of the 
cell cycle, they need to increase transcription and translation to make proteins and enzymes that 
are necessary to enter the cell cycle again and to be able to fulfil the cell cycle. All together this 
could mean that we see an increase in metabolic activity of the cells preparing to enter the cell 
cycle actively again but as they are not synthesising DNA yet, this is not reflected in the cell cycle 
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profile by a shift of cell numbers towards S-phase and M/G2. This suggests that not all viable 
cells, that cause the metabolic activity increase, are proliferating at that time point. Another 
reason for the increase in metabolic activity could also be the confrontation of cells with growth 
factors, hormones and other ingredients in that medium that they were not confronted with in 
their own medium and therefore they have to produce enzymes for example to break them 
down or convert them. Again this initiates transcription and translation processes unless the 
needed enzymes have been readily available and this will increase the cells metabolic activity. 
For C38 and IB3-1 the results are almost identical to each other with a significant increase in 
metabolic activity when cultured in conditioned HPFM or in either fresh or conditioned 
DMEM/F12. IB3-1 also showed a significant increase for metabolic activity when fresh HPFM was 
used for culturing them. This indicates a higher sensitivity of IB3-1 to environmentally changes.  
As already mentioned before, conditioned media can have a stimulating effect on some cells, 
which could be down to certain cytokines and growth factors that have been secreted by the 
cells that were cultured in the medium before. To determine exactly what is causing this change 
in metabolic activity further detailed analyses of the media and all the contents would have to 
be performed. Fresh DMEM/F12 also increases the metabolic activity of C38 and IB3-1, which 
again could be down to the higher concentration of FBS, which is 5% in AEM (as recommended 
by ATCC) and 15% in fresh DMEM/F12. The higher concentration of FBS ultimately supplies cells 
with more growth factors and other supporting nutrients. Comparing these results to the cell 
cycle analysis results there were differences to note as flow cytometric analysis of C38 and IB3-1 
only detected differences for fresh HPFM. There was a significant decrease of cell numbers in 
G1/G0 but simultaneously a slight increase of cell numbers in S-phase and M/G2 for C38. This 
increase in S-phase and M/G2 is actually significant for IB3-1. This again shows that IB3-1 react 
more sensitive to these medium changes. AEM was determined as the optimal medium for 
mono-and co-cultures that apply HPF and either of these two epithelial cell lines. 
 
Calu-3 cells did not show any differences in cell viability for DMEM/F12 or AEM, which is 
consistent with the flow cytometric data. However, when cultured in HPFM, fresh or 
conditioned, these cells show a significant decrease in metabolic activity. Again this could be 
down to the lower concentration of FBS in HPFM plus of course the other ingredients in HPFM 
might not perfectly meet the needs of this cell line. These results are not directly reflected by the 
cell cycle analysis as there are no significant differences of cell cycle profiles compared to their 
baseline profile, when cultured in fresh DMEM/F12. Looking at the bar graph of the cell cycle 
analysis (figure 3.18) there is a slight trend towards more cells being in G0/G1, fewer cells in 
M/G2. Usually when cells encounter difficult times or dramatic changes they will leave the active 
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cell cycle and wind down metabolic activity while in G0 phase. So a decrease in metabolic 
activity does not necessarily mean that the cells are dying and that is why there is no increase in 
cell numbers in the SubG0 phase in this flow cytometric analysis as these cells still have intact 
membrane integrity and the DNA is not degraded.  
 
Taken all together submerged cultures of HPF and mono-cultures of HPF at ALI were grown in 
HPFM throughout this project. For co-culturing HPF with either C38 or IB3-1, AEM was the 
chosen medium for all further experiments and epithelial cell mono-cultures of C38 and IB3-1the 
original culture medium AEM was used for submerged cultures. HPF-Calu-3 co-cultures were 
grown in DMEM/F12 as were the Calu-3 mono-cultures at ALI for further establishment and 
characterisation of these in vitro models for CF- and non-CF human airways. 
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4 Chapter 4 Characterisation of cell specific markers in the co-
culture model at ALI 
4.1 Introduction 
In order to validate that the mono- and co culture models grown at ALI mimic the human 
airways in vivo, it was necessary to be able to identify the different cell types especially when 
grown in co-culture applying fibroblasts and epithelial cells in the same model system. After 
determining collagen IV was a supporting growth substrate and selecting suitable cell culture 
media for all in vitro models established, the challenge now was to select experimental methods 
that allow the identification of different cell types as well as visualizing their location and 
distribution in the model system. A further complexity was that the cells were to be grown on 
TWs at ALI in order to promote epithelial differentiation, which has been shown for several 
airway epithelial cell lines before (Wiesel et al., 1983, Gruenert et al., 1995).  
Using light microscopy is not an option as it is almost impossible to see the cells once they are 
seeded on TWs and especially with the outlook towards an even more complex model 
employing HPF and epithelial cell lines, another method is needed. One way of identifying 
specific proteins, peptides and thereby different cell types is to use immunocytochemistry. In 
order to be able to identify an immunogen of interest, specific antibodies against that particular 
immunogen are raised and those can then be used in cultured cells or in tissues samples to 
detect localisation of the protein of interest (see 2.7). Many antibodies are commercially 
available from life sciences companies, such as Abcam.  
All in vitro models presented in this project, apart from HPF in mono-culture, employ bronchial 
epithelial cells, which are known to express cytokeratins (CK). CKs are a subfamily of 
intermediate-sized filaments, are classed as epithelial cell specific markers. Expression profiles of 
CKs are not only cell type specific and tissue specific, but are also indicative of the cellular state 
of differentiation, which has been reported to be tightly correlated (Moll et al., 1982). CKs can be 
classed into type I (acidic) and type II (neutral basic), which always form heteropolymeric pairs 
with one another to constitute their filamentous structure (Moll et al., 1982). Type II CK5, for 
example, forms a heteropolymer with type I CK14 and is expressed in the basal epithelial layer, 
therefore antibodies to CK5 or CK14 are generally used to identify basal cells in epithelial tissue 
or cell cultures (Purkis et al., 1990, Moll et al., 1982). These intermediate filaments also serve 
basal cells to strongly attach to the BM through forming cell-ECM junctions, termed 
hemidesmosomes, supporting the mechanical integrity of the tissue. Additionally CK filaments 
 106 
 
also span through the cytoplasm, hold the nucleus in place and attach to the desmosomes, 
intercellular junctions (Green and Jones, 1996). 
As described in chapter 1, the large airways are lined by a pseudostratified epithelium (simple 
epithelium), which comprises not only basal epithelial cells, but also lumen-lining differentiated 
cells, which are columnar ciliated cells. These can be detected using antibodies against CK 8 or 
CK18, markers of differentiated epithelial cells, which are typically co-expressed to form the 
intermediate filament (Moll et al., 2008). Thus, antibodies to CK5 and CK8 could be used for 
presented mono- and co-cultures on TWs to specifically identify basal and differentiated 
epithelial cells respectively. In addition, a distinct, cell-specific marker was also needed for 
identifying fibroblasts in these mono- and co-cultures. For this, the 1B10 antibody against 
fibroblast surface protein and an antibody to vimentin were used. The 1B10 was developed in 
the nineties mainly to remove non-epithelial cells from thymic epithelial cell cultures, as it was 
shown that 1B10 binds human fibroblasts, tissue macrophages and peripheral monocytes (Singer 
et al., 1989). Vimentin is one of the main structural components of intermediate filaments 
expressed in cells of the mesenchyme. Intermediate filaments are expressed in fibroblasts and 
are needed not only for stability of the cell and structural support but also for some vital cell 
functions and motility; vimentin helps with chemotactic migration and it has been shown if 
vimentin is absent, fibroblasts show a slower wound-healing process (Eckes et al., 1998, Wang 
and Stamenovic, 2002, Eriksson et al., 2009). 
Furthermore it was essential to analyse whether the mono- and especially the co-culture models 
mimicked the in vivo situation closely in terms of their appearance as a pseudostratified 
epithelium (with HPF underlining the epithelial cells), forming a confluent cell layer of tightly 
connected epithelial cells. Additionally, it was important to identify whether mucociliary 
ciliogenesis takes place and the expression of microvilli and cilia had been initiated. Cilia play an 
important role in the respiratory system as part of the innate defence mechanism by 
transporting the mucus and all entrapped bacteria, viruses and toxins towards the pharynx 
(mucociliary escalator). As described in chapter 1 this clearance and defence system is impaired 
in CF lungs because cilia get trapped in vast amounts of viscous and dehydrated mucus, which 
makes it impossible for them to beat and ultimately frustrates the mucociliary escalator 
(Houtmeyers et al., 1999). Thus, the evaluation of these novel in vitro mono- and co-cultures 
included an investigation for the presence of cilia and microvilli on the apical surface.  
 
Another aspect of importance was the influence of HPF on pseudostratified mucociliary 
differentiation and intercellular communication. As already mentioned in chapter 3, 
mesenchymal- epithelial interactions as well as epithelial- ECM interactions are important for 
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lung development and repair (Knight, 2001). Furthermore fibroblasts play an active role in 
cytokine production for example (Kelley et al., 1991) as well as in growth factor production (Shoji 
et al., 1989).  
In vivo the epithelial cells attach to a region called the basement membrane zone (BMZ), which 
serves as connective junction between these and the underlying connective tissue. The 
epithelium attaches through adhesins and hemidesmosomes to the BMZ and in close proximity 
to fibroblasts, which are immediately beneath the epithelium (Evans et al., 1993) and have been 
suggested to modulate several important functions, including recruitment and activation of 
inflammatory cells (Evans et al., 1993, Evans et al., 1999). The recruitment of neutrophils in the 
high numbers in which they appear in the CF airways has so far mostly been related to immune 
cell/epithelial IL-8 secretion whilst fibroblast involvement in the strong inflammatory response is 
still unknown.  
 
There are co-culture models that have revealed that postmitotic fibroblasts, which serve as static 
feeder layers, are able to stimulate airway epithelial growth under submerged conditions and on 
TWs (Wiszniewski et al., 2006, Skibinski et al., 2007). However in these models the proliferation 
effects that epithelial cells have on fibroblasts were eliminated by irreversibly blocking 
proliferation of fibroblasts by using mitomycin C. Whether this has a direct effect on 
accumulation of epithelial derived stimulators, the direct physical interaction of these two cell 
types and the interaction with ECM are not known but these important features need to be 
investigated to elucidate the controlled interactions of these two cell types that are found in 
vivo. Furthermore it has been shown that mitomycin C upregulates IL-8 secretion in corneal 
fibroblasts, even after removal from culture medium (Chou et al., 2007). IL-8 is the key 
chemokine in CF and, since accurate analysis of IL-8 release is of paramount importance to this 
project, the use of mitomycin C-treated, IL-8 secreting fibroblasts would prevent this. In 
addition, the project aimed to measure the fibroblast response to stimuli, such as bacteria, 
therefore employing actively proliferating, responsive primary human fibroblasts is an 
imperative feature required to make these co-culture models more accurate and closer mimic 
the in vivo situation.  
Additionally, proliferating HPF were in direct contact with the epithelial cells in the current 
model system without having a physical barrier (membrane) between the two. One challenge 
was thus to characterise the different cellular locations in the co-culture models and validate 
that active fibroblasts can be used for these kinds of studies.  
For over twenty years mono-cultures of epithelial cells at ALI have been used routinely for 
studying epithelial cells and behaviour in vitro. During this time, better techniques have evolved 
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and biotechnological, semi-permeable membranes have improved but no one has reported a 
model applying proliferating, metabolically active airway fibroblasts directly underlying the 
epithelial cells, which are then grown at ALI. As already mentioned above, fibroblasts play an 
important role in lung development and cell-cell interactions (Shoji et al., 1989), therefore these 
models would be a valuable addition to existing cell culture models in vitro as well as to available 
animal models in vivo. 
Further characterisation of the models, especially the co-culture models of non-CF and CF 
human airways in vitro is required to verify that the epithelium develops into a well 
differentiated functional pseudostratified epithelium in the mono- and co-culture model systems 
and secondary that the fibroblast cell population supports this and do not overgrow the 
epithelium. 
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4.2 Aims 
 
The overall aim of the studies described in this chapter was to further characterise the in vitro 
mono- and co-culture model systems for non-CF and CF human airways with the criterion of 
epithelial differentiation in terms of generating a multi-cellular, ciliated and pseudostratified 
airway epithelium and to characterise the influence of HPF on epithelial differentiation in the co-
culture model. 
 
In order to achieve this, the first aim was to determine cell type specific markers useful for cell-
specific immunocytochemistry labelling in mono-and co-cultures under submerged conditions as 
well as for cultures at ALI.  
The second aim was to be able to distinguish between the epithelial cells and the fibroblasts and 
to localise their position, especially in the co-culture models. In order to achieve this histologic 
analysis of mono- and co-culture cross sections (ALI) was performed. 
The third aim of this chapter was further investigation of fibroblast and epithelial cell layer 
morphology in mono-and co-cultures and to investigate whether cilia formation takes place and 
whether this is modulated by HPF as subepithelial cell layer. 
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4.3 Methods 
4.3.1 Antibodies 
Mouse monoclonal antibody to fibroblast surface protein (1B10; ab11333, 0,2 mg/ml), mouse 
monoclonal anti-cytokeratin 8 antibody (0.5 mg/ml, ab9023) and mouse monoclonal anti-basal 
cell cytokeratin (CK5) antibody (1 mg/ml ab9272) were purchased from Abcam (Cambridge, 
USA). The mouse monoclonal anti-vimentin [V9] antibody was purchased from Gene Tex 
(GTX76575), mouse IgG kappa (Mopc 21, 5 mg, m-7894), and goat anti-mouse fluorescein 
isothio-cyanate (FITC) secondary antibody (F0257) was purchased from Sigma. 
 
4.3.2 Immunocytochemistry 
Immunocytochemistry was performed on 4- well slides as well as TWs and the methods are 
described in detail in chapter 2.7.2 and 2.7.3. All primary antibodies used were mouse 
monoclonal antibodies, as detailed above. The secondary antibody for all staining was goat anti-
mouse fluorescein isothio-cyanate (FITC, green). The staining was always finished by mounting 
the samples in a hard set mounting medium containing DAPI to stain the nuclei blue. 
 
4.3.3 Histology 
The TW samples were fixed with 10% (v/v) formaldehyde added to the cell culture medium. Any 
further processing, sectioning and staining was performed in Birmingham University by Gary 
Reynolds, Healthcare Scientist. The process is described in more detail in chapter 2.8. 
 
4.3.4 Electron microscopy 
Electron microscopy was conducted at the University of Birmingham at the Department of 
Metallurgy with the expert assistance of Paul Stanley (Manager of the Centre for Electron 
Microscopy). His protocols for SEM and TEM are described briefly in chapter 2.12 . 
  
 4.4 Results 
4.4.1 Immunocytochemical characterisation 
To determine the presence and distribution of the two different cell types in the final 
establishment of the proposed co
employed that were cell type specific (i.e. fibroblast or epithelial) and did not show any reactions 
with the other cell types.
4.4.1.1 Immunocytochemistry on submerged cell cultures on 4
In order to identify whether the chosen an
able to differentiate between epithelial cells and fibroblasts in the final co
immunocytochemical staining was performed on submerged cell mono
first indicator of the specificity, and therefore usefulness, of these antibodies (described in detail 
in 2.7.2).  
Figure 4.1 Representative immunofluorescence images of submerged 
HPF cells were seeded on collagen IV coated
medium and were incubated for 2 days before immunocytochemistry staining was performed. 1B10, an 
antibody against fibroblast surface antigen stained HPF positive (green), whereas the two antibodies 
against the epithelial cell mar
for cell type specific markers, staining with 
performed, which were all negative. One sample was fixed and stained with DAP
used as counterstain in all other samples. Images are representative of three individual experiments each 
done in duplicates and random fields of view were chosen and images taken (x 63 magnification; scale bar 
= 31µm) 
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-culture model system, different an
 
-well slides
tibodies suited the requirements in terms of being 
-cultures. This provided a 
cultures of 
 4 well slides at a density of 3.5 
kers CK5 and CK8 did not show any staining. Alongside with 
IgG1 isotype control and secondary antibody on its own 
tibodies needed to be 
 
-culture model, 
 
HPF 
x 10
4
 cells/well in 200 µl 
the antibodies 
was 
I only, which was also 
 After HPF were cultured for 2 days under submerged conditions on 4
and stained with 1B10, which binds to a fibroblast surface protein. The other two antibodies 
used for characterising epithelial cells were anti
used antibodies to CK5 (basal cells) and CK8 (lumen lining). In addition we performed the whole 
experiment following the same protocol with an isotype control (IgG1) or with using only the 
secondary antibody goat anti
only but this sample was only fixed before stained in order to see if processing has a significant 
impact on cellular morphology. Representative fluorescent images are shown in figure 4.1 for 
submerged fibroblasts. HPF
DAPI stained nuclei (blue). No antibody specific staining was observed for CK5 and CK8 in 
submerged HPF cell cultures. The two controls using IgG1 as isotype control or the secondary 
antibody on its own were negative for detectable FITC signal. DAPI staining in the absence of 
antibody treatment showed the same nuclear appearance as on all other samples.
Figure 4.2 Representative Immuno
C38 were seeded on collagen IV coated
and after a 2 day incubation time, 
an antibody against fibroblast surface antigen 
fluorescent signal was seen.
line either but when using 
three negative control staining procedures were carried out: DAPI
secondary antibody alone (FITC only). Images are representative of three individual experiments each 
done in duplicates and fields of view capture
31µm) 
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-well slides they were fixed 
-cytokeratin antibodies. In this
-mouse FITC. One other additional staining was done with DAPI 
 show positive staining for the fibroblast surface antigen (green) and 
cyotchemistry staining of submerged C38 
 4 well slides at a density of 3.5 x 10
4
 cells/well
immunocytochemistry staining was performed. 
did not bind to the cell surface of C38, since no detectable 
 The epithelial cell marker CK5 did not show any specific binding to this cell 
CK8 a positive staining result was observed. Alongside 
 alone, IgG1 isotype control 
d at random for presentation (x 63 magnification; scale bar = 
 experiment we 
 
 
 in 200 µl medium 
It appeared that 1B10, 
cell marker antibodies, 
alone and 
 Submerged C38 cells were cultured on collagen IV coated 4
antibody staining was carried out. For the fibroblast marker antibody 1B10, C38 were found to 
be negative and only DAPI stained nuclei are visualized (figure 4.2 top left panel). CK5, which is a 
basal epithelial cell marker, was noted to be absent from C38 cells as well. However, there is 
strong positive staining for CK8 and this marker can therefore b
in these mono- and co-culture models. C38 are also negative for the two controls and as for HPF, 
DAPI showed that processing after fixation does not change cell morphology.
 
Figure 4.3 Representative immunocytochemistry staining of the epithelial cell line IB3
IB3-1 were seeded at a density of 3.5 x 10
and were incubated for 2 days before 
for fibroblast surface antigen did not specifically bind to the cell surface but a low signal of fluorescence 
could be detected on some cells. The epithelial cell marker
cell line, like C38, but when using 
antibodies, staining with IgG1 isotype control 
were all negative. One sample was stained directly after fixing wit
counterstain in every sample shown. Images are representative of three individual experiments each done 
in duplicates and random pictures were chosen (x 63 magnification; scale bar = 31µm).
 
Immunocytochemistry staining of I
expressed in these cells, whereas, whilst the anti
with this epithelial cell line, the staining intensity is very weak. 1B10 is the antibody against 
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-well slides for two days before 
e used to identify epithelial cells 
4
 cells/well in 200 µl medium on collagen IV coated
immunocytochemistry staining was performed. 1B10
 CK5 did not show any specific binding to this 
CK8 a positive staining result is observed. Additionally
and secondary antibody on its own 
h DAPI only, which was also the 
B3-1 revealed that the epithelial cell marker CK8 is strongly 
-CK5 antibody does occasionally show reaction 
 
 
-1 
 4 well slides 
, an antibody 
 to the cell marker 
were performed, which 
 
 fibroblast surface antigen and in some cases a very weak fluorescence signal on some cells could 
be detected. Cells stained with DAPI alone showed that nuclei look round and equally stained 
with no morphological changes to be identified in the other sample
4.3). 
Figure 4.4 Immunocytochemistry staining representative of Calu
Calu-3 cells were seeded at 
slides and after an incubation of 2 days 
used as fibroblast marker did show some binding to the cell surface of Calu
CK5 and CK8 both stain Calu
directly after fixation to verify that processing does not change cell morphology. An
and secondary antibody only, 
individual experiments each done in duplicates and random pictures were chosen (x 63 magnification; 
scale bar = 31µm) 
 
In figure 4.4 results for immunocytochemistry staining of Calu
1B10, which was used as fibroblast marker an
population of the Calu-3 cells, but this staining is extremely weak compared to expression of the 
epithelial cell markers. In contrast to the other two cell lines Calu
for the basal epithelial cell marker CK5. The green fluorescence created by the antibody staining 
visualizes the intermediate filaments clearly and seems to be located around every nucleus. 
Some cells seem to be slightly on top of others as they are clearly sho
anti-CK8 antibody for differentiated lumenal epithelial cells also shows strong staining of these 
intermediate filaments, which seem to be denser then CK5. The negative control of IgG1 and 
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s through processing (figure 
-3 cells in submerged culture
a density of 3.5 x 10
4
 cells/well in 200 µl medium on collagen IV coated
immunocytochemistry staining was performed. 1B10, 
-3. The epithelial cell marker
-3 specifically. The counterstain DAPI was used in each sample plus on its own 
was performed, which were all negative. Images are representative of three 
-3 cells is presented. The antibody 
tibody, appears to recognise the cell surface of a 
-3 also stains strongly positive 
wn in their full outline. The 
 
 
 4 well 
an antibody 
 
 IgG1 isotype control 
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secondary antibody on its own was negative for any green fluorescence due to antibody binding. 
Again, DAPI staining applied straight after fixing Calu-3 cells, showed that fixation and processing 
has had no direct effects on cell morphology.  
 
4.4.1.2 Immunocytochemistry staining of HPF mono-cultures grown in submerged 
culture on TWs and epithelial cell mono-cultures on TW at ALI 
Additionally to immunocytochemistry staining performed on 4-well slides, it was necessary to 
perform the same staining protocol for HPF grown in submerged culture on TWs as well as the 
epithelial cell lines grown at ALI on TWs to analyse if the different growth conditions and the 
differentiation of epithelial cells would change the staining pattern of each cell type compared to 
cells grown in complete submerged conditions. For this experiment HPF were grown on TWs but 
this cell type has to be kept submerged, whereas the different epithelial cell lines were put at ALI 
after 4 days submerged culture on TWs (see 2.4.6 and 2.7.3). After a further 14 days of culture 
the cells were fixed, permeabilised and blocked before the primary antibodies 1B10, CK5 and 
CK8 were applied.  After the defined incubation time the secondary antibody was applied to all 
samples apart from one TW per cell type, which was pulled out the processing line earlier; 
straight after fixation one TW was stained with DAPI only again to compare if processing changes 
the morphological appearance of the cell layer. This was done for every cell line and as there 
were no differences to be noted these images will not be discussed for every figure but will be 
presented. 
 Figure 4.5 Immunocytochemistry pictures of HPF cultured under submerged conditions on TWs
HPF cells were seeded on collagen IV coated TWs at a cell density of 3
submerged culture HPF mono
staining, whereas CK5 and CK8 do not stain HPF. Negative controls of IgG1 and secondary antibody only 
were run alongside. Images are representative of two individual exp
random pictures were chosen (x 63 magnification; scale bar = 31µm)
 
HPF grown under submerged conditions on collagen IV coated TWs were immunostained using 
the same antibodies as were used to stain cells under submerged
HPF the same staining pattern was observed as was seen for submerged cultures. The fibroblast 
marker antibody 1B10 showed specific staining of HPF and clearly delineated the spindle
morphology of this cell type, where
not show any specific staining under these culturing conditions. The controls were all negative 
indicating specific staining of HPF. 
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 x 10
4
 cells/well. After 14 days in 
-cultures were immunostained with 1B10, which gives the only positive 
eriments each done in duplicates and 
 
 conditions on 4 well slides. For 
as the two other antibodies against epithelial cell markers do 
 
 
 
-like 
 Figure 4.6 Immunocytochemistry pictures of C38 mono
C38 were seeded on collagen IV coated TWs at a cell density of 3
at ALI the mono-cultures were immunostained with 1B10, CK5 and CK8 as primary antibodies f
goat anti- mouse FITC as secondary antibody. For 1B10, a little positive staining of C38 was observed. CK5 
does not stain these cells but CK8 shows positive staining. Negative controls of IgG1 and secondary 
antibody only were run alongside. Imag
duplicates and random pictures were chosen (x 63 magnification; scale bar = 31µm)
 
The staining patterns of the two epithelial cell lines C38 (figure 4.6) and IB3
from what was seen for these cells in submerged cultures. For both cell lines grown at ALI, 
positive staining was seen with the 1B10 antibody, which is directed against a surface protein on 
fibroblasts. Moreover C38 was negative for CK5 under submerged condition
grown at ALI but IB3-1 showed weak positive staining for CK5 when cultured at ALI. Strong CK8 
staining in both mono-cultures of C38 and IB3
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-cultures at ALI 
 x 10
4
 cells/well. After 14 days in culture 
es are representative of two individual experiments each done in 
-1 grown at ALI was observed.
 
ollowed by 
 
-1 (figure 4.7) differ 
s and still is when 
 
 Figure 4.7 Immunocytochemistry pictures of IB3
IB3-1 were seeded on collagen IV coated TWs at a cell density of 3
mono-cultures were immunostained with 1B10, which showed very little posit
also shows little staining and CK8 as the d
staining. Negative controls of IgG1 and secondary antibody only were run alongside. Images are 
representative of two individual experiments each done in duplicates and random pictures were chosen
63 magnification; scale bar = 31µm)
 
The Calu-3 cell line grown at ALI (figure 4.8) showed the following staining patterns after being 
grown in mono-culture at ALI for 14 days.
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-1 mono-cultures at ALI 
 x 10
4
 cells/well. After 14 days the 
ive staining, with CK5, which 
ifferentiated epithelial cell marker showing strong specific 
 
 
 
 
 (x 
 Figure 4.8 Immunocytochemistry pictures of Calu
Calu-3 cells were seeded on collagen IV coated TWs and after 14 days in culture at ALI the mono
were immunostained with 1B10, which was observed to show little staining. Antibodies against the 
epithelial cell markers CK5 and CK8 both showed strong
conditions. Negative controls of IgG1 and secondary antibody only were run alongside. Images are 
representative of two individual experiments each done in duplicates and random pictures were chosen (x 
63 magnification; scale bar = 31µm)
 
1B10 immunostaining revealed a positive result for these cultures showing 1B10 staining around 
some Calu-3 cells presented in the image but no particular pattern can be identified. Strong 
staining of CK5 and CK8 was seen in thes
All negative controls that were run along with each of these experiments showed no staining, 
indicating that other stainings were specific for of any of the cell types. DAPI staining was carried 
out on one TW per staining procedu
was then compared to all other staining to be able to identify possible changes of cell 
morphology due to processing. The anti
specific and stain only epithelial cells, whereas 1B10 appears to show very weak cross
with all three epithelial cells when grown at ALI. 
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-3 mono-cultures at ALI 
 specific staining of these cells under these 
 
e ALI cultures of Calu-3.  
re straight after fixation of cells to stain the nucleus, which 
-cytokeratin antibodies were observed to be cell type 
 
 
 
-cultures 
-reaction 
 4.4.1.3 Immunocytochemistry staining of co
The establishment of co-
1 or Calu-3 needed to be analysed for cell type location and distribution throughout the model. 
HPF were seeded first into the collagen IV coated TW and incubated for four days before the 
epithelial cells were seeded on
for the epithelial cells to adhere and proliferate before establishing ALI. 
 
Figure 4.9 Immunocytochemistry staining of co
After 14 days at ALI the co-
These were 1B10, CK5 and CK8. 1B10 staining was observed in all three co
stronger in HPF-C38 and HPF
HPF-Calu-3, which show weak 1B10 staining but strong CK5 staining. All three co
expression of CK8 but the appearance of staining pattern is different in all three of them different. 
Negative controls of IgG1 and secondary antibody only were run alongside as well as one sample being 
stained with DAPI directly after fixing the cells for observation of morphological changes through 
processing (data not shown). DAPI also served as counterstain for all TWs an
are representative of two individual experiments each done in duplicates and random pictures were 
chosen (x 63 magnification; scale bar = 31µm)
 
Immunocytochemistry staining of all three co
showed that expression patterns of the different immunogens for these antibodies are the same 
as for mono-cultures grown at ALI. 1B10 showed positive staining in all co
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-cultures grown at ALI
culture models applying HPF and one of the epithelial cell lines C38, IB3
 top. Further incubation under submerged conditions was allowed 
 
-cultures at ALI (HPF-C38, HPF-IB3
cultures were immunostained with the same antibodies as the mono
-culture systems but much 
-IB3-1, whereas these 2 models show very weak CK 5 expression compared to 
alysed (blue nucleus). Images 
 
-culture model systems was undertaken and 
 
-
 
-1, and HPF-Calu-3) 
-cultures. 
-cultures show strong 
-cultures but to a much 
 lesser degree in the HPF
were both strongly expressed in HPF
other two models. CK8 is strongly expressed i
show a slightly different pattern when comparing to each other. Compared to each other HPF
C38 and HPF-IB3-1 showed very similar staining for 1B10 but this reaction indicates that this is 
not a possible method to distinguish between the two cell types for any of these co
models. 
 
Immunocytochemistry is a useful tool for identifying expression profiles of cell type specific 
markers, such as cytokeratins for epithelial cells, in mono
as well as for mono-cultures at ALI. However, antibodies can sometimes show non
staining or cross-reaction with different antigens on other cell types than those proposed by the 
manufacturer. This appears to be the case for the 1B10 
staining of fibroblasts but also some staining of all applied epithelial cultures (apart from C38 
submerged) and can in this case not be used for further characterisation of the co
system for distinguishing the two d
For this reason another fibroblast antigen vimentin, was selected and tested. The vimentin 
antibody was shown to be specific for fibroblasts without showing any reaction with the 
epithelial cell surface of C38, I
Figure 4.10 Representative immunofluorescent
submerged mono-cultures on 4
Cells were seeded on collagen IV coated 4 well slides at a density of 3.5 x 10
and were incubated for 2 days before immunocytochemistry staining was performed. 
antibody targeting intermediate filaments in
using a FITC labelled second
any of the epithelial cell lines. The negative controls, IgG1 isotype control and secondary antibody only as 
well as DAPI on its own are shown figure 4.1
each done in duplicates and random pictures were chosen (x 63 magnification; scale bar = 31µm).
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-Calu-3 model system, whereas the epithelial cell markers CK5 and CK8 
-Calu-3. However, CK5 just showed very weak staining in the 
n HPF-C38 and in HPF-IB3
-cultures under submerg
antibody, which showed not only 
ifferent cell types in these model systems.
B3-1 or Calu-3 (figure 4.10). 
 images of Vimentin staining on HPF, C38, IB3
-well slides. 
4
 cells/well in 200 µl medium 
 fibroblasts was used as primary antibody and was visualized 
ary antibody. Positive staining could only be indentified for HPF and not for 
- 4.2. Images are representative of two individual experiments 
-1 but it appeared to 
-
-culture 
ed conditions 
-specific 
-culture 
 
 
-1 and Calu-3 
Vimentin, an 
 
 Figure 4.10 shows that the anti
when observing HPF and the 
was only detected on fibroblasts (indicating antibody binding) while the epithelial cells were only 
visible because of their DAPI
make it possible to accurately, specifically distinguish between fibroblasts and epithelial cells. As 
fluorescent microscopy, where the cultures are viewed from the top (epithelial to fibroblasts to 
membrane), can be useful as shown above, cross s
distinguishing the location of fibroblasts and epithelial cells followed by histoloigic analysis 
appeared to more clearly reveal where cell are in the model. For this method vimentin will be 
used for fibroblasts. 
 
4.4.2 Histological staining of mono
Histology processing was performed at Birmingham University after mono
formalin fixed in our laboratory. 
 
Figure 4.11 Light micrographs of hematoxylin and eosin (H&
HPF (submerged but on TW) and C38 and IB3
Hematoxylin stained the nuclei, while eosin was used to counterstain the non
and cytoplasm. In all three cell types HPF, C38 a
HPF showed a much greater distance between the nuclei compared to the epithelial cells, as their spindle 
shaped cell bodies were stretched out, whilst the epithelial mono
population, in which cells are closely linked together to form a pseudostratified like epithelium with much 
less intercellular space compared to HPF. No gross histological differences could be determined between 
the non-CF and CF model. T
it can still be seen on pictures of C38 and IB3
cell type. 
 
Histological staining on paraffin embedded cross sections of 
performed as earlier described in 2.8. Formalin fixed cross sections shown in figure 4.11 were 
haematoxylin and eosin (H&E) stained to visualize nuclei 
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-vimentin antibody showed absolute specificity for fibroblasts, 
three bronchial epithelial cell lines. Positive fluorescent staining 
-stained nucleus. Therefore, the anti-vimentin antibody ap
ectioning mono
- and co-culture models at ALI
 
E) stained cross sections of mono
-1 grown at ALI. 
-nuclear tissue components 
nd IB3-1 the dark purple nuclei could be identified readily. 
- cultures both show a di
he membrane of the TW was accidently separated from the HPF section, whilst 
-1. Images are representative of two TWs processed 
mono
(dark purple) and the cytoplasm
pears to 
- and co-cultures for 
 
- and co-cultures were 
 
-cultures of 
fferentiated cell 
for each 
- and co-cultures was 
 (pink) 
 of the three mono-culture models. On th
been lost during processing, whereas for the cross sections of C38 and IB3
can clearly be seen underneath the cells. The image in the left panel shows that the HPF grow as 
multiple, disorganised cell layers showing their typical long and spindle shaped morphology. The 
oval elongated nuclei are surrounded by a large stretched out cytoplasm that was stained pink 
and it looks like these cells are rather “gappy” compared to the tight appearance
cells. For epithelial cell lines this is quite a different picture, as the epithelial cell lines C38 and 
IB3-1 (middle and right images respectively) have built up to a pseudostratified epithelium with 
little pink stained cytoplasm compared 
close but located on different levels, which is a hallmark of pseudostratified epithelia. 
Interestingly, no obvious morphological differences were seen between C38 and IB3
mono-culture cross sections were assessed, the co
vimentin staining to locate the fibroblasts.
 
Figure 4.12 Formalin fixed cross sections of co
Vimentin to identify the fibr
epithelium formation with vimentin stained fibroblasts underneath the epithelial cell layer. The same was 
observed for HPF-IB3-1 but unfortunately the membrane of the TW was lost
appears that the epithelial cell layer on top of the HPF is a bit smaller for the IB3
 
The cross sections of HPF
co-culture model system does not appear to inhibit the epithelium from forming a tall, 
multilayered epithelium that appears to be pseudostratified with nuclei being located at 
different levels throughout, which resembles the appearance of the respiratory epithelium. The 
vimentin-positive HPF are mainly located underneath the epithelial cell layer.
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e image of HPF mono-culture, the TW membrane has 
to the HPF. For the epithelial cells, the nuclei are quite 
-culture systems were analysed using 
 
-cultures of HPF-C38 and HPF-IB3
oblast’s location in the model system. HPF-C38 showed a pseudostratified like 
 
-
-C38 and HPF-IB3-1 showed that the introduction of fibroblasts into the 
-1 the TW membranes 
 of epithelial 
-1. After the 
 
-1 stained with H & E and 
during processing. It also 
1 co-culture model (n=2). 
 
 4.4.3 Scanning electron microscopy of mono
ALI 
Figure 4.13 Scanning electron micrograph of HPF mono
HPF showed their typical morphology after being 
conditions. This appearance implies a long and spindle shaped cell (left picture) that stands in close 
contact with neighbouring cells (right picture) forming a confluent cell layer. This layer of cells looked l
one big sheet of fibroblasts. Images are representatives of two individual experiments. Scale bar, left 
picture = 20 µm; right picture = 50
 
When HPF were grown in mono
microscopy revealed that they formed a confluent layer of spindle
 
Figure 4.14 Scanning electron micrographs of C38 and IB3
Both epithelial cell lines form a confluent and tight layer of cells when cultured on TW at ALI f
days. Microvilli are expressed on the apical surface of both cell lines but they seemed to be more 
numerous on IB3-1 cells. Cell morphology of both cell lines is the same; they appear as large, flat cells, 
which appear closely connected to n
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- and co-
-culture 
cultured at least 14 on a TW under submerged 
 µm 
-culture on TWs under submerged conditions, scanning electron 
-shaped cells (figure 4.13). 
-1 mono-cultures at ALI
eighbouring cells. Scale bar: C38 = 20 µm; IB3
cultures grown at 
 
ike 
 
 
 
or at least 14 
-1 = 10 µm (n=4) 
 SEM analysis (figure 4.14) revealed that C38 and IB3
layer of cells with epithelial cell morphology, close connections to their neighbouring cells 
Furthermore microvilli expression was observed in mono
epithelial cell lines, although these microvilli and immature cilia were unorganised and differed 
in length. One difference between C38 and IB3
to be more numerous on IB3
Figure 4.15 Scanning electron micrographs of C38 and IB3
Mono-cultures of C38 and IB3
microvilli and some longer ones, possibly immature cilia. 
IB3-1’s apical surface. Scale bars in both pictures are 2 µm.
 
A close up of the apical surface of C38 and IB3
microvilli expression in more detail and supports the suggestion that IB3
microvilli. The expressed microvilli are 
show any kind of organization (figure 4.15). 
Co-cultures of HPF-C38 and HPF
confluent cell layer with clear cell
the upper-most apical side of the co
surface were epithelial cells and that the HPF cell layer is located subepithelial and therefore 
were not visible, which was already shown earlier by H & E and vimentin staining of paraffin
embedded sections of co
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-1 mono-cultures at ALI grow as a confluent 
-culture on the apical surface of both 
-1 mono-cultures was that the microvilli seemed 
-1 mono-cultures.  
-1 mono-cultures’ microvilli expression
-1 showed heterogeneous expression of apical extensions and
The number of microvilli seems to be higher on 
  
-1 mono-cultures showed the 
about 1 µm long pointing in several directions and did not 
 
-IB3-1 were also analysed using SEM and these cultures showed 
-cell boundaries (figure 4.16). In addition these SEM images of 
-culture show that the cells presented at the uppermost 
-cultures (figure 4.12). 
 
 
 some short 
heterogeneous 
-1 express more 
-
 Figure 4.16 Scanning electron micrographs of HPF
SEM analysis of fibroblast and epithelial cell co
These microvilli-like cilia are expressed on
numerous on IB3-1 cells, as they were in monocultures (figure 4.14) Cell morphology of both cell lines is of 
a typical epithelial appearance, and individual cells appear to be closely connec
forming a sheet like blanket (on top of the HPF, since these cells are not visible). Scale bar: C38 = 20 µm; 
IB3-1 = 10 µm n=2) 
 
Both co-culture model systems showed the same appearance of epithelial cells, which form a 
confluent cell layer with close contacts to neighbouring cells that seem to adjoin closely to their 
neighbours, in the “tight” physiology typical of the airways epithelium. The expression of 
microvilli seems to be more numerous on HPF
agreement with the data from the epithelial mono
that the presence of HPF did not inhibit the epithelial cell differentiation.
 
Figure 4.17 Scanning electron micrographs of HPF
microvilli like extensions on the apical membrane.
Co-cultures of HPF-C38 and HPF
thick microvilli and some longer immature cilia. 
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-C38 and HPF-IB3-1 co-cultures at ALI
-cultures showed a confluent and tight layer of ciliated cells, 
 the apical surface of both cell lines but they seemed to be more 
ted to neighbouring cells 
-IB3-1 compared to HPF
-cultures (figure 4.14), which again indicates 
-C38 and HPF-IB3-1 co-
 
-IB3-1 showed a heterogenous population of apical
Scale bars in both pictures are 2 µm. 
 
 
-C38 co-culture, in 
 
 
cultures showing cellular 
 extensions, short and 
 
 HPF-C38 and HPF-IB3-1 (figure 4.17) were also looked at in more detail and the micrographs 
revealed that in both co-
be longer and thinner in appearance but were still rela
whole apical surface of these epithelial cells. 
 
The third epithelial cell line that was used to establish mono
These were also analysed for the epithelial cell appearance and 
reveal more detail of cell morphology and epithelial specific features.
 
Figure 4.18 Scanning electron micrographs of Calu
(right picture).  
For mono- and co-cultures of Cal
contact with their neighbouring 
bars in both pictures are 20 µm. 
HPF cell layer was revealed as the epithelium has been damaged during processing. These images indicate 
that HPF do support epithelial cell growth at ALI when grown in co
 
The scanning electron micrographs showed that the epithelial cell layer in mono
form a confluent layer of Calu
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cultures the microvilli appear to be more cilia-like, as they appeared to 
tively unorganised and scattered over the 
 
- and co-culture models was Calu
were viewed under SEM to 
 
-3 mono-culture (left picture) and HPF
u-3 a confluent tight epithelial cell layer was observed. All cells are in 
cells in both models, which appeared seamless for adjacent cells.
In the right bottom corner of HPF-Calu-3 co-culture picture the confluent 
-culture.  
-3 cells with the typical cobblestone morphology (figure 4.18)
-3. 
 
-Calu-3 co-culture 
 Scale 
- and co-culture 
 
 Figure 4.19 Higher magnification of Scanning electron micrographs
showing that these cells were covered in microvilli extensions as well as some longer more organized 
immature cilia (arrow on right image) on the apical surface of these epithelial cells. Again all cells are in 
contact with their neighbouring 
 
Calu-3 mono-cultures were shown to be covered in apical microvilli extensions on most cells. 
Some of these seemed to be a bit longer and thinner than othe
cells meet each other. On a few cells there were bundles of organised looking cilia (figure 4.19, 
right picture).  
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 of a confluent Calu
cells as typical for epithelial cells. Scale bars in both pictures are 5
rs especially in areas where two 
 
 
-3 mono-culture 
 µm.  
 Figure 4.20 Scanning electron micrograph of HPF
This picture clearly showed that the 
HPF, which did not inhibit this formation 
Scale bar 20 µm.  
 
The micrograph shown in figure 4.19 shows where the epit
processing and this showed very clearly that the HPF layer of cells is present underneath the 
epithelium without changing its morphological appearance. This image also demonstrates that 
both cell types look identical in morp
3 (figure 4.13 and 4.18 respectively).
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-Calu-3 co-culture  
epithelial cells form a confluent layer on top of a confluent layer of 
of a tight epithelium, where all neighbouring cells are in contact. 
helial layer was damaged during 
hology in co-culture and to mono-cultures of HPF and Calu
 
 
 
-
 4.4.4 Transmission electron microscopy of Calu
grown at ALI 
 
Figure 4.21 TEM micrograph of confluent Calu
In this image typical features of pseudostratified epithelium were observed. At the bottom there is a basal 
(B) epithelial cell that does not reach the “luminal side” and straight above the basal cell, two ciliated cells 
meet and are connected by a tight junc
expression was observed on these two cells on the apical side of the cells and some secretory granules 
(SG) were identified on the left side of the image. (n=1)
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-3 mono and co
-3 mono-cell culture at ALI 
tion (TJ) at the most apical point of both cells. Microvilli (MV) 
 
-culture 
 
 Figure 4.22 TEM micrograph
In this image of HPF-Calu-3 co
when HPF were present and HPF showed a cell multilayer that is clearly distinguishable from the 
pseudostratified epithelium on top of them. At the bottom of Calu
cells that did not reach the “luminal side” but ciliated cells (C) expressing microvilli (MV) were present 
throughout the apical surface of this cross section with inter
 
TEM micrographs of Calu
showed that these cells established into a pseudostratified epithelium and in both cases the 
Calu-3 cell layer looks identical and 
microvilli (MV). In co-cultures, the HPF cell layer (figure 4.22) is clearly distinguishable from the 
epithelium as they showed typical morphological appearance being spindle shaped with oval and 
elongated nuclei. The images indicate that there is a clear distinction between fibroblasts and 
epithelial cell layer. Fibroblasts are clearly located subepithelial on the TWs and epithelial cells 
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 of HPF-Calu-3 co-culture at ALI 
-culture typical features of pseudostratified epithelium were observed even 
-3 there were several basal (B) epithelial 
cellular tight junctions (TJ).
-3 mono-culture (figure 4.21) and HPF-Calu-3 co
consists mainly of basal (B) and ciliated cells (C) with 
 
 
-culture (figure 4.22) 
 132 
 
located on top of the fibroblasts on the luminal side. Furthermore the expression of microvilli 
was identified for both cultures as well as presence of basal cells. In mono- and co- cultures 
intercellular tight junctions (TJ) were apparent, along with secretory granules (SG) (figure 4.21 
and 4.22). 
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4.5 Discussion 
CF is a multiorgan disease but one organ is affected the most and failure of the airways causes 
most morbidity in patients. CF lung tissue is not readily available and therefore lots of different 
models have been developed to enable researching the pathogenesis of CF. Another challenge is 
to understand the direct link between CFTR mutations and development of lung disease. 
 
Several murine models, of which some are reviewed in Mall (2008), as well as other animal 
models, such as pigs and ferrets, have been reported (Rogers et al., 2008, Sun et al., 2010, Mall, 
2008) and been used to investigate the pathogenesis of this disease as much as possible but all 
models have their inherent limitations. This is also true for in vitro models of human airway cells, 
either primary or generated cell lines. Numerous in vitro single cell culture models of airway 
epithelial cells, which are either polarized or non-polarized, have been used in this research field. 
Single cell culture models of airway cells, especially cultured under submerged conditions have 
been shown neither to reflect the in vivo cell appearance nor to reflect typical cell behaviour in 
terms of inflammatory responses, for example. Primary human epithelial cells in culture are 
arguably the closest model for optimal study but in terms of CF, not much is known about the 
phenotype, which is isolated from patients and how the cells behaviour might have changed 
over the years facing chronic infection, for example.  
 
4.5.1 There is a need for new cell culture models for CF 
The establishment of multicellular co-culture models employing human cells and research on 
multicell systems are another important step forward to mimic the in vivo situations more 
closely and accurately in vitro. These models will be a valuable addition to what has already been 
established, plus these will enable to look at human intercellular communications, for example 
fibroblast-epithelial cell communication in response to infection. 
It is important for in vitro cell culture models that the in vivo biological properties of the target 
tissue, in this case of the bronchial epithelium, are mirrored by the cells used in vitro. After 
determining the basic culture conditions for the mono- and co-culture models (chapter 3), 
further characterisation of these mono- and co-cultures grown under these defined conditions 
was necessary.  
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4.5.2 Cell specific markers for model characterisation 
Immunocytochemistry was one method proposed for use to distinguish HPF from the epithelial 
cell lines in the models, as cell type specific marker antibodies are available to visualise these 
cells. Optimum concentrations for 1B10 and vimentin were determined before these antibodies 
were used to stain HPF, C38, IB3-1 and Calu-3 in mono- and co-cultures. HPF and all three 
epithelial cell lines were also with anti-CK5 and anti-CK8 under submerged conditions as well as 
mono-cultures at ALI. CKs were first identified in the late seventies and were extensively 
catalogued by Moll et al. in 1982; this catalogue was updated in 2006 (Schweizer et al., 2006, 
Moll et al., 1982). Cytokeratins are epithelial specific intermediate filaments that allow 
researchers to discriminate between tissue specific epithelial cells but also allow them to 
distinguish between the various stages of differentiation with respect to their CK specific pattern 
(Purkis et al., 1990). For this reason antibodies have been developed against these filaments and 
the two antibodies used for this project were CK5 and CK8. CK5 is a marker for basal epithelial 
cells, whereas CK8 is strongly expressed in differentiated simple epithelial cells and has also be 
found in the respiratory tract, where it is mainly found in the lumen lining cells (Moll et al., 2008, 
Purkis et al., 1990). 
 
Submerged cells grow into a mono-layer of cells, which resulted in clear images with low or no 
background staining (figures 4.1 – 4.4). This was found to be different, when staining was 
performed on mono-cultures grown at ALI. The high number of cells, which were in multi layers, 
lead to strong overlapping staining, which made it sometimes difficult to identify single nuclei 
and get a clear picture of the stained cell markers. This often produced high overall fluorescence 
staining as well as sometimes overlapping fluorescence signals of green and blue, so it was 
almost impossible to find the right exposure time to get clear and focused pictures. Another 
point was the difficulty of getting a reasonable sized area of view that was in focus all around, 
was also encouraged by the fact that once a TW membrane was excised from the outer support 
it needed to be handled with extensive care to not start rolling up or to become wavy and 
distorted. 
 
The TW membrane itself has been reported to be a problem in imaging. This has been shown for 
Calu-3 mono-cultures before, when grown at ALI and it was also mentioned that staining of cells 
on TW membranes can appear pixellated, depending on how close to the membrane the images 
are taken (Grainger et al., 2006). This was the same problem when cells were co-cultured at ALI 
but as shown in this chapter valuable images for analysis can be produced using these methods. 
Clear quality allow images allow morphology analysis as well as cell type identification. 
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Analysing these images revealed that 1B10 did not only staining HPF, which was a strong and 
clean staining pattern for fibroblast surface antigen, but it also showed some staining on the 
epithelial cells in submerged cultures, which was even stronger at ALI (figure 4.1-4.8). The 
staining pattern is very different when comparing HPF’s staining pattern to the epithelial ones 
but 1B10 would not be the perfect antibody for identifying HPF in co-cultures.  
 
In contrast both anti-CK antibodies were epithelial cell specific and did not show any reaction 
with HPF (figure 4.1 and 4.5). Surprisingly CK5 did not stain C38 and IB3-1 under submerged 
conditions and only very little when grown at ALI, which needed such a high exposure time to 
visualize that the background staining was almost the same. However, CK5 is strongly expressed 
in Calu-3, which is paired with CK14 in vivo and they are the major CKs in basal cell populations 
(Purkis et al., 1990), which indicates that a basal cell population is present in these cultures, 
alongside with ciliated cells, which has also been demonstrated in figure 4.21 and figure 4.22. 
CK8 however, is strongly expressed in all three epithelial cells and the anti-CK8 antibody does 
not show any reactivity towards HPF.  
 
4.5.3 Cytokeratin differences observed in cultured cell lines  
Interestingly the expression pattern of the CK8/CK18 intermediate filaments seems to differ in 
each cell line. In C38 it looks like the CK8 filaments are polarised to one end of the cell in most 
cases and only a thin bundle of them appear rather than all around in the cytoplasm (figure 4.2). 
IB3-1’s CK8 expression looks quite different as it seems the positive staining appears in all the 
spaces between the stained nuclei, which would imply CK8 is present in most areas of the 
cytoplasm. It looks as if they express more of it and therefore it seems to be denser compared to 
C38 (figure 4.3). For other CKs it has been shown that the expression pattern does change in 
response to stimulation. CK13, for example, has been reported to be increased by exposure to 
chronic inflammation, which is the characteristic condition of the CF airways. When chronic 
inflammation is present in CF airways the epithelium undergoes squamous metaplasia and/or 
repair after tissue injury (Mithal and Emery, 1976, Sajjan et al., 2000b). CK8 expression in CF has 
been addressed in one report concerning the localization of CFTR in homozygous Δ-F508 cell 
lines. This work showed that reorganization of CK18 within the CK8/CK18 network after 
treatment with curcumin was accompanied by relocalization of CFTR to the plasma membrane in 
CF cells, whereas curcumin had no effect on non-CF cells (Calu-3) (Lipecka et al., 2006), 
indicating that there is a difference in CK expression present comparing non-CF and CF cells.  
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C38 has been transfected and stably expresses CFTR, this could be accompanied by CK8 changes 
in terms of reorganization of the intermediate filaments to enable the translocation of CFTR to 
the plasma membrane and as shown here (figure 4.6, 4.7 and 4.9) the CK8 expression pattern 
differs comparing C38 and IB3-1, which could be shown to exactly this change in intermediate 
filament organisation. 
 
Transfection, but mainly transformations, can have an influence on CK expression as discussed 
later on in this chapter. CK8 staining of Calu-3 cells is also different in its appearance compared 
to the other two epithelial cell lines, which is possibly down to their different origins as Calu-3 
derived from a bronchial adenocarcinoma whereas IB3-1 are from a CF patient. This could mean 
that there are fundamental differences in their morphology and maybe even some functional 
(apart from being immortal) characteristics. Interestingly it has been reported that although 
CK5/CK14 expression levels are similar in tumours compared to normal epithelial cells, low or no 
CK5 is expressed in adenocarcinomas (Moll et al., 2008). This was not the case here for CK5 
epxression of Calu-3, where strong CK5 expression was apparent(figure 4.4 and 4.8) and which 
has been described before (Daniel and Burnett, 1991). On top of these findings Calu-3 have been 
reported to have an abnormal set of chromosomes, which could affect several cell function and 
expression patterns but this has not been linked directly to CK expression until now (Shan et al., 
2011).  
 
For all epithelial mono-cultures at ALI their CK staining patterns were different compared to 
submerged cultures, which is plausible as the epithelial cells differentiate and so the 
cytoskeleton needs to rearrange and establish cell-cell junctions such as desmosomes for 
example, which involves intermediate filaments (Green and Jones, 1996). As just mentioned CKs 
play a role in cell-cell junctions, for example as well as providing stability. Therefore these 
inherent structures and their distribution will change when a single cell is integrated into tissue 
formation (Moll et al., 2008). C38 staining with CK8 looks like the filaments are more dispersed 
at ALI, rather than in big bundles and were found at the very top level of cells, the apical layer. 
Filaments stretched out through the whole cytoplasma and were now even found even 
stretching over the nucleus (figure 4.6). CK8 staining of IB3-1 at ALI looked now very similar to 
C38’s staining pattern at ALI just slightly less diffuse, which supports the finding that no visual 
morphologic differences are observed comparing non-CF and CF cells (Yankaskas et al., 1985).  
 
Cytokeratins were thought to be inert structures for mechanical support but nowadays we know 
that they are active, mobile and have also been reported to be polarised in the case of simple 
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epithelial cells, which are themselves polarised with an apical and basolateral side (Oriolo et al., 
2007). The cytokeratin expression profiles of epithelial cells can change for several reasons. One 
is naturally occurring in terms of embryogenesis, where keratin 5 expression increases in certain 
simple epithelial cells (epidermis) as these become basal cells for the development of a stratified 
epithelium (Coulombe et al., 1989). Another reason for dramatic changes in the expression 
profile is being cultured in vitro. For example, it was reported that rat tracheobronchial epithelial 
cells changed cytokeratin expression over short period of 72 h when first cultured in vitro. The 
expression of CK14, a basal cell marker and partner of CK5, significantly increased over this time 
and it was also shown that prominent morphological changes took place (Yamamoto et al., 
1998).  
As C38 and IB3-1 were isolated in 1992 and have been cultured for a long time in vitro, it is 
impossible to tell whether this weak CK5 staining of C38 and IB3-1 is correlated to these cells 
being cultured and no CK staining data of the first days of in vitro culture is available for 
comparison.  
 
Changes in CK expression has been reported to occur when cells are transformed with the 
oncogenic SV-40 virus, which has been described as “a stage specific process in which normal 
patterns of differentiation are progressively altered over time following infection” (Steinberg 
and Defendi, 1985). The infection with the virus created human epidermal keratinocytes with 
different variations of keratin expressions, some of which were deficient for some CKs of their 
normal keratin cytoskeleton, including CK5, which correlates with negative staining found in C38 
and IB3-1. These changes happened after a short time (10-15 passages) after the infection. 
These changes were ongoing for months after the infection and led to the loss of certain keratins 
but also to the appearance of some others, which were not present in uninfected cells (Steinberg 
and Defendi, 1985). In second report of keratins expressed in human keratinocytes, it has been 
shown that there is an overall reduction in keratin RNA synthesis and that Ck5 is markedly 
reduced in transformed cells compared to their parental strain, which usually expressed a stable 
pattern. For these keratinocytes it has been observed that viral transformation changes the 
differentiation ability (Morris et al., 1985). The human bronchial epithelial cell line VA 10, which 
was used for investigating branching morphogenesis in 3D culture were reported to maintain 
their basal cell appearance in terms of CK14/17 expression even though they partially 
differentiated into a type II alveolar cell (Franzdottir et al., 2010). This shows that CK expression, 
like it was found in the presented models, does not have to change completely in terms of 
switching on and off certain CKs in correlation with differentiation.  
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Furthermore pseudostratified epithelium as it is found in the respiratory tract is, generally 
speaking, classed as a simple epithelium, which has been shown to have a fairly simple 
cytokeratin profile as well. Usually these epithelial express CK8/CK18 and sometimes CK19 and 
CK7. The stratified epithelial cells express a more complex range of CKs as they express 1-6 and 
9-17, which is thought to be linked to their stratification (Bosch et al., 1988). The 
pseudostratified epithelium has all cells attached to the underlying BM but as its name implies, 
the stratification is not complete. It has been reported that in some cases typical CKs of stratified 
epithelia (CK5) can be co-expressed with those of simple epithelia (CK8) (Bosch et al., 1988), 
which is exactly what was observed in HPF-Calu-3 co-cultures. The fact that CK5 is not expressed 
in C38 and IB3-1 does therefore not rule out the presence of a basal cell population in these 
culture models, since CK8 was present.  
 
For the purpose of identifying epithelial cells in the co-culture models, CK8 is a reliable epithelial 
cell marker that is expressed by all three epithelial cell lines in submerged culture conditions as 
well as in ALI conditions. Also this CK was not found to be expressed by HPF and therefore would 
be of use in defining the location of each cell type within the co-culture. Immunocytochemistry 
staining was also performed on all three co-culture models grown at ALI and they were stained 
with 1B10, CK5 and CK8 the result observed was 1B10 showing a strong staining in HPF-C38 and 
HPF-IB3-1, which showed that HPF are present in the model and no mesenchymal to epithelial 
transition has taken place. In HPF-Calu-3 co-cultures staining seems to be weak for 1B10 but it 
seems like the epithelial cell layer is very tight in this and either did not let the antibody 
penetrate through to the HPF or if the antibody got to its antigen, the fluorescence is not coming 
through and could not clearly be captured. CK5 expression again is low in HPF-C38 and HPF-IB3-1 
but strong in Calu-3, whereas CK8 is strongly expressed in all three co-cultures (figure 4.9). CK8 
staining for HPF-C38 looked different to mono-culture staining, as in the way that the filaments 
are now located all around the nucleus outlining the cells morphology. In the top left corner 
there is only DAPI stained HPF nuclei and it seems that some C38 have been lost during 
processing. IB3-1 and Calu-3 in co-culture show the same staining patterns as in mono-culture at 
ALI.  
 
4.5.4 A closer look at mono- and co-cultures  
As immunocytochemistry used on excised TWs and imaging these cultures using fluorescence 
microscopy is not the ideal method for identifying two different cell types in one model system 
when looking at them from the apical side, another method needed to be applied. Cross 
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sectioning of these models seemed the next best way of reaching this aim. As there is no 
histology department and not the essential equipment at Aston University these experiments as 
well as the electron microscopy analysis were performed in Birmingham University. Handling TW 
membranes is challenging and often the membrane is lost on the way through processing (figure 
4.11 and 4.12).  
H&E staining of HPF, C38 and IB3-1 mono-culture cross sections (figure 4.11) were obtained and 
show a tall pseudostratified like epithelium. In the next set of images antibodies to vimentin 
were used as an HPF marker to localize the fibroblasts in the co-culture system of C38 and IB3-1 
(figure 4.12) and fibroblasts were shown to be located underneath the epithelium, which 
maintained a pseudostratified like appearance. No fibroblast overgrowth was seen in any of 
these co-cultures, despite previous reports of fibroblast over-proliferation, especially when 
isolating primary epithelial cell from tissue samples (Heckman, 1983). The same finding was 
observed for HPF-Calu-3 co-culture when analysed using SEM (figure 4.18 and 4.20) as well as 
TEM (4.20 and 4.21). In all these micrographs the two layers of different cell types are readily to 
distinguish; with HPF underneath showing their specific morphology as being spindle shaped and 
Calu-3 are located on top of these presenting a tight confluent pseudostratified epithelium. The 
confluent layer showed the typical cobblestone like appearance. When looking at the SEM 
micrographs it seems like in the co-culture the apical surface of Calu-3 is a little smoother (figure 
4.18). TEM further revealed that in both models Calu-3 showed the appearance of a 
pseudostratified epithelium with TJs, microvilli and secretory granules. These pictures are very 
similar to what has been shown by Grainger in 2006 and supports our theory that fibroblasts do 
not overgrow the epithelium under the right conditions (Grainger et al., 2006). 
C38 and IB3-1 mono- and co-cultures were also analysed using SEM and morphologically there is 
no difference to be seen comparing mono-cultures to co-cultures and the typical cobblestone 
appearance is very prominent. Both cell lines grew to a confluent epithelium in both model 
systems. It was also possible to verify the presence of apical microvilli and cilia like extensions, 
which in some cases could be immature cilia, on all seven model systems by using SEM (figure 
4.15, 4.17 and 4.19). For Calu-3 mono-cultures it has been summarised before that there can be 
significant differences in certain cell specific features such as cilia when comparing results of 
different laboratories, which could be down to different culture conditions and passage numbers 
(Grainger et al., 2006). Grainger also found small microvilli on submerged cell cultures, which 
were more prominent in cultures at ALI but this work also emphasizes that they resemble 
immature cilia or extended microvilli rather than fully developed ones (Grainger et al., 2006).  
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To conclude, the methods presented in this chapter and their outcomes helped to successfully 
identify cell type specific marker antibodies for future analyses of cross-sections. Anti-vimentin 
and anti-CK8 can be used for identifying HPF and epithelial cells, respectively in the co-culture 
models. IHC staining on co-cultures and vimentin staining on cross sections also show that there 
is no fibroblastic overgrowth, fibroblasts are located subepithelial and both cell types show 
specific morphology, next to expressing cell type specific markers. 
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5 Chapter 5 Characterisation of functional properties of mono- 
and co-culture models  
5.1 Introduction 
The data presented in the previous chapters have determined that collagen type IV is a suitable 
growth substrate, have identified the culture media to be used for co-culturing HPF together 
with one of the epithelial cell lines C38, IB3-1 or Calu-3 and have used antibodies against cell 
type specific markers in paraffin embedded cross sections to identify the distribution of each cell 
type in the co-culture models. Furthermore the presence of microvilli and immature cilia was 
verified in cultures at air-liquid interface and now the next task was to look at additional 
essential features for modelling human airways in vitro for non-CF and CF human airways. 
Further analysis of mono-and co-cultures was carried out to identify whether additional essential 
features, such as epithelial cell integrity and barrier formation (tight junctions) were present in 
this model. Furthermore, preliminary analysis of air-surface secretions (ASL) for the presence of 
mucin and proteolytic enzyme activity was carried out.  
 
The airway epithelium is a complex and active physicochemical barrier and primarily protects the 
airways and the whole organism by acting as a first line of contact with the outer environment. It 
protects the respiratory tract from inhaled particles and pathogens, such as bacteria and viruses. 
The cells in the respiratory tract form complex connections with adjacent cells to ensure three 
dimensional structure and normal function is maintained (Breeze and Wheeldon, 1977, Gail and 
Lenfant, 1983). In the large airways a pseudostratified epithelium is found, where every 
epithelial cell is attached to the basement membrane (BM). The major epithelial cell types of the 
large airways are basal, columnar, ciliated and secretory cells (goblet cells) (Knowles and 
Boucher, 2002, Breeze and Wheeldon, 1977). In order to maintain the integrity of the 
epithelium, the basal cells are strongly attached to the BM through hemidesmosomes, which 
additionally give mechanical integrity. In a similar manner basal cells are connected to the 
columnar cells via desmosomes, which also create trans-cellular networks throughout the tissue 
and provide certain resistance to mechanical stress (Green and Jones, 1996). Additionally 
epithelial cells form a permeability barrier between two compartments, which inhibits molecules 
and ions crossing via the intercellular route (Stevenson et al., 1986). This sealing connection 
where the columnar cells are adjoined is achieved by the tight junctions (TJ), which are located 
most apically and close to the lumen. This strong barrier formation plays its important role in 
lung innate immune function by selective blocking of the paracellular pathway (Farquhar and 
 142 
 
Palade, 1963). Another part of innate immune protection in the airways is the production and 
secretion of mucus. Secretory epithelial cells produce mucus that forms a thin lining on the 
luminal side of the airways on top of the PCL (Gail and Lenfant, 1983, Knowles and Boucher, 
2002). The viscoelastic mucus layer is responsible for entrapping any inhaled pathogens and 
inhaled particles, which reach the airways through every breath (Voynow and Rubin, 2009). 
Airway mucus consists of a mixture of water, ions and mainly of two of the oligomeric 
glycoprotein mucins, MUC5AC and MUC5B (Thornton and Sheehan, 2004, Breeze and 
Wheeldon, 1977). This mixture of mucus, entrapped pathogens and particles is in healthy 
airways moved towards the pharynx by the net movement of cilliary beating, where it is 
swallowed (Gail and Lenfant, 1983).This defence mechanism is called the mucociliary escalator 
(MCC) (Crystal et al., 2008). As already described in chapter one this whole situation is different 
in CF, where a CFTR mutation leads to dehydrated ASL and hypersecretion of mucus, which then 
entraps and impairs cilliary beating leading to vast amounts of stationary mucus in the lungs that 
invites bacteria to colonize this habitat and results in chronic infections in CF patients (Knowles 
and Boucher, 2002, Matsui et al., 2005). 
Normal lung function is controlled by various different mechanisms, cells and chemokines, just 
to name a few influential aspects. The structure of the lung, which is supported by the 
scaffolding network of ECM is also essential to maintain lung function and the ECM synthesis and 
degradation needs to be tightly controlled. Next to other residential cell (neutrophils), epithelial 
cells secrete proteolytic enzymes called matrix metalloproteinases (MMPs), which are 
responsible for controlled ECM turnover (O'Connor and FitzGerald, 1994). Human bronchial 
epithelial cells express MMPs, which have a broad spectrum of degradation substrates, including 
collagen IV and, importantly MMPs were found to be increased in bronchoalveolar lavage (BAL) 
of CF children compared to healthy controls (Sagel et al., 2005). The increased amount of MMPs 
has been suggested to play a role in the tremendous tissue destruction found in some CF 
patients but further research is need to link certain MMPs directly to CF lung disease (Sagel et 
al., 2005, Greenlee et al., 2007).  
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5.2 Aims 
Since the growth and culturing conditions have been determined and cell specific marker 
antibodies that can be used to distinguish between epithelial cells and HPF it was now the aim to 
characterise the typical, essential functional features for these in vitro models. 
In order to achieve further characterisation the electrical resistance properties of HPF and the 
epithelial cell lines were determined in mono- and co-cultures. 
The second aim was to investigate the expression and location of the TJ protein ZO-1 under 
submerged condition and at ALI.  
Another important feature that was analysed was the directional MUC5AC secretion of mono-
and co-cultures.  
The last aim here was to investigate whether there is any MMP-activity present in apical 
secretions of these cultures. 
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5.3 Methods 
5.3.1 Cell culture on TWs 
Briefly, (see 2.4.6 for detailed description) for mono-cultures of HPF, C38, IB3-1 and Calu-3, cells 
were seeded apically onto TWs at 3 x10
4
 cells/well. Calu-3 cells were seeded in full DMEM/F12, 
whilst C38 and IB3-1 cells were seeded in AEM. HPF cells were seeded in HPFM. Cells were 
cultured submerged for four days before ALI was established on epithelial cell cultures. The 
apical medium on HPF was refreshed as was the basolateral medium of all cells. Medium was 
refreshed twice a week. 
For co-cultures HPF cells were seeded exactly as described above and apical HPFM was removed 
4 days after seeding to allow epithelial cell seeding in AEM at a cell density of 5 x 10
4
 cells/well. 
At this point also the basolateral medium was changed to the epithelial medium used in the co-
culture. Again four days of submerged culture followed before ALI was established to induce 
differentiation of the epithelial cell layer. 
 
5.3.2 Transepithelial electrical resistance (TER) measurements on mono- 
and co-cultures 
TER is a measure of the resistance to ion flux across the epithelial cell layer, which reflects the 
degree of confluence and the tightness of the cell barrier (Foster et al., 2000). TER is commonly 
used in airway related research working with cell cultures at ALI as it is convenient, reliable and 
non-destructive to the cell layer. It allows monitoring of the growth of epithelial tissue cultures 
in vitro and to monitor the formation of epithelial cell layer integrity, which also indicates the 
presence of TJs.  
Briefly, the chopstick electrodes were sterilised by immersing in 70% ethanol for approximately 
15 min before being used as shown and described in detail in chapter 2.9. The electrodes were 
rinsed every time in ethanol before moving on to the next cell line or another multi-well plate. 
Three readings per TW were taken and background TER of a collagen IV coated TW was 
subtracted from the average and multiplied by the surface area of the culture to give TER 
readings as Ω×cm2. TER was measured on day 0, day 4, day 7, day 11 and day 14 to create a TER 
profile for each epithelial cell line and for HPF 
 
 145 
 
5.3.3 Dot blot analysis of MUC5AC 
Air surface liquid secretions (from the apical compartment) of mono- and co-cultures, as well as 
basolateral medium, were collected on day 0, 10 and 14 to be analysed for the presence of 
MUC5AC, the main mucin in airways mucus. Sample collection as described in 2.10 was either 
followed by immediate analysis or samples were frozen at -80°C till analysis. After preparing the 
dot blotter, samples were applied and driven through the nitrocellulose membrane by a vacuum 
pump. Blocking of the membrane was followed by exposure to a monoclonal anti-mouse 
muc5AC antibody overnight before the membrane was treated with secondary antibody 
followed by ECL for 5 min to make the visualization of MUC5AC possible by detection of the 
exposed light on a photographic film. 
 
5.3.4 Zymography for MMP activity 
Gelatin zymography is a common method for analysing the expression of the gelatinase matrix 
metalloproteinase-2 (MMP-2) in cells and media samples. After collecting the ASL samples 
(carried out in the same manner as for the dot blot) these were either frozen at -80°C or directly 
prepared for zymography. The 10% gelatin zymograms were bought from Invitrogen (Novex®) 
and were used as recommended by the manufacturer.  
After the gels were mounted in the running chamber and Tris-glycine SDS running buffer was 
added the samples were loaded in non-reducing sample buffer (Novex®) as well as recombinant 
MMP-2 standard (Peprotech; 62kDa).  
After electrophoresis at 120V for 60 minutes, the gel was washed (4 x 15 min) with 2.5% (v/v) 
Triton X-100 in incubation buffer (50mM Tris-HCl, 10mM CaCl2, 1mM ZnCl2 , pH 7.6), to remove 
SDS and renature the MMP-2 species in the gels. Gels were then placed into incubation buffer 
for at least 72 hours at 37°C. This induced gelatin lysis by renatured MMP-2. The gels were 
incubated in staining solution (1 % (w/v) Coomassie Blue G in 40 % (v/v) methanol and 10 % (v/v) 
acetic acid) for 20 minutes, before de-staining in 40 % (v/v) methanol and 10 % (v/v) acetic acid 
until the gelatinolytic activity was apparent as clear bands on a blue background. 
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5.4 Results 
5.4.1 TER profiles of mono- and co-cultures grown at ALI 
The development of co-culture systems (HPF-C38, HPF-IB3-1 and HPF-Calu-3) was the overall 
main aim of this study, as the first step towards developing a useful test platform system to 
mimic CF airways disease. In order to validate the disease model, it was also just as important to 
produce a reliable, realistic non-CF model of the airways. One critical feature of such a model is 
epithelial cell integrity and associated barrier function (Foster et al., 2000). The TER reflects this 
integrity, although the intrinsic electrical resistance across the epithelial cell layer is different for 
the different epithelial cell lines used for the co-culture models.  
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Figure 5.1 TER development of monocultures of HPF (pale green), C38 (light green) and co-cultures of HPF-
C38 (dark green) over 14 days.  
HPF were kept submerged and C38 mono- and co-cultures were cultured at ALI. Mono-and co- cultures 
with C38 show equal values of TER after 11 days of culture. TER is expressed as measured resistance per 
area (cm
2
) of the cell layer and background TER of an empty TW coated with collagen IV was subtracted 
from the reported values. In each of the three separate experiments TER of 8 individual TWs were 
measured in triplicate and data are presented as mean ± SD. 
 
In figure 5.1 changes in TER over time for HPF-monoculture (submerged), C38 mono-culture and 
HPF-C38 co-culture (both at ALI) are presented. HPF mono-cultures do not show any increase in 
the electrical resistance measured over this 14 day period shown and the overall average TER 
was 8.85 ± 0.89 Ω x cm
2
. In contrast, the TER of the epithelial cell line C38, even in mono-culture, 
at 19.48 ± 3.8 Ω × cm
2
, was more than twice as high compared to HPF mono-culture on day 0. 
For C38, TER showed a steady increase up to day 7, after which it plateaued. The final TER of C38 
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mono-culture after 14 days at ALI was 50.3 ± 1.12 Ω × cm2. HPF-C38 co-culture TER was 
observed and found to show the same steady increase as mono-cultures but the initial TER on 
day 0 was with 10.52 ± 3.94 Ω x cm
2
 significantly lower than for C38 in mono-culture. 
Throughout the increase over time this significantly lower TER was also found for day 4 and day 
7 but by day 11 the co-culture TER reached 48.26 ± 1.32 Ω x cm
2
, which is equivalent to C38 
mono-cultures.  
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Figure 5.2 TER developments of HPF (pale orange), IB3-1 (orange) and HPF-IB3-1 (red) over 14 days. HPF 
were kept submerged and IB3-1 mono- and co-culture were cultured at ALI. Mono-and co- culture show 
equal values from day 4 onwards up to day 14 of culture. TER is expressed as measured resistance per 
area (cm
2
) of the cell layer and background TER of an empty TW coated with collagen IV was subtracted 
from the reported values. Data presented as mean ± SD. In each of the three separate experiments 8 TWs 
were measured in triplicate. 
 
In figure 5.2 TER profiles for HPF mono-cultures, IB3-1 mono-culture and HPF-IB3-1 co-culture 
are presented. The electrical resistance of HPF mono-cultures did not increase over time. IB3-1 
mono-cultures show a steady increase from day 0 (18.81 ± 4.78 Ω × cm2) up to day 14 (53.92 ± 
2.1 Ω × cm2). The TER of HPF-IB3-1 co-cultures showed a rapid increase straight after day 0 
(25.38 ± 1.5 Ω × cm2) and carried on increasing till day 11 (53.83 ± 0.45 Ω × cm2). On day 14 TER 
was found to be at the same level (53.38 ± 1.99 Ω × cm2) for mono- and co-cultures.  
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Figure 5.3 TER profiles of HPF (pale blue), Calu-3 (light blue) and HPF-Calu-3 (dark blue) over 14 days. HPF 
were kept submerged and Calu-3 mono- and co-culture were cultured at ALI. Mono-and co- culture show 
equal values on day 11 but at day 14, the mono-culture continued to increase and reached a significantly 
higher TER compared to the co-culture. TER is expressed as measured resistance per area (cm
2
) of the cell 
layer and background TER of an empty TW coated with collagen IV was subtracted from the reported 
values. Data presented as mean ± SD. In each of the three separate experiments 8 TWs were measured in 
triplicate. 
 
HPF mono-cultures do not show an increase in electrical resistance over time, whereas TER 
measurements of Calu-3 mono-cultures and HPF-Calu-3 co-cultures showed a steep, time-
depdendent increase in TER. TER of the mono-culture model was measured and was 19.99 ± 
2.54 Ω × cm2 on day 0. The electrical resistance continously increased up to 399.55 ± 37.99 Ω × 
cm
2
 on day 14. The co-culture model had an electrical resistance of 69.66 ± 2.14 Ω × cm2 on day 
0 and after a steady increase over 14 days the resistance reached 291.96 ± 14.90 Ω × cm2. The 
TER of HPF-Calu-3 co-cultures was significantly lower on the last day measurment compared to 
the mono-culture. 
  
 5.4.2 Immunostaining of zonula occludens
cultures  
5.4.2.1 ZO-1 expression under submerged conditions
 
Immunostaining with an antibody against the tight junction protein ZO
submerged mono-cultures of HPF, C38, 
Figure 5.4 Representative images for staining of the tight junction protein Zonula Occludens
submerged mono-cultures of C38, IB3
counterstained with DAPI and ZO
and the bar corresponds to 31µm. The images show that ZO
submerged conditions (arrows). Images
wells stained per antibody. 
 
For submerged C38 and IB3
looked rather scattered throughout the cell, rather than concentrated a
junctions. C38 seemed to show less expression compared to IB3
expressed ZO-1 and the protein showed the typical junctional staining pattern for distribution 
can be identified as continous rings at cell
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-1 (ZO-1) on mono
 
IB3-1 and Calu-3 on collagen IV coated 4
-1 and Calu-3 cultured on collagen coated 4
-1 is shown in green (FITC labelled antibody). Magnification is 63 times 
-1 is present in epithelial cells cultured under 
 are representative of 3 individual experiments, with duplicate 
-1 mono-cultures low expression of the TJ protein was observed and 
-1. Calu
-cell contacts. 
- and co-
-1 was performed on 
-well slides.  
 
-1 (ZO-1) in 
-well slides. Nuclei were 
t the intercellular 
-3, however, strongly 
 5.4.2.2 ZO-1 expression in mono
Figure 5.5 Representative immunostaining images for the tight junction protein Zonula Occludens
of mono- and co-cultures of HPF, C38, IB3
kept submerged throughout the experiment. Nuclei were count
green. All epithelial cells showed ZO
subepithelial cell layers promote TJ protein expression in co
corresponds to 31µm. Images are representative of 3 individual experiments, with duplicate wells stained 
per antibody. 
 
When HPF were cultured on TWs under submerged conditions they showed scattered staining 
for ZO-1 (green), whereas the epithelial cell lines all 
mono-and co-culture. Mono
which is shown as the ring staining around each cell with partial interruptions where scattered 
green staining is shown. Cal
staining of the tight junction protein ZO
cytoplasmic staining. The co
very similar to the patterns observed for the mono
staining now appeared more concentrated at the periphery. ZO
again the typical ring staining around cells was observed. For HPF
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-and co-cultures grown at ALI 
-1 and Calu-3 cultured on TW for 14 days at ALI but HPF were 
erstained with DAPI and ZO
-1 expression in mono-and co-cultures when grown at ALI. HPF 
-culture. Magnification is 63 times and the bar 
show strong, peripheral ZO
-cultures of C38 and IB3-1 both show the typical ZO
u-3, in contrast, show a very clear staining only showing typical ring 
-1 around the cell periphery with no background or 
-culture staining profiles of ZO-1 for HPF-C38 and HPF
-cultures, with the major difference that 
-1 staining is very prominent and 
-Calu
 
-1 (ZO-1) 
-1 is shown in 
-1 expression in 
-1 staining, 
-IB3-1 look 
-3 the staining is very 
 prominent, clean and showed what looked like a nice even layer of cells, which were all in focus 
and so were the typical ZO
revealed that this was at the most apical,
the location of ZO-1 in the TJ complex.
 
5.4.3 MUC5AC secretion by mono
Identification of mucin secretion was performed using dot blot analysis with a monoclonal 
antibody against MUC5AC, w
(Guyonnet Duperat et al
compartments of all mono
Figure 5.6 Dot Blot analysis of mucus secretion by HPF (submerged cultures), C38 and IB3
co-culture before establishing ALI and at ALI by using a MUC5AC antibody. 
Negative controls and samples were applied in duplicates as followed: lane A: 1+2 = PBS; 3+4 = 1% BS
5+6 = AEM, 7+8 = DMEM/F12; For all the other lanes, black boxes indicate where apical samples were 
loaded and white boxes show where basolateral samples were loaded. All samples were loaded as the 
neat, undiluted sample (upper dot of the pair) and 1:2 d
submerged HPF cultures are shown: 1+2, apical, day 10, 3+4, apical, day 14, 5+6, basal, day 10, 7+8, basal, 
day 14; In lane C the results of HPF
basal, day 10, 7+8, basal, day 14; In lane D the results for HPF
described for HPF-C38. In lanes E and H the results for IB3
and day 14 (5-8), where 1+2 were apical,
again. In lanes F and G the results for C38 mono
1+2 in both lanes were apical samples and 3+4 were basal samples; also in both lanes 5+6 we
samples and 7+8 were basal samples. In lane I samples of C38 (1
ALI was established, were analysed with 1+2: C38, apical and 3+4: C38, basal; 5+6, IB3
IB3-1, basal. Overall MUC5AC was onl
controls were negative for MUC5AC. Data presented are representative of 3 individual experiments.
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-1 rings around each cell. Z-stack analysis of the ZO
 luminal aspect of each cell type, which correlates with 
 
-and co-cultures  
hich is one of the two major mucins expressed in the airways 
., 1995, Kirkham et al., 2002). Samples from apical and basolateral 
- and co-cultures were analysed (figures 5.6 and 5.7). 
 
ilution (lower dot). In lane B samples from 
-C38 co-culture are shown: 1+2, apical, day 10, 3+4, apical day 14, 
-IB3-1 are shown in the same order as just 
-1 mono-cultures are shown with day 10 (1
 3+4 were basal and where 5+6 were apical and 7+8 were basal 
-cultures are shown with day 10 (1
-4) and IB3-1 (5
y observed in apical samples and only after ALI was established. All 
-1 staining 
 
 
-1 in mono-and 
A, 
5+6, 
-4) 
-4) and day 14 (5-8). 
re apical 
-8) mono-cultures before 
-1, apical and 7+8, 
 
 The dot blot shown in figure 5.6 shows the results of qualitative analysis of MUC5AC secretion by 
the established mono- 
MUC5AC either to the apical side (lane B, 1
cultures (lane F and G) and IB3
to the apical surface (black boxes), no MUC5AC was observed in the basolateral medium (white 
boxes). However, this was only observed after ALI 
samples of day 0 (before ALI was established) were analysed and were negative for MUC5AC for 
C38 mono-culture (lane I, 1
(lane C) only secreted M
(white box) was found to be negative for MUC5AC antibody staining. For HPF
(lane D) the same secretion profile was observed. MUC5AC was observed in the apical samples 
(black boxes) but not in the basolateral medium (white box). The controls, including full culture 
medium, shown in separate grey boxes in lane A (each in duplicate) were all found to be 
negative for MUC5AC.  
 
Figure 5.7 Dot blot analysis of mucus secretion
In lanes A and B samples of Calu
basolateral medium samples in well 5
collected on day 10 of culture, whereas lane B shows samples of day 14 of culture. In lane C samples of 
day 0 (before ALI) are shown. Using the same dilutions HPF
same way, with apical samples in wells 1
lanes. Here lane D shows the results for samples collected on day 10 and lane E shows samples of day 14 
of culture. Samples collected on day 0 were loaded in wells of lane F. The last lane shows 4 grey b
where negative control were applied in duplicates in the following order: PBS (1+2), 1% BSA (3+4), AEM 
(5+6) and DMEM/F12 (7+8). Data presented are representative of 3 individual experiments.
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and co-culture models. HPF in submerged culture did not secrete 
-4) or to the basal side (lan
-1 mono- cultures (lane E and H) were found to secrete MUC5AC 
was established as apical and basolateral 
-4) and also for IB3-1 mono-culture (lane I, 5
UC5AC to the apical side (black box) and again the basolateral medium 
 by Calu-3 mono- and co-culture using a MUC5AC antibody
-3 mono-cultures were applied with apical samples in well 1
-8 in the dilutions mentioned in 2.10. Lane A shows samples 
-Calu-3 co-culture samples were applied in the 
-4 of lane D-F and with basolateral samples in wells 5
e B: 5-6). C38 mono-
-6). HPF-C38 co-culture 
-IB3-1 co-culture 
 
 
-4 and 
-8 of these 
oxes 
 
 The dot blot presented in figure 5.7 shows the results of
Calu-3 mono-culture as well as for HPF
MUC5AC into the apical compartment only, when cultured at ALI (A and B, 1
also detected in apical supernatants th
established (C, 1-4). For none of these serial dilutions (well 1
was observed. The same secretion pattern was observed for HPF
MUC5AC detection signal was quite weak and even was undetectable in any of the highest 
dilutions (lane D-E, well 4). Basolateral medium samples were observed to be negative for all 
analysed samples apart from one (lane A, 6), which showed weak staining. No MUC5AC was 
detected in any of the controls applied to the dot blot (G).
5.4.4 MMP activity in apical 
 
Figure 5.8 MMP activity in apical supernatants of Calu
Aliquots of apical secretions of Calu
zymogram. Activated MMP
weight of 62 kDa (as given by manufacturer)
whereas the apical secretions of IB3
presumably the latent form of the enzyme at an apparent molecular weight of 72 kDa, higher than the 
activated form of enzyme with a molecular weight of 62kDa. The lower band falls exactly in the same 
position as the purified MMP
 
Figure 5.8 shows air surface liquid collected from Calu
that were subjected to gelatin zymography. Only for IB3
proteolytic activity was observed as clear bands on the zymogram, where the substrate gelatin 
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 MUC5AC analysis for secretions from 
-Calu-3 co-culture. Mono-cultures of Calu
at were collected on day 0, which was before ALI was 
-4) a difference in detection signal 
-Calu
 
surface liquid 
 
-3 and IB3-1 
-3 and IB3-1, along with purified, activated MMP
-2 exhibits a distinct characteristic band of active enzyme with a molecular 
. Apical secretions of Calu-3 did not exhibit any bands, 
-1 mono-culture contained two distinct bands, which were 
-2. (Gel is representative of n=3). 
-3 mono-cultures and IB3
-1 mono-culture’s apical secretions 
-3 secreted 
-4). MUC5AC was 
-3 co-cultures but the 
-2 were applied to a 
-1 mono-cultures 
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was digested. In those three lanes of IB3-1 secretions, two distinct bands were identified, of 
which the lower one corresponds to activated MMP-2. The second band was seen at a slightly 
higher molecular weight, corresponding to the inactive form of the enzyme at 72kDa. Thus these 
data show that these enzymes are proteases of metalloproteinase origin. As there are two bands 
shown for IB3-1 secretions this indicates presence of the active as well as the latent form of a 
gelatinase, which is most likely MMP-2.  
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5.5 Discussion 
In this chapter the main focus was directed towards essential airway features which make the 
proposed in vitro models a valuable tool for further investigating CF airways pathogenesis in 
addition to other in vitro and in vivo models that already exist.  
The co-culture models employed fibroblasts as well as epithelial cells in one system with direct 
intercellular contact. The challenge was now to demonstrate that these fibroblasts support 
epithelial cell differentiation, which has partially been done in chapter 3 and 4 but additional 
essential features were analysed here. One of these features was cell layer integrity of the 
epithelial cell layer and whether this is supported by the addition of pulmonary fibroblasts. This 
was addressed by TER measurements as well as staining for TJ protein expression (ZO-1). 
Furthermore, directional MUC5AC expression by mono-and co-cultures was observed as well as 
proteolytic enzyme activity in apical secretions of these models.  
 
5.5.1 Epithelial cell layer integrity in mono- and co-cultures of C38 and 
IB3-1 
One way of analysing epithelial barrier formation was to measure the electrical resistance across 
the epithelial cell layer in mono-and co-cultures. TER is an accepted way of measuring cell layer 
integrity, and is convenient, reliable and non-destructive. Measurements were first carried out 
on mono-cultures of HPF, C38, IB3-1 and Calu-3. For HPF no change in electrical resistance across 
the TWs over time could be identified, which fits with results found by Myerburg et al. (2007) 
and supports that HPF do not form impermeable barriers themselves (day 0 = 8.03 ± 0.42 Ω x 
cm
2
, day 14 = 9.54 ± 0.18 Ω x cm
2
), even when grown over 14 days to a multilayered cell 
population on TWs. This indicates that the TER measured in these co-culture models is 
established by the epithelial cell layer and is not a function of the fibroblasts. 
Similar final TER values were reached, when comparing mono-cultures of C38 and IB3-1; thus 
after 14 days at ALI C38 mono-culture TER was 50.29 ± 1.12 Ω x cm
2
, whereas for IB3-1 mono-
culture it was 53.93 ± 2.11 Ω x cm
2
. IB3-1 TER was higher but was not found to be significant, 
which was different after the addition of HPF. 
At first the TER results of co-cultures of HPF with C38 or IB3-1 were similar. HPF-C38 co-cultures 
reached a final TER of 48.26 ± 1.32 Ω x cm
2
 and IB3-1 in co-culture with HPF reached a final TER 
of 53.38 ± 1.99 Ω x cm
2
. Interestingly when cultured with HPF, IB3-1 reach significantly higher 
TER values for every day of measurement compared to HPF-C38 co-cultures. These findings 
match what has already been reported by Nilsson et al. (2010), who also found higher TER in CF 
 156 
 
cell lines compared to non-CF cell (Nilsson et al., 2010) This provides evidence for a relevant 
feature of the disease in the presented model systems. As suggested by Nilsson et al. (2009) 
functional CFTR is necessary for correct ionic conductance of TJ. This group has compared the 
cell lines CFBE410- (CF) and its plasmid corrected counterpart CFBE41o- pCep4 for their ability to 
establish an epithelial barrier over time on TWs and found that the CF cells used here also show 
a significantly higher TER. Furthermore this group has also shown that the CFTR inhibitor CFTRinh-
172 is able to increase the TER in the non-CF cell line 16HBE14o-, also shown in the reverse 
direction by using CFTR activators, which caused a drop in TER in 16HBE14o indicating a 
connection between CFTR and TJ ionic permeability. On top of these findings this group has 
shown that the decrease in TER was paralleled by an increase in permeability and the other way 
around (Nilsson et al., 2010). Similar results were found when HTE cells were treated with CFTR 
inhibitor. The short circuit current measured before and after complete abolishment of CFTR 
function was shown to drop (Perez et al., 2007).  
The data of this present study show clearly that HPF do not interfere with epithelial 
differentiation at ALI in these co-culture models under the determined culture conditions and in 
support of others the co-cultures show the CF presented higher TER.  
 
5.5.2 Epithelial cell layer integrity of Calu-3 mono- and co-cultures 
Looking at TER of Calu-3 mono-cultures and co-cultures it was clear that after the culture period 
of 14 days at ALI the co-culture TER is still lower (291.96 ± 14.9 Ω × cm2) compared to the mono-
culture (399.55 ± 37.99 Ω × cm2). For Calu-3 mono-cultures it was reported that in general the 
maximum TER is reached between day 10 and 14 of culture (Florea et al., 2003), however this is 
the first time that a co-culture of this combination and under these conditions was analysed and 
it is possible that these cultures take longer to reach similar values to the mono-culture. These 
were not monitored for longer time periods in this project but there is a possibility that the co-
culture will eventually reach a TER as high as measured for the mono-culture. Calu-3 mono-
cultures were shown before to vary in the final TER values drastically. There is a report showing 
TER >1000 Ω × cm2 (Mathia et al., 2002) compared to some that show TER values around 300 Ω 
× cm
2 
(Grainger et al., 2006, Wan et al., 2000), even when using similar techniques. These 
reports underline that there is a lot of variability found in final TERs for this cell line, which can 
be due to laboratory differences in handling cells or different passage numbers, for example, as 
well as growth conditions, such as choice of medium, choice of TW, as they are available with 
different membranes, as well as choice of TW coating (fibronectin, collagen IV etc.). 
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The data presented here (figure 5.3) show that from day 7 onwards Calu-3 mono and co-cultures 
both show a higher TER than the highest TER measured for C38 or IB3-1. Again Calu-3 do show 
essential features for airway modelling in vitro, such as TJ protein expression (Wan et al., 2000) 
and MUC5AC secretion, however tremendous differences of TER values between mono- and co-
cultures seen here and the fact that Calu-3 vary in their cell layer integrity drastically among 
different reports, it seems that Calu-3 are not the cell line of choice to serve as a non-CF model. 
Additionally this cell line was shown to also behave very differently compared to the other two 
epithelial cell lines and therefore Calu-3 are not likely to be a non-CF control in this project. As 
Calu-3 originated from a lung adenocarcinoma lines there are likely to be tremendous 
differences between these cells and C38 and IB3-1. It is recommended to only compare cells that 
originate from the same donor as the genetic background will be different otherwise, which 
might have an effect on several things rather than only CFTR function (Nilsson et al., 2010, Perez 
et al., 2007). Also if cells originate from different diseases it is likely that they are exposed to 
very different environments, which will influence the cell phenotype. 
 
5.5.3 Tight junction expression in mono-and co-cultures 
In addition to the TER data presented in this study fluorescence microscopic imaging of ZO-1 
protein expression was performed following immunostaining of submerged mono-cultures as 
well as mono- and co-cultures grown at ALI. ZO-1 protein is one of the structural components of 
TJs and was identified in 1986 to be present in epithelial cells (Stevenson et al., 1986). Out of the 
three junctions forming the apical complex, TJs are located most apically and serve to selectively 
regulate the passage of neutral molecules and ions through the paracellular space. ZO-1 is found 
in the region of apicolateral borders, where cell-cell contacts have been arranged (Stevenson et 
al., 1986) , thus its expression pattern is typically rings around every cell. ZO-1 was clearly 
expressed in all three epithelial cell lines as shown in figures 5.4 and 5.5. For C38 and IB3-1 
typical, ring ZO-1 staining could only be observed when grown at ALI in mono-and co-cultures. In 
these cultures TJs appeared nearly continuous rings that were localized to the periphery of each 
cell. 
The ZO-1 expression observed for submerged C38 and IB3-1 was less continuous with greater 
incidences of breaks compared to the cultures at ALI, which indicates that tight junctions are 
formed under certain conditions by these two cell lines. In submerged culture, cells show a 
different cell organisation and morphology compared to their pseudostratified like appearance 
at ALI and this could prevent the ZO-1 colocalization with other necessary TJ components to 
form the typical ring seen around each cell at ALI. It appears that these cells might need the 
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establishment of an ALI, by exposure to air on the apical side of the epithelium, to promote 
differentiation into a pseudostratified confluent and tight epithelium as it has been reported 
before, for primary nasal and bronchial epithelial cells (Wiszniewski et al., 2006).  
In contrast, Calu-3 show clearly defined typical ZO-1 expression around each cell under 
submerged conditions as well as at ALI (figures 5.4 and 5.5). It has been previously reported that 
Calu-3 cultured on TW show continuous “rings” of stained ZO-1 around each cell under both 
conditions but in that study staining was weaker at ALI. This is in contrast to what was observed 
here but it could be down to the fact that cultures presented here were grown on 4-well slides 
rather than on TWs for submerged conditions (Grainger et al., 2006).  
Taken together results from TER measurements and ZO-1 staining both support that epithelial 
cell layer integrity is established and it was observed that in C38 and IB3-1, which had less 
continuous ZO-1 staining the TER was also lower when compared to Calu-3, which is in 
accordance with ZO-1 staining, which is continuous in Calu-3. Even though cell layer integrity is 
measured by TER and TJ are responsible for ion flow across the paracellular pathway in epithelial 
cells there is no clear, direct correlation between TER and ZO-1 expression and the data should 
be interpreted with care (Claude and Goodenough, 1973). For Calu-3 it has been shown that cells 
cultured at ALI produce a cell layer with greater similarity to the airway epithelial morphology 
and electrical resistance in vitro (Grainger et al., 2006), which is presented here for C38 and IB3-
1. It is clearly shown that in terms of TER and ZO-1 expression, C38 and IB3-1 are able to 
establish a cell layer showing airway epithelial cell morphology.  
Another interesting finding in the present study was that HPF grown under submerged 
conditions on TWs showed positive staining for ZO-1, which was perhaps not expected, given the 
absence of TER in this cell type, however, there were no continuous strands of ZO-1 at all, only 
very scattered staining with no particular organisation. This shows that the expression of ZO-1 
protein does not automatically mean functional TJ are present at site of adjacent cells. And this 
also underlines that the expression of ZO-1 protein does not necessarily correlate with 
increasing TER.  
The presence of TJs has been noted in other fibroblasts, for example, fibroblasts of ocular tissue 
were found to show similar pattern of TJ protein expression as is shown here. For ocular 
fibroblasts it was reported that these tight junctions did not form a belt and rather looked like TJ 
fragments scattered on the plasma membrane (Raviola et al., 1987).  
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5.5.4 MUC5AC secretion of mono- and co-cultures 
Another desirable essential feature for in vitro airway model systems would be measurable 
mucus production by the epithelial cells. As described in chapter 1 air-surface liquid (ASL) is the 
collective name for mucus and the periciliary liquid layer (PCL) underneath the mucus. In 
comparison to mucus, the PCL has low viscosity and lubricates the cilia, which can then beat 
frequently to propel the overlying mucus towards the pharynx (Thornton and Sheehan, 2004, 
Livraghi and Randell, 2007, Gail and Lenfant, 1983). One defining feature of CF airways 
pathogenesis is the impaired mucociliary escalator and deficient mucus clearance, as a result of 
dehydrated mucus and changes in the amount of gel-forming mucins expressed in the airways. It 
has been reported that MUC5AC mRNA was found upregulated after stimulation with bacterial 
products, however, mRNA might not be an accurate indicator of mucin quantities in the mucus-
gel as these glycoproteins can be expressed and be stored in cells before secretion (Kirkham et 
al., 2002). Furthermore the quantitative analysis of mucins found in different airways diseases 
(asthma, CF and COPD) showed that MUC5AC and MUC5B glycoforms appear in variable 
amounts but also that MUC5B in its low charge glycoform is increased in CF and COPD compared 
to asthma (Kirkham et al., 2002, Thornton and Sheehan, 2004). MUC5B needs to be analysed in 
future experiments to verify it is secreted and to see whther it is hypersecreted in IB3-1. In the 
study presented here all epithelial cell lines used were shown to secrete MUC5AC apically and 
C38 and IB3-1 only secrete MUC5AC after ALI was established. This identification was carried out 
by dot blot analysis, which does not allow accurate quantitation of mucin and therefore whether 
IB3-1 hypersecrete mucin still needs to be addressed.  
Dot blot analysis of Calu-3’s apical secretions showed very strong signals and they therefore 
appeared to secrete relatively high levels of MUC5AC, which could be down to the cellular origin, 
as they are derived from serous cells of submucosal glands of human airways (Ramesh Babu et 
al., 2004).  
HPF mono-culture were screened in this dot blot to see whether they still show a typical non-
mucus producing phenotype and also to confirm that the mucus produced could be correlated 
to the presence of differentiated epithelial cells in the co-culture models. IB3-1 and C38 
continued to apically secrete MUC5AC at ALI in mono- and co-cultures. The fact that co-cultures 
show MUC5AC secretion indicates that HPF do not inhibit this epithelial cell feature, which has 
also been found for HPF-Calu-3 but in this co-culture model MUC5AC secretion seemed to be 
much lower compared to the mono-cultures. Interestingly C38 and IB3-1 do not show any sign of 
MUC5AC secretion before ALI, indicating that differentiation is a necessary event before mucin is 
produced or released by these cells.  
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All models presented here produce and secrete MUC5AC, apart from the HPF mono-culture, 
which underlines the epithelial origin of MUC5AC found in these apical secretions. C38 and IB3-1 
only secreted MUC5AC after ALI was established and again this is completely different to Calu-3 
mono- and co-culture models, which secrete mucus before the established ALI.  
 
5.5.5 MMP activity in apical secretions of mono- and co-cultures 
Another hall mark of CF is the progressive lung destruction, which eventually leads to death, but 
for which the underlying mechanisms have not yet been completely elucidated. Proteolytic 
enzymes, such as MMPs, were reported to be upregulated in CF for the first time in 1995 
(Delacourt et al., 1995). These enzymes are collectively able to degrade most ECM components 
and therefore some of them (MMP-8, MMP-9) have been suggested to be partially responsible 
for this lung destruction if excessively secreted and activated. In BAL fluid of patients, even with 
mild lung disease, MMP-8 was found to be increased by 300-fold and MMP-9 by 116-fold. In the 
same study it was also shown that, although the specific MMP inhibitor, TIMP-1, was increased, 
this was only by 6-fold, which leads to an imbalance in activation and inhibition of the MMPs. 
Therefore there is evidence that these enzymes play a role in the persistent lung destruction in 
CF (Ratjen et al., 2002).Whilst there is limited evidence on the roles and expression of MMP-2 in 
the CF lung it has been suggested that MMP-2 is involved in CFTR channel regulation in human 
airways. Using a MMP inhibitor (phenanthroline) an increase of the short circuit current was 
observed. Additionally antibodies against MMP-2 were shown to have the same effect, whereas 
recombinant MMP-2 reduced the current. These short circuit profiles match the ones of CFTR 
(Duszyk et al., 1999) and further investigation of MMP-2 in CF airways might elucidate what 
direct input this enzyme has. 
Other MMPs have also been reported to play a role in CF lung disease. MMP-9, which is mainly 
produced by neutrophils has been found to be increased in sputum of children with CF and was 
correlated to increased inflammation and decreased lung function (Sagel et al., 2005), for 
example.  
In the presented models, proteolytic activity in apical secretions was only observed for IB3-1 
mono-cultures, which was shown as clear bands on the zymogram (figure 5.8), where the 
substrate gelatin was digested. In each sample of IB3-1 two clear bands were observed, with the 
second band located slightly higher on the zymogram, indicating a higher molecular weight, 
corresponding to the inactive form of the enzyme, whereas the lower one was located 
corresponding to the MMP-2 standard used, which had a molecular weight of 62kDa. Thus these 
data show that these enzymes are proteases of metalloproteinase origin. As there are two bands 
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shown for IB3-1 secretions this indicates presence of the active as well as the latent form of the 
present MMP, which is most likely MMP-2. MMP-2 is secreted by structural cells, such as 
epithelial cells but has not been extensively studied in CF. However, it has been reported that 
MMP-2 is upregulated by neutrophil elastase and this was found on mRNA level as well as for 
the enzyme activity in cell supernatants. Latent and active MMP-2 were significantly different 
compared to control (unstimulated) cells (Geraghty et al., 2007). This finding is very interesting 
as CF is characterised by an intense neutrophil dominated airway inflammation and huge 
amounts of free elastase have been reported to be present in CF patients, even in early stages of 
the disease (Konstan et al., 1994, Khan et al., 1995).  
 
In conclusion the results presented in this chapter show that the presented mono- and co-
culture models have additional features, which are required to develop a successful co-culture 
model for non-CF and CF human airways in vitro. For all models employing epithelial cells, it was 
shown that epithelial cell layer integrity was established after 14 days of culture and that the 
tight junction protein ZO-1 was also expressed in the apicolateral periphery of epithelial cells. 
Furthermore it has been shown that MUC5AC is secreted apically by the epithelial cells but not 
by HPF. Apical secretion were also analysed for proteolytic activity, which was only observed for 
IB3-1. All together it becomes clear that in mono- and co-cultures using these epithelial cell lines 
CF features are presented in the CF models but only when compared to their corrected 
counterpart, not when compared to Calu-3. The models presented show potential for further 
analysing the disease pathogenesis of CF. 
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6 Chapter 6 Inflammatory response of mono-and co-cultures to 
LPS 
6.1 Introduction 
It is known that CF lungs provide an environment which is readily infected by bacteria and that 
the developing chronic infection leads to significant lung damage and eventually results in 
patient mortality (Boucher, 2007). 
 
The airway epithelium is the interface between airways and inhaled pathogens where the 
epithelium plays a vital role in innate immune responses. The epithelium presents a physico-
chemical barrier and once this barrier is penetrated by bacteria, epithelial cells have direct 
contact with these opportunistic pathogens. Detection of bacterial infections in general occurs 
via pathogen-associated molecular patterns (PAMPs), such as LPS (Schroeder et al., 2002). LPS is 
an integrated component of the outer membrane of gram-negative bacteria and can be shed by 
bacteria during growth, exposure to antibiotics and death. These PAMPs are then presented to 
the host airway epithelial cells as well as to immune cells, which express pattern recognition 
receptors (PRR) on their cell surface and upon binding trigger a highly pro-inflammatory 
response. This response involves the production and release of pro-inflammatory cytokines and 
chemokines such as IL-8, which is considered the most important inflammatory mediator in CF. 
IL-8 causes a sustained neutrophil influx to the site of infection, where they in turn compound 
the initial infection and this leads to a non-resolving cycle of inflammation (Akira and Takeda, 
2004, Ratjen, 2009).  
 
LPS can mediate its pro-inflammatory effects in part, at least, by binding to the PRR Toll-like 
receptor 4 (TLR). TLRs play a crucial role in innate immunity as these receptors recognize the 
invader and rapidly cause an inflammatory response including the secretion of IL-8 (Greene et 
al., 2005b). In this specific case, TLR-4 cannot work on its own but rather a receptor complex 
delivers the signal. There are three core receptors in this signalling pathway of LPS, which are 
CD14, TLR-4 and MD-2. CD14 does not have an intracellular domain and cannot deliver a signal 
across the epithelial membrane and therefore transfers LPS to the complex of TLR-4/MD-2 to 
ensure downstream signalling occurs.TLR-4 has an intracellular domain that then recruits other 
proteins involved in this pathway to translocate NF-κB from the cytoplasm to the nucleus, where 
this complex then can activate the transcription of target genes, such as IL-8 (Kim et al., 2005a). 
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Common pathogens found in CF lungs are the opportunistic bacterium P. aeruginosa (Kipnis et 
al., 2006) and B. cepacia, which in the last two decades has gained notoriety as a pathogen in CF 
(Silipo et al., 2007) and isolated LPS of these types of bacteria were analysed here for their 
imunnologic affect on established mono- and co-cultures. Cell culture supernatants were 
analysed for IL-8 secretion as well as cell layer integrity and cell viability to test the functionality 
of these models compared to existing literature. 
  
 164 
 
6.2 Aims 
In this chapter submerged mono-cultures as well as mono-and co-cultures at ALI were exposed 
to LPS of B. cepacia J2135 and LPS of two different P. aeruginosa strains. One was a 
commercially available LPS from serotype 10 P. aeruginosa and the other was P. aeruginosa 
50DR isolated from CF sputum and provided by Prof Peter Lambert, Aston University. The aim 
was to investigate the influence of these common immunostimulatory stimuli found in CF on the 
presented models and to compare results with other published literature to determine 
functionality of these models and how well they reflect CF. 
In order to achieve these aims it was necessary to analyse cell viability of submerged mono-
cultures as well as of mono-and co-cultures at ALI after exposure to these three types of LPS. 
Furthermore monitoring of the cell layer integrity by measuring TER before and after the 
challenges was essential to estimate the affect LPS has on the barrier formation of mono-and co-
cultures at ALI. 
Another important aim was to measure the concentration of the chemokine IL-8 after exposure 
to LPS to identify whether an inflammatory response is induced or not 
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6.3 Methods 
6.3.1 Cell viability assay – Cell Titer Blue™ (Promega) 
Cell Titer Blue (CTB)
 
is an endpoint assay that provides a homogeneous, fluorometric method to 
monitor cell viability. Viable cells, which are metabolically active, can convert resazurin (blue 
with little intrinsic fluorescence activity) into its highly fluorescent product, called resorufin 
(pink). CTB was directly applied to fresh cell medium after samples have been collected and the 
plate was then incubated for 2 h at 37 °C prior to analysis. The fluorescent intensity was 
measured on a standard multiwell fluorescent plate reader (Spectramax Gemini XS, Molecular 
Devices, Berkshire UK) with a 560 nm excitation, and 590 nm emission wavelength. 
 
6.3.2 Transepithelial electrical resistance (TER) measurements 
TER of mono- and co-cultures on TWs was measured using an Epithelial Voltohmeter with STX2 
chopstick electrodes (World Precision Instruments) to monitor confluence and barrier formation 
of the epithelial cell layer. TER was measured on day 14 or just before exposure to live bacteria 
to verify epithelial cell confluence and intactness of epithelial cell layer and TJ formation. 
TER values reported in this work take into account the area of the cell layer (area of TWs = 
0.33cm
2
) and are expressed as Ωcm
2
. Triplicate measurements were taken for TW and the 
background resistance, which was typically between 100-120 Ωcm
2
 (cell-free collagen IV coated 
TW) was subtracted from the average of a triplicate measurement.  
TER was measured immediately before and straight after the 24 h incubation with live bacteria 
to analyse whether this cell layer integrity was affected and changed compared to the control 
TWs. 
6.3.3 Bacterial growth conditions 
P. aeruginosa 50DR and B. cepacia J2315 were grown in MHB at 37°C and placed in a shaker at 
150 rpm over night or were plated out on MHA plates and incubated in a 37°C incubator. 
Bacteria were also stored on MicroBank beads (Pro-Lab Diagnostics, Ceshire, UK) at -70°C until 
required. 
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6.3.4 Phenol extraction of LPS 
The detailed description of LPS extraction can be found in Chapter 2.13. Briefly LPS was isolated 
from Pseudomonas aeruginosa 50DR (P. aeruginosa) and Burkholderia cenocepacia J2315 (B. 
cenocepacia), which are both CF relevant bacterial strains. These bacteria cultured overnight on 
MHA plates at 37 
°
C. On the next day, one colony was picked to be used to inoculate another 
overnight culture (100ml) in sterile MHB at 37 
°
C on a shaker. Afterwards a sterile MHB was 
inoculated, grown over night and transferred into 2 litres of sterile MHB the next day and 
incubated 48 h. Test for purity of the bacterial cultures was carried out before each culture was 
centrifuged to pellet the bacteria. After washing these were re-suspended in sterile water and 
aqueous phenol (80 
°
C) was added and the suspensions were stirred for 30 min followed by 
centrifugation for 20 minutes. Centrifugation yielded 2 distinct phases, the upper phase 
(containing the LPS) was recovered and transferred into a cellulose acetate dialysis membrane 
tubing and dialysed against running water for 4 days to remove the phenol. After collection of 
the dialysate, magnesium sulphate was added to a final concentration of 10 mM to encourage 
LPS micelle formation. After ultracentrifugation pellet of LPS was re-suspended in 10 ml sterile 
H2O and frozen in liquid nitrogen and LPS was freeze dried, weighed and a stock solution 
prepared and sterilised by filtration. This was further diluted in sterile AEM (serum free) to make 
a stock solution of 1 mg/ml which was stored at -20 
°
C until required.  
 
6.3.5 LPS treatment of submerged mono-cultures and of mono- and co-
cultures at ALI 
LPS from P. aeruginosa 50DR (P. aeruginosa), B. cepacia and P. aeruginosa serotype 10 (P. 
aeruginosa 10; obtained from Sigma Aldrich Ltd) were used at 0.1, 1, 10, 100 and 1000ng/ml to 
treat mono- and co-cultures under submerged conditions or at ALI.  
For submerged conditions, cells were seeded onto 24-well plates at a cell density of 1 x 10
5
 
cells/well in full growth medium. After 24 h incubation under standard conditions the full 
medium was replaced with serum-free (SF) medium containing ITS supplement (1.0 mg/ml 
insulin from bovine pancreas, 0.55 mg/ml human transferrin and 0.5 μg/ml sodium selenite; ITS, 
Sigma), normocin (50mg/ml) and 2mM L-glutamine. For AEM and HPFM, the manufacturer’s 
supplement is added in addition to ITS, as suggested by manufacturer. After another 24 h the 
ITS-medium is replaced with ITS-medium containing different concentrations of LPS. Four wells 
were set up for each concentration of LPS and samples were collected 24 h after LPS exposure 
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for analysis. Cell viability was assessed using CTB as described in 2.4 and Interleukin-8 (IL-8) 
concentration was measured by ELISA (Peprotech EC Ltd). 
The same experimental outline was used for mono- and co-cultures grown at ALI but, based on 
the results of LPS stimulation of submerged cultures, only the highest concentration of LPS 
(1000ng/ml) was applied. On these ALI cultures three different challenges were carried for each 
LPS type. Cells were challenged either from the apical side, from the basal side or from both 
sides at the same time. 
 
6.3.6 Detection of Interleukin 8 (IL-8) by ELISA  
For the quantification of human IL-8 in cell culture supernatants of submerged and ALI mono- 
and co-cultures treated with live bacteria, a human IL-8 ELISA development kit, was purchased 
from Peprotech EC Ltd. (London, UK). All reagents were part of the kit unless otherwise stated 
and were prepared according to manufacturer’s product information. IL-8 ELISA protocol is 
described in detail in 2.19. 
 
6.3.7 Indirect Immunofluorescence staining (flow cytometry) 
2 x10
5
 cells were washed and incubated with 100µl of primary antibody for 30mins on ice. Cell 
surface CD14 expression was detected with undiluted 63D3 or the IgG1 isotype control MOPC 
21. Following incubation cells were washed twice (PBS/0.1 BSA (w/v) before incubation with 
100µl secondary-conjugated antibody (goat anti-mouse PE (1:50) or goat anti-rabbit FITC (1:50)) 
for at least 30mins on ice. Cells were analysed straight afterwards on the flow cytometer.  
 
6.3.8 Direct Immunofluorescence staining (flow cytometry) 
Cell surface TLR4 was determined using direct immunofluorescence staining with PE-conjugated 
anti-TLR4 antibodies (HTA 125) or IgG2a/Κ-isotype control. 2 x 10
5
 cells, Which were grown 
submerged in cell culture flasks. Cells were then washed and incubated with 2 µL of HTA 125 or 
the isotype control for 30mins on ice. Following incubation cells were washed twice with PBS 
containing 0.1 % BSA (w/v) and analysed straight away using flow cytometry. 
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6.3.9 Statistical analysis 
Throughout this chapter statistical analysis of results and significant differences were 
determined by 1Way-Anova followed by Tukey’s multiple comparison test. Results are presented 
as mean ± SD. Results were considered significant when p≤ 0.05 = *; p≤ 0.01 = **; p≤ 0.001 = 
***. 
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6.4 Results 
6.4.1  Cell viability and IL-8 release of submerged mono-cultures after 
exposure to LPS  
In this chapter all submerged mono-cultures were challenged with three different types of LPS. 
B. cepacia LPS, P. aeruginosa 10 LPS and P. aeruginosa 50DR LPS were all used in serial dilutions 
of 0.1, 1, 10, 100, 1000ng/ml. The other mono-and co-cultures were also exposed to these three 
LPS types but only at 1000 ng/ml. 
 
6.4.1.1 Exposure of submerged HPF mono-cultures to LPS  
 
No
 
LP
S
0.1
 
ng
/m
l
1 n
g/m
l
10
 
ng
/m
l
10
0 n
g/m
l
10
00
 
ng
/m
l
0
500
1000
1500
2000
2500
Fl
u
o
re
sc
en
ce
 
u
n
its
56
0n
m
/5
90
n
m
No
 
LP
S
0.1
ng
/ m
l
1n
g/ 
m
l
10
ng
/ m
l
10
0n
g/m
l
10
00
ng
/m
l
0
25
50
75 ***
Il-
8 
pg
/m
l
A B
 
Figure 6.1 Cell viability (A) and IL-8 secretion (B) of HPF after exposure to B. cepacia LPS 
HPF were seeded onto a 24-well plate at 1 x 10
5
 cells per well and incubated for 24 h before they were 
serum starved for 24 h. Afterwards HPF were exposed to serial dilutions of B. cepacia LPS for 24 h. 
Supernatants were collected and analysed for IL-8 concentrations and cell viability was determined. No 
effect of any LPS concentration on cell viability was observed. There was no significant stimulation of IL-8 
secretion by B. cepacia LPS for LPS concentrations 0.1-100 ng/ml. Only 1000 ng/ml B. cepacia LPS 
stimulated a significant increase of IL-8 into the supernatant. Each bar represents the mean ± SD from 3 
separate experiments (each experiment quadruplicate wells).  
 
HPF mono-cultures were grown in 24-well plates and were challenged with serial dilutions of B. 
cepacia LPS for 24 h (figure 6.1). After the incubation with 0.1, 1, 10, 100, 1000ng/ml B. cepacia 
LPS, HPF’s cell viability (A) was analysed and found to be constant compared to the control, 
which had a baseline fluorescence of 1987.13 ± 314.34 FU. Collected supernatants were assayed 
by ELISA for the presence of IL-8 (B). Of the concentrations of B. cepacia LPS tested, only 
1000ng/ml induced IL-8 secretion, which increased significantly from 37.17 ± 5.28 pg/ml in the 
control to 69.06 ± 3.06 pg/ml after LPS challenge.  
 170 
 
No
 
LP
S
0.1
 
ng
/m
l
1 n
g/m
l
10
 
ng
/m
l
10
0 n
g/m
l
10
00
 
ng
/m
l
0
500
1000
1500
2000
2500
Fl
u
o
re
sc
en
ce
 
u
n
its
56
0n
m
/5
90
n
m
No
 
LP
S
0.1
ng
/ m
l
1n
g/ 
m
l
10
ng
/ m
l
10
0n
g/m
l
10
00
ng
/m
l
0
10
20
30
40
50
60
70
80
IL
-
8 
pg
/m
l
A B
 
Figure 6.2 Cell viability (A) and IL-8 release (B) of HPF induced by P. aeruginosa 10 LPS 
HPF were seeded onto a 24-well plate at 1 x 10
5
 per well and incubated for 24 h before they were serum 
starved for 24 h. Afterwards HPF were exposed to serial dilutions of P. aeruginosa LPS for 24 h. 
Supernatants were collected and analysed for IL-8 concentrations by ELISA. HPF’s cell viability was 
determined and no effect of P. aeruginosa LPS for any of the concentrations of LPS was found. P. 
aeruginosa LPS did induce IL-8 secretion of this cell line at a concentration of 1000ng/ml. Each bar 
represents the mean ± SD from 3 separate experiments (each experiment quadruplicate wells per 
concentration).  
 
HPF were challenged with P. aeruginosa 10 LPS at the indicated concentrations. Cell viability 
(figure 6.2 A) was not changed after 24 h incubation with LPS by any of the concentrations. The 
control wells had a baseline fluorescence of 1977.26 ± 114.04 FU.IL-8 secretion (figure 6.2 B) was 
only induced by the highest concentrations of 1000ng/ml of P. aeruginosa LPS. In this 
supernatant the IL-8 concentration was 62.09 ± 5.33 pg/ml compared to 45.98 ± 3.15 pg/ml in 
the control supernatants. 
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Figure 6.3 Cell viability (A) and IL-8 secretion (B) of HPF after exposure to P. aeruginosa 50DR LPS 
HPF were seeded onto a 24-well plate at 1 x 10
5
 per well and incubated for 24 h before they were serum 
starved for 24 h. Afterwards HPF were exposed to serial dilutions of P. aeruginosa LPS for 24 h. 
Supernatants were collected and analysed for IL-8 concentrations. HPF’s cell viability was determined and 
no effect of any LPS concentration on cell viability or IL-8 secretion was observed. Each bar represents the 
mean ± SD from 3 separate experiments (each experiment quadruplicate wells).  
 
When HPF mono-cultures were challenged with P. aeruginosa 50DR LPS (figure 6.3) under 
submerged conditions, neither the cell viability (A) nor the IL-8 secretion (B) was changed in 
response to the induction with LPS. The baseline fluorescence measured for the control mono-
cultures was 2018.84 ± 156.48 FU after the challenge. The observed IL-8 concentration was was 
65.45 ± 10.58 pg/ml for the control wells. 
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6.4.1.2 Exposure of submerged C38 mono-culture to LPS  
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Figure 6.4 Cell viability (A) and IL-8 secretion (B) of C38 challenged with B. cepacia LPS 
C38 were grown to confluence on a 24-well plate and incubated for 24 h before they were serum starved 
for 24 h. Afterwards C38 were exposed to serial dilutions of B. cepacia LPS for 24 h. Supernatants were 
collected and assayed by ELISA for the presence of IL-8. Cell viability was determined and no effect could 
be observed for any of the LPS concentrations, when compared to the control, which was C38 with 
medium only. 100ng/ml as well 1000ng/ml of B. cepacia LPS induced significant IL-8 secretion. Each bar 
represents the mean ± SD from 3 seperate experiments (each experiment quadruplicate wells).  
 
After C38 submerged mono-cultures were challenged with different concentrations of B. cepacia 
LPS (0.1, 1, 10, 100, 1000ng/ml), cell viability (A) was analysed and no significant changes were 
observed for any of the LPS concentrations (baseline fluorescence = 2687.05 ± 14.76 FU) (figure 
6.4). IL-8 secretion (B), however was significantly increased after 24 h incubation with 100 ng/ml, 
the IL-8 concentration increased to 46.5 ± 6.75 pg/ml and with 1000ng/ml it increased to 38.77 ± 
6.43 pg/ml compared to the control, which had an IL-8 concentration of 21.39 ± 1.25 pg/ml.  
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Figure 6.5 Cell viability (A) and IL-8 release (B) of C38 induced with P. aeruginosa 10 LPS 
C38 were grown to confluence on a 24-well plate and incubated for 24 h before they were serum starved 
for 24 h. Afterwards C38 were exposed to serial dilutions of P. aeruginosa LPS for 24 h. Supernatants were 
collected and assayed by ELISA for the presence of IL-8. Cell viability was determined and no effect could 
be observed for any of the LPS concentrations, when compared to the control, which was C38 with 
medium only. 100ng/ml as well 1000ng/ml of P. aeruginosa LPS induced no significant increases in IL-8 
secretion. Each bar represents the mean ± SD from 3 seperate experiments (each experiment 
quadruplicate wells).  
 
When submerged C38 mono-cultures were exposed to different concentrations of P. aeruginosa 
10 LPS, no effects on the cell viability (figure 6.5 A) were observed after 24 h incubation. The 
control mono-cultures of C38, which were exposed to SF-growth medium only, showed a 
baseline fluorescence of 2352.48 ± 118.25 FU. P. aeruginosa 10 LPS did not increase IL-8 
secretion (figure 6.5 B) at any of the concentrations employed. For the control the IL-8 
concentration observed was 15.64 ± 0.29 pg/ml. 
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Figure 6.6 Cell viability (A) and IL-8 secretion (B) of C38 after exposure to P. aeruginosa 50DR LPS 
C38 were seeded onto a 24-well plate at 1 x 10
5
 per well and incubated for 24 h before they were serum 
starved for 24 h. Afterwards C38 were exposed to serial dilutions of P. aeruginosa LPS for 24 h. S All 
supernatants were collected and analysed for IL-8 concentrations and C38’s cell viability was determined. 
For both assays no effect of different LPS concentration were identified Each bar represents the mean ± 
SD from 3 separate experiments (each experiment quadruplicate wells) 
 
Challenging submerged C38 mono-cultures with LPS from P. aeruginosa 50DR gave similar data 
to P aeruginosa 10. No changes in cell viability (figure 6.6 A) in response to any of the LPS 
concentrations were seen, compared to baseline fluorescence of 1833.28 ± 44.51 FU, measured 
for the control. After 24 h incubation P. aeruginosa 50DR LPS did not induce an increase in IL-8 
secretion (figure 6.6 B), which was measured in the cell culture supernatants. Control mono-
cultures secreted 36.45 ± 9.36 pg/ml. 
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6.4.1.3 Exposure of submerged IB3-1 mono-cultures to LPS 
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Figure 6.7 Cell viability (A) and IL-8 secretion (B) of IB3-1 after exposure to B. cepacia LPS 
IB3-1 were seeded onto a 24-well plate at 1 x 10
5
 per well and incubated for 24 h before they were serum 
starved for 24 h. Afterwards HPF were exposed to serial dilutions of B. cepacia LPS for 24 h. Supernatants 
were collected and analysed for IL-8 concentrations by ELISA. IB3-1’s cell viability was determined and no 
effect of B. cepacia LPS for any of the concentrations of LPS was found. B. cepacia LPS did not stimulate IL-
8 secretion by this cell line. Each bar represents the mean ± SD from 3 separate experiments (each 
experiment quadruplicate wells).  
 
When IB3-1 were challenged with different dilutions of B. cepacia LPS the cell viability (figure 6.7 
A) was not significantly affected compared to the control, which had a baseline fluorescence of 
2479.79 ± 290.01 FU. IL-8 concentrations (figure 6.7 B) in the collected supernatants were 
assayed and no IL-8 secretion was observed to be induced, when compared to the control, which 
had an IL-8 concentration of 10.15 ± 0.75 pg/ml.  
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Figure 6.8 Cell viability (A) and IL-8 release (B) of IB3-1 after exposure to P. aeruginosa 10 LPS 
IB3-1 were seeded onto a 24-well plate at 1 x 10
5
 per well and incubated for 24 h before they were serum 
starved for 24 h. Afterwards HPF were exposed to serial dilutions of P. aeruginosa LPS for 24 h. 
Supernatants were collected and analysed for IL-8 concentrations by ELISA. IB3-1’s cell viability was 
determined and no effect of P. aeruginosa LPS for any of the concentrations of LPS was found. P. 
aeruginosa LPS did not stimulate IL-8 secretion in this cell line. Each bar represents the mean ± SD from 3 
separate experiments (each experiment quadruplicate wells).  
 
IB3-1 mono-cultures were grown under submerged conditions and were then exposed to the 
indicated concentrations of P. aeruginosa 10 LPS for 24 h. IB3-1’s cell viability (figure 6.8 A) was 
not influenced at all, when compared to the control (baseline FU 2440.06 ± 44.96). Neither were 
the IL-8 concentrations affected by this event, which was 6.60 ±2.29 pg/ml in the supernatants 
of the control (figure 6.8 B).  
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Figure 6.9 Cell viability (A) and IL-8 secretion (B) of IB3-1 after induction by P. aeruginosa 50DR LPS 
IB3-1 were seeded onto a 24-well plate at 1 x 10
5
 per well and incubated for 24 h before they were serum 
starved for 24 h. Afterwards the cells were exposed to serial dilutions of P. aeruginosa LPS for 24 h. 
Supernatants were collected and analysed for IL-8 concentrations. IB3-1’s cell viability was examined and 
no effect of different LPS concentration on cell viability or IL-8 secretion was observed. Each bar 
represents the mean ± SD from 3 separate experiments (each experiment quadruplicate wells).  
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IB3-1 mono-cultures were grown under submerged conditions and were this time challenged 
with P. aeruginosa 50 DR LPS at the indicated LPS concentrations but no significant changes 
were observed, when examining cell viability (figure 6.9 A) and IL-8 release (figure 6.9 B) in the 
collected supernatants. The baseline fluorescence that was measured for control wells was 
1889.93 ± 188.07 FU and the IL-8 concentration found in control wells was 73.35 ± 2.00 pg/ml 
 
6.4.1.4 Exposure of submerged Calu-3 mono-cultures  
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Figure 6.10 Cell viability (A) and IL-8 secretion (B) of Calu-3 induced with B. cepacia LPS 
Calu-3 were grown to confluence on a 24-well plate and incubated for 24 h before they were serum 
starved for 24 h. Afterwards Calu-3 were exposed to serial dilutions of B. cepacia LPS for 24 h. 
Supernatants were collected and assayed by ELISA for the presence of IL-8. Cell viability was determined 
and no effect could be observed for any of the LPS concentrations, when compared to the control, which 
was Calu-3 with medium only. Apart from 0.1 ng/ml B. cepacia LPS, all other concentrations of LPS tested 
induced a significant increase in IL-8 secretion compared to control. Each bar represents the mean ± SD 
from 3 seperate experiments (each experiment quadruplicate wells).  
 
B. cepacia LPS was used in the indicated concentrations to challenge submerged Calu-3 mono-
cultures. Cell viability (figure 6.10 A) of this mono-culture was not influenced by exposure to B. 
cepacia LPS for 24 h incubation, when compared to control wells, which showed a baseline 
fluorescence of 1100.39 ± 122.36 FU. IL-8 secretion (figure 6.10 B), however was induced by LPS 
concentrations higher than 0.1 ng/ml. Control supernatants had an IL-8 concentration of 1265.48 
± 138.66 pg/ml, which increased to 3664.67 ± 525.27 pg/ml with an LPS concentration of 1 ng/ml 
and to 4455.77 ± 470.04 pg/ml with LPS used at 10 ng/ml. When LPS was used at 100 ng/ml or 
1000ng/ml the IL-8 concentration increased to a similar level with 4094.44 ± 622.27 pg/ml and 
4294.31 ± 610.60 pg/ml, respectively.  
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Figure 6.11 Cell viability (A) and IL-8 secretion (B) of Calu-3 induced with P. aeruginosa 10 LPS 
Calu-3 were grown to confluence on a 24-well plate and incubated for 24 h before they were serum 
starved for 24 h. Afterwards Calu-3 were exposed to serial dilutions of P. aeruginosa LPS for 24 h. 
Supernatants were collected and assayed by ELISA for the presence of IL-8. Cell viability was determined 
and no effect could be observed for any of the LPS concentrations, when compared to the control, which 
was Calu-3 with medium only. Only 100ng/ml and 1000ng/ml induced significant increase in IL-8 secretion 
by Calu-3 mono-culture. Each bar represents the mean ± SD from 3 separate experiments (each 
experiment quadruplicate wells).  
 
Submerged Calu-3 mono-cultures did not show any changes in cell viability (figure 6.11 A) when 
this was analysed after 24 h incubation with several different concentrations of P. aeruginosa 10 
LPS. Control mono-cultures, which were exposed only to SF-growth medium produced a baseline 
fluorescence of 780.10 ± 81.61 FU. IL-8 secretion (figure 6.11 B) by Calu-3 mono-cultures was 
induced at a concentration of 100 ng/ml (2734.89 ± 115.95 pg/ml) as well as at 1000 ng/ml 
(3264.48 ± 196.09 pg/ml) compared to control (2032.74 ± 109.1 pg/ml). 
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Figure 6.12 Cell viability (A) and IL-8 secretion (B) of Calu-3 induced with P. aeruginosa 50DRLPS 
Calu-3 were grown to confluence before they were serum starved for 24 h. Afterwards Calu-3 were 
exposed to serial dilutions of P. aeruginosa LPS for 24 h. Supernatants were collected and assayed by 
ELISA for the presence of IL-8. Cell viability was determined and found to be unchanged, when compared 
to the control, which was Calu-3 with medium only. IL-8 secretion was induced by 1000ng/ml LPS of P. 
aeruginosa. Each bar represents the mean ± SD from 3 separate experiments (each experiment 
quadruplicate wells).  
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For Calu-3 mono-cultures, the cell viability (figure 6.12 A) was found to be constant after the 
exposure to P. aeruginosa 50DR LPS, compared to the control, which showed 1083.14 ± 119.44 
FU when measured after the challenge. IL-8 secretion (figure 6.12 B), however, was significantly 
increased by an LPS concentration of 1000 ng/ml and reached 4325.58 ± 552.54 pg/ml. The 
control supernatant contained 2767.52 ± 325.92 pg/ml of IL-8.  
 
6.4.2  Cell viability and IL-8 release of mono-cultures at ALI after exposure 
to LPS  
6.4.2.1 Exposure of submerged HPF mono-cultures on TWs to LPS 
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Figure 6.13 Cell viability (A), TER (B) and IL-8 secretion (C) of HPF after exposure to B. cepacia LPS 
HPF were grown under submerged conditions on TWs for 14 days before these were challenged with 
1000ng/ml B. cepacia LPS, which was applied either apically, basolaterally or from both sides 
simultaneously, excluding the control TWs, which were only exposed to HPFM medium. Cell viability of 
HPF mono-culture was not affected by the presence of B. cepacia LPS and nor was the TER, which was 
measured before (clear bars) and directly after (striped bar) the 24 h incubation with B. cepacia LPS. 
Supernatants were analysed for IL-8 concentrations but no significant differences were observed in apical 
supernatants (clear bars) or basolateral medium (checked bars), compared to the control TWs. Data are 
presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
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HPF mono-cultures were grown under submerged conditions on TWs for 14 days before they 
were challenged with B. cepacia LPS. The control TWs were treated the same way as all others 
but were exposed to SF-growth medium only, whereas the TWs that were challenged with LPS 
were exposed to this from either the apical side, the basal side or they were exposed to LPS on 
both sides at the same time. HPF’s cell viability (figure 6.13 A) was not changed after 24 h 
incubation with 1000ng/ml B. cepacia LPS, when compared to the control, for which a baseline 
fluorescence of 2478.22 ± 758.96 FU was measured. This was also found for TER (figure 6.13 B) 
measured before (clear bars) and after (striped bars) the challenge. The control cultures had a 
TER of 16.20 ± 0.33 Ω x cm
2
 before the exposure to LPS and a TER of 16.43 ± 0.34 Ω x cm
2
 after 
the challenge. IL-8 release from HPF mono-cultures was not increased significantly compared to 
control (figure 6.13 C). This was true for IL-8 was measured after the challenge in apical 
supernatants (clear bars) as well as in the basolateral medium (checked bars). The control 
cultures of HPF had 225.87 ± 58.75 pg/ml IL-8 in the apical supernatant and 230.41 ± 34.2 pg/ml 
IL-8 in the basolateral medium. 
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Figure 6.14 Cell viability (A) TER (B) and IL-8 release (C) of HPF mono-culture after exposure to P. 
aeruginosa 10 LPS 
HPF mono-cultures were grown submerged on TWs for 14 days before these cells were exposed to P. 
aeruginosa 10 LPS, which was applied either apically, basally or simultaneously from both sides. Cell 
viability after 24 h exposure to LPS was not significantly affected compared to the control TWs, which 
were exposed to growth medium only. TER was measured before (clear bars) and after (striped bars) the 
experiment but no significant difference was observed after 24 h incubation with P. aeruginosa 10 LPS. IL-
8 release of HPF mono-culture, however, was significantly increased when LPS was applied simultaneously 
on both sides. This was seen in the apical supernatants (clear bars) as well as in the basal medium samples 
(checked bars). Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
Mono-cultures of HPF were exposed to P. aeruginosa 10 LPS after they have been cultured 
under submerged conditions for 14 days on TWs. After the TWs were challenged with 1000 
ng/ml P. aeruginosa 10 LPS from either the apical side, the basolateral side or from both sides 
simultaneously the cell viability (figure 6.14 A) was assayed and was found to be unaffected by 
these events, when compared to the control’s baseline fluorescence, which was 2297.08 ± 
193.45 FU. HPF mono-cultures were also monitored in terms of changes in electrical resistance 
and the TER (figure 6.14 B) was measured before (clear bars) and after (striped bars). No 
significant changes were observed for any of the challenges. Here the control TWs had a TER of 
7.77 ± 1.29 Ω x cm
2
 before the exposure to P. aeruginosa 10 LPS and 8.87 ± 0.83 Ω x cm
2
 after 
the challenge. Furthermore the IL-8 concentrations (figure 6.14 C) in apical supernatants (clear 
bars) and basal medium samples (checked bars) was analysed. The exposure to P. aeruginosa 10 
LPS induced a significant increase of IL-8 in apical supernatants of TWs that were challenged 
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from both sides at the same time. This increase was seen in the apical supernatant (220.14 ± 
18.25 pg/ml) as well as in the basolateral medium (229.61 ± 18.98 pg/ml). The control TWs had 
112.65 ± 0.79 pg/ml of IL-8 in the apical supernatants and 130.30 ± 28.22 pg/ml of IL-8 in the 
basolateral medium. 
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Figure 6.15 Cell viability (A) TER (B) and IL-8 release (C) of HPF mono-culture after exposure to P. 
aeruginosa 50DR LPS 
HPF mono-cultures were grown submerged on TWs for 14 days before these cells were exposed to P. 
aeruginosa LPS, which was applied either apically, basally or simultaneously from both sides. Cell viability 
after 24 h exposure to LPS was not significantly affected compared to the control TWs, which were 
exposed to growth medium only. TER  and IL-8 concentratione were also examined and found to be 
unchanged. Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
HPF mono-cultures were grown on TWs for 14 days under submerged conditions before these 
were used to be exposed to the third type of LPS under investigation, which was from the clinical 
isolate of P. aeruginosa 50DR LPS was used at 1000 ng/ml and was applied either apically, 
basolaterally or on both sides at the same time. Cell viability (figure 6.15 A), TER (figure 6.15 B) 
and IL-8 concentrations (figure 6.15 C) in apical (clear bars) and basolateral samples (checked 
bars) were analysed. None of the measured parameters were influenced by P. aeruginosa 50DR 
LPS after 24 h incubation. For control cultures of HPF at ALI a baseline fluorescence of 2146.73 ± 
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171.28 FU was measured. The TER for the control was 16.20 ± 0.99 Ω x cm
2
 before (clear bars) 
the challenge and 14.67 ± 1.08 Ω x cm
2
 afterwards (striped bars). The IL-8 concentrations of 
these controls were 60.17 ± 14.22 pg/ml in the apical supernatant and 48.30 ± 3.88 pg/ml in the 
basolateral medium. 
 
6.4.2.2 Exposure of C38 mono-culture at ALI to LPS 
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Figure 6.16 Cell viability (A), TER (B) and IL-8 secretion (C) of C38 at ALI after exposure to B. cepacia LPS 
C38 were grown on TWs for 14 days before these were challenged with 1000ng/ml B. cepacia LPS, which 
was applied either apically, basolaterally or from both sides simultaneously, excluding the control TWs, 
which were only exposed to AEM medium. Cell viability of C38 mono-culture was not affected by the 
presence of B. cepacia LPS and nor was the TER, which was measured before (clear bars) and directly after 
(striped graphs) the 24 h incubation with B. cepacia LPS. Supernatants were analysed for IL-8 
concentrations but no significant differences were observed in apical supernatants (clear bars) or 
basolateral medium (checked bars), compared to the control TWs. Data are presented as mean ± SD of 3 
individual experiments (3TWs each, n=3). 
 
C38 mono-cultures that were challenged with 1000ng/ml of B. cepacia LPS did not show any 
change in cell viability (figure 6.16 A) after exposure to LPS for 24 h, which was either applied 
apically, basolaterally or on both sides simultaneously. Baseline fluorescence of control cultures 
was 1707.47 ± 96.68 FU. Exposure of C38 mono-cultures to B. cepacia LPS did not have a direct 
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influence on the TER (figure 6.16 B) when comparing the TER before (clear bars) and the TER 
after the challenges (striped bars). TER measured for the control was 49.09 ± 4.06 Ω x cm
2
 before 
the challenge and it was 48.44 ± 1.99 cm
2
 after the challenge. The third aspect that was analysed 
was IL-8 concentration (figure 6.16 C) and was measured in all apical supernatants (clear bars) as 
well as in all basolateral medium samples (checked bars). IL-8 concentrations were not affected 
by any of the three different approaches of exposure, when compared to the control, which had 
an IL-8 concentration of 84.02 ±11.08 pg/ml in the apical supernatant and 71.24 ± 9.75 pg/ml in 
the basolateral medium.  
 
No
 
LP
S
Ap
ica
l L
PS
Ba
sa
l L
PS
Ap
ica
l/B
as
al 
LP
S
0
500
1000
1500
2000
2500
3000
3500
Fl
u
o
re
sc
en
ce
 
u
n
its
56
0n
m
/5
90
n
m
No
 
LP
S
Ap
ica
l L
PS
Ba
sa
l L
PS
Ap
ica
l/B
as
al 
LP
S
No
 
LP
S 
Ap
ica
l L
PS
 
Ba
sa
l L
PS
Ap
ica
l/B
as
al 
LP
S 
0
10
20
30
40
50
60
TE
R
 
(O
hm
 
x
 
cm
2 )
No
 
LP
S
Ap
ica
l L
PS
Ba
sa
l L
PS
Ap
ica
l/B
as
al 
LP
S
No
 
LP
S 
Ap
ica
l L
PS
 
Ba
sa
l L
PS
Ap
ica
l/B
as
al 
LP
S 
0
25
50
75
100
IL
-
8 
in
 
pg
/m
l
A B
C
 
Figure 6.17 Cell viability (A), TER (B) and IL-8 release (C) of C38 mono-cultures after exposure to LPS of P. 
aeruginosa 10 
C38 mono-cultures were grown at ALI for 14 days before they were exposed to P. aeruginosa 10 LPS, 
which was applied either apically, basolaterally or from both sides simultaneously. Control TWs were 
exposed to medium only. Cell viability (A), TER (B) or IL-8 concentrations (C) were all found to be 
unchanged compared to applicable controls throughout this experiment. Data are presented as mean ± SD 
of 3 individual experiments (3TWs each, n=3). 
 
C38 mono-cultures at ALI were challenged with 1000 ng/ml P. aeruginosa 10 LPS after 14 days of 
culture. LPS was applied either apically, basolaterally or simultaneously from both sides and cells 
were exposed for 24 h. P. aeruginosa 10 LPS did not influence any of the measured parameters. 
Cell viability (figure 6.17 A) of all mono-cultures analysed was comparable to the viability found 
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in control TWs (2472.67 ± 265.50 FU). TER values (figure 6.17 B) measured were not changed 
significantly by any of the three challenges when comparing TERs from afterwards (striped bars) 
to the corresponding one measured beforehand (clear bars). For the control TWs a TER of 42.91 
± 0.22 Ω x cm
2
 was measured before and a TER of 49.87 ± 0.44 Ω x cm
2
 was measured 
afterwards. Secretion of IL-8 (figure 6.17 C) among all samples assayed was similar, even when 
comparing apical supernatants (clear bars) to basolateral medium samples. For control cultures 
an IL-8 concentration of 82.25 ± 5.95 pg/ml was observed in the apical supernatant and an IL-8 
concentration of 82.91 ± 7.10 pg/ml was measured in the basolateral medium.  
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Figure 6.18 Cell viability (A), TER (B) and IL-8 release (C) of C38 mono-cultures after exposure to LPS of P. 
aeruginosa 50DR 
C38 mono-cultures were grown at ALI for 14 days before they were exposed to P. aeruginosa LPS, which 
was applied either apically, basolaterally or from both sides simultaneously. Control TWs were exposed to 
medium only. Cell viability (A), TER (B) or IL-8 concentrations were all found to be unaffected compared to 
applicable controls throughout this experiment. Data are presented as mean ± SD of 3 individual 
experiments (3TWs each, n=3). 
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Cell viability (figure 6.18 A) of C38 mono-cultures at ALI, which were apically, basolaterally or 
simultaneously challenged, on both sides with P. aeruginosa 50DR LPS for 24 h, was not affected. 
The FU observed for the challenged mono-cultures of C38 were similar to the control, which was 
2440.13 ± 432.55 FU. TER (figure 6.18 B) was also monitored and was measured before (clear 
bars) and after (striped bars) all three different ways of treatment. The TER of the control was 
59.03 ± 2.44 Ω x cm
2
 before the challenge and it was 64.35 ± 1.35 Ω x cm
2
 afterwards and was 
not significantly different after any of the different exposures to LPS. IL-8 concentrations (figure 
6.18 C) were assayed after exposure to P. aeruginosa 50DR  
LPS in apical supernatants (clear bars) as well as in basolateral medium samples (checked bars) 
and no significant differences were observed, when compared to the control, which had 17.46 ± 
3.57 pg/ml in the apical supernatant and 13.12 ± 4.53 pg/ml in the basolateral medium.  
 
6.4.2.3 Exposure of IB3-1 mono-cultures at ALI to LPS 
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Figure 6.19 Cell viability (A), TER (B) and IL-8 secretion (C) of IB3-1 at ALI after exposure to B. cepacia LPS 
IB3-1 were grown on TWs for 14 days before these were challenged with 1000ng/ml B. cepacia LPS, which 
was applied either apically, basolaterally or from both sides simultaneously, excluding the control TWs, 
which were only exposed to AEM medium. Cell viability of IB3-1 at ALI was not affected by the presence of 
B. cepacia LPS, nor was TER or IL-8 secretion after 24 h incubation with B. cepacia LPS, compared to the 
appropriate control TWs. Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
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The cell viability (figure 6.19 A) of IB3-1 mono-cultures at ALI did not show any significant 
changes after 24 h exposure to B. cepacia LPS, when compared to the baseline fluorescence of 
the control (1759.40 ± 169.24 FU). TER (figure 6.20 B) was monitored before (clear bars) and 
after (striped bars) the challenges but did not show any significant differences to the resistance 
measured in control TWs, which was 52.73 ± 1.9 Ω x cm
2
 before the challenge and 51.6 ± 1.34 Ω 
x cm
2
 after afterwards. IL-8 concentrations (figure 6.19 C) of challenged TWs were observed to 
be similar to the control (apical supernatant: 105.25 ± 24.22 pg/ml, basolateral medium: 90.54 ± 
18.85 pg/ml)  
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Figure 6.20 Cell viability (A), TER (B) and IL-8 release (C) of IB3-1 mono-cultures after exposure to LPS of P. 
aeruginosa 10 
IB3-1 mono-cultures were grown at ALI for 14 days before they were exposed to P. aeruginosa 10 LPS, 
which was applied either apically, basolaterally or from both sides simultaneously. Control TWs were 
exposed to medium only. Cell viability (A), TER (B) and IL-8 concentrations were examined and all found to 
be unchanged compared to applicable controls throughout this experiment. Data are presented as mean ± 
SD of 3 individual experiments (3TWs each, n=3). 
 
P. aeruginosa 10 LPS was used at a concentration of 1000 ng/ml to challenge IB3-1 mono-
cultures at ALI. Three different approaches were carried out and TWs were challenged either 
apically, basolaterally or from both compartments at the same time. Cell viability (figure 6.20 A) 
was not influenced by the exposure to P. aeruginosa 10 LPS and was similar for all measured 
TWs, including the control (2248.89 ± 84.63 FU). TER (figure 6.20 B) was monitored before (clear 
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bars) and after (striped bars) the challenges and no change in electrical resistance was observed, 
when comparing these to the control (44.22 ± 1.27 Ω x cm
2
 before, 50.86 ± 1.50 Ω x cm
2
 
afterwards). Apical supernatants and basolateral medium was collected of each TW and 
analysed for IL-8 concentrations (figure 6.20 C). In the apical supernatant (clear bars) of the 
control there was 102.15 ± 14.32 pg/ml of IL-8 and 95.86 ± 14.29 pg/ml was observed in the 
basolateral medium.  
 
No
 
LP
S
Ap
ica
l L
PS
Ba
sa
l L
PS
Ap
ica
l/B
as
al 
LP
S
0
1000
2000
3000
*** ***
Fl
u
o
re
sc
en
ce
 
u
n
its
56
0n
m
/5
90
n
m
No
 
LP
S
Ap
ica
l L
PS
Ba
sa
l L
PS
Ap
ica
l/B
as
al 
LP
S
No
 
LP
S 
Ap
ica
l L
PS
 
Ba
sa
l L
PS
Ap
ica
l/B
as
al 
LP
S 
0
10
20
30
40
50
60
70
80
90
TE
R
 
(O
hm
 
x
 
cm
2 )
No
 
LP
S
Ap
ica
l L
PS
Ba
sa
l L
PS
Ap
ica
l/B
as
al 
LP
S
No
 
LP
S 
Ap
ica
l L
PS
 
Ba
sa
l L
PS
Ap
ica
l/B
as
al 
LP
S 
0
10
20
30
40
50
IL
-
8 
pg
/m
l
A B
C
 
Figure 6.21 Cell viability (A), TER (B) and IL-8 release (C) of IB3-1 mono-cultures after exposure to LPS of P. 
aeruginosa 50DR 
IB3-1 mono-cultures were grown at ALI for 14 days before they were exposed to P. aeruginosa LPS, which 
was applied either apically, basolaterally or from both sides simultaneously. Control TWs were exposed to 
medium only. Cell viability (A) was analysed and was significantly decreased when LPS was applied either 
basolaterally or from both sides at the same time. TER (B) and IL-8 concentrations (C) were also examined 
and these were found to be unaffected compared to applicable controls throughout this experiment. Data 
are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
LPS from P. aeruginosa 50DR was used at 1000 ng/ml to treat mono-cultures of IB3-1 grown at 
ALI for 14 days. LPS was applied either apically, basolaterally or simultaneously on both sides and 
cells were exposed for 24 h before samples were collected to be assayed for cell viability (figure 
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6.21 A). IB3-1’s cell viability was significantly reduced when cells were challenged basolaterally 
or from both sides at the same time. After 24 h exposure to basal medium containing LPS the cell 
viability showed a signal of only 1711.41 ± 105.41 FU compared to 2742.35 ± 42.20 FU in the 
control samples. When challenged from both sides simultaneously the result was similar with 
1703.94 ± 207.46 FU. However, TER (figure 6.21 B) measured before (clear bars) and after 
(striped bars) these three challenges was not changed significantly after 24 h incubation with 
LPS. TER measured for the control was 62.77 ± 23.56 Ω x cm
2
 before the exposure to LPS and 
54.85 ± 8.05 Ω x cm
2
 afterwards. Furthermore IL-8 concentrations (figure 6.21 C) were measured 
in all apical supernatants (clear bars) and in all basolateral medium samples (checked bars) after 
the three different approaches of LPS exposure and no significant differences in concentration 
were found for any of the challenges, when compared to IL-8 concentrations found in the 
control. In the apical supernatant there was 26.15 ± 5.67 pg/ml of IL-8 and in the basolateral 
compartment there was 24.36 ± 7.57 pg/ml.  
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6.4.2.4 Exposure of Calu-3 mono-cultures to LPS 
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Figure 6.22 Cell viability (A), TER (B) and IL-8 secretion (C) of Calu-3 at ALI after exposure to B. cepacia LPS 
Calu-3 were grown on TWs for 14 days before these were challenged with 1000ng/ml B. cepacia LPS, 
which was applied either apically, basolaterally or from both sides simultaneously, excluding the control 
TWs, which were only exposed to growth medium. Cell viability of Calu-3 at ALI was not affected by the 
presence of B. cepacia LPS for 24 h. The measured TER, however, was significantly higher after this 
incubation in all cases including the control. IL-8 secretion was not changed comparing apical supernatants 
(clear bars) to basolateral media samples (checked bars) but was in all cases significantly lower when 
measured in the basolateral samples compared to their corresponding apical sample. Data are presented 
as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
Calu-3 mono cultures were challenged apically, basolaterally and simultaneously on both sides 
with 1000 ng/ml B. cepacia LPS. The cell viability (figure 6.22 A) of these mono-cultures was not 
affected by the exposure to this concentration of B. cepacia LPS in either way after 24 h 
incubation. The baseline fluorescence that was measured for the control was 1633.76 ± 152.16 
FU. The electrical resistance (figure 6.22 B) was measured before (clear bars) and straight after 
(striped bars) the incubation with LPS. TER was significantly increased in all cases, including the 
control, which had a TER of 200.57 ± 81.59 Ω x cm
2
 beforehand and a TER of 396.15 ± 53.74 Ω x 
cm
2
 after the 24 h challenge period. Apically challenged TWs had a TER of 215.19 ± 56.01 before 
the exposure and 436.52 ± 8.66 Ω x cm
2
 after the challenge. When treated from the basolateral 
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side the TER after the challenge was 387.02 ± 34.35 Ω x cm
2
 compared to 204.82 ± 37.89 Ω x cm
2
 
beforehand. Calu-3 mono-cultures were also treated simultaneously from both sides and the 
resulting TER was 421.34 ± 66.09 Ω x cm
2
, whereas it was 196.06 ± 79.42 Ω x cm
2
 before the 
challenge. The measured IL-8 in apical supernatants (clear bars) or basolateral collected medium 
samples (checked bars) were not increased compared to the control (figure 6.22 C). However, IL-
8 concentrations were observed to be significantly lower in all basolateral medium samples 
compared to the corresponding apical supernatant. This was also found for the control TWs, 
where the IL-8 concentration was 756.30 ± 23.81 pg/ml in the apical supernatant and 359.58 ± 
76.56 pg/ml in the basolateral medium.  
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Figure 6.23 Cell viability (A), TER (B) and IL-8 release (C) of Calu-3 mono-cultures after exposure to LPS of 
P. aeruginosa 10 
Calu-3 mono-cultures were grown at ALI for 14 days before they were exposed to P. aeruginosa 10 LPS, 
which was applied either apically, basolaterally or from both sides simultaneously. Control TWs were 
exposed to medium only. Cell viability (A) and TER (B) and were examined and all found to be unchanged 
compared to applicable controls throughout this experiment. IL-8 concentration (C), however, showed a 
significant increase in apical supernatants (clear bars) when challenged apically and again all basolateral 
medium samples have significantly lower IL-8 concentrations compared to their corresponding apical 
supernatant. Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
Calu-3 mono-cultures were challenged with P. aeruginosa 10 LPS (1000 ng/ml) after these were 
grown at ALI for 14 days. LPS was applied in three different ways, which were apically, 
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basolaterally or simultaneously from both sides. Cell viability (figure 2.23 A) was analysed 
straight after 24 h incubation with this type of LPS and was observed not to be influenced, when 
compared to the baseline fluorescence of the control, which was 2762.33 ± 233.38 FU. Before 
LPS was added to target compartments of TWs with Calu-3 mono-cultures, the TER (figure 6.23 
B) of each TW was measured. After 24 h exposure to P. aeruginosa 10 LPS, no significant 
differences could be identified. TER of the control measured, was 321.31 ± 29.54 Ω x cm
2
 
beforehand and it was 382.76 ± 44.99 Ω x cm
2
 after the challenge. IL-8 secretion (figure 6.23 C) 
was only significantly increased in the apical supernatant after LPS was added apically. The 
control TWs had an IL-8 concentration of 2657.94 ± 413.77 pg/ml compared to 5109.82 ± 
1264.78 pg/ml after the apical challenge in the apical supernatants (clear bars). This significant 
difference was not observed in the basolateral medium sample (checked bar) following the 
apical challenge. However, all basolateral samples had a significantly lower concentration of IL-8 
compared to their corresponding apical sample.  
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Figure 6.24 Cell viability (A), TER (B) and IL-8 release (C) of Calu-3 mono-cultures after exposure to LPS of 
P. aeruginosa 50DR 
Calu-3 mono-cultures were grown at ALI for 14 days before they were exposed to P. aeruginosa LPS, which 
was applied either apically, basolaterally or from both sides simultaneously. Control TWs were exposed to 
medium only. Cell viability (A) did not show any significant differences after 24 h incubation, when 
compared to control. TER (B) measured before (clear bars) and after (striped bars) the experiment was 
found to be significantly higher in all TWs, including the control, after the exposure to LPS. IL-8 secretion 
(C) on the other hand was found to be significantly increased for all three challenges in the apical 
supernatants (clear bars) compared to the control. IL-8 concentrations in basolateral medium samples 
showed again significant lower IL-8 concentrations compared to their corresponding apical supernatant 
for this cell line. Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
The cell viability (figure 6.24 A) of Calu-3 mono-cultures grown at ALI was not significantly 
changed by exposure to 1000 ng/ml of P. aeruginosa 50DR LPS for 24 h (baseline fluorescence of 
control = 1117.50 ± 180.58 FU). The control TWs were exposed to medium only, whereas the LPS 
was applied either apically, basolaterally or simultaneously from both sides. TER (figure 6.24 B) 
of these cultures was measured before (clear bars) and after (striped bars) these challenges and 
interestingly all TWs, including the control, showed a significant increase in electrical resistance 
after 24 h exposure compared to their corresponding value beforehand. In order, the control 
increased from 331.026 ± 2.66 Ω x cm
2
 to 507.39 ± 18.7 Ω x cm
2
, apically challenged TWs showed 
an increase from 303.82 ± 5.72 Ω x cm
2
 to 511.61 ± 35.79 Ω x cm
2
, basolaterally challenged ones 
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increased from 287.467 ± 12.97 Ω x cm
2 
to 469.40 ± 7.3 Ω x cm
2 
and TER of simultaneous 
challenged Calu-3 went from 287.72 ± 14.64 Ω x cm
2
 up to 538.23 ± 14.56 Ω x cm
2
. IL-8 secretion 
(figure 6.24 C) was measured in apical supernatants (clear bars) as well as in the basolateral 
medium (checked bars). The apical supernatant of the control had an IL-8 concentration of 
3106.57 ± 561.96 pg/ml and only 176.09 ± 36.68 pg/ml were found in the basolateral medium. 
When Calu-3 were apically challenged, 7790.17 pg/ml of IL-8 was found in the apical supernatant 
and 177.08 ± 9.18 pg/ml were found in the basolateral medium. For the basal and simultaneous 
challenges from both sides these findings were 6361.06 ± 189.27 pg/ml and 5288.41 ± 238.77 
pg/ml in apical supernatants and 227.54 ± 66.84 pg/ml and 234.75 ± 42.64 pg/ml in the basal 
medium samples. All basolateral samples were also significantly lower in IL-8 compared to their 
corresponding apical supernatant. 
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6.4.3  Cell viability and IL-8 release of co-cultures at ALI after exposure to 
LPS 
6.4.3.1 Exposure of HPF-C38 co-cultures at ALI to LPS 
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Figure 6.25 Cell viability (A), TER (B) and IL-8 release (C) after exposure to B. cepacia LPS of HPF-C38 co-
culture grown at ALI  
HPF-C38 co-culture was challenged with B. cepacia LPS, which was applied to either the apical side of the 
culture, to the basolateral side or to both at the same time. HPF-C38 on their own without bacteria were 
treated with medium only and served as control. In this case cell viability, TER and IL-8 secretion was not 
affected by B. cepacia LPS. Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
HPF-C38 co-cultures were grown at ALI for 14 days before they were challenged with B. cepacia 
LPS, which was applied either apically, basolaterally or simultaneously from both sides at a 
concentration of 1000ng/ml apart from the control TWs, which were exposed to SF-growth 
medium only. After 24 h incubation, cell viability (figure 6.25 A) was analysed and no significant 
changes were seen, when compared to the measured fluorescence baseline of the control, 
which was 2033.24 ± 265.78 FU. Before the challenge TER (figure 6.25 B) of these co-culture 
were measured as well as afterwards (striped bars) but this was also observed to be unaffected 
by this type of LPS. For the control TWs the TER was 47.89 ± 2.24 Ω x cm
2
 before the challenge 
and it was 47.56 ± 1.21 Ω x cm
2
 after the challenge. All apical supernatants (clear bars) and all 
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basolateral medium samples (checked bars) were collected and assayed for the concentrations 
of IL-8 (figure 6.25 C). In the control there was 987.0 ± 160.8 pg/ml in the apical supernatant and 
714.97 ± 50.12 pg/ml in the basolateral medium. All samples analysed had similar 
concentrations to these.  
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Figure 6.26 Cell viability (A) TER (B) and IL-8 release (C) of HPF-C38 co-culture after exposure to P. 
aeruginosa 10 LPS 
HPF-C38 co-cultures were grown at ALI on TWs for 14 days before these cells were exposed to P. 
aeruginosa 10 LPS, which was applied either apically, basally or simultaneously from both sides. Cell 
viability and TER measurements were not affected by exposure to this type of LPS after 24 h exposure. IL-8 
release of HPF-C38 co-culture was not induced in either apical supernatants (clear bars) or in basolateral 
medium samples (checked bars). However, basolateral medium was significantly lower in its IL-8 
concentration, when apically challenged or from both sides simultaneously compared to the 
corresponding apical supernatant. Data are presented as mean ± SD of 3 individual experiments (3TWs 
each, n=3).  
 
HPF-C38 co-cultures were challenged with P. aeruginosa 10 LPS after they were grown at ALI for 
14 days. Control TWs were exposed to medium only whereas the other TWs were challenged 
either apically, basolaterally or simultaneously with 1000 ng/ml LPS of P. aeruginosa 10. The cell 
viability (figure 6.26 A) was checked after the 24 h incubation with LPS and was unaffected by 
this event compared to the control (baseline fluorescence = 1517.48 ± 48.13 FU). TER (figure 
6.26 B) was found to be stable throughout the experiment and showed similar values, when 
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measured  before (clear bars) and after (striped bars) the challenges. The control TWs had a TER 
of 46.53 ± 0.19 Ω x cm
2
 beforehand and a TER of 48.99 ± 0.99 Ω x cm
2
 after the exposure to LPS. 
IL-8 secretion (figure 6.26 C) was also assayed and found to be unchanged in apical supernatants 
(clear bars) as well as in basolateral medium samples (checked bars). IL-8 concentrations found 
in the apical supernatant of the control was 3322.86 ± 160.33 pg/ml and it was 1582.63 ± 164.90 
pg/ml, which was significantly lower in the basolateral medium of the control. Basolateral 
medium samples of apically challenged and basolaterally challenged were also observed to be 
significantly lower in IL-8 than their corresponding apical supernatant. Apically challenged HPF-
C38 co-cultures had 3628.83 ± 333.41 pg/ml in their apical supernatant and basolaterally 
challenged ones had 3405.64 ± 1168.02 pg/ml of IL-8. Their corresponding basal medium 
samples had 1273.94 ± 557.45 pg/ml and 1193.12 ± 299.56 pg/ml of IL-8.  
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Figure 6.27 Cell viability (A), TER (B) and IL-8 secretion (C) of HPF-C38 grown at ALI after exposure to P. 
aeruginosa 50DR LPS  
HPF-C38 were grown on TWs at ALI for 14 days before they were challenged with P. aeruginosa LPS, which 
was applied either apically, basolaterally or from both sides simultaneously. HPF-C38’s cell viability and 
measured TER before (clear bars) and after the challenges (striped bars) were not changed by this 24 h 
incubation with P. aeruginosa LPS. Neither was the IL-8 secretion of this co-culture significantly increased 
in apical supernatants (clear bars) or basolateral medium samples (checked bars). However, basolateral 
samples were all, including the control, significantly lower in IL-8 concentrations compared to their 
corresponding apical supernatants. Data are presented as mean ± SD of 3 individual experiments (3TWs 
each, n=3). 
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After HPF-C38 were challenged with P. aeruginosa 50DR LPS, the cell viability (figure 6.27 A) was 
analysed. Compared to the control, of which the baseline fluorescence was 3276.43 ± 538.73 FU, 
none of the challenges influenced the cells cell viability, whether LPS was applied apically, 
basolaterally or simultaneously from both sides. TER (figure 6.27 B) was monitored before (clear 
bars) and after (striped bars) each challenge and was observed to be stable throughout the 
experiment. All readings were similar to the control, which had a TER of 56.11 ± 12.11 Ω x cm
2
 
beforehand and 56.61 ± 1.60 Ω x cm
2
 afterwards. IL-8 secretion (figure 6.27 C) was not induced 
by 1000 ng/ml LPS of P. aeruginosa applied in the different compartments of the TWs. In all 
cases, including the control, were basolateral IL-8 concentrations (checked bars) significantly 
lower compared to their corresponding apical supernatants (clear bars). In the control these 
concentrations were 1107.21 ± 166.67 pg/ml on the apical side and 594.59 ± 26.43 pg/ml on the 
basal side of the co-culture. 
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6.4.3.2 Exposure of HPF-IB3-1 co-cultures to LPS 
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Figure 6.28 Cell viability (A), TER (B) and IL-8 release (C) after exposure to B. cepacia LPS of HPF-IB3-1 
grown at ALI  
HPF-IB3-1 co-cultures were at ALI for 14 days before they were challenged with B. cepacia LPS, which was 
applied either apically, basolaterally or from both sides simultaneously. HPF-IB3-1 control TWs were 
challenged with medium only. In this case neither cell viability, TER nor IL-secretion was significantly 
affected by any of these three challenges with B. cepacia LPS for 24 h. Data are presented as mean ± SD of 
3 individual experiments (3TWs each, n=3). 
 
HPF-IB3-1 were also challenged with B. cepacia LPS (1000ng/ml) for 24 h, which was applied in 
three different ways. TWs were either challenged from the apical side, the basal side or from 
both sides at the same time. LPS had no significant affects on HPF-IB3-1’s cell viability (figure 
6.28 A), where the control had a baseline fluorescence of 2866.65 ± 578.51 FU. TER (figure 6.28 
B), which was measured before (clear bars) and after (striped bras) the challenges was observed 
to be stable throughout the experiment and all results were similar to the control, which had a 
TER of 50.85 ± 0.80 Ω x cm
2
 beforehand and a TER of 51.04 ± 1.32 Ω x cm
2
 afterwards. IL-8 
secretion (figure 6.28 C) was not increased by the exposure to B. cepacia LPS and concentrations 
found in the control were 844.99 ± 110.49 pg/ml on the apical side (clear bars) and 843.40 ± 
138.15 pg/ml on the basolateral side (checked bars).  
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Figure 6.29 Cell viability (A) TER (B) and IL-8 release (C) of HPF-IB3-1 co-culture after exposure to P. 
aeruginosa 10 LPS 
HPF-IB3-1 co-cultures were on TWs for 14 days before these cells were exposed to P. aeruginosa 10 LPS, 
which was applied either apically, basally or simultaneously from both sides. Cell viability and TER 
measurements were not affected by exposure to this type of LPS after 24 h exposure. IL-8 secretion was 
induced by apically, basolaterally treatment with LPS of P. aeruginosa 10, as well as by a simultaneous 
treatment of HPF-C38 in apical supernatants (clear bars). All basolateral collected samples (checked bars) 
showed a significantly lower IL-8 concentration, when compared to their corresponding apical 
supernatant. Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
HPF-IB3-1 co-cultures were challenged with P. aeruginosa 10 LPS after they were grown at ALI 
for 14 days. Control TWs were exposed to medium only whereas the other TWs were challenged 
either apically, basolaterally or simultaneously with 1000 ng/ml LPS of P. aeruginosa 10. The cell 
viability (figure 6.29 A) was checked after the 24 h incubation with LPS and was unaffected by 
this event compared to the control (baseline fluorescence = 1517.48 ± 48.13 FU). TER (figure 
6.29 B) of this co-culture was stable throughout the experiment and showed similar values 
before (clear bars) and after (striped bars) the challenges. TER of the control was 45.76 ± 1.44 Ω 
x cm
2
 before the challenge and it was 49.90 ± 1.65 Ω x cm
2
 after the challenge. IL-8 secretion 
(figure 6.29 C), however, was significantly increased by all three different exposures. In the apical 
supernatant (clear bars) of control TWs the mean IL-8 concentration found was 3006.32 ± 273.16 
pg/ml compared to 5228.74 ± 466.28 pg/ml after the apical challenge, compared to 5855.73 ± 
1038.51 pg/ml after the basolateral challenge and compared to 5140.15 ± 75.73 pg/ml after the 
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simultaneous challenge from both sides. In the basolateral medium samples, which were all 
significantly lower compared to their apical samples, although LPS did not alter basal IL-8 
compared to control. The corresponding values were 1294.59 ± 79.11 pg/ml for the control, 
1307.7 ± 147.41 pg/ml for the apical challenge, 1827.48 ± 188.61 pg/ml for the basolateral 
challenge and 1540.59 ± 245.4 pg/ml for the simultaneous challenge from both sides.  
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Figure 6.30 Cell viability (A), TER (B) and IL-8 secretion (C) of HPF-IB3-1 grown at ALI after exposure to P. 
aeruginosa 50DR LPS  
HPF-IB3-1 were grown at ALI for 14 days before they were induced with P. aeruginosa LPS, which was 
applied either apically, basolaterally or from both sides simultaneously. Neither HPF-IB3-1’s cell viability 
nor the TER measured after the challenges (striped bars) were affected by this 24 h incubation with P. 
aeruginosa LPS. IL-8 secretion did not significantly change in apical supernatants (clear bars) or basolateral 
medium samples (checked bars) but again the basolateral samples were all, including the control, 
significantly lower in IL-8 concentrations compared to their corresponding apical supernatants. Data are 
presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
HPF-IB3-1 co-cultures were exposed to P. aeruginosa 50DR LPS at a concentration of 1000 ng/ml. 
LPS was either applied apically, basolaterally or from both sides at the same time, apart from 
control TWs, which were exposed to SF-medium only. Analysis of cell viability (figure 6.30 A) 
revealed that LPS has no affect on the co-cultures viability, where the baseline fluorescence of 
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the control was 2015.08 ± 227.20 FU. TER (figure 6.30 B) was again found to be stable 
throughout the experiment and all mean TERs were comparable to the control, which had a TER 
of 46.31 ± 1.71 Ω x cm
2
 before the challenge and a TER of 48.29 ± 0.76 Ω x cm
2
 afterwards. No 
induction of IL-8 secretion (figure 6.30 C) was noted for any of the challenges, when compared 
to control, which had an IL-8 concentration of 8101.58 ± 2402.56 pg/ml in the apical supernatant 
and 1716.73 ± 250.67 pg/ml in the basolateral medium. All basolateral samples showed a 
significantly lower IL-8 concentration after all challenges, when compared to their corresponding 
apical supernatants.  
 
6.4.3.3 Exposure of HPF-Calu-3 co-cultures to LPS 
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Figure 6.31 Cell viability (A), TER (B) and IL-8 release (C) after exposure to B. cepacia LPS of HPF-Calu-3 co-
culture grown at ALI  
HPF-Calu-3 co-culture was challenged with B. cepacia LPS, which was applied to either the apical side of 
the culture, to the basolateral side or to both at the same time. HPF-C38 on their own without bacteria 
were treated with medium only and served as control. In this case cell viability, TER and IL-8 secretion was 
not affected by B. cepacia LPS. Data are presented as mean ± SD of 3 individual experiments (3TWs each, 
n=3). 
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HPF-Calu-3 co-cultures were exposed to B. cepacia LPS for 24 h with LPS added to the SF-culture 
medium either in the apical compartment, the basolateral compartment or in both 
compartments at the same time. This co-culture’s cell viability (figure 6.31 A) was not affected 
by this type of LPS as all measured fluorescence signals were similar to the control, of which the 
baseline fluorescence was 3695.40 ± 704.20 FU. Neither did the TER (figure 6.31 B) show a 
significant change over this 24 h incubation. The control TWs had a TER of 267.67 ± 57.92 Ω x 
cm
2
 before (clear bars) the exposure to LPS and a TER of 287.17 ± 37.86 Ω x cm
2
 afterwards 
(striped bars). IL-8 secretion (figure 6.31 C) was similar in all apical samples as well as in all 
basolateral samples analysed, including the control TWs, which had an IL-8 concentration of 
374.04 ± 12.76 pg/ml in the apical supernatant (clear bars) and 390.54 ± 14.83 pg/ml in the 
basolateral medium (checked bars).  
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Figure 6.32 Cell viability (A) TER (B) and IL-8 release (C) of HPF-Calu-3 co-culture after exposure to P. 
aeruginosa 10 LPS 
HPF-Calu-3 co-cultures were grown at ALI on TWs for 14 days before exposure to P. aeruginosa 10 LPS, 
which was applied either apically, basally or simultaneously from both sides. Cell viability and TER 
measurements were not affected by a 24 h exposure to this type of LPS. IL-8 secretion was not induced by 
any of the three treatments with LPS of P. aeruginosa 10. All basolateral collected samples (checked bars) 
showed a significantly lower IL-8 concentration, when compared to their corresponding apical supernatant 
(clear bars). Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
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HPF-Calu-3 co-cultures at ALI were challenged with P. aeruginosa 10 LPS. Control TWs were only 
exposed to SF-culture medium, whereas the other TWs were challenged in three different ways. 
LPS was added either apically, basolaterally or simultaneously at the same time. Afterwards cell 
viability (figure 6.32 A) was analysed and found to be unchanged, when comparing results of 
challenged TWs to the control, of which the baseline fluorescence was 989.14 ± 178.58 FU. TER 
(figure 6.32 B) was also monitored before (clear bars) and after (striped bars) the challenges but 
no significant differences were observed. Before the exposure to this type of LPS the TER of the 
control was 162.84 ± 5.13 Ω x cm
2
 and it was 178.09 ± 5.51 Ω x cm
2
 after the challenge. IL-8 
secretion (figure 6.32 C) was not induced by LPS, no matter which way it was applied. 
Significantly differences were only observed for basolateral samples, which were all lower in IL-8 
compared to their corresponding apical supernatants. Concentrations of IL-8 in the apical 
supernatant (clear bars) were all similar to the control, in which it was 6401.12 ± 1131.92 pg/ml. 
In the basal medium the same was observed with the control containing 3726.11 ± 583.77 pg/ml 
of IL-8.  
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Figure 6.33 Cell viability (A) TER (B) and IL-8 release (C) of HPF-Calu-3 co-culture after exposure to P. 
aeruginosa 50DR LPS 
HPF-Calu-3 co-cultures were grown at ALI on TWs for 14 days before exposure to P. aeruginosa 50DR LPS, 
which was applied either apically, basally or simultaneously from both sides. Cell viability was not affected 
after 24 h incubation compared to the control TWs and neither was TER affected by a 24 h exposure to 
this type of LPS. IL-8 secretion was not induced by any of the three treatments with LPS of P. aeruginosa. 
All basolateral collected samples (checked bars) showed a significantly lower IL-8 concentration, when 
compared to their corresponding apical supernatant (clear bars). Data are presented as mean ± SD of 3 
individual experiments (3TWs each, n=3). 
 
HPF-Calu-3 were exposed to P. aeruginosa 50DR LPS after they were grown at ALI for 14 days. 
LPS was applied to the apical side, to the basal side or to both sides at the same time and cell 
viability (figure 6.33 A) was assayed straight after the 24 h challenge and was observed to be 
unaffected, compared to the control’s baseline fluorescence of 1171.24 ± 187.91 FU. TER (figure 
6.33 B) was also unchanged by these challenges and all TWs showed similar readings before 
(clear bars) and after (striped bars) the LPS exposure like the control. TER of the control was 
259.86 ± 115.42  Ω x cm
2
 before the challenge and it was 242.88 ± 62.30 Ω x cm
2
 after the 
challenge. IL-8 concentrations (figure 6.33 C) were assayed as well and no differences were 
found in the apical supernatants (clear bars) or in the basolateral medium samples (checked 
bars). The IL-8 concentration observed in the apical supernatant of the control was 13006.16 ± 
1858.64 pg/ml and it was 1769.39 ± 787.33 pg/ml in the basal medium analysed. Again all 
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basolateral medium samples have a significantly lower concentration of IL-8 compared to their 
corresponding apical samples.  
 
6.4.4  TLR-4 and CD14 surface expression  
The surface expression of TLR-4 and CD14 was measured by flow cytometry after direct and 
indirect immunofluorescent staining with anti-TLR-4 and anti-CD14 antibodies (figure 6.34) 
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Figure 6.34 TLR4 and CD14 surface expression of HPF (A), C38 (B), IB3-1 (C) and Calu-3 (D) 
Using direct and indirect immunoflorescent antibody staining (anti-TLR-4 and anti-CD14) on submerged 
unstimulated cells in connection with flow cytometry showed the surface membrane expression of these 
receptors on each cell type used. None of the cells analysed had TLR-4 expressed on the cell surface 
membrane. Neither did HPF show CD14 surface expression but all three epithelial cell lines showed CD14 
expressed on the surface as analysed by the significant increases of relative fluorescent units after staining 
with anti-CD14 and compared to the control antibody. (n=3) 
 
HPF did not show any membrane surface expression of TLR-4 or CD14. The fluorescent signal for 
the specific antibodies compared to the control antibodies was not observed to be significantly 
increased. However, for all three epithelial cell lines there was a significant increase in 
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fluorescent signal after staining these cells with anti-CD14 antibody and compared to the control 
antibody’s fluorescent signal. No TLR-4 expression was found on the epithelial cells though. 
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6.5 Discussion  
In this chapter submerged mono-cultures as well as mono- and co-cultures at ALI were 
challenged with three different types of LPS. One was a commercially available LPS, which is 
isolated from P. aeruginosa serotype 10 (Sigma) and the other two were phenol extracted 
previous to these experiments (see Chapter 2.13). One was extracted from a P. aeruginosa strain 
called 50DR, which is a CF isolate and the other one was extracted from B. cepacia J2315. 
Cellular responses were analysed in terms of cell viability, cell layer integrity when cultured on 
TWs and the pro-inflammatory cytokine secretion of IL-8 was observed. In addition, the 
expression of the surface membrane receptor expression required to respond to LPS stimulation, 
was analysed by direct and indirect immunofluorescence antibody staining followed by flow 
cytometric analyses. 
 
6.5.1  HPF mono-cultures challenged with LPS 
HPF mono-cultures either under submerged conditions on 24-well plates or grown under 
submerged conditions on TWs were not influenced by exposure to LPS looking at their cell 
viability (figures 6.1-6.3, 6.13-6.15). In terms of IL-8 secretion a significant increase was observed 
in submerged mono-cultures in response to B. cepacia LPS as well as for P. aeruginosa 10 LPS. At 
1000ng/ml LPS, both types of LPS induced the same strength of inflammatory response in these 
cells, which is surprising as it has been reported that B. cepacia LPS is more potent than P. 
aeruginosa LPS, at least in terms of activating monocytes (Shaw et al., 1995, Zughaier et al., 
1999). Koyama et al. (2000) reported that, at a concentration of 100 µg/ml of P. aeruginosa LPS, 
human fetal lung fibroblasts responded positively and released neutrophil chemotactic activity 
(IL-8 and granulocyte colony-stimulating factor (G-CSF). The group did not show data of IL-8 
release for each cell line but the results presented by this group underlines the responsiveness 
of airway fibroblasts to LPS activation and that these cell types take actively part in pro-
inflammatory responses by secreting IL-8 (Koyama et al., 2000). This pro-inflammatory response 
has recently been shown for primary human lung fibroblasts under the same conditions as were 
used here. After 24 h exposure to 1 µg/ml LPS (E. coli) these fibroblasts showed a significant 
increase in IL-8 secretion (Zhang et al., 2011).  
When HPF were grown on TWs they only responded to P. aeruginosa 10 LPS and IL-8 was found 
to be 3 times as high in concentration compared to submerged cultures on 24-well plates. 
Interestingly this was only observed when HPF were challenged simultaneously from both sides. 
Little increases were seen for the other two challenges but were not found significant. These 
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results suggest that receptors, such as PRR TLR-4 are expressed by HPF to initiate the pro-
inflammatory signalling pathway necessary for IL-8 production.  
In figure 6.34 A it is shown that HPF did not have TLR4 or CD14 expressed on their surface 
membrane when these cells were unstimulated, whether the LPS signalling pathway receptors 
are intracellular and whether they are translocated to the surface membrane upon stimulation 
in these cells has to be further analysed. However, it was shown that in corneal fibroblasts TLR-4 
expression was increased in a dose-dependent matter, when stimulated with P. aeruginosa LPS 
(Wong et al., 2011). Another group studied rat lungs and found that TLR-4 mRNA was not 
detectable until 6-12h after LPS exposure, which then lasted up to 36h after exposure before the 
level dropped again (Janardhan et al., 2006). Another group looked at human embryonic lung 
fibroblasts and also reported that TLR-4 mRNA was not detectable by PCR (Paladino et al., 2006). 
All together these data indicate that expression of TLR-4 on lung fibroblasts is initiated upon LPS 
exposure but further investigation is necessary to confirm TLR-4 surface expression after HPF 
were stimulated with LPS.  
 
6.5.2  Challenge of submerged epithelial mono-cultures and mono-
cultures at ALI with LPS 
Epithelial cells are the first line defenders in the airways and encounter different inhaled 
particles, including bacteria, viruses and LPS, an endotoxin of gram-negative bacteria. It is 
controversial whether human airway epithelial cells in culture respond to challenge with LPS or 
not. Another area of controversy that was observed throughout the years of CF research is the 
debate about, which comes first inflammation based on the CFTR defect and the consequences 
of it or does infection trigger the highly inflammatory state seen in lungs of CF. There are 
reports, which support the pre-inflammatory state of CF cell lines (Kube et al., 2001) and also the 
IL-8 concentration in BAL fluid has shown a significant increase in CF compared to healthy 
patients (Bonfield et al., 1995). In contrast other groups have found that there is no difference in 
IL-8 release in either primary or cell line epithelial cells (John et al., 2010, Becker et al., 2004). 
Here we find that IB3-1 secretes slightly higher IL-8 compared to C38 at baseline level but this 
was not consistent throughout this whole project and due to the large amount of material 
supporting both types of hypothesis it is hard to currently explain any mechanism behind these 
observations.  
Here we find that under submerged conditions LPS did not stimulate IL-8 secretion in the 
epithelial cell line C38 and IB3-1, except for two challenges. C38 did respond to B. cepacia LPS, 
when stimulated with 100 ng/ml or 1000 ng/ml but the response was quite low considering that 
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the baseline secretion was 21.39 ± 1.25 pg/ml and the highest IL-8 concentration after 
stimulation came only up to 46.5 ± 6.75 pg/ml. Concerning the LPS type it has been reported 
that B. cepacia LPS is a more potent immunomodulatory stimuli compared to LPS from P. 
aeruginosa (Zughaier et al., 1999), which is consistent with findings here. However the LPS 
concentrations used here are quite low compared to the concentrations used by other groups. 
Palfreyman et al. (1997) showed that A549 cells in submerged mono-cultures were not 
stimulated by 10µg/ml LPS from B. cepacia (Palfreyman et al., 1997). In contrast, another group 
has shown that 10µg/ml P. aeruginosa 10 LPS is able to induce A549 cells to produce neutrophil 
chemotactic activity, including IL-8, but measured after prolonged (72 h rather than 24 h) 
exposure. This group indicated that responsiveness was dependent on the bacterium and 
serotype of LPS (Koyama et al., 2000). Controversially, as already mentioned before it has been 
reported that B. cepacia LPS is a more potent inflammatory stimuli than P. aeruginosa LPS 
(Zughaier et al., 1999), which is not reflected in the results of these two studies (Palfreyman et 
al., 1997, Koyama et al., 2000). 
The difference in IL-8 response between C38 and IB3-1 is in accordance with findings in CF 
patients. It has been shown that TLR-4 is reduced in the airway epithelium of patients with CF 
compared to healthy controls (Hauber et al., 2005, John et al., 2010). The vast amounts of IL-8 
concentrations usually found in CF patients have been suggested to be due to the increased TLR-
4 expression found on cells located in the submucosa, especially on neutrophils. 60 % of the TLR-
4 positive cells in CF lungs are neutrophils and the overall number of these immune cells is 
massively increased in CF lungs, when compared to normal lungs. On top of these findings it was 
also reported that TLR-4 positive monocytes/macrophages were increased in numbers in CF 
compared to non-CF patients (Hauber et al., 2005). These findings all together suggest that CF 
airway epithelial cells might not be able to respond as efficiently to LPS, which could favour 
bacterial colonisation but considering the other immune cells in vivo showing increased TLR-4 
expression and knowing that there is a massive neutrophillic infiltration will still lead to 
constantly increased IL-8 concentrations in CF. In addition it should be kept in mind that live 
bacteria as found in CF airways display other virulence factors that are also able to induce IL-8 
secretion. 
Furthermore it has been shown that intracellular TLR-4 has been reported to be located in the 
Golgi apparatus and there it co-localizes with internalized LPS in intestinal epithelial cells for 
example (Hornef et al., 2002). This could be a way of LPS stimulation in epithelial cells as well, 
which might be to control inflammatory responses, so that low concentrations of LPS do not 
evoke a response but high concentrations of free LPS or exposure to life bacteria will. However it 
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is not known yet whether TLR-4 is relocated to the surface membrane through activation of LPS 
or through IL-8 or bioactive lipids for example (Guillot et al., 2004).  
In A549 and BEAS 2B, for example, it has been shown as well that TLR-4 is not expressed on the 
surface membrane but has been indentified to be present intracellularly in the cytoplasm, 
whereas in U-937 (monocytic cell line) it has been shown to be present in both membrane and 
cytoplasm, which underlines the levels of responsiveness of these cells compared to the 
epithelial ones. It has been shown that phagocytic cells only need to encounter about 1-10 ng/ml 
of LPS in contrast to epithelial cells that need high concentrations of around 0.1-1 µg/ml for 
induction of IL-8 secretion (Guillot et al., 2004). These concentrations were exactly those C38 
responded to.  
Membrane surface CD14 expression is significantly higher in C38 (figure 6.34 B) but as CD14 does 
not have an intracellular signalling domain (that is why it works together with TLR-4/MD-2) this 
cannot be the reason for such a difference in IL-8 secretion (Kim et al., 2005a). It has been 
reported though that in non-CF lung tissue TLR-4 was found strongly expressed on the apical side 
of the membrane of epithelial cells, whereas in CF lung tissue there was almost no staining for 
TLR-4 (John et al., 2010). Together with the surface expression of CD14 found here in C38 this 
could indicate that after stimulation, TLR-4 is relocated to the membrane of C38 and leads to IL-8 
secretion via NF-κB, which is partially impaired in IB3-1. As already mentioned above this could 
lead to an impairment of this one innate immunity pathway and might lead to initial colonisation 
with bacteria. Additionally the input of other immune cells in CF in terms of TLR-4 mediated 
signalling after exposure to LPS is huge and still leads to the clinical picture seen in CF with high 
IL8 concentrations and constant neutrophillic infiltration compared to normal lungs.  
 
When these two cell lines were cultured at ALI though, no IL-8 response was observed at all. At 
ALI a concentration of 1000ng/ml of LPS of each type was used to stimulate the cells, which 
might simply not be high enough for resistant airway epithelial cells, when differentiated. As 
TLR-4 surface expression and CD14 surface was only analysed in unstimulated submerged 
monolayers of these cells it is impossible to comment on whether it is higher or lower in CF 
compared to non-CF under these conditions and also whether it is found on the surface 
membrane or intracellularly. As earlier mentioned in lung tissue of CF and non-CF patients there 
was a huge difference observed in TLR-4 expression on the apical side of epithelial cells, with 
non-CF showing strong expression and CF showing reduced expression of TLR-4 (John et al., 
2010, Hauber et al., 2005). John et al. (2010) have also reported that similar results for 
submerged CF and non-CF cell lines. A bronchial epithelial cell line, CFBE (CF) expressed the 
lowest level of surface TLR-4, when compared to its corrected counterpart corrCFBE and the 
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plasmid controlled cell line dfCFBE (John et al., 2010). For cells grown at ALI analysis methods, 
such as flow cytometry, cannot be employed and therefore the PRR expression on well-
differentiated airway epithelial cells has not been analysed extensively.  
TLR-4 and CD14 mRNA studies and immunohistochemistry paraffin sections of these cultures will 
help to elucidate and compare findings. As C38 is the corrected form of IB3-1 and has been 
exposed to CF environment before it will be interesting to investigate whether the correction in 
CFTR function also brings these differences back to a non-CF state, in terms of receptor 
expression, for example. 
Interestingly, when IB3-1 mono-cultures at ALI were stimulated with LPS from the basal side and 
from apical and basal side at the same time, a decrease in cell viability was observed. Therefore 
LPS of the CF isolated P. aeruginosa strain seems to have a cytotoxic affect on IB3-1 only when 
these were challenged from the basolateral side.  
For whole intact P. aeruginosa it has been reported before that on well differentiated epithelial 
cells binding occurs preferably at the basolateral membrane rather than apically. Furthermore it 
has been shown that cells at ALI are more susceptibe when encountering P . aeruginosa to its 
cytotoxic effects (Fleiszig et al., 1997). There is definitely evidence that polarized cells react 
differently upon bacterial challenges compared to submerged cells but whether there is an 
basolateral expression difference of receptors between these CF and non-CF cells used here 
needs to be further analysed. 
 
6.5.3  Challenge of co-cultures at ALI with LPS 
In the case of HPF-C38 and HPF-IB3-1 there were no significant changes in cell viability or TER 
observed following challenge in any compartment with any of the LPS tested.  
Even though B. cepacia LPS was reported to be more potent in terms of causing an inflammatory 
response compared to P. aeruginosa (Zughaier et al., 1999), no IL-8 response was observed here 
for HPF-C38 and HPF-IB3-1. The only IL-8 increase was observed for HPF-IB3-1 after the 24 h 
challenge with P. aeruginosa 10 LPS for all three challenges.  
One reason for this difference in response of HPF-IB3-1 to the commercial LPS and the isolated 
one could be possible differences in the lipid A structure. It has been shown before that isolated 
P. aeruginosa strains from CF patients show different lipid A structures compared to the parental 
strain or compared to an earlier isolate of the same bacterium from the same patient (Ernst et 
al., 2007, Cigana et al., 2009). In general it is thought that the selective pressure in the CF lung 
leads to modifications of Lipid A, the immunomodulatory component of LPS and Cigana et al. 
(2009) showed a decrease of TLR-4 mediated IL-8 secretion comparing an early LPS isolate 
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stimulation to a late isolate. It has been shown that bacterial isolates taken later in the course of 
CF lung disease activate TLR-4 to a lesser extent compared to early isolates of infection from the 
same patient. This was shown using submerged mono-layers of IB3-1 and C38, where LPS of an 
early P. aeruginosa isolate induced higher IL-8 secretion in both cell lines compared to LPS of late 
isolates (Cigana et al., 2009). However, further studies are required to understand the molecular 
mechanisms better and the microbial LPS modifications and how exactly this leads to persistent 
P. aeruginosa infections in CF. 
The commercial LPS of P. aeruginosa serotype 10 did induce IL-8 secretion in HPF-IB3-1 co-
cultures but the LPS from the clinical isolate (50DR) did not. No additional information about the 
patient or the isolate is available and therefore, this makes it difficult to make definite 
statements here as to whether changes in lipid A over time of infection is the reason for not 
stimulating these cultures of HPF-IB3-1. Plus these studies presented here were done on well 
differentiated ALI cultures, where the receptor repertoire on the cell surface and intracellularly is 
most likely to be different compared to submerged cultures (Fleiszig et al., 1997) and has yet to 
be characterised.  
Furthermore it is interesting to note that submerged C38 mono-cultures are responsive to B. 
cepacia LPS but not when grown at ALI or in co-culture with HPF. In contrast IB3-1 do not 
respond to any LPS when submerged or at ALI but they do when co-cultured with HPF. These 
results point out that culturing cells at ALI can cause a different immune response of epithelial 
cells but also that the addition of fibroblasts has a modulating effect. What exactly causes these 
differences in IL-8 response is impossible to say at this moment and needs further investigation. 
 
6.5.4  Challenges of Calu-3 submerged monocultures and mono- and co-
cultures at ALI with LPS 
Calu-3 mono-cultures under submerged conditions responded to all three types of LPS with 
increased IL-8 secretion. B. cepacia LPS stimulated IL-8 secretion at a concentration as little as 1 
ng/ml, whereas the other two LPSs from P. aeruginosa needed to be at a concentration of 100 – 
1000 ng/ml, which fits with reports stating that B. cepacia LPS of J2315 is more potent than LPS 
of P. aeruginosa (Zughaier et al., 1999). In contrast, when these cells were cultured at ALI and 
were stimulated with 1000ng/ml LPS the responses were different as we only see an induction of 
IL-8 secretion after exposure to P. aeruginosa 50 DR LPS, with the CF isolate being more potent. 
In this case significant increase of IL-8 was seen after all three challenges in the apical 
supernatant collected. Comparing results of ALI mono-culture and ALI co-culture, again the 
results are completely different as no induction of IL-8 was observed at all in co-cultures of HPF-
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Calu-3. HPF mono-cultures on TWs did respond to P. aeruginosa 10 LPS, when these were 
challenged from both sides. They might not be as responsive in the co-culture challenges as they 
only encounter LPS from the basolateral side and have Calu-3 as a protective tight epithelial 
layer on the top. However, HPF mono-cultures did not show a response to B. cepacia and P. 
aeruginosa 50DR LPS, which suggests that HPF do not respond here either. Why Calu-3 in co-
culture do not respond to P. aeruginosa 50DR LPS is not exactly known yet. PRR expression has 
not been analysed for HPF and Calu-3 after stimulation or on TWs and makes it impossible to 
comment on possible TLR-4 translocation to the membrane surface and whether on Calu-3 there 
is a difference in apically or basolaterally receptor expression.  
For submerged unstimulated Calu-3 it has been shown that CD14 is surface expressed but not 
TLR-4. The expression of MD-2 was not observed here but another group has analysed mRNA 
expression of these three receptors and found that all of them are expressed in Calu-3 cultured 
at ALI (O'Grady, 2007). These were mRNA analyses and did not define membrane and 
intracellular expression but based on these finding and results presented here it is assumed that 
Calu-3 are able to respond to LPS via this signalling pathway. The huge difference in response of 
submerged mono-cultures to B. cepacia compared to mono-cultures at ALI, which do not 
respond to this type is interesting as submerged cultures respond to very low levels of B. cepacia 
LPS. This indicates that responses of epithelial cells that are well differentiated are very different 
and submerged cultures might not reflect at all, what affect LPS and other stimuli have on 
epithelial cells in vivo. 
For Calu-3 mono-cultures and HPF-Calu-3 co-culture the responses are quite different and 
identification of receptor expression of both cell types could shed some more light on these 
differences. It is clear though that HPF do modulate the response of Calu-3 to LPS and further 
investigation should elucidate the meaning and importance of cell-to-cell communication. 
 
All together HPF mono-cultures were observed to respond to different types of LPS under 
submerged conditions and when grown on TWs. How HPF physiology is affected by the different 
culture conditions needs to be further analysed but it has been shown that they did form a 
multi-cell layer rather than a mono-layer, when grown on TWs, which could explain the 
differences of IL-8 concentrations observed.  
Presumably this was the same for epithelial cell lines used. Surface expression of CD14 and TLR-4 
has only been analysed for cells grown under submerged conditions and in an unstimulated 
manner. However, there is a significant difference in responses to LPS comparing these cell 
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models, and therefore these need further investigation in terms of receptor expression, for 
example. Especially further investigation of the co-culture models is needed to analyse how the 
addition of HPF modulate the epithelial cell response to LPS as these were different comparing 
mono- and co-culture models. This was also shown for Calu-3 in this chapter. The responses of 
mono- compared to co-cultures did have completely different outcomes in terms of IL-8 
secretion and emphasizes that cytokines and their receptors are crucial for these cellular 
responses and functions. However, variations found among these epithelial cell lines, especially 
comparing C38 and IB3-1 to Calu-3, in terms of inflammatory response by secreting IL-8 could be 
due to different genotypic background of these epithelial cells, which originated from different 
diseases. Other factors that might play a role are differences in CFTR expression levels for 
example and results might be cell type specific.  
 
Co-culture models are needed to elucidate the cell-to-cell communication and identify the 
constantly ongoing interactions and how these are related to cystic fibrosis. This might lead a 
way to new strategies for manipulating clinical settings. 
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7 Chapter 7 Inflammatory response to intact bacteria 
7.1 Introduction  
Morbidity and mortality of CF patients is largely due to lung disease, which is caused to a large 
extent by the chronic, lifelong bacterial infection and concomitant neutrophilic inflammation. 
Some of the hallmarks of the CF lung, such as impaired mucociliary clearance and accumulation 
of highly viscous mucus, participate in the increased susceptibility to bacterial colonisation and 
provide an environment that can be readily infected. In early stages of CF Staphylococcus aureus 
(S. aureus) is one of the most common pathogens to be isolated and is the most prominent 
bacterium in children and in early adolescents. Later on, P. aeruginosa is found the most 
prominent pathogen in the CF lung (by the age of 18 about 80 % of patients are chronically 
infected) and most mortality is accounted to this well established bacterium (Burns et al., 
1998).Next to these two bacteria there are others found specifically in the CF lung, such as B. 
cepacia, which is known to be transmissible between patients and usually leads to a rapid 
decline in lung function (Govan et al., 1993). All three of these bacteria are regularly found in CF 
patients, with P. aeruginosa being the most common one in adulthood (de Bentzmann et al., 
1996c), B. cepacia being a very destructive one (Drevinek and Mahenthiralingam, 2010) and S. 
aureus, which is usually found in infants and young children but is also found in 40% of CF adult 
patients next to P. aeruginosa (Kahl, 2010, Burns et al., 1998). 
Bacterial infections have been studied extensively in vivo and in vitro but the tremendous 
amount of variables make it difficult to link single factors to the pathogenesis of CF, which is 
more likely to be multifactorial. There are several organisms found in CF lungs and a lot of them 
have been isolated and found to be different strains with different genotypes and phenotypes 
(Razvi et al., 2009). These can differ in their expression of virulence factors and also it has been 
shown that some bacteria significantly change to adapt to the harsh CF lung environment to 
maintain infection (Smith et al., 2006). In vitro, the main attention has been directed towards 
analysing the response of the epithelial cells of the airways (Zhang et al., 2005, Kube et al., 2001, 
da Silva et al., 2004, Martin and Mohr, 2000) and there are few co-culture models that 
investigate cell-to-cell communication and the multi-cellualr response to relevant pathogens. 
Additionally there is very little research published on the role of pulmonary fibroblasts in the 
extensive pro-inflammatory state characteristic of the CF airways. There is a need for 
multicellular models and throughout this work a multicellular non-CF as well as a multicellular CF 
model are presented, which will help to investigate multi cell responses to CF relevant 
pathogens to fill gaps in the puzzle of understanding CF pathogenesis. 
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Bacterial infections are initially recognised by the host through pathogen associated molecular 
patterns (PAMPs), which are presented to the host epithelial and immune cells, and which 
usually initiate a pro-inflammatory response. These PAMPs can be of different nature, while LPS 
is found in the membrane of gram-negative bacteria, such as P. aeruginosa for example (Raoust 
et al., 2009), peptidoglycan (PGN) and Lipoteichoic acid (LTA) are PAMPs in the bacterial cell 
walls of gram-positive bacteria, such as S. aureus (Fournier and Philpott, 2005). The ensuing 
inflammatory response involves the production and release of pleitropic cytokines such as IL-6 
and TNF-alpha. In addition, for CF airways disease pathogenesis, the most important chemokine 
secreted is IL-8. IL-8 is a potent neutrophil chemoattractant; sustained release of this chemokine 
causes an excessive influx of activated neutrophils, which in turn take their part in the cycle of 
inflammation by releasing more inflammatory mediators (e.g. elastase).  
Pattern recognition receptors (PRR), which are located on the host’s cell surface membranes, 
recognise PAMPs. Typical PRRs are the toll-like receptors, such as TLR-4 and TLR-2. TLR-4 
recognises bacterial LPS of gram-negative bacteria, whereas TLR-2 recognises lipoproteins and 
PGN of gram-positive bacteria (Hauber et al., 2005), for example. In both cases these TLRs lead 
to NF-κB activation and its translocation to the nucleus, where target genes are then transcribed, 
such as the gene for IL-8.  
In this chapter S. aureus, B. cepacia and P aeruginosa were used, as live organisms, to induce a 
pro-inflammatory response in the characterised mono- and co-culture systems in order to and 
investigate cellular responses to these bacteria in their intact and infectious state.  
Host cell viability was measured after a 24 h exposure of the mono-and co-culture systems to 
these live bacteria, as well as the secretion of the key chemokine in CF lungs, IL-8. Furthermore 
TER measurements were used as an indicator of epithelial integrity; this is one of the main 
functions of the airways in innate immunity.  
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7.2 Methods 
7.2.1 Cell viability assay using Cell Titer Blue™  
Cell Titer Blue™ (CTB)
 
is an endpoint assay that provides a homogeneous, fluorometric method 
to monitor cell viability. Viable cells, which are metabolically active, can convert resazurin (blue 
with little intrinsic fluorescence activity) into its highly fluorescent product, resorufin (pink; 
detectable with 560 nm excitation and 590 nm emission). CTB was directly added to the cell 
medium at dilution (1:5) after live bacteria have been exposed to gentamicin for 1 h and the 
plate was then incubated for 2 h at 37 °C prior to analysis. The fluorescent intensity was 
measured on a standard multiwell fluorescent plate reader (Spectramax Gemini XS, Molecular 
Devices, Berkshire UK) with a 560 nm excitation, and 590 nm emission wavelength. CTB was 
used in different experimental layouts, which will be discussed individually in the chapters 
affected. 
7.2.2 Transepithelial electrical resistance (TER) measurements 
TER of mono- and co-cultures on TWs was measured using an Epithelial Voltohmeter with STX2 
chopstick electrodes (World Precision Instruments) to monitor confluence and barrier formation 
of the epithelial cell layer. TER was measured on day 14 or just before exposure to live bacteria 
to verify epithelial cell confluence and intactness of epithelial cell layer and TJ formation. 
TER values reported in this work take into account the area of the cell layer (area of TWs = 0.33 
cm
2
) and are expressed as Ω × cm
2
. Triplicate measurements were taken for each TW and the 
background resistance, which was typically between 100-120 Ω × cm
2
 (cell-free collagen IV 
coated TW) was subtracted from the average of a triplicate measurement.  
TER was measured immediately before and straight after the 24 h incubation with live bacteria 
to analyse whether cell layer integrity was affected compared to the control TWs. 
 
7.2.3 Bacterial culture 
P. aeruginosa 50DR, B. cenocepacia J2315 and S. aureus (ATCC 6538) were initially grown on 
MHA plates in a 37°C incubator. Colonies of P. aeruginosa 50DR, B. cenocepacia J2315 and S. 
aureus were then picked from a freshly cultivated MHA plate and grown in 50 ml MHB at 37 °C 
overnight in a shaker at 150 rpm. On the next day cultures were spun down at 3500 x g for 15 
min and washed in 10 ml PBS. This wash was repeated three times before the optical density 
(OD) was measured at 470 nm. The OD was then adjusted to 1, which corresponds to 
approximately 1 x 10
9
 CFU/ml for P. aeruginosa, S. aureus and B. cepacia. These bacterial 
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suspensions were then diluted 1:10 to make a stock solution of 1 x 10
8
 CFU/ml. The final 
bacterial cell density used in the experiments under submerged conditions or at ALI was 1 x 10
7 
CFU/ml.  
 
7.2.4 Antibiotic susceptibility of S. aureus, B. cepacia and P. aeruginosa 
In order to prove that the applied cell viability test (CTB) and the conversion of CTB from non-
fluorescent to fluorescent was down to the epithelial cells it was necessary to determine the 
susceptibility of P. aeruginosa 50DR, B. cenocepacia J2315 and S. aureus (ATCC 6538) to the 
antibiotic gentamicin to validate the killing affect of this antibioticum. Small filter paper discs 
containing 200µg/ml gentamicin were placed onto MHA plates, which were covered with 
bacterial suspension using a swab to generate a bacterial lawn. If the bacteria applied were 
sensitive to gentamicin, a clear zone of growth inhibition was seen around the gentamicin 
containing filter. Control plates were set up and filters with PBS were added to the plate. No 
clear zone was observed here (data not shown). A similar experiment was carried out with 
Normocin, an antibiotic routinely used in cell culture media. In this case agar plates were 
prepared all at the same volume and holes were punched into the agar, which were then filled 
with 50µl of normocin (either 50 mg/ml stock solution or at working concentration 100µg/ml 
diluted in full growth media, one for each type) after the bacterial suspension was spread using a 
swab. Bacteria need to be spread before because otherwise the corners of the punched holes 
possibly catch the swab and a strong inoculate will colonize there. Again PBS was used a 
negative control. 
 
7.2.5 Treatment of submerged mono-cultures and mono- and co-cultures 
grown at ALI with live bacteria 
Submerged mono-cultures were set up as described in 2.17. Cells were grown in SF medium, 
which contains ITS, for 24 h before bacteria were added. ITS-medium containing approximately 1 
x 10
7
 CFU/ml of live bacteria were then added and cells were incubated for 24 h. Apical 
supernatant and basolateral medium samples were then collected and stored at -80°C for IL8 
ELISA analysis. Cell cultures were incubated with ITS-medium containing 100 µg/ml gentamicin 
for one hour. After the gentamicin treatment, the medium was removed and ITS-medium 
containing CTB
 
was added to assess cell viability.  
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The same procedure was followed to expose mono-and co-cultures grown at ALI. After 14 days 
of culture three TWs per experiment were challenged either apically, basolaterally or 
simultaneously from both sides with live bacteria at 1 x 10
7
 CFU/ml. Samples were collected 
from each TW from the apical side and from the basolateral side and were independently 
analysed for IL-8 release. 
 
7.2.6 Detection of Interleukin 8 (IL-8) by ELISA  
For the quantification of human IL-8 in cell culture supernatants of submerged and ALI mono- 
and co-cultures treated with live bacteria, a human IL-8 ELISA development kit, was purchased 
from Peprotech EC Ltd. (London, UK). All reagents were part of the kit unless otherwise stated 
and were prepared according to manufacturer’s product information. IL-8 ELISA protocol is 
described in detail in 2.19. 
 
7.2.7 Statistical analysis 
Throughout this chapter statistical analysis of results and significant differences were 
determined by 1Way-Anova followed byTukey’s multiple comparison test. Results are presented 
as mean ± SD. Results were considered significant when p≤ 0.05 = *; p≤ 0.01 = **; p≤ 0.001 = 
***. 
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7.3 Aims 
In this chapter submerged mono-cultures as well as mono-and co-cultures at ALI were exposed 
to live S. aureus, B. cepacia and P. aeruginosa in order to investigate the response of the in vitro 
models to these common, life-threatening CF pathogens and to compare results with other 
published literature to determine functionality of these models and how well they reflect the CF 
airways. 
In order to achieve these aims it was necessary to analyse host cell viability after exposure to live 
bacteria. 
Additionally the cell layer integrity was monitored by measuring TER before and after the 
challenges 
Measurement of the concentration of CF’s key chemokine IL-8 after exposure to live bacteria 
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7.4 Results 
7.4.1 Cell viability and IL-8 release of submerged mono-cultures after 
exposure to live bacteria 
7.4.1.1 Exposure of submerged HPF to live bacteria 
HPF in submerged mono-cultures were exposed to live bacteria for 24 hours. The bacteria used 
were S. aureus, B. cepacia and P. aeruginosa and out of these only P. aeruginosa had an effect 
on HPF cell viability (figure 7.1 A). The baseline fluorescence of HPF when exposed to medium 
only was 1597.6 ± 28.34 FU and after a 24 h exposure to live P. aeruginosa it was reduced to 
807.74 ± 317.42 FU, a 1.9 fold decrease. 
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Figure 7.1 Cell viability and IL-8 release of HPF after exposure to live bacteria 
HPF were seeded onto a 24-well plate at 1 x 10
5
 per well and incubated for 24 h before they were serum 
starved for 24 h. Afterwards HPF were exposed to 1 x 10
7
 cfu/ml for 24 h. Supernatants were collected and 
analysed for IL-8 concentrations and HPF were assessed for cell viability after bacteria were exterminated 
using 100µg/ml gentamicin for 1 h. On HPF, only P. aeruginosa exposure caused a significant decrease of 
cell viability and also a tremendous increase in IL-8 concentration. Data are presented as mean ± SD from 
3 individual experiments (n=4).  
 
It is interesting to note that, even though there was a P. aeruginosa-dependent decrease in cell 
viability there was an significant increase in IL-8 secretion after 24 h exposure to this bacterium 
(figure 7.1 B). IL-8 concentration of control supernatants was 35.95 ± 1.5 pg/ml compared to 
1431.44 ± 239.77 pg/ml in cells exposed to P. aeruginosa. This is almost a 6-fold increase, even 
without taking into account the decrease in viability. No significant changes in IL-8 release were 
observed in response to S. aureus or B. cepacia.  
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7.4.1.2 Exposure of submerged C38 to live bacteria 
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Figure 7.2 Cell viability (A) and IL-8 release (B) of C38 submerged mono-cultures after exposure to live 
bacteria 
C38 were seeded onto a 24-well plate at 1 x 10
5
 cells per well and incubated for 24 h before they were 
serum starved for 24 h. Afterwards C38 were exposed to 1 x 10
7
 cfu/ml bacterial suspensions for 24 h. 
Supernatants were collected and analysed for IL-8 concentrations and the cells were assessed for cell 
viability after bacteria were killed using 100µg/ml gentamicin for 1 h. For C38, none of the live bacteria 
used had an effect on cell viability but exposure to P. aeruginosa caused a significant increase in IL-8 
secretion into the supernatant. Data are presented as mean ± SD from 3 individual experiments (n=4 
replicates).  
 
Cell viability (figure 7.2 A) of C38 was not affected by exposure to live S. aureus, B. cepacia or P. 
aeruginosa. No significant changes of FU could be observed compared to the control, C38 
without bacteria which had a baseline fluorescence of 1597.60 ± 28.35 FU. When IL-8 secretion 
(figure 7.2 B) was analysed, a significant increase in comparison to control was noted after a 24 h 
exposure of C38 to live P. aeruginosa. The IL-8 secretion in the control wells was at an average of 
0.96 ± 0.77 pg/ml, which increased to 61.85 ± 5.78 pg/ml after exposure to live P. aeruginosa. 
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7.4.1.3 Exposure of submerged IB3-1 to live bacteria 
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Figure 7.3 Cell viability (A) and IL-8 release (B) of IB3-1 after exposure to live bacteria 
IB3-1 were seeded onto a 24-well plate at 1 x 10
5
 per well and incubated for 24 h before they were serum 
starved for 24 h. IB3-1 were then exposed to 1 x 10
7
 cfu/ml of each bacterium for 24 h. Supernatants were 
collected and analysed for IL-8 concentrations. Cell viability was assessed after bacteria were killed using 
100µg/ml gentamicin for 1 h. IB3-1 did not show any significant decrease of cell viability after a 24 h 
incubation with these live bacteria. IL-8 secretion by IB3-1 was significantly increased following exposure 
to either B. cepacia or P. aeruginosa. 
Data are presented as mean ± SD from 3 individual experiments (n=4 replicates).  
 
The exposure of IB3-1 submerged mono-cultures to S. aureus, B. cepacia and P. aeruginosa did 
not show any effect on cell viability (figure 7.3 A). The control mean FU measured in the viability 
assay was 2219.58 ± 46.53 FU. There was a slight decrease of cell viability after the exposure to 
P. aeruginosa, with average FU of 1924.88 ± 152.33 but this was not significantly different to the 
control.  IL-8 secretion by IB3 cells (figure 7.3 B) was significantly increased by exposure to B. 
cepacia and P. aeruginosa. IL-8 secretion of unstimulated IB3-1 cells was 9.93 ± 1.98 pg/ml 
compared to 286.63 ± 25.13 pg/ml after exposure to B. cepacia and to 1342.54 ± 45.74 pg/ml 
after exposure to P. aeruginosa.  
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7.4.1.4 Exposure of submerged Calu-3 to live bacteria 
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Figure 7.4 Cell viability (A) and Il-8 release (B) of Calu-3 after exposure to live bacteria 
Submerged mono-cultures of Calu-3 were seeded onto a 24-well plate at 1 x 10
5
 per well and incubated 
for 24 h before they were serum starved and then exposed to live bacteria (1 x 10
7
 cfu/ml) for 24 h. 
Supernatants were collected and analysed for IL-8 concentrations. Cell viability was assessed after bacteria 
were killed using 100µg/ml gentamicin for 1 h. Calu-3 did not show any significant decrease of cell viability 
after 24 h incubation with these live bacteria. IL-8 secretion by Calu-3 was significantly increased following 
incubation with S. aureus B. cepacia or P. aeruginosa. Data are presented as mean ± SD from 3 individual 
experiments (n=4 replicates).  
 
After 24 h exposure to live S. aureus, B. cepacia or P. aeruginosa, no significant changes in cell 
viability (figure 7.4 A) could be observed for Calu-3 when grown under submerged conditions. 
This is different when IL-8 concentrations (figure 7.4 B) were analysed. Significant increases were 
seen after exposure to all three different bacteria. The control supernatant of Calu-3 without 
exposure to bacteria contained 2975.33 ± 304.6 pg/ml of IL-8 compared to 5869.97 ± 314.58 
pg/ml of IL-8 after exposure to live S. aureus for 24 h. IL-8 concentration observed after exposure 
to B. cepacia was 4501.53 ± 696.12 pg/ml and was 5923.42 ± 549.9 pg/ml following challenge 
with P. aeruginosa.  
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7.4.2 Cell viability and inflammatory response of mono- and co-cultures 
at ALI after exposure to live bacteria 
7.4.2.1 Exposure of submerged HPF mono-cultures grown on TWs to live bacteria 
HPF were grown on TWs under submerged conditions for 14 days before these were challenged 
with live S. aureus from either the apical side, the basolateral side or simultaneously from both 
sides and were then assessed for cell viability (fig 7.5 A), TER (B) of the mono-culture and IL-8 
secretions (C) after the 24 h challenge. 
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Figure 7.5 Cell viability (A), cell layer integrity (B) and inflammatory response (C) of HPF after exposure to S 
.aureus 
HPF were grown under submerged conditions on TWs for 14 days before these were challenged with live 
S. aureus, which was applied either apically, basolaterally or from both sides simultanously, excluding the 
control TWs. Cell viability was not effected significantly, nor was TER measured before (clear bars) and 
directly after (striped bars) the 24 h incubation with live S. aureus. Significant increases of IL-8 
concentrations were observed for apically challenged as well as simultaneously (apical and basal) 
challenged HPF. This increase was observed in both apical (clear bars) and basolateral (checked graphs) 
samples analysed. Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
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In figure 7.5 cell viability (A) is shown for HPF after exposure to S. aureus and no significant 
differences were seen for any of the three challenges when compared to the control, which 
showed a baseline fluorescence of 2304.27 ± 143.00 FU. Graph B represents the results for TER 
(B) measured before (clear bars) and after (striped bars) the challenges. For HPF, which were 
shown before not to build up a high electrical resistance, the average TER of the control TWs 
before the challenge was 7.74 ± 1.06 Ω x cm
2
 and was 9.94 ± 1.166 Ω x cm
2
after the challenges. 
IL-8 secretion (C: apical samples =clear bars, basolateral samples =checked bars), however, was 
significantly increased following apical challenge with live S. aureus as well as for simultaneous 
challenge from both sides. HPF on their own without exposure to live S. aureus secreted 94.54 ± 
12.68 pg/ml to the apical side and 99.16 ± 31.82 pg/ml in the basolateral medium, which 
increased to 302.15 pg/ml in the apical supernatant and to 312.59 ± 39.74 pg/ml in the 
basolateral compartment after the apical challenge with live S. aureus. There is almost equal 
concentrations of IL-8 found on both sides of the cell layer, which is also true for the increased 
IL-8 secretion after the simultaneous challenge from both sides. In this case the apical 
supernatant contained 671.14 ± 70.52 pg/ml of IL-8 and the basolateral medium contained 
649.95 ± 102.06 pg/ml.  
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Figure 7.6 Cell viability (A), TER (B) and IL-8 release (C) of HPF after exposure to live B. cepacia 
HPF were grown under submerged conditions on TWs for 14 days before challenge with live B. cepacia, 
which was applied either apically, basolaterally or from both sides simultaneously,. Cell viability of HPF 
mono-culture was not affected by the presence of live B. cepacia and nor was the TER, which was 
measured before (clear bars) and directly after (striped bars) the 24 h incubation with live B. cepacia. IL-8 
concentrations, however, were significantly increased in all apical supernatants (clear bars) and 
basolateral medium (checked bars), irrespective of the site of the challenge. Data are presented as mean ± 
SD of 3 individual experiments (3TWs each, n=3). 
 
HPF mono-cultures were grown under submerged conditions on TWs for 14 days before they 
were challenged with live B. cepacia. The control TWs were treated the same as all others but 
without bacteria, whereas the TWs that were challenged were exposed to live B. cepacia from 
either the apical side, the basal side or they were exposed to bacteria on both sides at the same 
time. HPF’s cell viability (figure 7.6 A) was not changed after a 24 h incubation with live B. 
cepacia (baseline fluorescence 3107.46 ± 225.35 FU) and this was also found for the TER (B) 
measured before (clear bars) and after (striped bars) the challenge. The control TWs showed an 
average TER of 12.47 ± 3.33 Ω x cm
2 
before the challenge and a TER of 11.92 ± 2.51 Ω x cm
2
.IL-8 
secretion (C), however, was significantly increased after each challenge and this was true for 
apical supernatants (clear bars) as well as basolateral medium (checked bars). The control TWs 
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had an average of 190.21 ± 29.62 pg/ml in the apical compartment and 166.42 ± 40.9 pg/ml in 
the basal medium. For the apical challenge 2599.38 ± 343.84 pg/ml IL-8 was found apically and 
2543.67 ± 244.25 pg/ml was found basally. When HPF were challenged on the basolateral side 
only, the apical supernatant contained 1637.69 ± 135.89 pg/ml and the basolateral medium 
contained 3286.86 ± 1081.48 pg/ml IL-8 and when cells were challenged on both sides there was 
2431.85 ± 515.65 pg/ml IL-8 in the apical supernatant and 4143.27 ± 117.57 pg/ml IL-8 in the 
basal medium.  
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Figure 7.7 Cell viability (A), TER (B) and IL-8 release (C) of HPF mono-culture after exposure to live  
P. aeruginosa 
HPF mono-cultures were grown submerged on TWs for 14 days before these cells were exposed to live P. 
aeruginosa, which were applied either apically, basally or simultaneously from both sides. Cell viability 
after 24 h exposure to live bacteria was not significantly affected compared to the control TWs, which 
were handled the same but without the exposure to bacteria. TER was measured before (clear bars) and 
after (striped bars) the experiment but no significant difference was observed after 24 h incubation with 
live P. aeruginosa. IL-8 release of HPF mono-culture, however, was significantly increased by live bacteria 
applied apically and also when applied simultaneously on both sides. This was seen in the apical 
supernatants (clear bars), whereas in the basal medium samples (checked bars) the increase noted was 
only significant when challenged from both sides. Data are presented as mean ± SD of 3 individual 
experiments (3TWs each). 
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Mono-cultures of HPF were exposed to live P. aeruginosa after 14 days culture on TWs. Cell 
viability (figure 7.7 A) was analysed after a 24 h incubation with live bacteria and was found to 
not be affected significantly by this event. HPF control mono-cultures showed a baseline 
fluorescence of 1943.62 ± 254.59 FU. These cultures were also monitored in terms of changes in 
electrical resistance and the TER (B) was measured before (clear bars) and after (striped bars) 
the 24 h incubation. For the control TWs the TER was 10.30 ± 1.38 Ω x cm
2
 before the challenge 
and it was 11.95 ± 1.82 Ω x cm
2
. No significant changes were observed for apically, basally or 
simultaneous challenged HPF with live P. aeruginosa. Furthermore the IL-8 concentration (C) in 
apical supernatants (clear bars) and basal medium samples (checked bars) was analysed. The 
exposure to live P. aeruginosa caused a significant increase of IL-8 in apical supernatants, when 
HPF were challenged apically or apically and basolaterally at the same time. The control TWs 
showed IL-8 concentrations of 45.38 ± 1.49 pg/ml in the apical supernatant and 39.28 ± 9.04 
pg/ml in the basal medium compared to 1344.54 ± 291.54 pg/ml in apical supernatant and 371.5 
± 192.48 pg/ml in the basal medium, which was increased but not significant. Both samples of 
the simultaneous challenge were significant and increased to 922.38 ± 124.18 pg/ml on the 
apical side and to 540.2 ± 126.84 pg/ml in the basal compartment.  
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7.4.2.2 Exposure of C38 mono-cultures to live bacteria 
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Figure 7.8 Cell viability (A), TER (B) and IL-8 release (C) of C38 grown at ALI after exposure to S. aureus 
C38 were grown on TWs at ALI for 14 days before they were challenged with live S. aureus, which was 
applied either apically, basolaterally or from both sides simultaneously. Control TWs were C38 without 
bacteria but medium was applied apically to create similar conditions. Cell viability was significantly 
decreased in all three challenges when compared to the control. The measured TER after the challenges 
(striped bars) was not significantly different compared to before (clear bars) and nor was the IL-8 
concentration. Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
C38 mono-cultures grown at ALI were analysed after they were exposed to live S. aureus. Live 
bacteria decreased cell viability (figure 7.8 A) significantly when applied apically, basolaterally or 
from both sides at the same time. The average FU measured for control TWs was 2304.26 ± 
143.00 FU compared to 1817.44 ± 107.27 FU after apically treatment with live S. aureus. When S. 
aureus was applied basolaterally cell viability was reduced to 1726.23 ± 101.7 FU and similarly 
lowered to 1830.2 ± 109.7 FU after simultaneous challenge on both sides. Interestingly the 
cellular integrity was not directly affected and no significant differences were identified when 
comparing TER (B) to control TWs before (clear bars) and after (striped bars) the challenges. The 
control mono-cultures had an TER of 53.27 ± 1.23 Ω x cm
2
 before the 24 h incubation and they 
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had a TER of 52.43 ± 1.38 Ω x cm
2
 after this challenge. IL-8 release into either apical (clear bars) 
supernatants or the basolateral compartments (checked bars) did not change for any of the 
challenges. The baseline IL-8 secretion (figure 7.8 C) was 173.03 ± 17.0 pg/ml in the apical 
sample (clear bars) of the control and 188.37 ± 19.65 pg/ml in the basaolateral medium (checked 
bars).  
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Figure 7.9 Cell viability (A), TER (B) and IL-8 release (C) of C38 mono-cultures after exposure to live B. 
cepacia 
C38 grown at ALI were exposed to live B. cepacia, which was applied either apically, basolaterally or from 
both sides simultaneously.  Untreated TWs, which were only challenged with growth medium and no 
bacteria served as control. Cell viability (A) and cell layer integrity (B) were not affected by the presence of 
live B. cepacia. IL-8 concentrations, however, were significantly increased after all three different 
exposures and in apical supernatants (clear bars) as well as in the corresponding basolateral media 
collected (checked bars) compared to the control TWs. Data are presented as mean ± SD of 3 individual 
experiments (3TWs each). 
 
C38 mono-cultures did not show any change in cell viability (figure 7.9 A) after exposure to live 
B. cepacia for 24 h, which was either applied apically, basolaterally or on both sides 
simultaneously. The baseline fluorescence measured for the control was 3619.74 ± 502.29 FU. 
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The exposure to live B. cepacia did not have a direct influence on TER (figure 7.9B), when 
comparing the TERs from before (clear bars) and the TER after the challenges (striped bars). TER 
of control TWs was 41.14 ± 0.69 Ω x cm
2
 before the challenge and was 41.54 ± 0.85 Ω x cm
2
. The 
third aspect that was analysed was IL-8 concentration (figure 7.9C), which was investigated in 
apical supernatants (clear bars) as well as in the basal media collected (checked bars). IL-8 
release was increased significantly in apical as well as in basal samples. The control TWs had an 
IL-8 concentration of 231.33 ± 12.42 pg/ml in the apical supernatant and 191.26 ± 1.35 in the 
basal compartment. After the apical challenge 452.43 ± 18.33 pg/ml IL-8 was found in the apical 
supernatant and 287.56 ± 3.9 pg/ml IL-8 was found in the basal medium. For the basal challenge 
these were 316.53 ± 13.45 pg/ml IL-8 apically and 234.6 ± 22.49 pg/ml IL-8 basolaterally. When 
challenged from both sides values were similar to the apical challenge at 426.85 ± 19.12 and 
267.02 ± 17.40 pg/ml IL-8 for the apical and basal supernatants, respectively.  
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Figure 7.10 Cell viability (A), TER (B) and IL-8 release (C) of C38 mono-cultures after exposure to live  
P. aeruginosa 
C38 mono-cultures were grown at ALI for 14 days and were then exposed to live P. aeruginosa, which was 
applied either apically, basolaterally or from both sides simultaneously. Untreated TWs, which were 
treated the same but without bacteria served as control. Cell viability (A) of C38 was significantly 
decreased by all three different challenges, whereas the TER (B) was not affected by this exposure to live 
P. aeruginosa. IL-8 concentrations, however, were significantly increased in the apical supernatant (clear 
bars) after challenged for 24 h either apically or apically and basolaterally at the same time. The basal 
medium (checked bars) only showed a significant increase after the simultaneous challenge from both 
sides. Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
The cell viability (figure 7.10 A) of C38 mono-cultures was significantly decreased to a similar 
degree after all three challenges. The reading of FU from the control TWs was 3766.4 ± 79.97 FU 
compared to 2838.69 ± 232.14 FU when challenged apically, to 2261.26 ± 72.95 FU when 
challenged basolaterally and to 2390.87 ± 519.34 FU when challenged from both sides. TER 
(figure 7.10 B) of C38 mono-culture was measured before (clear bars) and after (striped bars) 
this 24 h exposure to live P. aeruginosa but was found to be stable without showing any 
significant changes, compared to the control, which showed a TER of 51.85 ± 3.79 Ω x cm
2
 
beforehand and of 52.98 ± 1.56 Ω x cm
2
 afterwards. After collecting all supernatants and 
analysing these for their IL-8 concentration (figure 7.10 C) it was observed that IL-8 was 
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significantly increased in the apical supernatants (clear bars) after C38 were challenged apically 
or apically and basolaterally at the same time. The IL-8 concentration of the control TWs was 
63.56 ± 9.36 pg/ml in the apical supernatant and 48.73 ± 4.70 pg/ml in the basal medium of the 
mono-culture. When C38 were challenged apically this increased to 261.81 ± 49.89 pg/ml IL-8 in 
the apical supernatant and increased non significantly to 107.68 ± 9.54 pg/ml in the basal 
medium. Both samples following the simultaneous challenge were significantly different from 
control and increased to 274.92 ± 57.14 pg/ml IL-8 in the apical supernatant and to 137.61 ± 
26.16 pg/ml IL-8 basolaterally.  
 
7.4.2.3 Exposure of IB3-1 mono-cultures at ALI to live bacteria 
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Figure 7.11 Cell viability (A), TER (B) and IL-8 release (C) of IB3-1 grown at ALI after exposure to S. aureus 
IB3-1 were at ALI for 14 days before they were challenged with live S. aureus, which was applied either 
apically, basolaterally or from both sides at the same time (apical/basal). Control TWs with IB3-1 on their 
own without bacteria were treated the same way as all other TWs with medium applied apically 
throughout the experiment. Cell viability was significantly decreased for all three exposures when 
compared to the control. TER after the exposure to live S. aureus (striped bars) was only significantly 
different when IB3-1 were exposed to live S. aureus simultaneously from the apical and basal side of the 
TW compared to TER measured before (clear bars). IL-8 concentration was not affected by this bacterium 
and did not significantly change. Data are presented as mean ± SD of 3 individual experiments (3TWs each, 
n=3). 
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The effects of S. aureus, in its intact state on IB3-1, on cell viability (figure 7.11 A), TER (B) and IL-
8 secretion (C) were analysed. Cell viability after exposure to live S .aureus was significantly 
decreased irrespective of the direction of challenge. FU in the cell viability assay for the control 
TWs of IB3-1 was 2840.95 ± 24.73 FU, which decreased to 2411.63 ± 141.57 FU when challenged 
apically, to 2135.25 ± 203.21 FU when challenged on the basal side and to 2050.37 ± 165.8 when 
live S. aureus was applied simultaneously on both sides. TER (B) was measured before (clear 
bars) and after (striped bars) the challenges with live S. aureus. Only when live bacteria were 
applied apically and basolaterally at the same time was a significant decrease observed. Before 
the challenge these TWs showed a TER of 51.26 ± 0.76 Ω x cm
2
, which was only 45.4 ± 2.26 Ω x 
cm
2
 after the 24 h incubation with live S. aureus. IL-8 secretion (7.11 C)of this mono-culture was 
not induced by any of these three different ways of exposure. The IL-8 concentration found in 
control TWs was 131.46 ± 20.84 pg/ml on the apical side and 123.40 ± 6.35 pg/ml in the 
basolateral medium. 
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Figure 7.12 Cell viability (A), TER (B) and IL-8 release (C) after exposure of IB3-1 grown at ALI to live  
B. cepacia  
IB3-1 mono-cultures were grown at ALI for 14 days before they were challenged with live B. cepacia, 
which was applied either apically, basolaterally or from both sides at the same time. IB3-1 on their own 
without bacteria were treated the same way as all other TWs and served as control. In this case cell 
viability was not significantly changed by the exposure to the bacteria. TER was found to stable for all 
three challenges after 24 h incubation (striped bars) when compared to TER of control TWs before (clear 
bars) and after (striped bars) the 24 h challenge. IL-8 concentrations observed in apical supernatants (clear 
bars) were significantly increased after live B. cepacia was applied apically or simultaneously on both 
sides. The basal medium collected (checked bars) did not show any significant changes. Data are 
presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
The cell viability (figure 7.11 A) of IB3-1 mono-cultures at ALI did not show any significant 
changes after 24 h exposure to B .cepacia . A slight decrease in cell viability was seen for apically 
or basolaterally challenged IB3-1 but this was not significantly different when compared to the 
baseline fluorescence of the control, which was 4127.91 ± 277.62 FU. TER (figure 7.11 B) of all 
challenged TWs compared to the control was found to be stable and was not significantly 
changed. The control TWs showed a TER of 51.19 ± 1.75 Ω x cm
2
 before the challenge and 53.13 
± 1.52 Ω x cm
2
 after the challenge. Secretion of IL-8 (figure 7.11 C) was measured and found to 
be significantly increased after 24 h exposure to live B. cepacia when challenged apically or when 
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challenged apically and basolaterally at the same time. For the control mono-cultures 297.74 ± 
21.11 pg/ml of secreted IL-8 into was found in the apical (clear bars) supernatant and 272.49 ± 
6.00 pg/ml were found in the basolateral compartment (checked bars). This was significantly 
increased in the apical supernatants of apically challenged (1491.15 ± 314.93 pg/ml) and 
simultaneously challenged (1301.73 ± 196.79) IB3-1 mono-culture TWs. This increase was not 
apparent in the basolateral compartments of these two challenges.  
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Figure 7.13 Cell viability (A), TER (B) and IL-8 release (C) of IB3-1 mono-culture after exposure to live  
P. aeruginosa 
IB3-1 mono-cultures were maintained at ALI for 14 days before these cells were exposed to live P. 
aeruginosa,  either apically, basally or simultaneously from both sides. Cell viability after 24 h exposure to 
live bacteria was significantly decreased for all three challenges compared to the control TWs, which were 
handled the same but without the exposure to bacteria. TER was measured before (clear bars) and after 
(striped bars) the experiment but no significant difference was observed after 24 h incubation with live P. 
aeruginosa. IL-8 release of IB3-1 mono-culture, however, was significantly increased by live bacteria 
applied apically and also when applied simultaneously on both sides. This was seen in the apical 
supernatants (clear bars), whereas it was not seen in the basal medium samples (checked bars). Data are 
presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
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Cell viability (figure 7.13 A) of IB3-1 mono-culture was significantly affected by the exposure to 
live P. aeruginosa, when live bacteria were applied either apically, basolaterally or from both 
sides simultaneously. The fluorescent signal measured for the control TWs (3780.50 ± 452.94 FU) 
was decreased to 2635.98 ± 297.41 FU after the apical challenge. The basolateral challenge 
caused a decrease in cell viability to 2780.24 ± 420.81 FU and when challenged from both sides 
the fluorescence measured was only 2610.75 ± 286.50 FU. Despite the cell viability being 
decreased, unexpectedly the TER was not affected at all by this 24 h exposure to live P. 
aeruginosa, when comparing challenged TWs to the control ones. Control TWs had a TER of 
53.86 ± 3.94 Ω x cm
2
 before the challenge and one of 58.19 ± 3.98 Ω x cm
2
. IL-8 concentrations 
(figure 7.13 C), however, increased from 119.83 ± 6.25 pg/ml IL-8 in the apical supernatant of 
the control TWs to 676.33 ± 134.97 pg/ml when challenged apically and to 728.35 ± 185.73 
pg/ml when the cells are exposed to bacteria on both sides. No significant differences were 
observed for the basal medium samples. 
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7.4.2.4 Exposure of Calu-3 mono-cultures at ALI to live bacteria 
No
 
Ba
cte
ria
Ap
ica
l S
.
au
re
us
Ba
sa
l S
.
au
re
us
Ap
ica
l/B
as
al 
S.a
ur
eu
s
0
500
1000
1500
**
Fl
u
o
re
sc
en
ce
 
u
n
its
56
0n
m
/5
90
n
m
No
 
Ba
cte
ria
Ap
ica
l S
.
au
re
us
Ba
sa
l S
.
au
re
us
Ap
ica
l/B
as
al 
S.a
ur
eu
s
No
 
Ba
cte
ria
Ap
ica
l S
.
au
re
us
Ba
sa
l S
.
au
re
us
Ap
ica
l/B
as
al 
S.a
ur
eu
s
0
50
100
150
200
250
300
350
400
450
***
***
TE
R 
(O
hm
 
x 
cm
2 )
No
 
Ba
cte
ria
Ap
ica
l S
.
au
re
us
Ba
sa
l S
.
au
re
us
Ap
ica
l/B
as
al 
S.a
ur
eu
s
No
 
ba
cte
ria
Ap
ica
l S
.
au
re
us
Ba
sa
l S
.
au
re
us
Ap
ica
l/B
as
al 
S.a
ur
eu
s
0
500
1000
1500
2000
2500
3000
3500
4000
4500
 
***
Il-
8 
in
 
pg
/m
l
A
C
B
 
Figure 7.14 Cell viability (A), TER (B) and IL-8 release (C) of Calu-3 at ALI after exposure to S. aureus 
Calu-3 mono-culture at ALI were challenged with live S. aureus, either apically, basolaterally or both at the 
same time after 14 days of culture. Cell viability was significantly reduced when challenged from from 
both sides simultaneously with live bacteria. TER was monitored before and after the challenges and was 
significantly decreased after S. aureus was applied on the apical side and when applied on both sides for 
24 h incubation. IL-8 release was not increased by these exposures to live S. aureus in any of the apical 
samples (clear bars) or in any of the basal media samples (checked bars). Overall, the IL-8 concentration 
was significantly lower in all basal samples when compared to their corresponding apical samples. Data 
are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
Calu-3 mono-culture at ALI was challenged with live S. aureus, which was applied either apically, 
basolaterally or from both sides at the same time. Cell viability (figure 7.14 A) was only affected 
when live bacteria were applied from both sides and the FU for cell viability was reduced to 
1102.64 ± 12.54 FU compared to 1390.49 ± 70.48 FU in the control TWs. TER (B) of TWs that 
were challenged apically was 376.75 ± 12.88 Ω x cm
2
 before and was only 265.25 ± 18.1 Ω x cm
2
 
after. When Calu-3 mono-cultures were challenged from both sides simultaneously the TER was 
even lower with 211.6 ± 5.28 Ω x cm
2
 compared to the TER of these TWs before, which was 
412.87 ± 12.78 Ω x cm
2
. IL-8 release (figure 7.13 C) of these mono-cultures was not induced by 
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exposure to live S. aureus. The concentration found in the apical supernatant (clear bars) of the 
control was 3660.04 ± 239.97 pg/ml and it was 551.55 ± 55.22 pg/ml in the basolateral medium 
(checked bars) analysed, which was significantly lower in the basal compartment. The same 
significant difference was observed for all other TWs as well. Basal IL-8 levels were consistently  
significantly lower than in the corresponding apical supernatant. 
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Figure 7.15 Cell viability (A), TER (B) and IL-8 release (C) of Calu-3 after exposure to live B. cepacia 
Calu-3 mono-cultures at ALI were challenged with live B. cepacia, either apically, basolaterally or both at 
the same time after 14 days of culture at ALI. Cell viability of this mono-culture was not significantly 
changed throughout this bacterial challenge. TER was measured before (clear bars) and after (striped bars) 
the challenges and was only significantly decreased after simultaneous exposure to live B. cepacia on the 
apical side as well as on the basal side. IL-8 concentration in the apical supernatants (clear bars) was only 
significantly increased when challenged apically or simultaneously on both sides. The basolateral samples 
(checked bars) only showed a significant increase following apical challenge. Data are presented as mean ± 
SD of 3 individual experiments (3TWs each, n=3). 
 
Then Calu-3 mono cultures were challenged apically, basolaterally and simultaneously on both 
sides with live B. cepacia. The cell viability (figure 7.15 A) of these mono-cultures was not 
changed by the exposure to live B. cepacia for a 24 h period and the baseline fluorescence of 
 242 
 
control TWs was 825.33 ± 1.71 FU. The transepithelial electrical resistance was measured before 
(clear bars) and straight after (striped bars) the incubation with bacteria and apart from the 
simultaneous challenge on apical and basal side, no changes were observed. Before the 
exposure the TER (figure 7.15 B) of these TWs was 341.37 ± 115.5 Ω x cm
2
, whereas afterwards it 
was 193.34 ± 21.92 Ω x cm
2
. IL-8 secretion (figure7.15C) of these mono-cultures was also 
measured after 24 h exposure to live B .cepacia and was significantly increased to 3685.07 ± 
325.26 pg/ml in the apical supernatant (clear bars), when the bacteria were applied to this side 
as well compared to 2160.67 ± 603.97 pg/ml in the apical control supernatant. The IL-8 content 
of the basal medium (checked bars) from apically challenged Calu-3 was also significantly 
increased (2683.25 ± 604.83 pg/ml) by 2.9-fold compared to the control (917.54 ± 211.45 pg/ml). 
When Calu-3 were challenged from both sides no significant change was observed for the IL-8 
concentration in the basal medium. 
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Figure 7.16 Cell viability (A), TER (B) and IL-8 release (C) of Calu-3 mono-culture after exposure to live  
P. aeruginosa 
Calu-3 mono-cultures at ALI were challenged with live P. aeruginosa, either apically, basolaterally or both 
at the same time after 14 days of culture at ALI. Cell viability was not significantly decreased after any of 
these challenges. TER was measured before (clear bars) and after (striped bars) the challenges and was 
significantly decreased after all three different exposures to live P. aeruginosa. IL-8 concentration in the 
apical supernatants (clear bars) were increased significantly after the basal as well as the apical/basal 
challenge and in the basolateral samples (checked bars) did not show any significant changes for these 
challenges. The basolateral sample are all significant lower in IL-8 compared to their corresponding apical 
supernatant. Data are presented as mean ± SD of 3 individual experiments (3TWs each). 
 
Calu-3 mono-cultures were exposed to live P. aeruginosa, which was applied in three different 
ways. Either P. aeruginosa was added to the apical side of the mono-culture, to the basal 
medium or the bacteria were added in both compartments at the same time. After a 24 h 
incubation with the bacteria, cell viability (figure 7.16 A) of Calu-3 was assessed and found to be 
stable throughout the experiment. The baseline fluorescence that was measured for the control 
TWs was 2284.31 ± 519.29 FU. In contrast the electrical resistance was measured in TER (B) and 
was significantly decreased in all three occasions. The control TWs TER was measured and was 
267.53 ± 37.64 Ω x cm
2
 before (clear bars) and was 367.29 ± 33.62 Ω x cm
2
 after (striped bars) 
the 24 h incubation. Following the apical challenge the TER fell from 302.03 ± 57.36 Ω x cm
2
 to 
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169.32 ± 58.6 Ω x cm
2
, for the basolateral challenge it fell from 306.53 ± 25.97 Ω x cm
2
 to 192.57 
± 6.53 Ω x cm
2
 and when challenged simultaneously the TER of Calu-3 mono-culture fell from 
316.58 ± 62.72 Ω x cm
2 
to 95.40 ± 6.31 Ω x cm
2
. IL-8 concentration (C) of this mono-culture was 
observed and only when challenged basally or from both sides at the same time, a significant 
increase was seen. The basally challenged apical supernatant (clear bars) had an IL-8 
concentration of 6121.55 ± 363.81 pg/ml compared to 4346.8 ± 232.60 pg/ml found in the 
control apical supernatant. When challenged from both sides an IL-8 concentration of 5724.85 ± 
880.47 pg/ml was reached in the apical supernatant. The basal medium samples (checked bars) 
show the same trend of increase as the apical samples but were not significant. 
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7.4.2.5 Exposure of HPF-C38 co-cultures grown at ALI to live bacteria 
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Figure 7.17 Cell viability (A), TER (B) and IL-8 release (C) after exposure to S. aureus of HPF-C38 grown at 
ALI  
HPF-C38 were grown on TWs at ALI for 14 days before they were challenged with live S. aureus, which was 
applied either apically, basolaterally or from both sides simultaneously. HPF-C38 without bacteria, which 
were treated the same way throughout the experiment with medium only served as control. Cell viability 
was significantly decreased compared to the control, when this co-culture was challenged basolaterally or 
when challenged from both sides at the same time. The measured TER after the challenges (striped bars) 
was significantly lower in all bacterial challenged TWs compared their corresponding values before (clear 
bars). IL-8 secretion was significantly increased by simultaneous treatment with live S. aureus from apical 
and basal side. Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
Co-cultures of HPF and C38 were grown at ALI for 14 days before the challenges were carried 
out. Cell viability (figure 7.17 A) was assessed after the challenges with live S. aureus and was in 
this case significantly affected when challenged basolaterally (751.71 ± 5.88 FU) or from the 
apical and basal side at the same time (626.56 ± 214.59 FU) when compared to the control TWs 
(1143 ± 67.54 FU). The average TER (figure 7.17 B) for the control TWs measured after (striped 
bars) the 24 h was 50.45 ± 1.4 Ω x cm
2
 and was decreased significantly after all three challenges 
with live S. aureus. After 24 h apical exposure to live S. aureus the TER was 41.7 ± 0.61 Ω x cm
2
, 
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after basal exposure it was 39.86 ± 1.6 Ω x cm
2
 and when challenged from both sides the TER fell 
to 40.38 ± 0.48 Ω x cm
2
 compared to their corresponding measurement before the challenges. 
IL-8 concentrations (figure 7.12 C) that were observed were only significantly increased when 
live S. aureus was applied to both sides of the co-culture simultaneously. IL-8 secretion at 
baseline was 1708.2 ± 730.8 pg/ml in the apical medium (clear bars) and 1281.94 ± 526.3 pg/ml 
in the basal media. This increased to 6655.4 ± 1242.29 pg/ml in the apical supernatant and to 
3728.8 ± 430.9 pg/ml in the basal medium collected (checked bars).  
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Figure 7.18 Cell viability (A), TER (B) and IL-8 release (C) after exposure to live B. cepacia of HPF-C38 co-
culture grown at ALI  
HPF-C38 co-culture was challenged with live B. cepacia, which were applied to either the apical side of the 
culture, to the basolateral side or to both at the same time. HPF-C38 on their own without bacteria were 
treated the same way as all other TWs and served as control. In this case cell viability was significantly 
changed by the exposure to live B. cepacia, when the bacteria were applied on both sides of the co-
culture. However, the TER measured was found to be stable for all three challenges after (striped bars) 24 
h incubation when compared to TER of control TWs before (clear bars) and after (striped bars) the 24 h 
challenge. IL-8 concentrations observed in apical supernatants (clear bars) were significantly increased 
after live B. cepacia was applied apically as well as when applied on both sides. This was only reflected in 
the basal medium for the apical challenge but not when challenged on both sides (checked bars). Data are 
presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 247 
 
The only change in cell viability (figure 7.18 A) observed for HPF-C38 was a significantly decrease 
when this co-culture was challenged simultaneously from the apical as well as the basolateral 
side. Cell viability of control TWs was 2468.3 ± 199.8 FU compared to only 1465.8 ± 72.66 FU 
after they were challenged with live B. cepacia. The TER (figure 7.18 B) was stable throughout 
these experiments and was not significantly affected for this period of bacterial exposure, when 
compared to the control cultures, which had a TER of 42.94 ± 0.55 Ω x cm
2
 before the exposure 
to live B. cepacia and a TER of 43.75 ± 1.61 Ω x cm
2
. This was different from the analysis of IL-8 
concentrations (figure 7.18 C). Here, a significant increase was observed when C38-HPF co-
cultures were challenged from the apical side and IL-8 concentration (figure 7.18 C) increased to 
8095.19 ± 588.34 pg/ml in the apical supernatant (clear bars) compared to 2271.92 ± 439.19 
pg/ml of the apical supernatant of the control TWs. When the co-culture was challenged from 
both sides simultaneously IL-8 concentration was significantly increased to 5920.66 ± 518.52 
pg/ml compared to the control for the apical supernatants. After the basolateral samples were 
analysed, a significant increase was only observed after apical challenge with live B. cepacia. The 
concentration of IL-8 in the basal medium of control TWs was 2196.14 ± 880.8 pg/ml and 
increased to 5385.95 ± 1706.45 pg/ml after the challenge.  
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Figure 7.19 Cell viability (A), TER (B) and IL-8 release (C) after exposure to live P. aeruginosa of HPF-C38 
grown at ALI  
HPF-C38 were grown on TWs at ALI for 14 days before they were challenged with live P. aeruginosa, which 
was applied either apically, basolaterally or from both sides simultaneously. HPF-C38 without bacteria, 
which were treated the same way throughout the experiment with medium only, served as control. Cell 
viability was significantly decreased compared to the control, when this co-culture was challenged 
basolaterally or when challenged from both sides at the same time. The measured TER before (clear bars) 
and after the challenges (striped bars) was not changed by this 24 h incubation with live P. aeruginosa. IL-
8 secretion, however, was significantly increased by basolateral and simultaneous treatment with live P. 
aeruginosa from apical and basal side and this was only observed in the apical (clear bars) supernatants. 
Data are presented as mean ± SD of 3 individual experiments (3TWs each). 
 
HPF-C38 co-culture was also exposed to live P. aeruginosa. The cell viability (figure 7.19 A) was 
decreased significantly after the co-culture was exposed to P. aeruginosa on the basal side and 
when exposed to the bacteria on both sides. Cell viability of control TWs gave a reading of 
3379.93 ± 46.99 FU, which was only 2838.16 ± 313.03 FU after the basolateral challenge and 
only 2614.56 ± 250.95 FU after the simultaneous challenge from both sides. The electrical 
resistance properties, which were measured as TER (figure 7.19 B) were not affected by these 
challenges after 24 h. TER measured for the control cultures were 48.58 ± 3.05 Ω x cm
2
before 
(clear bars) the challenge and it was 54.85 ± 2.59 Ω x cm
2
 after the challenge (striped bars). IL-8 
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secretion (figure 7.19 C) of this co-culture significantly increased after TWs were exposed to 
basolateral bacteria and increased from 535.25 ± 51.28 pg/ml in the apical supernatant (clear 
bars) of the control TWs to 2432.04 ± 495.78 pg/ml and even higher to 4118.35 ± 544.57 pg/ml 
when these co-cultures were challenged from both sides at the same time. The same trend of 
increasing IL-8 concentration was seen in the basal medium samples (checked bars) but was not 
found to be significant. 
 
7.4.2.6 Exposure of HPF-IB3-1 co-cultures grown at ALI to live bacteria 
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Figure 7.20 Cell viability (A), TER (B) and IL-8 release (C) after exposure to live S. aureus of HPF-IB3-1 
grown at ALI  
HPF-IB3-1 co-cultures were at ALI for 14 days before they were challenged with live S. aureus, which was 
applied either apically, basolaterally or from both sides at the same time. HPF-IB3-1 on their own without 
bacteria were treated the same way as all other TWs and served as control. In this case cell viability was 
significantly decreased when the co-culture system was challenged apically or simultaneously from both 
sides with live S. aureus. TER was found to be significantly decreased for all three challenges after 24 h 
incubation (striped bars) when compared to TER of control after the 24 h challenge. IL-8 concentrations 
observed in apical supernatants (clear bars) were significantly increased after live S. aureus was applied 
apically or basolaterally. The basal medium collected (checked bars) showed a significant increase only for 
basal application of S. aureus. Data are presented as mean ± SD of 3 individual experiments (3TWs each). 
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HPF-IB3-1 co-cultures were exposed to live S. aureus after being grown for 14 days at ALI. S. 
aureus was applied apically, basolaterally or on both sides at the same time. The cell viability 
(figure 7.20 A) was observed after 24 h exposure to the bacteria and was significantly decreased 
for apically treated cells and for simultaneous treatment from both sides compared to untreated 
cells. The baseline FU for the control was 1282.48 ± 150.1 FU compared to the reduced value for 
apically challenged cells, which was 917.87 ± 84.58 FU and TWs challenged on both sides, which 
was only 586.77 ± 34.44 FU. The integrity of the epithelial cell layer was assessed by TER (figure 
7.20 B) and this was significantly lower for all three challenges compared to the control TWs. 
After the 24 h challenge the control’s TER was 49.42 ± 1.53 Ω x cm
2
 compared to 44.84 ± 0.92 Ω 
x cm
2
 when challenged apically, 40.0 ± 1.65 Ω x cm
2
when challenged basolaterally and compared 
to 40.55 ± 1.3 Ω x cm
2
 when live S. aureus was applied on both sides. The concentration of IL-8 
(figure 7.20 C) in the apical supernatants (clear bars) was significantly increased for two 
occasions. The first significant increase compared to the control TWs (2407.27 ± 755.82 pg/ml) 
was noted, when HPF-IB3-1 were challenged apically (4469 ± 290.8 pg/ml) and the other one 
when these cells were challenged basolaterally (4224.73 ± 210.02 pg/ml), which also caused a 
significant increase of IL-8 in the basal medium (checked bars) collected, which had a 
concentration of 3945.4 ± 590.37 pg/ml compared to (1995.18 ± 574.49 pg/ml) basal medium of 
the control TWs.  
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Figure 7.21 Cell viability (A), TER (B) and IL-8 release (C) after exposure to live B. cepacia of HPF-IB3-1 
grown at ALI  
HPF-IB3-1 co-cultures were at ALI for 14 days before they were challenged with live B. cepacia, which was 
applied either apically, basolaterally or from both simultaneously. HPF-IB3-1 on their own without bacteria 
were treated the same way as all other TWs and served as control. In this case cell viability was 
significantly decreased after all three challenges with live B. cepacia for 24 h. TER was found to be stable 
for all three challenges and did not change. IL-8 concentrations observed in apical supernatants (clear 
bars) were significantly increased after live B. cepacia were applied apically, basolaterally or on both sides 
at the same time. The IL-8 concentrations in basal media samples was not significantly changed and only 
showed a trend of increasing (checked bars). Data are presented as mean ± SD of 3 individual experiments 
(3TWs each). 
 
HPF-IB3-1 co-cultures were investigated for changes in cell viability (figure 7.21 A), TER (figure 
7.21 B) and IL-8 secretion (figure 7.21 C) into the medium after exposure to live B. cepacia, which 
was applied either apically, basolaterally or on both sides. Cell viability was significantly 
decreased in all three cases and decreased to 1280.31 ± 340.68 FU when challenged apically, to 
1093.05 ± 301.41 FU when challenged basally and to 1013.08 ± 121.22 FU when exposed to live 
bacteria on both sides compared to 2236.16 ± 120.41 FU measured for the control TWs. Even 
though cell viability was significantly lower the TER was not affected by this after 24 h 
incubation, when comparing challenged TWs to the control ones, which had a TER of 47.23 ± 
0.90 beforehand (clear bars) and a TER of 47.96 ± 6.49 afterwards (striped bars). IL-8 
concentrations were significantly increased in the apical supernatants (clear bars) after all three 
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challenges. IL-8 concentration measured for the control TWs was 3289.55 ± 447.96 pg/ml and 
was in increased to 11012.96 ± 325.18 pg/ml for the apical challenge, to 9022.79 ± 1990.16 
pg/ml for the basaolateral challenge and to 9545.64 ± 1680.05 pg/ml when challenged from 
both sides. The same trend was seen for basal medium (checked bars) analysed for IL-8 but this 
was not significant. 
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Figure 7.22 Cell viability (A), TER (B) and IL-8 release (C) after exposure to live P. aeruginosa of HPF-IB3-1 
grown at ALI  
HPF-IB3-1 co-cultures were grown at ALI for 14 days before they were challenged with live P. aeruginosa, 
which was applied either apically, basolaterally or from both sides at the same time. HPF-IB3-1 on their 
own without bacteria were treated the same way as all other TWs and served as control. In this case cell 
viability was significantly decreased when the co-culture system was challenged apically or simultaneously 
from both sides with live P. aeruginosa. TER was found to be significantly decreased for all three 
challenges after 24 h incubation (striped bars) when compared to their corresponding TER bar before 
challenge. IL-8 concentrations observed in apical supernatants (clear bars) were significantly increased 
after live P. aeruginosa was applied apically or basolaterally. The basal medium collected (checked bars) 
showed a significant increase in IL-8 only after basal application of P. aeruginosa. Data are presented as 
mean ± SD of 3 individual experiments (3TWs each). 
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HPF-IB3-1 co-cultures were challenged with live P. aeruginosa, which was either applied apically, 
basolaterally or from both sides at the same time. This 24 h incubation with live bacteria had a 
huge impact on cell viability (figure 7.22 A) and decreased it from 2140.0 ± 145.77 FU to 1568.00 
± 327.55 FU when challenged apically and to 697.84 ± 91.13 FU when challenged from apical and 
basal side at the same time. TER (figure 7.22 B) was analysed before (clear bars) and after 
(striped bars) these challenges and was also found to be affected as the control TWs showed a 
TER of 54.82 ± 3.34 Ω x cm
2
 before the challenge and 54.01 ± 2.10 Ω x cm
2
 after the challenge, 
whereas after the apical challenge it only was 46.35 ± 2.44 Ω x cm
2
 (before 56.02 ± 1.91 Ω x cm
2
), 
after the basal challenge it was only 47.34 ± 1.10 Ω x cm
2
 (before 56.61 ± 1.61 Ω x cm
2
) and when 
challenged from both sides the TER fell to 40.7 ± 1.29 Ω x cm
2
 (before 59.54 ± 1.31 Ω x cm
2
). IL-8 
concentrations (figure 7.22 C) found in apical supernatants (clear bars) and basal medium 
(checked bars) were also significantly changed. 1944.97 ± 98.62 pg/ml were found in apical 
supernatant of the control TWs and 2317.03 ± 73.09 pg/ml was found in the basal medium. 
Significant increases were observed for apical supernatants of the apical challenge (2909.78 ± 
48.94 pg/ml) as well as of the basolateral challenge (3071.98 ± 140.40 pg/ml). For the basal 
medium of these samples there was only one significant change and that was found for 
basolaterally challenged TWs that showed an IL-8 concentration of 3231.98 ± 126.09 pg/ml.  
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7.4.2.7 Exposure of HPF-Calu-3 co-cultures grown at ALI to live bacteria 
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Figure 7.23 Cell viability (A), TER (B) and IL-8 release (C) of HPF-Calu-3 after exposure to live S. aureus 
HPF-Calu-3 co-culture at ALI were challenged with live S. aureus, either apically, basolaterally or both at 
the same time after 14 days of culture. Cell viability was significantly reduced when challenged from 
apically or when challenged apically and basolaterally at the same time with live S. aureus. TER was 
measured before (clear bars) and after (striped bars) the challenges and was significantly decreased after 
all three challenges with live S. aureus. IL-8 release was only increased significantly when challenged 
simultaneously on both sides. This was found for the apical supernatant (clear bars) as well as the basal 
medium collected (checked bars). Data are presented as mean ± SD of 3 individual experiments (3TWs 
each). 
 
HPF-Calu-3 co-cultures were challenged with live S. aureus after they were grown for 14 days at 
ALI. The cell viability (figure 7.23 A) was significantly decreased compared to the control TWs 
(904.6 ± 154.63 FU) when S. aureus was applied apically (541.2 ± 48.19 FU) or from apical and 
basal side at the same time (436.94 ± 29.5 FU). TER (figure 7.23 B) was monitored before (clear 
bars) and after (checked bars) the challenges and was significantly decreased for all three 
challenges compared to their corresponding value before (clear bars). For the apical challenge, 
the TER fell from 343.12 ± 18.21 Ω x cm
2
 to 169.91 ± 27.64 Ω x cm
2
, for the basolateral challenge 
it went from 343.2 ± 13.6 Ω x cm
2
 down to 268.98 ± 10.77 Ω x cm
2
 and when challenged from 
both sides at the same time it drops from 383.75 ± 13.85 Ω x cm
2
 to 84.63 ± 7.75 Ω x cm
2
. IL-8 
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(figure 7.23 C) was measured in all apically collected supernatants (clear bars) as well as in the 
basal media (checked bars) of each TW and significant differences were only found when this co-
culture was challenged on both sides simultaneously compared to the control, which had an IL-8 
concentration of 3751.72 ± 503.98 pg/ml in the apical supernatant and 1915.62 ± 291.65 pg/ml 
in the basal medium. This concentration increased to 6386.6 ± 1133.81 pg/ml in the apical 
supernatant and to 3648.55 ± 294.02 pg/ml in the basolateral medium.  
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Figure 7.24 Cell viability (A), TER (B) and IL-8 release (C) of HPF-Calu-3 co-culture after exposure to live B. 
cepacia 
HPF-Calu-3 co-cultures at ALI were challenged with live B. cepacia, either apically, basolaterally or both at 
the same time after 14 days of culture at ALI. Cell viability of this co-culture was significantly decreased 
when challenged from both sides with live bacteria. TER was measured before (clear bars) and after 
(striped bars) the challenges and was significantly decreased after all three different exposures to live B. 
cepacia. IL-8 concentration in the apical supernatants (clear bars) was only significantly increased when 
challenged apically and basally at the same time. The basolateral samples (checked bars) did not show a 
significant increase for these challenges. Data are presented as mean ± SD of 3 individual experiments 
(3TWs each, n=3). 
 
HPF-Calu-3 cell co-culture viability (figure 7.24 A) was analysed after 24 h exposure to live B. 
cepacia and was found to be decreased significantly when challenged on both sides of the cells. 
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The FU of the control TWs measured were 2468.27 ± 199.8 FU and this was decreased to 1465.8 
± 72.66 FU after these co-cultures were exposed to live B. cepacia simultaneously on both sides. 
TER (figure 7.12B) was affected by all three different challenges significantly and was decreased 
to 171.34 ± 19.47 Ω x cm
2
 (before 242.03 ± 34.65 Ω x cm
2
) after the apical exposure, lowered to 
122.03 ± 12.167 Ω x cm
2 
 (before 306.53 ± 25.97 Ω x cm
2
) after the basal challenge and fell down 
to 138.93 ± 16.33 Ωcm
2
 (before 349.91 ± 20.62 Ωcm
2
) after simultaneously challenging the co-
culture on both sides. Even though these two parameters showed significant changes, the IL-8 
concentration shown in figure 7.24 (C) was only significantly increased in the apical 
compartment following simultaneous challenge of this co-culture. The control TWs showed 
5709.73 ± 832.55 pg/ml in the apical supernatant (clear bars) and 3845.69 ± 991.91 pg/ml in the 
basolateral medium (checked bars) compared to 7836.94 ± 1456.96 pg/ml apically and 2886.73 ± 
1052.6 pg/ml basally when challenged from both sides at the same time.  
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Figure 7.25 Cell viability (A), TER (B) and IL-8 release (C) of HPF-Calu-3 co-culture after exposure to live P. 
aeruginosa 
HPF-Calu-3 co-cultures at ALI were challenged with live P. aeruginosa, either apically, basolaterally or both 
at the same time after 14 days of culture at ALI. Cell viability of this co-culture was was not affected by any 
of these three challenges after 24 h. TER was measured before (clear bars) and after (striped bars) the 
challenges and there were no significant changes apparent after all three different exposures to live P. 
aeruginosa. IL-8 concentration in the apical supernatants (clear bars) was only significantly increased 
when challenged apically and simultaneously from both sides. The basolateral samples (checked bars) did 
not show a significant increase for these challenges. Data are presented as mean ± SD of 3 individual 
experiments (3TWs each, n=3). 
 
Then HPF-Calu-3 co-cultures were challenged with live P. aeruginosa after they were grown for 
14 days at ALI. P. aeruginosa was applied apically, basally or from both sides at the same time. 
These challenges did not significantly decrease cell viability (figure 7.25 A) after 24 h incubation 
with the bacteria and the baseline fluorescence of this culture was 1465.69 ± 355.19 FU. TER 
(figure 7.25 B) of this co-culture was not affected by the challenges at all and was stable 
throughout the experiment. Control co-cultures that were exposed to growth medium only had 
a TER of 267.41 ± 72.09 Ω x cm
2
 beforehand and a TER of 210.76 ± 71.25 Ω x cm
2
 afterwards. IL-8 
(figure 7.25 C) concentrations, however, did increase significantly in the apical supernatants 
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(clear bars) after being challenged apically or from both sides. The control TWs showed an IL-8 
concentration of 2488.17 ± 691.99 pg/ml compared to 4625.07 ± 374.77 pg/ml after the co-
culture was challenged apically with live P. aeruginosa and compared to 6288.10 ± 165.71 pg/ml 
after they were challenged simultaneously from both sides. No significant differences could be 
identified for the basal media samples (checked bars) collected from the TWs.  
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7.5 Discussion 
In this chapter submerged mono-cultures and mono-and co-cultures at ALI of HPF, C38, IB3-1 
and Calu-3 were exposed to viable S. aureus, B. cepacia and P. aeruginosa, which are all CF 
relevant pathogens of the airways. B. cepacia and P. aeruginosa used in the present study were 
isolated from CF patients and were provided by Professor Peter Lambert. 
Cellular responses, in terms of IL-8 release, cell viability and cell layer integrity were monitored 
to see what impact these CF relevant bacteria in their intact, viable form have on the established 
model systems. The responses of HPF mono-cultures in isolation was carried out in order to see 
what input this supporting cell type might have on pro-inflammatory responses to infection 
especially in respect of the co-culture models. 
7.5.1 S. aureus challenge of submerged mono-cultures and mono- and co-
cultures at ALI  
Submerged mono-cultures of HPF, C38, IB3-1 and Calu-3 were challenged with viable S. aureus 
for 24 h. Interestingly, under these conditions only Calu-3 mono-cultures responded to live S. 
aureus by secreting IL-8 into the culture medium. The cell viability was not affected in any of 
these mono-cultures. These findings are completely different when cells are grown on TWs.  
HPF were grown under submerged conditions on TWs and epithelial cells were grown at ALI. 
When grown on TWs, HPF did respond to this bacterial challenge with viable S. aureus by 
secreting IL-8, which was found in equal concentrations in the apical supernatant as well as in 
the basolateral compartment. The equivalent levels of IL-8 in the apical and basolateral 
compartments of HPF cultures are not surprising considering that fibroblasts do not form a 
barrier as tight as epithelial cells do. HPF constitute a weak physical barrier (Myerburg et al., 
2007) and they do not show an increase in TER over time (see chapter 5). The electrical 
resistance is very low (around 10 Ω x cm
2
) and just higher than background readings and could 
therefore be used as an indicator of viable cells on the TW. This low resistance suggests that 
chemokines like IL-8 and other small molecules can diffuse from the “apical” side to the 
“basolateral” side or vice versa along a concentration gradient. IL-8 was only released when S. 
aureus was applied to the apical side of HPF cultures or to both sides at the same time. The 
simultaneous challenge from both sides caused a stronger response in terms of IL-8 compared to 
the apical challenge. However, no IL-8 response was seen after the basal challenge of these 
mono-cultures. The increase in IL-8 response seen when cells were challenged from both sides 
may reflect a response to higher numbers of bacteria, or a response to direct interaction with 
bacteria from the apical surface, but has yet to be determined.  
 260 
 
This different behaviour of HPF on collagen IV coated TWs compared to these cells grown on 
collagen IV coated 24-well plates is surprising and suggests that pro-inflammatory responses of 
HPF, at least for IL-8 secretion, were altered by the different growth support and by the 
establishment of a multicell-layer (Chapter 5) rather than a mono-layer as it is seen on plastic 
ware (Chapter 3). Both the TWs and the 24-well plates were collagen IV coated and this should 
therefore not play a role in the different response observed. A significant difference is that cells 
cultured on TWs are supported on a semi-permeable membrane, which appears to support the 
formation of a multi-layered cell structure, even in these non-polarised fibroblasts. The “basal” 
cells which are nearest to the membrane do not have much freely exposed membrane surface 
area for the apically-applied S. aureus to adhere to, whereas the upwards facing cell surface 
membranes are completely accessible for the bacteria to adhere to. Whether HPF can show a 
certain degree of polarity (e.g. receptor expression) when grown on TWs and therefore whether 
these responses to apical bacteria were due to the freely exposed surface area with different 
receptors for bacterial adhesins cannot be answered yet. As already mentioned and as shown in 
figure 4.22, HPF grew into a multicell layer when cultured on TWs, whereas cells grown on 
plastic ware coated with collagen IV form a mono-layer (routine light microscopy observation of 
cells; Chapter 3), however whether this multiple cell layer formation is responsible for the 
“polarised” response of fibroblasts remains to be determined.  
 
The epithelial cell behaviour was also different comparing submerged mono-cultures and mono-
cultures at ALI. Under submerged conditions only Calu-3 showed an increase in IL-8 release after 
exposure to viable S. aureus, whereas C38 and IB3-1 did not respond at all and under these 
conditions S. aureus did not have any effect on epithelial cell viability. This different 
inflammatory response to S. aureus by these cell lines suggests that S. aureus or secreted 
virulence factors are able to bind to, and therefore stimulate, Calu-3 but not to the other two 
cell lines. Which receptor exactly was involved in the Calu-3 pro-inflammatory response is 
unknown, it is established that asialoGM1 can serve as a receptor for S. aureus (Ratner et al., 
2001), but this receptor has yet to be demonstrated on Calu-3 cells. It was unexpected to see no 
pro-inflammatory responses from C38 or IB3-1 considering that these cell lines have been shown 
to express asialoGM1, even under submerged conditions (DiMango et al., 1995) and to elicit an 
IL-8 response, asialoGM1 and TLR-2 need to be co-mobilized into a lipid raft (Soong et al., 2004),  
and it has been demonstrated previously that C38 and IB3-1 two cell lines express functional 
TLR-2 and that permits cellular response to P. aeruginosa by activating NF-κB (Firoved et al., 
2004). Calu-3 have also been shown to express TLR-2 at the level of mRNA and protein (O'Grady, 
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2007), but surface expression has not been confirmed. Such studies would provide a useful 
insight into the reasons behind the difference in response of these epithelial cell lines.  
 
The cellular responses were different when epithelial cell lines were cultured on TWs at ALI. 
Here, C38 and IB3-1 showed a significant decrease in cell viability following all three challenges 
with viable S. aureus. This shows that, when grown at ALI, these two cell lines appear more 
susceptible to bacterial infection than under submerged conditions, suggesting that cell 
morphology and differentiation plays a role possibly in terms of receptor expression on the 
apical and basolateral surface membranes. These data also confirm the importance of producing 
physiologically relevant models- the differentiated epithelial cells that are produced following 
ALI (figure 4.11 and 4.12) closely resemble the native human airways and therefore these 
responses to infection are assumed to more closely resemble those seen in vivo.  
 
Another important result to note was the difference between the models of normal and CF 
airways. TER was only affected in IB3-1 cells and only following the simultaneous challenge from 
both sides, which indicates a higher susceptibility of these cells (and thus the CF model) to viable 
S. aureus. Surprisingly even though there is significant reduction in cell viability, no increase in IL-
8 secretion was observed at all. This decrease in viability in the apparent absence of 
inflammation is quite interesting considering that viable S. aureus will secrete several virulence 
factors, which usually induce an inflammatory response. It has been shown though that on one 
hand S. aureus is able to induce apoptosis and on the other hand that epithelial cells are able to 
ingest apoptotic cells themselves through efferocytosis. Even though this process is slower 
compared to professional phagocytes clearing apoptotic cells, these results could indicate that 
epithelial clearance of apoptotic cells is rapid enough to prevent an inflammatory response. 
Effective apoptotic cell clearance, before the damaged cell release internal cell compartments 
and noxious contents, is known to actively suppress proinflammatory responses (Vandivier et al., 
2006). The decrease of cell viability seen here is therefore suggested to happen through 
apoptosis without inducing a pro-inflammatory IL-8 response.  
 
In contradiction to this hypothesis, it has been reported for primary CF epithelial cells, as well as 
for IB3-1, that CFTR negative cells are not able to clear apoptotic cells, which will then 
accumulate and induce IL-8 release by CF cells (Vandivier et al., 2009). However, in support of 
these suggestions made here it has been shown that after 24 h infection with S. aureus a CF 
(CFT-1) and a non-CF (LCFSN) epithelial cell line became apoptotic upon internalising the 
bacteria. No difference in internalisation was seen between CF and non-CF cells (Kahl et al., 
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2000). Additionally S. aureus is also able to kill epithelial cells, when a certain threshold of 
secreted autoinducer by S. aureus is reached, quorum sensing activates production of S. aureus’s 
virulence factor α-toxin, which has been shown to bind to a receptor called ADAM 10 and as a 
pore forming protein, α-toxin is able to lyse cells. At low level concentrations of α-toxin mainly 
apoptosis is induced (Essmann et al., 2003). To fully elucidate the decrease in cell viability seen 
here, further investigations will be needed.  
 
In contrast to the other two cell lines the cell viability of Calu-3 was only affected by the 
simultaneous challenge with S. aureus from both sides, indicating that these cells are less 
susceptible to viable S. aureus. After the three challenges no IL-8 increase was observed not 
even in the presence of decreased cell viability, which was already discussed above. For Calu-3, 
the TER was significantly lower following the apical and apical/basolateral challenge, which 
suggests that apical exposure is necessary to perturb cell layer integrity. It has been shown 
before that S. aureus is able to disrupt tight junctions of 16HBE polarized cell layers in a 24 h 
period and the bacterial traversed the cell layer and were recovered from the basal 
compartment (Soong et al., 2011).Basolateral bacteria were not investigated in the current 
study, but again it is surprising that S. aureus did not evoke a pro-inflammatory response and 
this therefore needs further investigation. 
 
Altogether these results show that there is no direct correlation between a decrease in TER and 
decrease in cell viability. Neither could the IL-8 secretion be directly linked not be directly linked 
to decreased cell viability and further studies will be elucidating whether these phenomenon is 
down to an anti-inflammatory effect of apoptotic cell clearance. 
 
These findings were also observed for the co-cultures consisting of HPF together with one of the 
epithelial cell lines. The cell viabilities of HPF-C38, HPF-IB3-1 and HPF-Calu-3 were affected in 
two cases each. First it was shown that all three co-cultures showed a decrease in cell viability 
after the apical/basolateral challenge and secondly it was observed that the cell viability of HPF-
C38 was decreased following the basal exposure to viable S. aureus, whereas HPF-IB3-1 and HPF-
Calu-3 showed a decrease in cell viability after the apical challenge. This decrease following the 
apical challenge was not observed in Calu-3 mono-cultures, where following the apical challenge 
no change in cell viability was observed. The fact that HPF-IB3-1 and HPF-Calu-3 show a similar 
pattern regarding the cell viability suggests modulation of cell survival possibly based on the 
addition of subepithelial fibroblasts is not dependant on the expression of CFTR. 
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Observations of TER following challenge with viable S. aureus reveal that in all co-culture models 
the TER is significantly decreased after all three different ways of exposures to S. aureus. Even 
though the TER values of epithelial mono-cultures are comparable to the one established in the 
co-cultures models, it seems that the epithelial cell layer integrity of these cells in co-culture is 
more readily compromised than in mono-culture.  
 
The induced proinflammatory responses of co-cultures were also found to be different 
compared to the mono-cultures, which is plausible as fibroblasts in mono-culture respond to S. 
aureus challenges. Interestingly in mono-culture HPF responded to apical challenges, where in 
the co-cultures they are subepithelial and the upwards facing surface membrane is not 
accessible for direct contact of S. aureus with HPF. This interaction can only occur from the basal 
side. However a basal response (potentially of fibroblast origin) was only registered for HPF-IB3-
1 after basal exposure. HPF-IB3-1 did not show a significant increase of IL-8 following the 
simultaneous apical/basal challenge but this might be down to the huge decrease in cell viability 
seen here. HPF-C38 and HPF-Calu-3 only responded to the simultaneous apical/basal challenge 
but not anymore to the apical challenge indicating a supporting role of the fibroblasts for the 
epithelial cell layer. As mentioned before it has been shown that fibroblast support epithelial cell 
differentiation and also ciliogenesis (Myerburg et al., 2007). Interestingly, it seems the 
subepithelial HPF cannot exhibit this support for IB3-1.This might indicate that there is a 
difference in direct cell communication- in terms of either the signalling molecules or the 
necessary receptors- for IB3-1 and HPF compared to the other two models. Whether this is down 
to IB3-1 expressing mutated CFTR, or a knock-on effect of genes modified by mutated CFTR 
needs to be further investigated.  
 
It is important to note that for HPF-C38 and HPF-IB3-1, baseline IL-8 secretion is much higher 
than in mono-cultures. Why there is an increase in baseline IL-8 release in these co-cultures has 
not yet been explored, but it appears that there is some co-stimulation of epithelial responses by 
the presence of proliferating fibroblasts, and vice versa. Understanding this mechanism of 
communication is one important aim of establishing these models.  
 
No pattern of IL-8 secretion could be identified comparing all three co-cultures, which is difficult 
as it is impossible to tell which cell type did secrete the IL-8, how much was secreted by each of 
the cell types or in which direction it was secreted by the individual cell populations. This is 
similar for cell viability, it is impossible to tell whether decrease in cell viability is down to only 
one cell type or down to both cell types being affected.  
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These results show that the addition of fibroblasts modulates epithelial cell behaviour in 
response to S. aureus. How exactly intercellular communication, between fibroblasts and 
epithelial cells influences the three measured parameters is not known but the challenge of 
understanding these mechanisms of communication needs to be taken up and may lead to novel 
ideas for targeted therapies. Co-cultures of fibroblasts and epithelial cells should help to move 
forward in the right direction to investigate molecular mechanisms, whereas animal models here 
are complicated by too many variables, which lead to lack of properly controlled experimental 
conditions (Skibinski et al., 2007). 
 
7.5.2 B. cepacia challenge of submerged mono-cultures and mono- and 
co-cultures at ALI  
The second CF relevant organism used throughout this work was B. cepacia. This bacterium has 
become a problem throughout the last 2 decades as a pathogen in patients of cystic fibrosis 
(LiPuma, 2003). Furthermore B. cepacia infections in CF patients have been correlated to a rapid 
decline of lung function as well as septicaemia (Sajjan et al., 2001), which differentiates this CF 
pathogens from the others discussed here.  
For mono-cultures under submerged conditions it was observed that viable B. cepacia did not 
have an impact on cell viability of the employed cells. However, for IB3-1 and Calu-3 submerged 
mono-cultures an increase of IL-8 was observed following the 24 h exposure to viable B. cepacia. 
Calu-3 have been shown before to respond to B. cepacia exposure under these conditions. In the 
same study A549, 16HBE14o- and CFBE41o- were analysed for their ability to respond to B. 
cepacia. Calu-3 were found to secrete the highest level of IL-8 compared to the other cell lines, 
similar to what was found here (Kaza et al., 2011). 
 Interestingly in response to this bacterium, IB3-1 secretes much more IL-8 compared to C38. At 
baseline IB3-1 secreted 10 times more IL-8 than C38 and after the challenge this increased to 
almost 300 times higher IL-8 in IB3-1 supernatant compared to C38. This higher baseline IL-8 also 
correlates with other studies. Kaza et al. (2011) found that the CF cell line CFBE41o- secreted 
more IL-8 when unstimulated compared to 16HBE14o- and it has also been reported before that 
16HBE14o- secrete less IL-8 compared to IB3-1 (Schwiebert et al., 1999, Kaza et al., 
2011).However, after stimulation with different B. cepacia strains, Kaza et al. (2011) reported 
CFBE41o- secreted the lowest level of IL-8 compared to the other cell lines used, which is in 
contrast to our findings (Kaza et al., 2011). A report by Fink et al. (2003) pointed out that in 
response to several different B. cepacia strains IL-8 responses of IB3-1 and C38 were only slightly 
different (Fink et al., 2003). However, for studies using P. aeruginosa as stimulus it was reported 
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that IB3-1 responds with constitutively higher secretion of IL-8 when compared to C38 (DiMango 
et al., 1998). These different studies show that there is variability in the concentrations of IL-8 
released after 24 h exposures. There are several points to remember when looking at these 
variable data. Cell lines that do not originate from the same patient and might have different 
CFTR mutations are difficult to compare to each other. Furthermore laboratory differences in 
handling and differences of growth conditions do play a role. For respiratory epithelial cells it is 
also important to remember that cell lines originate from different parts of the airways and 
therefore react differently to different stimuli. Whereas Calu-3 represent a serous type cell (Shen 
et al., 1994), A549 are a type II epithelial cell line (Lieber et al., 1976) and C38 (Flotte et al., 1993) 
and IB3-1 (Flotte et al., 1992) are bronchial cells. 
For HPF mono-cultures grown under submerged conditions on TWs the cell viability is not 
affected by exposure to live B. cepacia, similar to what was seen in submerged cultures. 
However, the pro-inflammatory response was again different when grown on TWs. These mono-
cultures did respond following the exposure to viable B. cepacia with a tremendous increase of 
IL-8 in both compartments after all three challenges of the model system. Interestingly the IL-8 
concentration after the basal and the apical/basal concentration was higher in the basolateral 
medium than in the apical supernatant suggesting that upon basal stimulation with this 
bacterium, IL-8 is secreted preferably to this compartment as the concentration was not 
equilibrated across this weak barrier after 24 h this seems to also be a continuous release. 
Fibroblasts of the airways have not been extensively studied in connection with CF but the 
strong responses of HPF found in terms of IL-8 secretion indicate that HPF play an important part 
in proinflammatory responses to bacterial infections, especially when the bacterium, such as B. 
cepacia is known for its ability to disrupt TJs and cause septicemia (Sajjan et al., 2001). This 
enables the organism to traverse the epithelial cell layer and get into direct contact with the 
subepithelial fibroblasts. This was already observed in CF patients, where B. cepacia was found 
in the terminal and respiratory bronchioles- much further down the respiratory tract than other 
pathogens. In addition intercellular migration was seen as well, again supporting that this 
bacterium crosses the epithelial barrier (Sajjan et al., 2001). It has also been shown for polarized 
16HBE, for example that after only 4 h after infection, B. cepacia was recovered from the 
basolateral medium of this culture (Kim et al., 2005), which supports the idea that B. cepacia 
would be able to reach the subepithelial fibroblasts and directly induce a proinflammatory 
response, which might play a huge role in CF airways, considering that HPF release between 
1500 – 4000 pg/ml here depending on the challenge and compartment analysed. 
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Interestingly the polarized epithelial cell mono-cultures presented here did not show a decrease 
in TER, even though Kim et al. (2005) has shown that TJ can be disrupted in a much shorter time 
frame than 24 h (Kim et al., 2005). Only for Calu-3 a decrease in TER was observed after the 
simultaneous apical/basal challenge for 24 h with live B. cepacia similar to what was shown for 
16HBE. Different B. cepacia strains were used by Kim et al. (2005) and all strains display different 
abilities in crossing well polarized 16HBE epithelial cells (Kim et al., 2005). Furthermore the cell 
viability of these epithelial mono-cultures was not compromised by these exposures to viable B. 
cepacia. This can be explained on one hand by the idea that traversing the epithelial cell layer 
does not cause cell injury or cell death (Kim et al., 2005) and on the other hand by B. cepacia’s 
ability to survive intracellularly in epithelial cells suggesting that this bacterium has an 
intracellular phase during pulmonary infections of CF patients (Martin and Mohr, 2000).  
The only significant changes were observed in IL-8 secretion, which was increased in all three cell 
lines after different challenges for 24 h exposure to live B. cepacia. B. cepacia J2315 is known to 
be one of the most potent inducers of inflammatory responses, transmissibility and fatal 
infections (Fang et al., 2011, Drevinek et al., 2008, Martin and Mohr, 2000) and strong 
proinflammatory responses to the intact bacterium were expected here.  
 
In comparison to C38, IB3-1 secreted more than 3-fold more IL-8 to the apical compartment 
after apical challenges, including the simultaneous challenge. IB3-1 cells do not always show 
higher IL-8 at baseline compared to C38 but the magnitude of stimulated IL-8 secretion is much 
higher, similar to what was found here in submerged mono-cultures and found elsewhere before 
in response to P. aeruginosa (DiMango et al., 1998). There are some other interesting 
differences to point out though. C38 also responds to the basolateral challenge and interestingly 
C38 samples of basolateral medium showed a significant increase in IL-8, which was not seen 
IB3-1. Calu-3 responded similarly to IB3-1 after the apical challenges with significant higher IL-8 
in apical supernatants but basolateral IL-8 was only found increased after the apical challenge. 
For all three cell lines though, the apical exposure to B. cepacia was definitely more 
immunomodulatory compared to basolateral exposures. For all three epithelial cell lines this 
pattern of IL-8 in apical supernatants was similar and interestingly there seems to be no additive 
response when challenged from both sides simultaneously as the final IL-8 concentration of this 
challenge is similar to the one found after apical exposure. The basolateral IL-8 measured was 
only significantly increased in C38 samples (all three challenges) and in the Calu-3 sample after 
apical challenge alone. These findings indicate that IB3-1 is unable to respond to the basolateral 
challenge and might suggest a basolateral receptor difference between CF and non-CF cells. 
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In vivo the epithelium is polarized with distinct apical and basolateral protein and lipid 
expression. B. cepacia can adhere to epithelial cells via both protein and glycolipid receptors, 
which could be presented differently in apical compared to basal membranes of these epithelial 
cells presented. The B. cepacia strain used here is a cable-pilus expressing one, which enables 
this bacterium to bind to secretory mucins as well as to CK13, for example. The stronger IL-8 
response of IB3-1 compared to C38 could be related to the increased surface exposure of CK13 
seen in chronic inflamed CF lungs (Sajjan et al., 2000, McClean and Callaghan, 2009). In addition 
to this, the apically expressed glycolipid receptor asialoGM1 (de Bentzmann et al., 1996a) has 
been shown to bind B. cepacia and other bacteria, such as P. aeruginosa and S. aureus (Krivan et 
al., 1988, Firoved et al., 2004). In relation to CF this receptor plays a significant role as it displays 
an apical binding site for this bacterium but also because superficial asialoGM1 has been found 
to be more numerous on primary CF cells (Saiman and Prince, 1993). This has also been shown 
for IB3-1 cells compared to C38 (DiMango et al., 1998), which would explain the stronger 
inflammatory response seen in IB3-1 apical supernatants compared to C38.  
 
The principles of B. cepacia binding and inducing a proinflammatory response to airway 
epithelial cells are the same in co-cultures. However, the basolateral membrane of epithelial 
cells is not directly accessible as in co-cultures the fibroblasts are located subepithelial. Instead 
the fibroblast membrane is accessible after bacteria managed to move through the 
semipermeable membrane and the bacteria can then travers across the HPF layer and reach the 
epithelial cells to induce an proinflammatory response. A striking difference is that after the 
simultaneous apical/basal challenge the cell viability was decreased in all three co-culture 
models. For HPF-IB3-1 additional decrease in cell viability was seen after the apical as well as 
after the basal challenge with viable B. cepacia, pointing out that this co-culture is most 
susceptible out of these three co-cultures.  
 
B. cepacia produces a haemolytic toxin that is able to induce apoptosis in cultured macrophages 
(Martin and Mohr, 2000) but whether this virulence factor plays a role in epithelial apoptosis is 
unclear. Furthermore another group has recently shown that B. cepacia is also able to induce 
apoptosis in airway epithelial cells (the BEAS 2B bronchial epithelial cell line) only 3h after 
infection (Moura et al., 2008) but the difference between CF and non-CF has not been addressed 
and so the role and the cause of apoptosis in the pathogenesis of B. cepacia is not completely 
understood and remains under investigation.  
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The TER however was not decreased in HPF-C38 and HPF-IB3-1 but it was decreased in all three 
cases of challenges in HPF-Calu-3 co-cultures. As already discussed earlier B. cepacia is known to 
be able to disrupt tight junctions but why there is such a difference between HPF-Calu-3 
compared to HPF-C38 and HPF-IB3-1 is not known. The difference might be because of different 
adhesion mechanism used by B. cepacia for these different cell lines depending on availability of 
receptors. 
IL-8 secretion was found to be in a similar pattern compared to mono-cultures in case of HPF-
C38 and HPF-IB3-1 with the difference that HPF-IB3-1 showed an apical increase in IL-8 after the 
basal challenge and in correlation with data of mono-cultures IB3-1 co-culture still produces 
more IL-8 compared to HPF-C38. HPF-Calu-3 only showed a significant increase in IL-8 secretion 
after the simultaneous challenge from both compartments but not following the apical 
challenge. These results indicate that HPF modulate epithelial cell behaviour at ALI and points 
out that they did not inhibit epithelial cell function. Assuming that the apical increase in IL-8 
following the basal challenge is partially due to the subepithelial fibroblasts this is an interesting 
finding and needs to be investigated further. One receptor that could induce IL-8 secretion by 
fibroblasts upon B. cepacia binding is TNFR1, which is known to be present in fibroblasts and 
epithelial cells (Saldias and Valvano, 2009) and has been shown to serve as binding site for B. 
cepacia. Interestingly this receptor has also been found to be expressed more numerous on 
primary CF cells compared to non-CF cells (Sajjan et al., 2008), which supports the stronger 
inflammatory response seen by HPF-IB3-1 co-cultures as well as the stronger response of IB3-1 
mono-cultures when these are compared to the corresponding C38 mono- or co-culture. 
 
7.5.3 P.aeruginosa challenge of submerged mono-cultures and mono- 
and co-cultures at ALI  
As already mentioned before P. aeruginosa is the most common bacterial infection found among 
CF patients and it is one of the main research goals in CF to elucidate how the reduction, 
elimination or dysfunction of CFTR leads to this hypersusceptibility of CF patients to this 
bacterium. The P. aeruginosa strain used here was isolated from a CF patient but no further 
patient details are available in terms of age, level of lung disease and treatments, for example. 
P. aeruginosa is known to produce and secrete several virulence factors, including elastase 
(Azghani et al., 1992), exoenzyme S (Epelman et al., 2000), exotoxin A (Azghani, 1996) and 
pyocyanin (Denning et al., 1998) for example, which support the persistence of P. aeruginosa 
infections in CF patients. Virulence factors definitely contribute to the pathogenesis and 
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establishment of infection of these bacteria and understanding the molecular and cellular events 
that allow adherence of P. aeruginosa and the establishment of chronic infection is vital to 
elucidate CF lung pathogenesis. The established mono- and co-cultures were exposed to live P. 
aeruginosa to analyse the affect of this bacterium on cell viability, TER and IL-8 secretion. 
 
Under submerged conditions in 24 well plates, HPF mono-cultures showed a significant decrease 
in cell viability (decreased by 1.9-fold) as well as a significant, almost forty-fold increase in the 
release of the inflammatory cytokine IL-8 after exposure to viable P. aeruginosa. The ability of P. 
aeruginosa to adhere to human lung fibroblasts was shown before and it was highlighted that 
bacterial elastase, which degrades surface bound and ECM fibronectin, leads to increased 
adherence of this bacterium, for example (Azghani et al., 1992). Bacterial elastase has also been 
shown to cause increase of epithelial cell layer permeability (rat alveolar epithelial cells) 
(Azghani, 1996), which indicates that P. aeruginosa is able to disrupt the protective barrier and 
possibly reach the subepithelial fibroblasts, where the bacterium can then induce additional IL-8 
responses, which could be part of the extensive IL-8 concentrations found in CF. Furthermore it 
has been shown that normal human lung fibroblasts were stimulated to secrete IL-8 (analysed 
on mRNA and protein level) in response to the exposure to one of P. aeruginosa’s autoinducers, 
which is freely diffusible and part of the quorum sensing system of this organism to regulate 
gene expression. As this small molecule has been shown to not only be present directly around 
the bacteria but also in the underlying epithelial cells it was suggested that this virulence factor 
can also reach the underlying fibroblasts to induce additional pro-inflammatory response. In that 
study the fibroblastic response was also found to be longer lasting than the one of epithelial 
cells, highlighting the importance of this cell type in inflammation (Smith et al., 2001). These two 
reports show that there is a need to elucidate the importance of fibroblasts during lung infection 
in CF and the role they play, which possibly helps to understand CF lung pathogenesis further.  
 
In submerged cultures of C38, IB3-1 and Calu-3 a strong induction of IL-8 release was observed in 
response to live P. aeruginosa. Following this challenge IL-8 concentrations in IB3-1 supernatants 
were found again to be about 30 times higher when compared to C38, which is the corrected 
counterpart of IB3-1 that expresses functional CFTR. Similar results were found for primary 
submerged CF and non-CF epithelial cells by Joseph et al. (2005), when stimulating primary CF 
and non-CF epithelial cells with P. aeruginosa PAO1. They demonstrated that a constitutive and 
increased NF-κB activation was associated with increased IL-8 mRNA after exposure to PAO1 in 
CF cells. This group also analysed cell viability before and after exposure and found a decrease in 
cell viability by almost 60%, with no differences seen between CF and non-CF (Joseph et al., 
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2005), whereas in the present study, cell viability of C38 and IB3-1 was stable after24 h exposure 
to P. aeruginosa under submerged conditions. This different observation of cell viability could be 
due to differences between transformed cell lines and primary cells or could also be down to the 
P. aeruginosa strain used. In another study PAO1 was used at 10
7
 CFU/ml to stimulate 
submerged cells and again CF cells were found to secrete more IL-8 (4-fold) in response 
compared to non-CF cells, which was proposed to be down to asialoGM1 expression on CF cells 
(DiMango et al., 1995). These findings are consistent with the results found here in terms of IL-8 
secretions. 
 
For Calu-3 the third epithelial cell line used in these experiments a much stronger response to P. 
aeruginosa was seen compared to C38 and IB3-1 but these adenocarcinoma-derived cells  have a 
baseline secretion of IL-8 higher than the P. aeruginosa induced response of IB3-1. As already 
mentioned above, this cell line also showed an increased IL-8 secretion after the exposure to S. 
aureus and B. cepacia. The cell viability, however, was not affected here either, similar to what 
was seen for C38 and IB3-1.  
When these cell lines were cultured on TWs the effect of P. aeruginosa on the cells was 
different. HPF were, as for the other bacterial challenges, cultured under submerged conditions 
on TWs, which enabled challenge of the cells from the apical side, basolateral side or from both 
sides at the same time. A decrease in cell viability as it was seen in submerged cultures could not 
be observed for these challenges carried out on TWs. Again, as already discussed above, this 
indicates a difference between submerged mono-cultures grown on plastic and submerged 
mono-cultures grown on TWs, whether the differences are down to the now established multi-
cell layer remains to be investigated but it has been shown before that fibroblasts that were 
dispersed in collagen gels represented a mesenchyme equivalent for epithelial cell 
differentiation (Tsai et al., 1994), which represents the in vivo situation closer than a mono-layer 
of fibroblasts and is suggested here to play a role in infection and inflammation responses. 
 
Exposures to viable P. aeruginosa from the apical side and from the apical/basal side 
simultaneously caused a massive increase in IL-8 concentration in apical supernatants of this 
mono-culture in response to P. aeruginosa. Only after the simultaneous challenge from both 
sides at the same time there was a significant increase of IL-8 in the analysed basolateral 
medium. Interestingly, in contrast to the mostly equilibrated basal and apical IL-8 concentrations 
found after S. aureus and B. cepacia stimulation, after this challenge there was more IL-8 found 
in apical secretions without equilibration after 24 h. This suggests that there may be defined 
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responses to specific pathogens by the HPF  and that these interactions might partially cause a 
directional secretion of IL-8.  
 
For the epithelial cell mono-cultures of C38 and IB3-1 at ALI, the cell viability following exposure 
to live P. aeruginosa was significantly reduced after all three challenges irrespective of the site of 
exposure. This decrease in cell viability was not observed for Calu-3 mono-cultures after the 24 h 
challenge and highlights cell line differences of these epithelial cells. The cell layer integrity was 
analysed before and after the challenges and found to be intact as no changes in TER were 
observed for C38 and IB3-1 comparing before and after, whereas the cell layer integrity of Calu-3 
was significantly lower after all three challenges with live P. aeruginosa. In mono-cultures of C38 
and IB3-1 there was a significant increase of apical IL-8 concentration after apical exposures to P. 
aeruginosa, including the simultaneous challenge from both sides at the same time. Similar to 
what was observed before, IB3-1 produces about three times as much IL-8 in response to live P. 
aeruginosa compared to C38. Another interesting difference to note is that after the 
simultaneous challenge from both sides at the same time an increase in basolateral IL-8 
concentration was observed for C38 mono-cultures but not for IB3-1. The pro-inflammatory 
response found for Calu-3 mono-cultures was quite different compared to IB3-1 and C38. IL-8 
concentrations were significantly increased after basal and after the simultaneous challenge 
from both sides but not following the apical exposure. Again it is important to keep in mind that 
these are different cell lines with different origins. 
 
P. aeruginosa has been reported to modulate lung epithelial cell functions as well as having a 
direct cytotoxic affect on these, which has been shown in vivo and in vitro (Lau et al., 2005, Rajan 
et al., 2000). One of P. aeruginosa’s virulence factors that is able to induce apoptotic and 
necrotic cell death is exotoxin A, which is has been shown to bind to the basolaterally presented 
receptor 2-macroglobulin, which supports internalisation of this virulence factor and is only 
expressed in polarized epithelial cells (Kounnas et al., 1992) therefore this could explain why the 
decrease in cell viability was not observed in submerged cultures. However it is interesting that 
no decrease in cell viability was observed for Calu-3 mono-cultures at least in this respect 
following the basal challenge and it is surprising that no IL-8 response was seen in C38 and IB3-1 
after the basal challenge, even though there is a decrease in cell viability. This was already 
discussed above as similar results were seen for S. aureus in terms of cell death in conjunction 
with no IL-8 increase. If the decrease in cell viability is down to apoptosis a pro-inflammatory 
response would not be expected (Vandivier et al., 2006). Apical challenges of C38 and IB3-1 
showed a decrease in cell viability and a strong IL-8 response, whereas in Calu-3 there is no 
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decrease in cell viability and no response to the apical challenge. This difference in response and 
direct affect of viable P. aeruginosa could be down to several reasons. One plausible explanation 
is the difference in the antibacterial activity of apical secretions. For Calu-3 it has been shown 
that the apical surface fluid exhibits antibacterial activity against P. aeruginosa. Whether this is 
true for C38 and IB3-1 grown under these conditions is unknown. However cell viability of C38 
and IB3-1 is also decreased after the basal exposure. Controversially Calu-3 showed a significant 
induction of IL-8 after basal exposure without cell viability decrease, which was not seen in the 
other two cell lines. Whether there is an expression difference of macroglobulin-2-receptor and 
possibly other receptors between these two cell lines and Calu-3 is not known and it remains to 
be elucidated why there are such different epithelial cell responses following the exposure to 
P.aeruginosa.  
 
C38 and IB3-1 responded to apical challenges with apical IL-8 release and as already mentioned 
before the apically expressed asialoGM1 (de Bentzmann et al., 1996a) receptor is a potential 
candidate to initiate this pro-inflammatory response. AsialoGM1 has been shown to be much 
more numerous in CF cells and that P. aeruginosa pili bind to this receptor (DiMango et al., 
1995) as well as flagella, which both serve as adhesins and induce IL-8 secretion in epithelial 
cells. The non-mucoid strain used in these experiments was originally isolated from a CF patient 
and even though it often was reported that irreversible genotypic modulation from a non-
mucoid to a mucoid strain occur in the CF lung environment this was not the fact here (Martin et 
al., 1993). Also it has been shown that this is usually accompanied by another genotypic 
modulation that has been documented for P. aeruginosa strains in CF lungs. This is 
transformation from a motile to a non-motile bacterium, which does not express flagella 
anymore (de Bentzmann et al., 1996a, Mahenthiralingam et al., 1994). It has been suggested 
that this transformation also affects pili (Pier et al., 1992). If this genotypic change to a non-
motile phenotype occurred then this would exclude asialoGM1 to be responsible for the 
increased IL-8 secretion in IB3-1 mono-cultures and it has been shown for several clinical isolates 
of P. aeruginosa that they do not show adhesion to asialoGM1 (Schroeder et al., 2001b).  
Another possible receptor that has been shown to be a binding site for P. aeruginosa is CFTR 
itself (Pier et al., 1996), which bind the bacterium and it is then internalized to clear the infection 
by shedding of epithelial cells. Epithelial cells start shedding into the ASL to clear the infection 
and it was also found that non-CF cells internalised P. aeruginosa at a very poor rate (Pier et al., 
1996). Assuming that CFTR plays a role here, the C38 data fit quite well to this story as there is a 
moderate IL-8 response, which will be initiated upon binding and possible cell-cell 
communications and this is accompanied by a decrease in cell viability, which is down to the 
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increase in cell shedding as an attempt to clear the infection. Looking at IB3-1 there is a similar 
pattern of pro-inflammatory response but three times as high compared to C38 and also there is 
a similar decrease in cell viability, which would not be expected if this is down to internalisation 
of P. aeruginosa upon CFTR binding, which should not be present in the apical surface 
membrane of IB3-1. And again it does not explain the decrease in cell viability following the 
basal exposure to viable P. aeruginosa. Calu-3 mono-cultures only responded to the basal and 
the simultaneous challenge with live P. aeruginosa, even though they have been shown to 
express CFTR (Shen et al., 1994). Additionally it has been suggested that mucoid clinical isolates 
loose the binding site for CFTR (Schroeder et al., 2001a) and so that may not be the cause of IL-8 
secretion here at all.  
 
In another study it was shown that P. aeruginosa binds more readily to basolateral membranes 
of polarized epithelial cells to induce an inflammatory response (Pier, 2002), like it was seen here 
for Calu-3. This means that in vivo the electrical resistance and therefore cell layer integrity is 
lowered by the massive influx of PMNs, which then creates access for the bacteria to the 
basolateral side of the epithelium to which bacteria can adhere and can be internalised 
(Goldberg and Pier, 2000). 
 
To confirm what exactly causes the differences in IL-8 response among epithelial cells but also 
between CF and non-CF cells (magnitude) further analysis is required. When considering that P. 
aeruginosa exhibits several different virulence factors, which are regulated by different 
autoinducers and quorum sensing systems, it is impossible here to appoint one or two factors 
that cause these responses. There is a report that concentrated on the altered gene expression 
of P. aeruginosa grown in different sputum samples for example and the list of genes that were 
altered in expression is enormous (Palmer et al., 2005) but by developing models like these and 
also the co-culture models it will be possible to dissect different responses and different stimuli. 
 
For the co-cultures of these three epithelial cell lines the following results were observed. For 
HPF-C38 and HPF-IB3-1 cell viability was decreased significantly after the simultaneous challenge 
with P. aeruginosa from the apical and basal side at the same time but for HPF-IB3-1 cell viability 
was decreased by almost 70% compared to only 33 % decrease of cell viability seen for HPF-C38 
again pointing out the higher susceptibility of CF co-culture system. Then it was interesting to 
find that the cell viability of HPF-C38 was decreased after the basal challenge with viable P. 
aeruginosa but here the cell viability for HPF-IB3-1 was unaffected but for the apical challenge 
this was observed to be the other way around. As already discussed for mono-cultures of IB3-1 
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and C38 it is difficult to identify the exact factor that causes this susceptibility, especially in a 
more complex model with a subepithelial HPF cell layer. Almost nothing has been reported 
about pulmonary fibroblasts and their role in these kind of inflammatory responses and 
availability of receptors on these fibroblasts, for example. For HPF-IB3-1 a decrease in TER was 
found after all three challenges, which was not observed in HPF-C38, where the TER was found 
to be stable, which was also found to be stable of HPF-Calu-3, which is a contrast to the 
decreased electrical resistance found in mono-cultures of Calu-3. AS already mentioned for 
mono-cultures, bacterial elastase has been shown to increase cell layer permeability, for 
example (Azghani, 1996) and the decreases seen here could be explained by active elastase in 
the cell supernatant.  
 
For HPF-C38 there was only a pro-inflammatory response following the basal and simultaneous 
apical/basal challenge with viable P. aeruginosa, which are the challenges after which also the 
cell viability was decreased. It seems that the addition of fibroblasts modulates IL-8 release of 
epithelial cells and possibly also the other way around. The IL-8 release of HPF-IB3-1 is also 
different to what was observed in IB3-1 mono-cultures, as there is now a strong response to the 
basal challenge but not after the simultaneous apical/basal challenge. The huge decrease of cell 
viability following the apical/basal challenge could be the reason that almost no increase of IL-8 
was seen though.  
HPF-Calu-3 showed a different pro-inflammatory response pattern as well, when compared to 
the mono-cultures. The co-culture still showed a significant increase after the apical/basal 
challenge but not anymore following the basal challenge. Furthermore did the co-culture 
respond to the apical challenge, which was not observed for the mono-culture. 
 
As single virulence factors of P. aeruginosa were not investigated here it is impossible to 
comment on direct influences of them on these co-cultures. One IL-8 stimulatory factor though 
that would be expected to be found in high density bacterial cultures is bacterial DNA, which has 
been shown to induce IL-8 secretion in CF cells like IB3-1 and CuFi1 cells and non-CF epithelial 
cells (NHBE) but IL-8 secretion was higher in CF cells, which is consistent with findings in this 
study (Delgado et al., 2006). However, it is difficult to analyse IL-8 data accurately because of the 
ongoing cell death in HPF-IB3-1 co-culture and therefore the direct comparison to HPF-C38 is not 
possible. Interesting is as well that in all three mono-cultures the IL-8 response to live P. 
aeruginosa is found mostly on the apical side of polarized cultures, whereas in the co-culture 
system basolateral IL-8 is observed as well after basal stimulation. The presence of fibroblasts 
seems to modulate the pro-inflammatory response in a way that we would expect in vivo, where 
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cytokines in the airway lumen prime the incoming neutrophils and keep them active, whereas 
the basolateral secreted IL-8 would build up a concentration gradient in the tissue to recruit 
more immune cells to the site of infection. It has been shown before that neutrophil migration 
across endothelial and epithelial cell layers is dose and time-dependant (Smart and Casale, 
1993), which supports the idea that apically secreted IL-8 is important to pull the neutrophils all 
the way through the cell layer and equally important is basal IL-8 to get neutrophils crossing the 
endothelial cell layer in vivo. It is suggested that fibroblasts do play an important role in fulfilling 
the correct inflammatory response in healthy airways if necessary and it is suggested that 
fibroblasts could play an important part in CF lung pathogenesis. 
 
Collectively these data show that HPF are able to respond to infection in terms of IL-8 secretion 
and would appear to be actively taking part in pro-inflammatory signalling. Fibroblasts play an 
important role in inflammatory responses as shown here and are not just structural support 
cells. Therefore are the established co-culture models presented here a valuable need for 
further investigation to shed some light on the input of these cells in healthy and in CF airways. 
IB3-1 mono-cultures do respond with significantly more IL-8 secretion compared to C38, which is 
also mainly the case in these co-cultures, indicating that HPF support epithelial cell behaviour to 
infection. In general B. cepacia is the most potent inducer of IL-8 secretion, which is also seen in 
mono- as well as in co-cultures. Similar results were found for the cell layer integrity. If it was 
affected by live bacterial exposure, TER decreased to a higher degree in IB3-1 or HPF-IB3-1 
cultures. Again CF cells susceptibility to infection was also reflected by cell viability decreases, 
which were mainly higher in CF compared to non-CF. 
Furthermore the difference of fibroblast responses when cultured on different supports (TWs or 
plastic, both collagen IV coated) needs further investigation. Fibroblasts are now recognised as 
active, participating cells, which play vital roles in inflammatory responses, rather than just being 
structural support cells, the co-cultures were established to gain more information about their 
inflammatory role in infection and will help to study epithelial cell and fibroblast interaction and 
communication.  
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8 Chapter 8 Inflammatory response to heat-inactivated (HIA) 
bacteria 
8.1 Introduction 
 
In this chapter the impact of heat-inactivated S. aureus, B. cepacia and P. aeruginosa on the cell 
viability, the TER of cultures at ALI and the pro-inflammatory response in terms of IL-8 was 
investigated. Purified LPS has already been shown to have limited impact on the established 
mono-and co-cultures, in terms of their inflammatory response (chapter 6), and further it was 
shown that live bacteria can have very different affects on these cultures, which was outlined in 
chapter 7.  
 
Heat-inactivation of bacteria is a method commonly used for the destruction of pathogenic 
bacteria, especially in the food industry, for example. Here thermal processing is commonly used 
to produce a safe product and enhance the shelf life of food. Heat inactivation of bacteria leads 
to irreversible changes and denaturation of membranes, ribosomes and nucleic acids (Lee and 
Kaletunc, 2002). The method used here involves heating bacterial suspensions with moist heat, 
close to boiling, which inactivates bacterial peptidal exotoxins completely (Gao et al., 2006). 
Washing of HIA bacteria before the cell suspension is adjusted to a standard bacterial cell 
density eliminates all inactivated exotoxins produced by these bacteria and any other secreted 
virulence factors and bacterial by-products. Different virulence factors and how they might 
affect the established mono- and co-culture models were discussed in chapter 7 and will not be 
taken into account here. Bacterial cell wall components, such as LPS of gram-negative bacteria is 
known as heat-resistant endotoxin but has been reported to be affected in its endotoxin activity 
when boiled at 100°C. At this temperature the endotoxin activity is reduced after only 15min 
(Gao et al., 2006). Here we used water at 80°C to heat inactivate the bacteria inactivation/cell 
death was confirmed by plating out samples on agar plates before and after the challenges.  
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8.2 Aims 
In this chapter submerged mono-cultures as well as mono-and co-cultures at ALI were exposed 
to heat-inactivated (HIA) S. aureus, B. cepacia and P. aeruginosa to investigate inflammatory 
responses to these heat-killed bacteria, when exotoxins are eliminated from the experiment and 
only heat stable cell wall components were present. In addition cell viability and cell layer 
integrity were monitored alongside IL-8 release.  
In order to achieve these aims the cell viability after exposure to HIA bacteria was investigated 
for all cell culture models presented. 
Furthermore monitoring of the cell layer integrity by measuring TER before and after the 
challenges was essential to estimate the affect of HIA bacteria on the barrier formation of mono-
and co-cultures at ALI. 
Finally it was necessary to determine the pro-inflammatory response (IL-8 secretion) of these 
mono- and co-cultures after exposure to HIA bacteria.  
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8.3 Methods  
8.3.1 Heat inactivation of bacteria 
Colonies of P. aeruginosa 50DR, B.cenocepacia J2315 and S. aureus were picked from a freshly 
cultivated MHA plate and grown in 50 ml MHB at 37 °C overnight in a shaker at 150 rpm. On the 
next day cultures were split into equal parts (one half was kept for experimental treatment of 
cell cultures with live bacteria) and one half was put into a waterbath maintained at 80 °C for at 
least 1 h. To be sure bacteria were alive prior to heat-inactivation and dead post heat-
inactivation; samples were taken before and after placing the bacterial suspension into the 
waterbath. Every 15 mins a sample was taken from the waterbath to determine at which time 
point the bacteria were all killed. After successful heat inactivation (1 hour) the heat-inactivated 
bacterial cultures were spun down at 3500 x g for 15 min and washed in 10 ml sterile PBS. This 
was repeated three times before the culture’s optical density (OD) was measured at 470 nm. The 
OD was then adjusted to an OD470nm of 1.0, which corresponds to a bacterial cell number of 
approximately 1 x 10
9
 CFU/ml for S. aureus, B. cepacia and P. aeruginosa. These bacterial 
suspensions were then diluted 1:10 to make a stock solution of 1 x 10
8
 CFU/ml. The final 
bacterial cell density used in the experiments under submerged conditions or at ALI was 1 x 10
7 
CFU/ml.  
 
8.3.2 Cell viability assay – Cell Titer Blue™ (Promega) 
Cell Titer Blue (CTB)
 
is an endpoint assay that provides a homogeneous, fluorometric method to 
monitor cell viability. Viable cells, which are metabolically active, can convert resazurin (blue 
with little intrinsic fluorescence activity) into its highly fluorescent product, called resorufin 
(pink). CTB was directly applied to fresh serum free cell medium after samples have been 
collected and the plate was then incubated for 2 h at 37 °C prior to analysis. The fluorescent 
intensity was measured on a standard multiwell fluorescent plate reader (Spectramax Gemini XS, 
Molecular Devices, Berkshire UK) with a 560 nm excitation, and 590 nm emission wavelength.  
 
8.3.3 Transepithelial electrical resistance (TER) measurements 
TER of mono- and co-cultures on TWs was measured using an Epithelial Voltohmeter with STX2 
chopstick electrodes (World Precision Instruments) to monitor confluence and barrier formation 
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of the epithelial cell layer. TER was measured on day 14 or just before exposure to live bacteria 
to verify epithelial cell confluence and intactness of epithelial cell layer and TJ formation. 
TER values reported in this work take into account the area of the cell layer (area of TWs = 
0.33cm
2
) and are expressed as Ωcm
2
. Triplicate measurements were taken for TW and the 
background resistance, which was typically between 100-120 Ωcm
2
 (cell-free collagen IV coated 
TW) was subtracted from the average of a triplicate measurement.  
TER was measured immediately before and straight after the 24 h incubation with live bacteria 
to analyse whether this cell layer integrity was affected and changed compared to the control 
TWs. 
 
8.3.4 Bacterial growth conditions 
P. aeruginosa 50DR and B. cepacia J2315 were grown in MHB at 37°C and placed in a shaker at 
150 rpm over night or were plated out on MHA plates and incubated in a 37°C incubator. 
Bacteria were also stored on MicroBank beads (Pro-Lab Diagnostics, Ceshire, UK) at -70°C until 
required. 
 
8.3.5 Treatment of submerged mono- cultures and mono- and co-cultures 
grown at ALI with HIA bacteria 
Submerged mono-cultures were set up exactly the same way as described in 2.17. On the third 
day of culture ITS-medium was replaced with ITS-medium containing approximately 1 x 10
7
 
cfu/ml of HIA bacteria and cells were incubated for 24 h. The same procedure was followed to 
expose mono-and co-cultures grown at ALI to these HIA bacteria. After 14 days of culture at ALI 
mono- and co-cultures were either apically, basolaterally or simultaneously from both sides, 
exposed to HIA bacteria. Control TWs with mono-and co-cultures were handled the same way 
but medium without bacteria was used.  
Samples were then collected from submerged mono-cultures as well as from TWs (apical side 
and from the basolateral side) and these were then analysed for IL-8 concentration separately 
using an ELISA kit as described in 8.3.6. CTB was applied to all cultures to analyse cell viability. 
After 2 h incubation with CTB the medium was removed and cell viability was assessed as 
described in 8.3.2. 
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8.3.6 Detection of Interleukin 8 (IL-8) by ELISA  
For the quantification of human IL-8 in cell culture supernatants of submerged and ALI mono- 
and co-cultures treated with HIA bacteria, a human IL-8 ELISA development kit, was purchased 
from Peprotech EC Ltd. (London, UK). All reagents were part of the kit unless otherwise stated 
and were prepared according to manufacturer’s product information. IL-8 ELISA protocol is 
described in detail in 2.19. 
 
8.3.7 Statistical analysis 
Throughout this chapter statistical analysis of results and significant differences were 
determined by 1Way-Anova followed byTukey’s multiple comparison test. Results are presented 
as mean ± SD. Results were considered significant when p≤ 0.05 = *; p≤ 0.01 = **; p≤ 0.001 = 
***. 
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8.4 Results 
8.4.1 Cell viability and inflammatory response of submerged mono-
cultures after exposure to heat-inactivated bacteria (HIA) 
8.4.1.1 Exposure of submerged HPF mono-culture to HIA bacteria 
No
 
Ba
cte
ria
S.a
ur
eu
s
B.
ce
pa
cia
P.a
er
ug
ino
sa
0
500
1000
1500
2000
2500
Fl
u
o
re
sc
en
ce
 
u
n
its
56
0n
m
/5
90
n
m
No
 
Ba
cte
ria
S.a
ur
eu
s
B.
ce
pa
cia
P.a
er
ug
ino
sa
0
5
10
15
20
25
30
35
IL
-
8 
in
 
pg
/ m
l
A B
 
Figure 8.1 Cell viability (A) and IL-8 release (B) of HPF after exposure to HIA bacteria 
HPF were grown to confluence in quadruplicate wells of 24-well plate after they were seeded at 1 x 10
5
 
cells per well. After 24 h medium was changed to serum free medium and another 24 h incubation 
followed. Afterwards HPF were exposed to approximately 1 x 10
7
 cfu/ml of bacterial suspensions for 24 h. 
Supernatants were collected and analysed for IL-8 concentrations and HPF cell viability was also assessed. 
For HPF, no significant differences were observed comparing cell viability after exposure to the control 
cells. Exposure of HPF to HIA S. aureus, B. cepacia and P. aeruginosa did not cause a significant increase in 
IL-8 secretion into the supernatant. Data are presented as mean ± SD from 3 individual experiments (n=4).  
 
HPF in submerged mono-cultures were exposed to HIA bacteria for 24 h, apart from control 
wells, which were exposed to SF-free growth medium only. The bacteria used were S. aureus, B. 
cepacia and P. aeruginosa and none of these had an effect on HPF cell viability (figure 8.1 A), 
when compared to the control baseline fluorescence of 2073.72 ± 68.26 FU. IL-8 concentrations 
(figure 8.1 B) in collected supernatants were assayed and none of the HIA bacteria induced an IL-
8 response by HPF submerged mono-cultures. The supernatants of the control wells had a mean 
IL-8 concentration of 26.07 ± 1.05 pg/ml.  
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8.4.1.2 Exposure of submerged C38 mono-culture to HIA bacteria 
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Figure 8.2 Cell viability (A) and IL-8 release (B) of C38 after exposure to HIA bacteria 
C38 were seeded onto a 24-well plate at 1 x 10
5
 cells per well and incubated for 24 h before they were 
serum starved for 24 h. Afterwards C38 were exposed to 1 x 10
7
 cfu/ml of bacterial suspensions for 24 h. 
Supernatants were collected and analysed for IL-8 concentrations and C38 were assessed for cell viability. 
For C38, no significant differences were observed comparing cell viability after exposure to the control (No 
Bacteria). C38 was exposed to HIA S. aureus, B. cepacia and P. aeruginosa for 24 h and did not cause a 
significant difference in IL-8 secretion into the supernatant. Data are presented as mean ± SD from 3 
individual experiments (n=4).  
 
Submerged C38 mono-cultures were exposed to HIA S. aureus, B. cepacia and P. aeruginosa for 
24 h. Control wells were only exposed to SF-growth medium and were analysed using CTB assay 
for cell viability (figure 8.2 A), which was 2404.21 ± 95.15 FU at baseline. Cell viability was 
analysed after the challenges and no significant changes were observed compared to the 
control. IL-8 secretion (figure 8.2 B) was assayed by ELISA for the presence of IL-8, which was 
found to unaffected by this exposure to HIA bacteria. IL-8 concentration in control supernatants 
was 2.27 ± 0.42 pg/ml. 
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8.4.1.3 Exposure of submerged IB3-1 mono-culture to HIA bacteria 
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Figure 8.3 Cell viability (A) and IL-8 release (B) of submerged cultures of IB3-1 after exposure to HIA 
bacteria 
IB3-1 were seeded onto a 24-well plate at a cell density of 1 x 10
5
 per well and incubated for 24 h before 
they were serum starved for 24 h. IB3-1 were then exposed to 1 x 10
7
 cfu/ml of each bacterium (HIA) for 
24 h. Supernatants were collected and analysed for IL-8 concentrations (B). Cell viability was assessed and 
no significant decrease of cell viability could be identified. IL-8 release into the supernatant was analysed 
and was found to not be significantly increased for any of these bacteria. Data are presented as mean ± SD 
from 3 individual experiments (n=4).  
 
For IB3-1 mono-cultures the same challenges were carried out and HIA S. aureus, B. cepacia and 
P. aeruginosa were added to target wells. Control wells were incubated with SF-growth medium 
only. IB3-1’s cell viability (figure 8.3 A) was not affected by this 24 h challenge and all samples 
were similar to the measured baseline fluorescence of 2499.49 ± 41.21 FU. IL-8 secretion (figure 
8.3 B) of this submerged mono-culture was not induced by any of the HIA bacteria tested. IL-8 
concentration of control wells was 7.23 ± 1.97 pg/ml.  
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8.4.1.4 Exposure of submerged Calu-3 mono-culture to HIA bacteria 
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Figure 8.4 Cell viability (A) and Il-8 release (B) of submerged cultures of Calu-3 after exposure to HIA 
bacteria 
Submerged mono-cultures of Calu-3 were seeded onto a 24-well plate at 1 x 10
5
 per well and incubated 
for 24 h before they were serum starved and then exposed to HIA bacteria (1 x 10
7
 cfu/ml) for 24 h. 
Supernatants were collected and analysed for IL-8 concentrations. Cell viability was also assessed but Calu-
3 did not show any significant decrease of cell viability after 24 h incubation with these HIA bacteria. IL-8 
secretion by Calu-3, however, was significantly increased in response to HIA S. aureus or P. aeruginosa. 
Data are presented as mean ± SD from 3 individual experiments (n=4).  
 
Cell viability (figure 8.4 A) of submerged Calu-3 mono-cultures was not influenced by the 
exposure to HIA S. aureus, B. cepacia or P. aeruginosa for 24 h. At baseline the fluorescent signal 
measured was 874.47 ± 9.08 FU. IL-8 secretion (figure 8.4 B), however was induced by HIA S. 
aureus and P. aeruginosa. The control cells released an IL-8 concentration of 3189.42 ± 306.4 
pg/ml, which was increased in response to HIA S. aureus to 4290.26 ± 121.23 pg/ml and when 
challenged with HIA P. aeruginosa, the IL-8 concentration was 7166.7 ± 651.69 pg/ml.  
 
 285 
 
8.4.2 Cell viability and IL-8 release of mono- and co-cultures at ALI after 
exposure HIA bacteria 
8.4.2.1 Exposure of submerged HPF mono-culture on TWs to HIA bacteria 
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Figure 8.5 Cell viability (A), TER (B) and IL-8 release (C) of HPF after exposure to HIA S. aureus 
HPF were cultured under submerged conditions on TWs for 14 days before these were challenged with 
HIA S. aureus, which was applied either apically, basolaterally or from both sides simultaneously, excluding 
the control TWs. Cell viability was not significantly affected, nor was TER measured before (clear bars) and 
directly after (striped bars) the 24 h incubation with HIA S. aureus. No significant increases of IL-8 
concentrations were observed for any of the challenges with HIA S. aureus. Data are presented as mean ± 
SD of 3 individual experiments (3TWs each, n=3). 
 
HPF were grown on TWs under submerged conditions for 14 days before these were challenged 
with HIA S. aureus from either the apical side, the basolateral side or simultaneously from both 
sides and were then assessed for cell viability (A), TER (B) of the mono-culture and IL-8 
secretions (C) after the 24 h challenge. In figure 8.5 A cell viability is shown for HPF after 
exposure to S. aureus and no significant differences were seen for any of the three challenges 
when compared to the control, which showed a baseline fluorescence of 3623.43 ± 636.22 FU. 
Figure 8.5 B represents the results for TER measured before (clear bars) and after (striped bars) 
 286 
 
the challenges.  TER was not significantly changed over this 24 h incubation with HIA S. aureus. 
TER of control mono-cultures was 14.78 ± 2.16 Ω x cm
2
 before and 17.44 ± 0.69 Ω x cm
2
 after the 
challenge. IL-8 concentrations (figure 8.5 C) were measured in apical supernatants (clear bars) 
and basolateral medium samples (striped bars) collected and secretion was not induced by 
adding HIA S. aureus to either compartment of the TW or to both compartments at the same 
time. Control cultures, which were exposed to SF-growth medium only had an IL-8 concentration 
of 159.81 ± 8.56 pg/ml in the apical supernatant and 126.25 ± 13.26 pg/ml in the basolateral 
medium.  
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Figure 8.6 Cell viability (A), TER (B) and IL-8 release (C) of HPF after exposure to HIA B. cepacia 
HPF mono-cultures were grown under submerged conditions on TWs for 14 days before these were 
challenged with HIA B. cepacia. Bacteria were applied either apically, basolaterally or from both sides 
simultaneously, excluding the control TWs, which were only challenged with growth medium. Cell viability 
of HPF mono-culture was not affected by the presence of HIA B. cepacia for 24 h and nor was the TER, 
which was measured before (clear bars) and directly after (striped graphs) the 24 h incubation with HIA B. 
cepacia. IL-8 concentrations in apical supernatants (clear bars) and basolateral medium (checked bars) did 
not show a significant change after any of the challenges compared to the control TWs. Data are 
presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
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HPF mono-cultures were grown under submerged conditions on TWs for 14 days before they 
were challenged with HIA B. cepacia. The control TWs were treated the same as all others but 
were exposed to SF-growth medium only. TWs that were challenged were exposed to HIA B. 
cepacia from either the apical side, the basal side or they were exposed to the bacteria on both 
sides at the same time. HPF’s cell viability (figure 8.6 A), which was analysed by CTB was 3340.6 ± 
543.59 FU at baseline and was not changed after a 24 h incubation with HIA B. cepacia. TER 
(figure 8.6 B) was measured before (clear bars) and after (striped bars) the challenge. Control 
TWs showed a TER of 12.21 ± 1.24 Ωcm
2
 beforehand and 12.10 ± 2.29 Ωcm
2
 afterwards. IL-8 
concentrations were analysed in all apical as well as all basolateral medium samples and were 
found to be unaffected by 24 h exposure to HIA S. aureus. The IL-8 concentration (figure 8.6) of 
the control was 47.02 ± 28.93 pg/ml, when measured in the apical supernatant and it was 48.99 
± 35.56 pg/ml in the basal medium.  
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Figure 8.7 Cell viability (A), TER (B) and IL-8 release (C) of HPF mono-culture after exposure to HIA P. 
aeruginosa 
HPF mono-cultures were grown under submerged conditions on TWs for 14 days before these cells were 
exposed to HIA P. aeruginosa. Bacteria were applied either apically, basally or simultaneously from both 
sides. Cell viability of HPF was not significantly changed after 24 h exposure to HIA P. aeruginosa. TER was 
measured before (clear bars) and after (striped bars) the experiment and was stable throughout as no 
significant difference was observed after 24 h incubation with live P. aeruginosa. HPF mono-culture 
supernatants (clear bars) as well as basolateral medium (checked bars) was analysed for IL-8 
concentrations and no significant differences were observed. Data are presented as mean ± SD of 3 
individual experiments (3TWs each, n=3). 
 
The cell viability (figure 8.7 A) of HPF-monocultures, which were grown under submerged 
conditions on TWs, was not affected by 24 h exposure to HIA P. aeruginosa. The baseline 
fluorescence measured for the control TWs was 1971.48 ± 528.44 FU. TER (figure 8.7 B) of these 
mono-cultures was neither affected, when comparing results from before (clear bars) and after 
(striped bars) the challenges. The control TWs had a TER of 13.27 ± 1.82 Ω x cm
2
 before the 
challenge and 13.20 ± 0.66 Ω x cm
2
 after the challenge with HIA P. aeruginosa. IL-8 
concentrations (figure 8.7 C) were measured in all apical as well as in all basolateral samples 
collected. The IL-8 secretion was not induced by either apically applied, basolaterally applied or 
by simultaneous exposure on both sides at the same time. The concentration measured in the 
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apical supernatant (clear bars) was 36.64 ± 4.21 pg/ml and it was 25.47 ± 3.95 pg/ml in the basal 
compartment.  
 
8.4.2.2 Exposure of C38 mono-culture at ALI to HIA bacteria 
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Figure 8.8 Cell viability (A), TER (B) and IL-8 release (C) of C38 grown at ALI after exposure to HIA S. aureus 
C38 were grown on TWs at ALI for 14 days before they were challenged with HIA S. aureus, which was 
applied either apically, basolaterally or from both sides simultaneously. Control TWs were treated with 
medium only. Cell viability was not significantly changed by this exposure to HIA S. aureus. The measured 
TER before (clear bars) and after (striped bars) the challenges did not show any significant changes. IL-8 
concentration was analysed but no differences were noted. Data are presented as mean ± SD of 3 
individual experiments (3TWs each, n=3). 
 
C38 mono-cultures grown at ALI were analysed after they were exposed to HIA S. aureus. This 
bacterium did not alter the cell viability (figure 8.8 A), TER (B) or IL-8 (C) concentration in its HIA 
state. None of the measured parameters were significantly affected. Control cultures of C38 that 
were exposed to SF-growth medium only showed a fluorescent baseline signal of 1614.75 ± 
363.22 FU. TER for these cultures was assessed and was 49.57 ± 3.26 Ω x cm
2
 before (clear bars) 
the challenge and 48.07 ± 1.73 Ω x cm
2
 after (striped bars) the bacterial exposure. IL-8 secretion 
into the apical supernatant (clear bars) of control mono-cultures of C38 was 6.87 ± 1.26 pg/ml, 
whereas no IL-8 was observed in the basolateral medium sample (checked bars). 
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Figure 8.9 Cell viability (A), TER (B) and IL-8 release (C) of C38 mono-cultures after exposure to HIA B. 
cepacia 
Mono-cultures of C38 grown at ALI were exposed to HIA B. cepacia, which was applied either apically, 
basolaterally or from both sides simultaneously. Control TWs were only challenged with growth medium 
and no bacteria. Cell viability (A) and IL-8 release (C) were not affected by the presence of HIA B. cepacia. 
TER after the challenge (striped bars), however, was significantly lower, including the control, comparing 
to the corresponding TER from before (clear bars) the challenges. Data are presented as mean ± SD of 3 
individual experiments (3TWs each, n=3). 
 
C38 mono-cultures grown at ALI for 14 days before they were challenged with HIA B. cepacia, 
which was either applied apically, basolaterally or from both sides at the same time. Cell viability 
(figure 8.9 A) was not affected after 24 h incubation and all challenged TWs had a similar 
fluorescent signal from CTB as the control (1875.07 ± 40.95 FU). TER (figure 8.9 B) of this mono-
culture was measured beforehand (clear bars) and straight afterwards (striped bars), which was 
significantly decreased for all TWs measured, including the control. In order, the control was 
47.74 ±0.58 Ω x cm
2
 before the challenge and 39.49 ± 0.85 Ω x cm
2
 afterwards. Apically 
challenged TWs had a TER of 48.95 ± 0.39 Ω x cm
2
 beforehand and 37.25 ± 2.06 Ω x cm
2
 were 
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measured afterwards. When TWs were challenged basolaterally these values were 49.43 ± 1.12 
Ω x cm
2
 before and 35.2 ± 0.76 Ω x cm
2
 after the exposure to B. cepacia. IL-8 secretion (figure 8.9 
C) was not induced by HIA B. cepacia and was 96.35 ± 2.43 pg/ml in the control’s apical 
supernatant and 79.47 ± 11.83 pg/ml in the control’s basolateral medium.  
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Figure 8.10 Cell viability (A), TER (B) and IL-8 release (C) of C38 mono-cultures after exposure to HIA P. 
aeruginosa 
C38 mono-cultures were grown at ALI for 14 days and were then exposed to HIA P. aeruginosa, which was 
applied either apically, basolaterally or from both sides simultaneously. Control TWs, which were treated 
the same but without bacteria served as control. Neither cell viability (A) of C38, nor the TER was 
significantly changed by any of these challenges. IL-8 concentrations in the apical supernatants (clear bars) 
were not found to be changed after 24 h exposure to HIA P. aeruginosa. The basolateral medium (checked 
bars) showed in all cases, including the control, significantly lower IL-8 compared to their corresponding 
apical supernatant. Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
C38-mono-cultures were grown at ALI for 14 days before these were challenged with HIA P. 
aeruginosa, either apically, basolaterally or from both sides at the same time. Cell viability 
(figure 8.10 A) was not significantly affected by this challenge. Baseline fluorescence measured 
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for the control was 1328.78 ± 257.56 FU. The electrical resistance was monitored by measuring 
the TER (figure 8.10 B) before (clear bars) and after (striped bars) the challenges and was found 
to be stable throughout the experiment. TER measured for control TWs was 59.03 ± 2.44 Ω x cm
2
 
before and 51.88 ± 3.05 Ω x cm
2
 after the exposure to HIA P. aeruginosa. IL-8 concentrations 
(figure 8.10 C) were assayed for apical supernatants (clear bars) as well as for basolaterally 
collected medium (checked bars). These were not significantly different to the analysed controls, 
which were 73.921 ± 5.52 pg/ml in the apical supernatant and 54.05 ± 7.59 pg/ml in the 
basolateral sample. All basolateral samples, however, were significantly lower compared to their 
corresponding apical supernatants. For the apical challenged TWs this was 66.25 ± 5.28 pg/ml on 
the apical side and IL-8 concentration was 49.69 ± 2.49 pg/ml on the basolateral side of the 
mono-culture. Basally challenged TWs had 72.60 ± 6.73 pg/ml in the apical supernatant 
compared to 46.28 ± 5.06 pg/ml in the basolateral medium. When C38 mono-cultures were 
challenged simultaneously from both sides, the IL-8 concentration found apically was 62.57 ± 
3.73 pg/ml and it was 45.81 ± 2.35 pg/ml in the basal medium collected.  
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8.4.2.3 Exposure of IB3-1 mono-cultures at ALI to HIA bacteria 
 
No
 Ba
cte
ria
Ap
ica
l S
.
au
re
us
Ba
sa
l S
.
au
re
us
Ap
ica
l/B
as
al 
S.a
ur
eu
s
0
1000
2000
3000
4000
Fl
u
o
re
sc
en
ce
 
u
n
its
56
0n
m
/5
90
n
m
No
 Ba
cte
ria
Ap
ica
l S
.
au
re
us
Ba
sa
l S
.
au
re
us
Ap
ica
l/B
as
al 
S.a
ur
eu
s
No
 Ba
cte
ria
Ap
ica
l S
.
au
re
us
Ba
sa
l S
.
au
re
us
Ap
ica
l/B
as
al 
S.a
ur
eu
s
0
10
20
30
40
50
TE
R
 
(O
hm
 
x
 
cm
2 )
No
 Ba
cte
ria
Ap
ica
l S
.
au
re
us
Ba
sa
l S
.
au
re
us
Ap
ica
l/B
as
al 
S.a
ur
eu
s
No
 Ba
cte
ria
Ap
ica
l S
.
au
re
us
Ba
sa
l S
.
au
re
us
Ap
ica
l/B
as
al 
S.a
ur
eu
s
0
10
20
30
40
50
60
IL
-
8 
in
 
pg
/m
l
A B
C
 
Figure 8.11 Cell viability (A), TER (B) and IL-8 release (C) of IB3-1 grown at ALI after exposure to HIA S. 
aureus 
IB3-1 were cultured at ALI for 14 days before they were challenged with HIA S. aureus. Bacteria were 
applied either apically, basolaterally or from both sides at the same time and the control TWs were only 
treated with medium. For IB3-1 no significant changes were observed looking at cell viability and when 
comparing TER from before (clear bars) and after (striped bars). IL-8 secretions were not increased 
significantly by this bacterium in the apical supernatant or in the basolateral medium analysed. Data are 
presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
IB3-1 mono-culture were grown at ALI for 14 days before these were challenged with HIA S. 
aureus, which was applied either apically, basolaterally or apically/ basolaterally at the same 
time. After 24 h exposure cell viability (figure 8.11 A) of this mono-culture was analysed and was 
found to be unaffected by this event. The baseline fluorescence of the control was 3125.13 ± 
147.00 FU. TER (figure 8.11 B) was measured before (clear bars) and after (striped bars) the 
challenge with no significant difference after any of the challenges when compared to the 
control, which showed a TER of 42.17 ± 1.31 Ω x cm
2
 beforehand and 48.40 ± 1.48 Ω x cm
2
. IL-8 
secretion (figure 8.11 C) was analysed in apical supernatants (clear bars) and basolateral medium 
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samples (checked bars) but no increase was observed for any of the challenges compared to the 
control (beforehand: 24.49 ± 0.26 pg/ml, afterwards: 21.87 ± 5.59 pg/ml).  
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Figure 8.12 Cell viability (A), TER (B) and IL-8 release (C) after exposure of IB3-1 to HIA B. cepacia of IB3-1 
grown at ALI  
IB3-1 mono-cultures were challenged with HIA B. cepacia. TWs were either challenged apically, 
basolaterally or from both sides simultaneously. IB3-1 control TWs were treated the same way as all other 
TWs but with medium only. In this case cell viability was not significantly changed by the exposure to HIA 
bacteria. TER was measured before (clear bars) and was significantly decreased for all three challenges 
after 24 h (striped bars) incubation. IL-8 concentrations observed in apical supernatants (clear bars) as well 
as in basolateral medium samples (checked bars) were not significantly changed by HIA B. cepacia. Data 
are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
IB3-1 mono-cultures grown at ALI were exposed to HIA B. cepacia. The HIA bacteria were added 
either to the apical side, to the basolateral side or to both sides simultaneously. Cell viability 
(figure 8.12 A) was measured straight after 24 h incubation and was found to be unaffected 
(control: 2230.26 ± 242.62 FU). TER (figure 8.12 B) measurements showed that HIA bacteria 
significantly decrease this mono-cultures electrical resistance. After all three challenges the TER 
was found to be significantly decreased, when compared to their corresponding TER from 
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before. The control TWs showed a TER of 51.11 ± 1.20 Ω x cm
2
 beforehand and 46.67 ± 1.52 Ω x 
cm
2
 afterwards. When IB3-1 were challenged from the apical side the TER fell from 51.66 ± 1.32 
Ω x cm
2
 down to 40.99 ± 1.29 Ω x cm
2
. Similarly readings were observed for basally challenged 
TWs as these had a TER of 50.93 ± 0.50 Ω x cm
2
 before the exposure to HIA B. cepacia, which 
then decreased to 42.35 ± 2.85 Ω x cm
2
 after 24 h incubation. IL-8 concentrations (figure 8.12 C) 
were not changed by any of these challenges and stayed roughly around the same 
concentrations as the control, which was 132.87 ± 13.01 pg/ml in the apical supernatants (clear 
bars) and 131.27 ± 20.46 pg/ml in the basolateral medium samples (checked bars).  
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Figure 8.13 Cell viability (A), TER (B) and IL-8 release (C) of IB3-1 mono-culture after exposure to HIA P. 
aeruginosa 
IB3-1 mono-cultures were grown at ALI for 14 days before these cells were exposed to HIA P. aeruginosa, 
which were applied either apically, basally or simultaneously from both sides. Cell viability after 24 h 
exposure to HIA bacteria was not significantly decreased for any of the challenges compared to the 
control. TER was measured before (clear bars) and after (striped bars) the experiment but no significant 
difference was observed after 24 h incubation with HIA P. aeruginosa. IL-8 release of IB3-1 mono-culture 
was not changed either but one interesting aspect to mention is significantly lower IL-8 concentrations in 
all basolateral media samples (checked bars) compared to their corresponding apical supernatant (clear 
bars). Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
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Mono-cultures of IB3-1 were challenged with HIA P. aeruginosa, which were applied apically, 
basolaterally or simultaneously from both sides for 24 h. Cell viability (figure 8.13 A) was 
investigated after these challenges and no significant differences were observed. Baseline 
fluorescence of this mono-culture was 3006.96 ± 98.67 FU. TER (figure 8.13 B) was measured 
before and after the 24 h incubation with HIA P. aeruginosa, which was not affected. The control 
TWs had a TER of 69.37 ± 9.10 Ω x cm
2
 before the challenge and 56.50 ± 1.84 Ω x cm
2
 afterwards. 
IL-8 concentrations (figure 8.13 C) were measured, and in the control TWs, were 70.59 ±4.36 
pg/ml apically and 38.92 ± 4.31 pg/ml basolaterally. No significant inductions of IL-8 secretions 
were observed but again all basolateral samples were significantly lower in IL-8 compared to 
their corresponding apical samples. Apically challenged cells secreted 62.38 ± 3.87 pg/ml IL-8 to 
the apical supernatant and 36.67 ± 3.49 pg/ml to the basolateral medium. When IB3-1 mono-
cultures were challenged with HIA P. aeruginosa in the basal compartment the measured IL-8 
concentration was 58.83 ± 4.82 pg/ml apically and 39.93 ± 2.93 pg/ml basolaterally. The 
simultaneous challenge from both sides resulted in 60.86 ±7.61 pg/ml apical IL-8 and in 31.46 ± 
1.79 pg/ml basal IL-8.  
 
  
 297 
 
8.4.2.4 Exposure of Calu-3 mono-cultures at ALI to HIA bacteria 
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Figure 8.14 Cell viability (A), TER (B) and IL-8 release (C) of Calu-3 at ALI after exposure to HIA S. aureus 
Calu-3 mono-culture were grown at ALI for 14 days before these cells were challenged with HIA S. aureus. 
Bacteria were applied either apically, basolaterally or on both sides at the same time. Neither Calu-3’s cell 
viability was affected by this 24 h exposure, nor was the TER, which was measured before (clear bars) and 
after (striped bars) the challenge. IL-8 secretion of Calu-3 at ALI was not significantly different to control 
either in apical supernatants (clear bars) or basolateral medium (checked bars) after any of the challenges. 
Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
Calu-3’s cell viability (figure 8.14 A) of the control TWs was 7660.61 ± 394.54 FU at baseline, 
which was similar to cell viability found after every challenge. TER (figure 8.14 B) measurements 
were taken before (clear bars) and after (striped bars) the challenges and were unaffected by 
this challenge with HIA S. aureus for 24 h. The control TWs had an electrical resistance of 315.77 
± 21.47 Ωcm
2
 before the challenge and 375.72 ± 43.98 Ωcm
2
 after the challenge. IL-8 secretion 
(figure 8.14 C) was not induced by any of the challenges using HIA S. aureus. The baseline IL-8 
secretion was 2368.60 ± 30.06 pg/ml in the apical supernatant and 2259.32 ± 98.87 pg/ml. 
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Figure 8.15 Cell viability (A), TER (B) and IL-8 release (C) of Calu-3 after exposure to HIA B. cepacia 
Mono-cultures of Calu-3 were at ALI for 14 days before they were challenged with HIA B. cepacia, either 
apically, basolaterally or from both sides at the same time after. Cell viability of this mono-culture was not 
significantly changed throughout this bacterial challenge. TER was measured before (clear bars) and after 
(striped bars) the challenges and was found to be significantly higher, including the control after the 24 h 
challenge. IL-8 concentration in the apical supernatants (clear bars) was not significantly increased when 
compared to the control. An aspect to be noted is the significantly lower IL-8 concentration in the 
basolateral medium (checked bars) of apically challenged and apically/basolaterally challenged TWs. Data 
are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
Calu-3 mono-cultures at ALI were challenged with HIA B. cepacia after they were cultured for 14 
days. Bacteria were added either to the apical compartment, to the basal compartment or to 
both at the same time. Cell viability (figure 8.15 A) was measured after the 24 h challenge and 
was not affected by this event. 3243.40 ± 962.09 FU were measured for the control TWs and the 
challenged TWs were not significantly different. TER (figure 8.15 B) for this mono-culture was 
assayed before (clear bars) the challenge and after (striped bars) the challenge. TER from before 
the challenges were 233.61 ± 8.31 Ω x cm
2
for the control, 192.87 ± 14.6 Ω x cm
2
 for the apical 
challenges TWs, 195.16 ± 37.01 Ω x cm
2
 for the basally challenged TWs and 189.56 ± 34.72 Ω x 
cm
2
, when challenged from both sides. After the challenges these were found to be significantly 
higher compared to their corresponding TER from before. The results were 333.92 ± 13.04 Ω x 
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cm
2
 for the control, 295.64 ± 40.12 Ω x cm
2
 for the apical challenged TWs, 358.67 ± 10.64 Ω x 
cm
2
, for the basally challenged and 368.94 ± 67.35 Ω x cm
2
, when TWs were challenged from 
both sides at the same time. IL-8 secretion (figure 8.15 C) in apical supernatants and basolateral 
medium samples were analysed and were not significantly increased by this challenge. IL-8 
concentration in the apical supernatant of the control was 1485.88 ± 103.98 pg/ml and it was 
779.08 ± 67.36 pg/ml in the basolateral control. 
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Figure 8.16 Cell viability (A), TER (B) and IL-8 release (C) of Calu-3 mono-culture after exposure to HIA P. 
aeruginosa 
Calu-3 mono-cultures at ALI were challenged with HIA P. aeruginosa, either apically, basolaterally or both 
at the same time after 14 days of culture at ALI. Cell viability was not significantly decreased after any of 
these challenges. TER was measured before (clear bars) and after (striped bars) the challenges and was 
significantly increased after all three challenges with HIA P. aeruginosa. IL-8 concentration in the apical 
supernatants (clear bars) were all at a similar level and so were the basolateral samples (checked bars), 
which were all significantly lower in IL-8 than their corresponding apical supernatants. Data are presented 
as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
Calu-3 mono-cultures were grown at ALI for 14 days before they were challenged with HIA P. 
aeruginosa for 24 h. HIA bacteria were added to the apical side, basal side or on both sides at 
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the same time. Calu-3’s cell viability (figure 8.16 A) was not affected by these HIA bacteria and 
the baseline fluorescence measured for the control was 1613.77 ± 128.51 FU. TER (figure 8.16 B) 
was found to be significantly increased after all three challenges, which was not observed for the 
control. TER of the control TWs was 271.44 ± 18.42 beforehand and 306.68 ± 18.54 afterwards. 
Apically challenged TWs showed an increase from 339.31 ± 4.40 Ω x cm
2
 before to 469.00 ± 8.02 
Ω x cm
2
 after the challenge. When Calu-3 were challenged basolaterally the TER afterwards was 
486.12 ± 24.03 (before 349.87 ± 2.56 Ω x cm
2
) and when challenged from both sides the TER 
resulted in 579.48 ± 10.40 (before 367.51 ± 5.82 Ω x cm
2
). IL-8 concentrations (figure 8.16 C) 
were found to be unaffected by this exposure. Basolateral samples, including the control were 
significantly lower than their corresponding apical sample. In control TWs there was 6751.17 ± 
634.90 pg/ml of IL-8 in the apical supernatant compared to 1071.96 ± 465.68 pg/ml found 
basolaterally. When TWs were challenged apically, 6452.28 ± 1004.17 pg/ml was found in the 
apical sample and 924.23 ± 242.56 pg/ml was found in the basal medium. Calu-3 mono-cultures 
were also exposed to HIA P. aeruginosa from the basolateral side and 6837.03 ± 594.22 pg/ml of 
IL-8 were found in the apical supernatant compared to 806.19 ± 74.75 pg/ml IL-8 in the 
basolateral sample. Challenging the mono-culture from both sides simultaneously resulted in 
5331.49 ± 785.41 pg/ml in the apical supernatant and in 858.93 ± 243.65 pg/ml in the basal 
medium analysed.  
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8.4.2.5 Exposure of HPF-C38 co-cultures to HIA bacteria 
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Figure 8.17 Cell viability (A), TER (B) and IL-8 release (C) after exposure to HIA S. aureus of HPF-C38 grown 
at ALI  
After 14 days at ALI HPF-C38 were challenged with HIA S. aureus, which was applied either apically, 
basolaterally or from both sides simultaneously apart from the control TWs, which were challenged with 
medium only. Cell viability of this co-culture was not significantly affected after 24 h exposure to HIA S. 
aureus compared to the control. The measured TER after the challenges (striped bars) was not different 
when compared to their corresponding TER measured before (clear bars). IL-8 secretion was only 
significantly increased in the apical supernatant (clear bars) by simultaneous treatment with HIA S. aureus 
from apical and basolateral side. This increase was not observed for basolateral medium samples (checked 
bars). Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
HPF-C38 co-cultures were grown on TWs for 14 days before these were exposed to HIA S. 
aureus, which were applied either apically, basolaterally or from both sides at the same time. 
Cell viability (figure 8.17 A) was assessed after the 24 h incubation and was found to be 
unaffected compared to the baseline fluorescence of the control (1341.06 ± 48.15 FU). TER 
(figure 8.17 B) of this mono-culture system was stable throughout the experiment and measured 
47.08 ± 1.81 for the control before the challenge and 48.62 ± 2.12 after the challenge. IL-8 
secretions (figure 8.18 C) were only significantly increased in apical supernatants (clear bars) by 
HIA S. aureus, when the bacteria were applied simultaneously on both sides. In this case IL-8 was 
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2587.65 ± 223.37 pg/ml compared to 1355.34 ± 337.57 pg/ml in the apical supernatant of the 
control.  
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Figure 8.18 Cell viability (A), TER (B) and IL-8 release (C) after exposure to HIA B. cepacia of HPF-C38 co-
culture grown at ALI  
HPF-C38 co-culture TWs were challenged with HIA B. cepacia, which were applied to either the apical side 
of the culture, to the basolateral side or to both sides at the same time. HPF-C38 controls were only 
challenged using medium without bacteria. In this case cell viability was not affected by HIA B. cepacia. 
However, the TER measured before (clear bars) and after (striped bars) the challenges was observed to be 
significantly lower after all three challenges. IL-8 concentrations were analysed and none of the apical 
supernatants (clear bars) and none of the basolateral media samples (checked bars) were found to be 
significantly changed. Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
HPF-C38 co-culture was grown at ALI for 14 days before these were exposed to HIA B. cepacia, 
which was added either to the apical side, to the basal side or to both sides at the same time. 
Cell viability (figure 8.18 A) was observed after 24 h exposure to HIA B. cepacia and was not 
found to be significantly changed by this event. The baseline fluorescence of the control was 
1912.06 ± 365.94 FU. TER (figure 8.18 B) of this co-culture was measured before (clear bars) and 
after (striped bars) this event and was observed to be significantly decreased after the 24 h 
incubation with HIA B. cepacia. The control TWs TER was 47.34 ± 0.63 Ω x cm
2
 before the 
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challenge and slightly lower with 40.52 ± 0.85 Ω x cm
2
 after the challenge. When this co-culture 
was exposed to bacteria apically the TER fell from 48.69 ± 1.07 Ω x cm
2
 down to 37.36 ± 1.24 Ω x 
cm
2
. Exposure from the basal compartment caused a similar effect and TER was 35.79 ± 0.55 Ω x 
cm
2
 afterwards compared to 49.06 ± 1.46 Ω x cm
2
 beforehand. Simultaneous challenge from 
both sides of the co-culture decreased TER from 48.88 ± 0.23 Ω x cm
2
 down to 36.81 ± 0.35 Ω x 
cm
2
. IL-8 secretion (figure 8.18 C) by this co-culture was not significantly affected by this HIA 
bacterium. In the apical supernatant (clear bars) of the control there was 812.14 ± 61.23 pg/ml 
and in the basal medium there was 879.69 ± 248.81 pg/ml. 
 
No
 
Ba
cte
ria
Ap
ica
l P
.
ae
ru
gin
os
a
Ba
sa
l P
.
ae
ru
gin
os
a
Ap
ica
l/B
as
al 
P.a
er
ug
ino
sa
0
1000
2000
3000
4000
5000
Fl
u
o
re
sc
en
ce
 
u
n
its
56
0n
m
/5
90
n
m
No
 
Ba
cte
ria
Ap
ica
l P
.
ae
ru
gin
os
a
Ba
sa
l P
.
ae
ru
gin
os
a
Ap
ica
l/B
as
al 
P.a
er
ug
ino
sa
No
 
Ba
cte
ria
Ap
ica
l P
.
ae
ru
gin
os
a
Ba
sa
l P
.
ae
ru
gin
os
a
Ap
ica
l/B
as
al 
P.a
er
ug
ino
sa
0
10
20
30
40
50
60
70
TE
R 
(O
hm
 
x 
cm
2 )
No
 
Ba
cte
ria
Ap
ica
l P
.
ae
ru
gin
os
a
Ba
sa
l P
.
ae
ru
gin
os
a
Ap
ica
l/B
as
al 
P.a
er
ug
ino
sa
No
 
Ba
cte
ria
Ap
ica
l P
.
ae
ru
gin
os
a
Ba
sa
l P
.
ae
ru
gin
os
a
Ap
ica
l/B
as
al 
P.a
er
ug
ino
sa
0
1000
2000
3000
4000
5000
6000
7000
8000
**
**
*IL
-
8 
in
 
pg
/m
l
A B
C
 
Figure 8.19 Cell viability (A), TER (B) and IL-8 release (C) after exposure to HIA P. aeruginosa of HPF-C38 
grown at ALI  
HPF-C38 were grown at ALI for 14 days before HIA P. aeruginosa were applied were either apically, 
basolaterally or from both sides simultaneously. HPF-C38 control was challenged with medium only. Cell 
viability was not significantly decreased but showed a trend toward it compared to the control. The 
measured TER before (clear bars) and after the challenges (striped bars) was not changed by this 24 h 
incubation with HIA P. aeruginosa. IL-8 concentrations in apical supernatants (clear bars) as well as in the 
basolateral media samples (checked bars) stayed roughly at the same levels but concentrations were 
significantly lower in basolateral samples when compared to their corresponding apical supernatant. Data 
are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
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HPF-C38 co-cultures that were challenged with HIA P. aeruginosa after 14 days at ALI did not 
show any significant change in cell viability (figure 8.19 A) after a 24 h exposure. The baseline 
fluorescene observed for this co-culture was 4113.83 ± 509.10 FU. TER (figure 8.19 B) was stable 
throughout the experiment and before (clear bars) the challenges the control showed a TER of 
53.13 ± 3.02 Ω x cm
2
 and afterwards it was 59.62 ± 2.43 Ω x cm
2
. IL-8 secretions (figure 8.19 C) 
were measured in the apical supernatants (clear bars) as well as in the basolateral medium 
samples (checked bars) and was not significantly changed by the exposure to HIA P. aeruginosa 
but all basolateral medium samples, apart from basally challenged ones, had significantly less IL-
8 compared to their corresponding apical supernatant. The control had a concentration of 
6409.29 ± 134.69 pg/ml in the apical supernatant compared to 3460.45 ± 529.41 pg/ml in the 
basal medium samples analysed.  
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8.4.2.6 Exposure of HPF-IB3-1 co-culture to HIA bacteria  
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Figure 8.20 Cell viability (A), TER (B) and IL-8 release (C) of HPF-IB3-1 grown at ALI after exposure to HIA S. 
aureus 
HPF-IB3-1 co-cultures were grown at ALI for 14 days before they were challenged with HIA S. aureus, 
which was applied either apically, basolaterally or from both sides at the same time. Control TWs were 
challenged with medium only. Cell viability of this co-culture was not significantly decreased after being 
challenged with HIA S. aureus. TER was found to be stable when comparing TER measured before (clear 
bars) and after 24 h exposure to HIA S. aureus (striped bars). IL-8 concentrations observed in apical 
supernatants (clear bars) showed a significant increase for all three challenges, and this was not observed 
in the basolateral medium (checked bars). Data are presented as mean ± SD of 3 individual experiments 
(3TWs each, n=3). 
 
HPF-IB3-1 co-cultures were exposed to HIA S. aureus for 24 h. HIA S. aureus were applied to the 
apical side of the co-culture, to the basal side or to both at the same time after 14 days of 
culture at ALI. Cell viability (figure 8.20 A) was not negatively influenced by these events 
(baseline fluorescence of control: 1370.54 ± 108.26 FU). TER (figure 8.20 B) was measured 
before (clear bars) and after (striped) the challenges and was observed to be unaffected by the 
exposure to HIA S. aureus. The measured TER of the control TWs was 51.88 ± 6.24 Ω cm
2
 
beforehand and 53.68 ± 3.46 Ω cm
2 
 afterwards. IL-8 secretion (figure 8.20 C) was assayed after 
the incubation of HPF-IB3-1 co-culture with HIA S. aureus and was significantly increased in the 
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apical supernatants after all three challenges compared to the control, which showed an IL-8 
concentration of 2181.63 ± 181.49 pg/ml. In the apical supernatant (clear bars) after apical 
challenge, the concentration of IL-8 increased to 5279.72 ± 858.11 pg/ml, after the basally 
challenge it was 9137.52 ± 321.12 pg/ml and when this co-culture was challenged from both 
sides at the same time IL-8 concentration was measured at 6244.91 ± 109.76 pg/ml. Basolateral 
medium samples did not show this increase and were similar to the control, which had an IL-8 
concentration of 3709.72 ± 55.66 pg/ml.  
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Figure 8.21 Cell viability (A), TER (B) and IL-8 release (C) after exposure to HIA B. cepacia of HPF-IB3-1 
grown at ALI  
HPF-IB3-1 co-cultures were grown at ALI for 14 days before they were challenged with HIA B. cepacia, 
which was applied either apically, basolaterally or from both sides simultaneously. HPF-IB3-1 on their own 
without bacteria were treated the same way as all other TWs and served as control. HPF-IB3-1’s cell 
viability was not significantly affected by the exposure to HIA B. cepacia. TER was found to be significantly 
decreased after (striped bars) all three bacteria challenges, when compared to the corresponding TER 
from before (clear bars) IL-8 concentrations observed in apical supernatants (clear bars) and in basal 
media samples (checked bars) was not significantly changed. Data are presented as mean ± SD of 3 
individual experiments (3TWs each, n=3). 
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HPF-IB3-1 co-cultures at ALI were exposed to HIA B. cepacia for 24 h. Bacteria were added either 
to the apical side, to the basal side or to both at the same time. Cell viability (figure 8.21 A) was 
not changed after this 24 h incubation for any of the challenges. Baseline fluorescence measured 
for control TWs was 2851.26 ± 410.85 FU. TER (figure 8.21 B) of this co-culture was monitored 
before (clear bars) and after (striped bars) this 24 h exposure to HIA B. cepacia and was found to 
be significantly decreased after all three challenges. Apically challenged co-cultures had a TER of 
52.25 ± 0.94 Ω x cm
2
 beforehand, which decreased to 40.70 ± 2.06 Ω x cm
2
 after the challenge. 
Basolaterally exposure of HIA B. cepacia caused the TER to fall from 51.11 ± 0.73 Ω x cm
2
 to 
42.35 ± 2.49 Ω x cm
2
. After the simultaneous challenge from both sides of co-cultures TER was 
found to be down to 42.5 ± 1.85 Ω x cm
2
 compared to TER before challenge (51.37 ± 0.19 Ω x 
cm
2
) Induction of IL-8 secretion (figure 8.21 C) could not be observed after this exposure to HIA 
B. cepacia and was 812.14 ± 61.23 pg/ml in the apical supernatant (clear bars) of the control and 
879.69 ± 248.80 pg/ml in the basal medium (checked bars) of the control. 
  
 308 
 
No
 
Ba
cte
ria
Ap
ica
l P
.
ae
ru
gin
os
a
Ba
sa
l P
.
ae
ru
gin
os
a
Ap
ica
l/B
as
al 
P.a
er
ug
ino
sa
0
1000
2000
Fl
u
o
re
sc
en
ce
 
u
n
its
56
0n
m
/5
90
n
m
No
 
Ba
cte
ria
Ap
ica
l P
.
ae
ru
gin
os
a
Ba
sa
l P
.
ae
ru
gin
os
a
Ap
ica
l/B
as
al 
P.a
er
ug
ino
sa
No
 
Ba
cte
ria
Ap
ica
l P
.
ae
ru
gin
os
a
Ba
sa
l P
.
ae
ru
gin
os
a
Ap
ica
l/B
as
al 
P.a
er
ug
ino
sa
0
10
20
30
40
50
60
TE
R 
(O
hm
 
x 
cm
2 )
No
 
Ba
cte
ria
Ap
ica
l P
.
ae
ru
gin
os
a
Ba
sa
l P
.
ae
ru
gin
os
a
Ap
ica
l/B
as
al 
P.a
er
ug
ino
sa
No
 
Ba
cte
ria
Ap
ica
l P
.
ae
ru
gin
os
a
Ba
sa
l P
.
ae
ru
gin
os
a
Ap
ica
l/B
as
al 
P.a
er
ug
ino
sa
0
1000
2000
3000
4000
IL
-
8 
in
 
pg
/m
l
A B
C
 
Figure 8.22 Cell viability (A), TER (B) and IL-8 release (C) after exposure to HIA P. aeruginosa of HPF-IB3-1 
grown at ALI  
HPF-IB3-1 co-culture were challenged with HIA P. aeruginosa, which was applied either apically, 
basolaterally or from both sides at the same time. HPF-IB3-1 on their own without bacteria were 
challenged with medium only and served as control. HPF-IB3-1’ cell viability was not affected by this 
exposure to HIA P. aeruginosa. TER was found to be stable throughout the experiment for all three 
challenges after 24 h incubation (striped bars) when compared to their corresponding TER bar before the 
challenge. HPF-IB3-1 released equivalent levels of IL-8 into either the apical supernatants (clear bars) or 
into the basolateral medium compared to the control TWs. Data are presented as mean ± SD of 3 
individual experiments (3TWs each, n=3). 
 
HPF-IB3-1’s cell viability was assayed after 24 h exposure to HIA P. aeruginosa, which were 
applied either apically, basolaterally or from both sides at the same time and was found to be 
unaffected by this event. Cell viability (figure 8.22 A) was observed by CTB assay and the baseline 
fluorescence was 1462.93 ± 36.54 FU for the control co-cultures. TER (figure 8.22 B) was 
analysed before (clear bars) and after (striped bars) the exposure but was found to be constant 
throughout the experiment. Control co-cultures had a TER of 51.88 ± 6.24 Ω x cm
2
 before the 
experiment and it was 53.06 ± 3.16 Ω x cm
2 
after the challenge. Secretion of IL-8 (figure 8.22 C) 
was not induced by any of the challenges and was not significantly altered either in apical 
supernatants (clear bars) or in basal medium samples (checked bars). IL-8 concentration found in 
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control co-cultures was 2142.98 ± 251.64 pg/ml on the apical side and it was 2363.83 ± 1018.11 
pg/ml on the basal side of the co-culture.  
 
8.4.2.7 Exposure of HPF-Calu-3 co-culture to HIA bacteria 
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Figure 8.23 Cell viability (A), TER (B) and IL-8 release (C) of HPF-Calu-3 at ALI after exposure to HIA S. 
aureus 
HPF-Calu-3 co-culture at ALI were challenged with HIA S. aureus, either apically, basolaterally or from both 
sides at the same time. HPF-Calu-3’s cell viability was not significantly reduced by any of the 24 h 
exposures to HIA S. aureus. TER was measured before (clear bars) and after (striped bars) the challenges 
and was significantly increased for all TWs after this 24 h exposure to HIA S. aureus. IL-8 release was only 
increased significantly in apical supernatant (clear bars) following basolateral challenge. The basolateral IL-
8 concentration (checked bars) was significantly lower in all TWs when compared to their corresponding 
apical supernatant. Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
Co-cultures of HPF-Calu-3 were challenged with HIA S. aureus and the cell viability (figure 8.23 A) 
was investigated after a 24 h incubation with this bacterium. No significant changes were found 
compared to the control, which showed a baseline fluorescence of 829.37 ± 8.28 FU. The co-
cultures TER (figure 8.23 B) was monitored before (clear bars) and after (striped bars) the 
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challenges, where S. aureus was applied either apically, basolaterally or simultaneously from 
both sides. The control TWs measured a mean TER of 314.08 ± 21.73 Ω x cm
2
 before the 
exposure to this bacterium and 404.36 ± 6.14 Ω x cm
2
 afterwards, which was significantly higher. 
All the other TERs were significantly increased after the challenges. Apically challenged TWs 
increased from 357.57 ± 11.21 Ω x cm
2
 beforehand to 430.97 ± 2.99 Ω x cm
2
 after the challenge. 
When exposed to HIA S. aureus from the basolateral side the TER was 413.09 ± 33.81 Ω x cm
2
 
after the exposure compared to 343.68 ± 2.79 Ω x cm
2
 beforehand. TWs that were exposed 
apically and basolaterally to HIA S. aureus showed a significant increase in TER as well, which 
was 355.41 ± 3.03 Ω x cm
2
 before the challenge and 438.75 ± 9.52 Ω x cm
2
 after the challenge. IL-
8 concentration (figure 8.23 C) in the apical supernatants (clear bars) was measured and only 
found to be significantly increased after basolateral challenge of co-cultures of HPF-Calu-3. The 
IL-8 concentration measured in this case was 2470.4 ± 314.28 pg/ml compared to 1902.38 ± 
178.01 pg/ml found in the control. Basolateral medium samples (checked bars) were analysed 
alongside and no significant increases could be observed for these compared to the basal control 
medium. However, for this co-culture basolateral medium samples all together showed a 
significantly lower concentration of IL-8 compared to their corresponding apical sample.  
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Figure 8.24 Cell viability (A), TER (B) and IL-8 release (C) of HPF-Calu-3 co-culture after exposure to HIA B. 
cepacia 
HPF-Calu-3 co-cultures at ALI were, either apically, basolaterally or from both sides at the same time, 
challenged with HIA B. cepacia. Cell viability of this co-culture was not significantly decreased when 
challenged with HIA B. cepacia. The TER was measured before (clear bars) and after (striped bars) the 
challenges and was found to be stable throughout the experiment. IL-8 concentrations in the apical 
supernatants (clear bars) were not significantly increased after 24 h incubation with HIA B. cepacia. The 
basolateral sample IL-8 content (checked bars) was found to be significantly lower than their 
corresponding apical supernatant. Data are presented as mean ± SD of 3 individual experiments (3TWs 
each, n=3). 
 
Co-cultures of HPF-Calu-3 grown at ALI were exposed to HIA B. cepacia for 24 h. The bacteria 
were applied either apically, basolaterally or from both sides at the same time, which did not 
influence the cell viability (figure 8.24 A), which was measured straight after exposure. Baseline 
fluorescence that was observed for control was 1137.85 ± 166.70 FU. Furthermore TER (figure 
8.24 B) was analysed before (clear bars) and after (striped bars) these exposures and was not 
changed either after 24 h incubation with HIA B. cepacia. The control co-cultures, which were 
exposed to SF-medium only, had a TER of 337.70 ± 36.65 Ω x cm
2
 beforehand and 347.05 ± 4.22 
Ω x cm
2
 after the challenges. IL-8 release (figure 8.24 C) by this co-culture was not enhanced by 
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the exposure to HIA B. cepacia, neither in the apical supernatants (clear bars) nor in the 
basaolateral medium samples (checked bars).  
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Figure 8.25 Cell viability (A), TER (B) and IL-8 release (C) of HPF-Calu-3 co-culture after exposure to HIA P. 
aeruginosa 
HPF-Calu-3 co-cultures at ALI were challenged with HIA P. aeruginosa, either apically, basolaterally or both 
at the same time after 14 days of culture. None of the measured parameters were changed significantly. 
Cell viability (A) was not affected by this challenge, TER (B) was not changed after 24 h incubation with HIA 
P. aeruginosa and the IL-8 concentrations (C) did not show any significant increases compared to the 
control. Data are presented as mean ± SD of 3 individual experiments (3TWs each, n=3). 
 
HPF-Calu-3 co-cultures were exposed to HIA P. aeruginosa for 24 h at ALI. Bacteria were applied 
either apically, basolaterally or simultaneously on both sides, which did not have any affect on 
cell viability (figure 8.25 A). The control co-cultures, which were exposed to SF-growth medium 
only showed a baseline fluorescence of 1316.89 ±151.52 FU. TER (figure 8.25 B) was assayed 
before (clear bars) and after (striped bars) the challenges and was not seen to be different after 
these exposures to HIA P. aeruginosa. Co-cultures that served as control had a TER of 264.11 ± 
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87.92 Ω x cm
2
 beforehand and 276.47 ± 93.61 Ω x cm
2
 afterwards. IL-8 concentrations (figure 
8.25 C) of all apical supernatants (clear bars) as well as of all basal medium samples (checked) 
were analysed and no significant differences were observed compared to the control, which had 
1420.59 ± 29.49 pg/ml IL-8 in the apical supernatant and 1437.87 ± 75.11 pg/ml in the basal 
medium.  
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8.5 Discussion 
After the established mono- and co-culture models have been tested for their ability to respond 
to LPS from various CF relevant pathogens and for their ability to respond to CF relevant live 
bacteria, in this chapter they have been exposed to heat-inactivated bacteria. Heat-inactivation 
of bacteria is one of the most widely used methods for destruction of pathogenic bacteria, which 
are then not able to produce and release, for example, exotoxins. In this chapter, therefore the 
induction of an inflammatory response in the culture models by heat-stable cell wall 
components of bacteria, such as LPS in gram-negative and LTA in gram-positive bacteria were 
analysed. This method of stimulating the models with heat-inactivated bacteria was carried out 
to see the differences in response compared to live bacteria, when all exoproducts and secreted 
virulence factors are not present. 
Here the results of challenging all the different models with each different heat-inactivated 
pathogen will be discussed together as there were not many significant changes after exposure 
of mono- or co-cultures to HIA bacteria.  
As these bacterial suspensions were washed several times after heat-inactivation and before 
determining the OD of bacterial suspensions it is most likely that all exoproducts and secreted 
virulence factors were eliminated from this experiment. No free LPS or LTA (or at least very low 
levels) were present in these experiments. Comparisons of these data with the models’ response 
to intact, live bacteria and concentrated, isolated LPS might help to elucidate further, the 
virulence of intact bacteria compared to heat-inactivated bacteria and shed some light on the 
ability of heat-stable cell wall components to induce an inflammatory response. 
After challenges with any of the HIA bacteria, no changes in cell viability for any of the models 
were observed. This shows that none of the heat-stable cell wall components are able to disrupt 
the epithelial cell membrane and no cytotoxic effect was observed. This indicates that only intact 
bacteria have the ability to decrease cell viability, as discussed in chapter 7. In that chapter it was 
observed that after S. aureus challenges the cell viability in epithelial cell mono-cultures at ALI 
and all three co-cultures was significantly decreased, which was not observed here or for LPS. 
This was similar for live P. aeruginosa as there was a significant decrease in cell viability of C38 
and IB3-1 mono-cultures at ALI and also in the co-cultures of these two cell lines. These effects 
could not be observed here for HIA P. aeruginosa. The only similarity in terms of decreased cell 
viability was seen for IB3-1 mono-cultures at ALI as P. aeruginosa 50 DR LPS decreased the cell 
viability of this mono-culture after the basal and apical/basal challenge but the cell viability was 
decreased to a greater extent after challenges with live bacteria, as here the decrease was 
observed after all three challenges with P. aeruginosa 50DR. No decrease was observed after 
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HIA P. aeruginosa stimulation. This indicates that there is a difference of the cytotoxicity of 
purified LPS and the HIA bacteria, which still contain LPS in the outer membrane. This is possibly 
down to Lipid A being mostly membrane bound after the heat-inactivation, whereas this part of 
LPS is free in purified LPS. It has been reported before that Lipid A is largely responsible for the 
cytotoxicity of LPS (Rietschel et al., 1994).  
8.5.1 HIA B. cepacia is able to compromise cell layer integrity 
For the cell layer integrity it was surprising to observe a decrease in TER after the challenges with 
HIA B. cepacia. This decrease was seen for IB3-1 mono-culture at ALI, for HPF-C38 at ALI and for 
HPF-IB3-1 at ALI. These findings suggest that HIA B. cepacia was still able to compromise the 
epithelial cell layer integrity, even after HIA. The mechanisms behind this virulent trait are 
unknown but different results were observed after the challenge using live bacteria. The TER has 
not been found to be compromised after this 24 h challenge even though in HPF-C38, HPF-IB3-1 
and HPF-Calu-3 there was some degree of decreased cell viability. Again it becomes clear here 
that TER is not necessarily a good indicator of cytotoxicity. In addition TER was only measured 
after 24 h and only shows what was different at this time point compared to the situation before 
bacterial exposures. Not much research has been done up until now that looks at exact 
mechanisms of the virulence factors on TER over time but there is one report that shows time-
courses of measured TER across human gingival keratinocytes with and without infection using 
Porphyromonas gingivalis (P. gingivalis). In this report it is shown that whole P. gingivalis is only 
able to modulate the TER upon a certain bacterial concentration used to infect the cells with. 
Above that concentration TER has been shown to increase first before it drops down to almost 
zero after 24 h following apical challenges. Different results were found for basal and 
simultaneous apical/basal exposure to this bacterium as the period of increase was not observed 
at all and instead the TER started dropping after only two hours of infection and after 8 h 
reached nearly zero following the basolateral challenge and following the apical/basal challenge 
TER almost reached zero after only 6 h (Groeger et al., 2010). These findings indicate that the 
cell layer integrity can be dynamically changed over a short period of 24 h and points out that a 
snapshot of one time point will only tell a bit of the story and that it is not possibly to conclude 
from the end result, what might have been going on in between. To see whether the drop in TER 
identified after 24 h following the HIA challenges with B. cepacia might rapidly recover, has to be 
investigated further. As no decrease in cell viability has been observed here the epithelial cells 
should be able to re-establish cell layer integrity.  
Another point to note here, is that Calu-3 mono- and co-cultures do not show a decrease in TER 
following the HIA challenge with B. cepacia. However, following the challenge with live/intact B. 
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cepacia the TER was compromised in the mono-culture after the simultaneous exposure to B. 
cepacia and was also compromised in the co-culture of HPF-Calu-3 but here following all three 
challenges. This suggests that there is a different dynamic interaction between the bacterium 
and different cell lines, which could lead to different level of potential for the bacterium to be 
able to disrupt cell layer integrity. The exact mechanisms behind these interactions are not fully 
elucidated yet.  
However for all these results presented here it needs to be kept in mind that the epithelial cell 
layer was not compromised completely and equilibration of the IL-8 concentration was not 
observed. TER measurements are not a direct indicator of cytotoxicity. No decrease in cell 
viability was observed for the HIA challenges but a decrease in TER. HIA B. cepacia binding to 
epithelial cells and the possible modulation of tight junctions has not been investigated here and 
it is impossible to make a statement about the ability of HIA bacteria to compromise the cell 
layer integrity, at least to a certain degree.   
8.5.2 HIA S. aureus stimulates IL-8 secretion 
IL-8 secretions after challenging the mono- and co-culture models with HIA bacteria were only 
observed in a few cases. Out of the submerged mono-cultures only Calu-3 responded to S. 
aureus and to P. aeruginosa but they did not following the challenges when cultured at ALI. HIA 
S. aureus was also able to induce an inflammatory response in terms of IL-8 secretion in HPF-C38 
and HPF-IB3-1, with the latter responding to all three challenges, whereas HPF-C38 only 
responded after the simultaneous apical/basal challenge with HIA S. aureus and this underlines 
once more the higher IL-8 responsiveness of HPF-IB3-1 to this stimulus under these conditions. 
Furthermore, HPF-Calu-3 responded to the basal challenge with S. aureus. This shows that 
following the challenges with HIA S. aureus only the co-culture models respond with secretion of 
IL-8 and no changes in cell viability or TER were observed after these challenges. In comparison 
to the challenges using live S. aureus it becomes clear that the results concerning IL-8 secretion 
are very similar as HPF-C38, HPF-IB3-1 and HPF-Calu-3 respond but none of the mono-cultures 
apart from HPF. However, live S. aureus is more virulent to these cultures, when in its intact 
form, as S. aureus was able to decrease the cell viability in all mono- and co-cultures, apart from 
HPF mono-culture, which did not show a decrease in cell viability. Additionally in the co-cultures 
S. aureus was also able to disrupt the epithelial cell layer and decrease the TER measured 
afterwards, which is possibly down to other virulence factors rather than heat-stable cell wall 
components and to the dynamic interactions of the pathogen and the cell cultures. Interestingly 
following both different challenges (live, HIA) of the co-culture models the IL-8 secretion seems 
to be mostly directional to the apical side of the culture.  
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It has been reported before that the gene expression profile of keratinocytes, for example, is 
different in response to live or HIA S. aureus and it was pointed out there that the different gene 
expression profiles highlight the variability and complexity of analysing host responses to 
inactivated bacteria even when the pathogen repertoire is reduced in killed bacteria (Menzies 
and Kenoyer, 2005). 
 
8.5.3 Submerged Calu-3 mono-cultures 
Calu-3 mono-cultures were not stimulated by HIA gram-negative bacteria, when cultured at ALI. 
Only under submerged conditions did these cells respond to HIA P. aeruginosa and as discussed 
above an induction of IL-8 secretion after S. aureus exposure under submerged conditions was 
seen.  
These results indicate that Calu-3 cells recognise pathogens differently under these different 
culture conditions. Whether this is down to direct binding to PRRs or to different adherence 
mechanisms has not been investigated here. This tremendous difference in response to 
pathogens comparing submerged and ALI cultures, points out once more that culture conditions 
and epithelial cell differentiation make a difference to the cellular response.  
In contrast to these findings, another group has reported that using HIA P. aeruginosa to 
stimulate the human bronchial non-CF epithelial cell line 16HBE14o-, the CF cell line CFBE41o 
and the CFTR corrected CFBE 41o- did lead to an increase in IL-8 concentration when grown at 
ALI. For all of these cell lines a significant increase of IL-8 was observed following the bacterial 
challenge (John et al., 2010). This is different to what was observed in these experiments 
presented here as no increase of IL-8 was observed following the challenges with HIA P. 
aeruginosa on ALI mono- and co-cultures. This underlines that different cell lines from different 
backgrounds respond differently to different stimuli.  
 
Heat inactivation of bacteria reduces the immunomodularity potency and virulence of these 
bacteria, which is not surprising when the effect of heat on bacteria is taken into account. 
Bacteria are dead and cannot actively multiply and furthermore they cannot produce anymore 
virulence factors, which will be mostly destroyed by the heat-inactivation. Apart from LPS and 
LTA, which are heat stable to a certain degree, most other bacterial components such as RNA, 
DNA, proteins, enzymes and membranes are heat sensitive (Lee and Kaletunc, 2002). As 
bacterial suspensions were washed twice before the OD was adjusted for experiments all 
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secreted virulence factors, including exotoxins were eliminated and were not the cause of 
induced IL-8 secretion after S. aureus challenged cultures.  
 
Heat-inactivated bacterial whole-cell vaccines have been widely used for infectious diseases, 
which are necessary because of arising antibiotic resistances by many bacteria and a major 
advantage is that a broad collection of antigens can be presented to the immune cells at one 
point, plus these cause minimal side effects because the virulence potential is decreased (Pace et 
al., 1998).  
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9 Chapter 9 Discussion 
9.1 Discussion  
The overall aim of this project was to develop co-culture models of normal and CF human 
airways in vitro. These co-culture models were established using HPF and the epithelial cell lines 
C38, IB3-1 and Calu-3. In the first part of this project it was all about characterising these models 
but not only the established co-culture models were characterised also the mono-cultures of 
each cell type was analysed. Mono-cultures were employed to all experiments throughout this 
work to be able to identify cell type specific characteristics, which could then be used for support 
in analysing the co-culture data. Throughout the first three chapters several essential basics 
were determined to be able to establish a co-culture model. Human placental collagen type IV 
was determined to be a supportive growth substrate for these mono-and co-culture models and 
further it was observed that co-cultures could be grown in the epithelial medium of the 
epithelial cell line used, whereas mono-cultures were all kept in their cell-type specific medium. 
An anti-vimentin antibody and an anti-CK8 antibody were identified as cell type specific and 
these be used for identifying HPF and epithelial cells, respectively in paraffin embedded cross 
sections of the co-culture models. Using the anti-vimentin antibody on paraffin embedded cross-
sections it was shown that no fibroblastic overgrowth occurred in the co-cultures and fibroblasts 
were located subepithelial. Further characterisation was achieved by analysing epithelial cell 
layer integrity, which was presented by barrier formation and these were measured using TER 
measurements. Apical expression of the tight junction protein ZO-1 was shown for all epithelial 
cells and staining patterns indicated an intercellular location of this protein- characteristic of the 
peripheral nature of the tight junctions in native airways epithelia. Directed, apical MUC5AC 
secretion was observed from epithelial cells at ALI- in mono- and co-cultures. Preliminary 
analysis also revealed the presence of proteolytic activity (in the form of activated MMP), 
however, this was only observed for apical secretions from the CF model.  
 
Following these characterisations in the second part of this project bacteria as well as bacterial 
related stimuli (LPS and HIA bacteria) were used to investigate pro-inflammatory responses of 
these mono- and co-cultures. In addition, the effects of these stimuli on cell viability and 
epithelial integrity were measured.  
LPS stimulation of HPF mono-cultures revealed that fibroblasts under submerged conditions, in 
24 well plates, and fibroblasts grown under submerged conditions on TWs respond differently to 
LPS, which might be a result of the formation of a multi-cell layer of HPF on TWs compared to 
mono-layers when grown in 24-well plates. Different results were also observed for epithelial 
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cells, when comparing data from submerged cultures with mono-cultures grown at ALI. 
Furthermore the results obtained from mono-culture challenges were mostly different to the 
results from co-cultures. Similar differences were observed when analysing the mono- and co-
culture models results after stimulation with live or HIA S. aureus, B. cepacia or P. aeruginosa, 
indicating a general lack of pathogen-specific responses.  
 
The main points to summarize from the data presented in chapters 7 and 8 were that HPF clearly 
responded to bacterial challenges and could therefore play an important role in the 
pathogenesis of CF airways disease. Furthermore this study has shown evidence of a hyper-
inflammatory response in the CF model; thus, IB3-1 mono-cultures respond to challenge with 
significantly more IL-8 secretion compared to C38, which was also mostly the case in IB3-1-HPF 
co-cultures. Interestingly it was also observed for cell layer integrity that, where cultures were 
affected by live bacterial exposure, then mono- or co-cultures of IB3-1 were usually more 
susceptible. For challenges with HIA bacteria it was found that the virulence of bacteria was 
decreased tremendously and therefore the effect of the bacteria on cell viability was reduced 
accordingly. Most interestingly, it becomes clear from comparing data from live and HIA 
challenges that mono-cultures react completely differently to co-cultures challenged with the 
same pathogen. These data therefore generate questions about the exact role HPF play in pro-
inflammatory responses in the airways, as well as what the exact mechanisms are of intercellular 
communication and which secreted chemokines, cytokines and growth factors may play a role in 
these responses.  
 
9.1.1 Cell culture models of diseased airways 
In general, in vitro cell culture models have been developed to mimic different tissues and 
microenvironments and they are simplified versions of certain organs and tissues, such as the 
models presented here, which have been designed to mimic the bronchial airways of normal and 
CF human airways. Three dimensional cell culture models have gained in popularity over the last 
decade and have been used in pathophysiological and biomedical research to investigate normal 
and diseased tissues (Parker et al., 2010), to study drug delivery (Foster et al., 2000), cell 
responses to different stimuli (Becker et al., 2004) or to observe signalling pathways (Nilsson et 
al., 2010), just to name a few. However, these in vitro cultures are only mono-cultures 
employing one cell type, which does only mimic a small area of the tissue, such as epithelial cells 
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of the airways. In vivo there are many other important cell types present, such as the 
subepithelial fibroblasts and other immune cells, such as neutrophils and macrophages. 
 
A few studies employing different variations of in vitro and in vivo co-culture models for airway 
related research have been published, not only for CF (Wiszniewski et al., 2006) but also for 
COPD and asthma (Choe et al., 2003), for example. However, in the co-culture model published 
by Wiszniewski, for example, the subepithelial fibroblasts are grown on the undersurface of the 
TW and are postmitotic, which does not mimic the in vivo situation. In vivo, there are controlling 
mechanisms for cell and tissue homeostasis, which need to be investigated to find out whether 
these are altered in disease and therefore determine if they might play a role in pathological 
settings.  
 
9.1.2 Selecting an appropriate epithelial cell to model the airways 
There are many immortalised epithelial cell lines available for airways research and all of these 
have advantages and disadvantages. In this study, the Calu-3 cell line was evaluated since this 
cell type is very well characterised in drug delivery studies, expresses CFTR and develops 
measureable TER (Shen et al., 1994, Grainger et al., 2006). However, Calu-3 were found to be 
very different compared to the other two cell lines for all the characteristics analysed.  
 
The expression of cell type specific markers were determined with the aim of using antibodies 
directed towards these markers for cell type identification in the co-culture models (HPF and 
epithelial cells). As discussed in chapter 4, cytokeratins (CK) are epithelial specific intermediate 
filaments that allow researchers not only to discriminate between tissue specific epithelial cells 
but also allow to distinguish the stage of differentiation with respect to their CK expression 
(Purkis et al., 1990). For this reason antibodies have been developed against these proteins and 
the two antibodies used in this project were raised against CK5 and CK8. CK5 is a marker for 
basal epithelial cells, whereas CK8 is strongly expressed in differentiated simple epithelial cells 
and has also been found in the respiratory tract, where it is mainly found in the lumen lining cells 
(Moll et al., 2008, Purkis et al., 1990). The CK staining pattern of Calu-3 that was observed here 
showed strong positive staining for both CKs, whereas IB3-1 and C38 were negative for CK5 
under submerged conditions and only showed very weak staining at ALI. In chapter 4 it was 
discussed in detail that several things can influence the expression profile of epithelial cells, 
including cancer. It has been summarized by Moll et al. (2008) that typical expression profiles 
appear in different types of carcinomas and according to this there should be no CK5 expression 
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or very low level CK5 in lung adenocarcinomas (from which Calu-3 were derived originally). 
However, when Calu-3 were initially characterised they were shown to express CK5, observed as 
patchy staining (Daniel and Burnett, 1991) indicating that these epithelial cells do not behave 
typically like cells from an adenocarcinoma but neither do they behave like normal epithelial 
cells of the airways, which will be discussed further.  
 
Another epithelial cell feature important for models in airway research is to establish a 
reasonable barrier by developing a tight epithelium as adjacent cells tightly connect through 
tight junctions, which regulate ion flow across the apical membrane of epithelial cells. The 
barrier formation was monitored here by using a voltohmmeter with chopstick electrodes to 
measure electrical resistance across the cell layer (TER). The maximal TER (figure 5.3) of Calu-3 in 
mono-culture and co-culture was measured at 399.56 ± 37.99 Ω x cm
2
 and 291.96 ± 14.91 Ω x 
cm
2
, respectively. It is important to note that HPF-Calu-3 co-cultures did not reach the same 
value as the mono-cultures and were still significantly lower after 14 days of culture at ALI. These 
substantial differences in TER suggest that either the Calu-3 mono-cultures develop artificially 
high values that are normalised in the presence of fibroblasts, or that the fibroblasts somehow 
modify the barrier characteristics of Calu-3. The reasons remain to be determined, but cast 
further doubt on the usefulness of Calu-3 in co-cultures. This difference in TER on day 14 of ALI 
culture of mono- and co-culture was not observed for the other two epithelial cell lines. 
Additionally the TER of Calu-3 mono-cultures were seven times higher than the TER of C38 or 
IB3-1 mono-cultures, suggesting functional differences between Calu and other epithelial cells. 
Similarly the TER of HPF-Calu-3 co-cultures were more than 5 times higher than HPF-C38 or HPF-
IB3-1 co-cultures. These data all suggest that Calu-3, whilst remaining a good choice for barrier 
studies where a high TER is a necessary feature, cannot be used in direct comparison with other 
epithelial cell models, such as IB3-1. 
 
 
TER cannot be correlated directly to ZO-1 protein expression (Claude and Goodenough, 1973) 
but the staining pattern of ZO-1 and strength of staining usually is in accordance with this. For 
Calu-3 there is a wide variability reported for TER throughout the literature. There are values 
ranging from around 300 Ω x cm
2
 (Grainger et al., 2006, Zhang et al., 2001b), which is similar to 
what was observed here, to 1000 Ω x cm
2
 (Mathia et al., 2002). The fact that the TER of Calu-3 
was so much higher compared to C38 and IB3-1 pointed out that Calu-3 cannot be a direct 
control in terms of non-CF, for IB3-1 (CF) as this would eliminate one of the required CF model 
features, which is a higher TER compared to the non-CF control. Therefore only C38 was used as 
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a direct control for IB3-1. It was shown in chapter five that HPF-IB3-1 had a significantly higher 
TER over the 14 day period compared to HPF-C38 and shows that this disease feature was 
presented by these models, as it has also shown for CFBE410- (CF) and CFBE41o-pCep4 (non-CF) 
mono-cultures (Nilsson et al., 2010). 
 
The lack of relevance of the Calu-3 as a non-CF model was also true for some other features 
analysed here. Apical secretions of each mono-culture and co-culture were investigated for the 
presence of MUC5AC – the main mucin species found in the airways. All epithelial cell lines 
secreted MUC5AC into the apical secretions following culture at ALI, but Calu-3 constitutively 
expressed and secreted MUC5AC, even in submerged culture (figure 5.7). Dot blot analysis of 
Calu-3 mono-culture secretions (figure 5.7, lane C) revealed that MUC5AC was already strongly 
expressed before ALI was established and this was also true for apical secretions of HPF-Calu-3 
(figure 5.7, lane F). This constitutive expression of mucin by Calu-3 cells has been reported 
before, where it was also found that mucin secretion was not different for cells cultured on 
glass-cover slips or on TWs (Kreda et al., 2007). In contrast, C38 and IB3-1 secreted MUC5AC only 
after ALI was established showing another important difference between these cells and Calu-3 
and again suggesting that direct comparisons between Calu-3 as a non-CF model and IB3-1 as a 
CF model are flawed. Dehydrated mucus and inefficient mucus clearance is one of the main 
problems observed in CF lung disease (Boucher, 2007) and therefore in vitro models for CF 
research should provide this feature for investigation but again there is such difference 
compared to the other cell lines that Calu-3 cannot serve as direct non-CF control for IB3-1.  
 
Even though Calu-3 have been shown before to express high levels of CFTR (Shen et al., 1994), 
which is one requirement for a good non-CF control, they have been shown to represent a mix of 
epithelial cell phenotypes with an important goblet cell component (Kreda et al., 2007) and 
throughout this work it has been shown that Calu-3 are very different in phenotypic 
characteristics as well as cell behaviour compared to C38 and IB3-1. The differences were also 
apparent when analysing inflammatory responses of all three epithelial cell lines to LPS. The first 
big difference is that Calu-3 respond to all three types of LPS, whereas C38 only responds to B. 
cepacia and IB3-1 does not respond at all. Furthermore C38 only responded to 100 ng/ml and 
1000 ng/ml of B. cepacia LPS (figure 6.4), whereas Calu-3 respond to all concentrations used 
apart from 0.1 ng/ml (figure 6.10). The responses in terms of IL-8 secretion were more than 80 
times higher in Calu-3 supernatant compared to C38 at the LPS concentration of 100 ng/ml and 
1000 ng/ml and the baseline IL-8 was also about 60 times higher comparing Calu-3 to C38. For 
mono-cultures at ALI it was observed that Calu-3 is the only cell line responding at all and again 
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showing a baseline IL-8 secretion of more than 3500 pg/ml, whereas control levels of IL-8 for the 
other cell lines was below 200 pg/ml. These huge differences in IL-8 secretions would make 
direct comparisons impossible and prevent validation of IB3-1 as a hyperinflammatory model 
that mimics the CF phenotype.  
 
9.1.3 Novel in vitro co-culture models to investigate CF bronchial airways 
– is there a need for these? 
Initially, this work concentrated on the characterization of these mono- and co-culture models, 
whereas the second part of the project focussed on assessing the functionality of the developed 
models, which was concentrated on inflammatory responses to LPS, intact bacteria as well as 
HIA bacteria. Altogether novel, valuable and functional co-culture models were developed, 
which represent a more complex model system, compared to the mono-culture systems 
available, as these include subepithelial fibroblasts. These novel models will enable the 
investigation of intercellular communications between epithelial cells and fibroblasts and as 
these co-culture models were established as non-CF and CF models these can help to elucidate 
differences of cell communication and behaviour, which could possibly be related to the major 
difference between C38 and IB3-1, which is the expression of CFTR. 
 
For in vitro cell culture models of airway epithelial cells it has been reported that cells grown on 
a growth substrate, which usually are components of the ECM found in vivo, such as collagens, 
fibronectin and laminin, show enhanced cell adherence (Wiesel et al., 1983). Furthermore it has 
long been recognised that in vivo cell-ECM interactions are important for normal growth and 
differentiation (Grobstein, 1967) as well as for some biological functions, such as adhesion 
(Hinenoya et al., 2008), proliferation (Robinson and Wu, 1993), migration and differentiation 
(Vlodavsky et al., 1980, Hinenoya et al., 2008). Plus two of the surface membrane receptors, 
which belong to the integrins, have been shown to be collagen receptors and are constitutively 
expressed in the human adult lung in vivo as well as in cultured primary human airway epithelial 
cells in vitro (Wang et al., 1996). Collagen IV is a major component of the BM (Timpl, 1989) and is 
known to underlie the epithelium in vivo (Sage, 1982). In addition Fiedler et al. (1991) has shown 
that epithelial cells grown on collagen retain the ability to produce secretory component, which 
is a receptor for dimeric IgA and this complex is eventually released to the lumen of the airways 
to prevent microorganism adherence to the mucosal surface and is therefore an important part 
if the immune defence in the airways (Fiedler et al., 1991).  
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Here it was also shown that cell adherence to collagen-IV coated plastic ware was enhanced 
compared to cell adherence to plain plastic surfaces (chapter 3). Collagen IV is only one 
component of ECM but one reason for the addition of fibroblasts to the models was that 
fibroblasts are the main producers of ECM components (Mutsaers et al., 1997). Adding 
fibroblasts to the model would therefore provide a source for naturally produced BM 
components, which would mimic the in vivo BM more closely, helping to make these models 
more relevant. It has been shown previously that primary fibroblasts lay down ECM components 
and furthermore that bronchial epithelial cells grow better on ECM produced by fibroblasts 
compared to standard collagen coated wells (Skibinski et al., 2007). The adhesion of epithelial 
cells to fibroblasts was not evaluated during this study, but the development of an epithelial cell-
dependent TER in co-cultures indicates successful growth of an epithelial cell layer on the 
fibroblasts and immunohistochemistry staining of paraffin-embedded sections confirmed the 
presence and relevant location of the two distinct cell populations, with fibroblasts remaining in 
close contact with the TW membrane. 
 
Furthermore for the establishment of the co-culture models the cell culture growth medium is 
important, as this delivers essential nutrition, such as growths factors and hormones to support 
proliferation and differentiation, for example (Moghal and Neel, 1998). HPF were shown to 
proliferate normally, when grown in epithelial cell growth medium, which were therefore used 
to establish co-culture models. Having successfully determined general but essential growth 
conditions the next aim was to find antibodies against cell type specific markers for 
distinguishing between fibroblasts and epithelial cells. As the fibroblasts were seeded 
subepithelial without an actual physical barrier in between the cell types, this was essential. 
Anti-CK8 and anti-vimentin were the antibodies with highest specificity and would therefore be 
used in future experiments to localise cell types in cross sections of these co-culture models. 
Here it was shown for the first time that actively proliferating fibroblasts grown subepithelial in 
co-culture with epithelial cells do not overgrow the epithelial cell layer, which in the presence of 
fibroblasts established a pseudo-stratified like appearance (figure 4.12). It has been also been 
mentioned in the work presented by Skibinski et al. (2007) that human bronchial fibroblasts, if 
not treated to be postmitotic (mitomycin C), will expand by three fold in ten to twelve days 
(Skibinski et al., 2007). However, this was not observed throughout this work and highlights once 
more that there is important communication going on between epithelial cells and fibroblasts, 
which seem to regulate cell growth.  
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9.1.3.1 Epithelial-fibroblast interaction promotes normal epithelial cell differentiation 
Mono-cultures of HPF and of each epithelial cell line were analysed alongside the co-cultures in 
each experiment because as already mentioned above it was important to analyse mono-culture 
features in turn to be able to verify cell type specific features and allocate them to one of the 
two cell types present in the co-culture if possible, such as shown for TER. 
In this study valid and functional co-cultures models are presented, which show that fibroblasts 
support epithelial differentiation. Even though these co-culture models are in their infancies 
they were proven to sustain essential characteristics of the airways in vivo.  
 
One of these characteristics is the formation of a tight epithelial cell barrier, which was shown to 
be established in mono-cultures. Further characterisation revealed that all co-culture models 
were also able to establish a tight barrier and considering that HPF only form a very weak 
physical barrier with an average TER of 8.85 ± 0.89 Ω x cm
2
 over a period of 14 days it is clear 
that this barrier formation is of epithelial origin (figure 5.1-5.3). Positive ZO-1 protein staining of 
the epithelial cells in mono- and co-culture (figure 5.5) further supported the identification of a 
tight epithelial cell layer.  
 
Another essential feature for models of CF airways in vitro, is mucus secretion. Mucus 
hypersecretion is one of the hallmarks of CF and is typically associated with airway inflammation 
as seen in CF. All the co-culture models presented here were observed to secrete MUC5AC into 
the apical secretions of each model over a period of at least 14 days (figure 5.6 and 5.7). Mucin 
secretion was related to differentiation of the airways, but this project did not to determine 
whether the IB3-1 cells secreted greater levels of mucin, as expected in CF, or if the mucins 
displayed the typical CF-dependent-changes in glycosylation/sulphation (Xia et al., 2005). For 
further experiments to analyse mucin quantity, for example, C38 and IB3-1 will be compared to 
validate whether IB3-1 hypersecrete mucus as it is seen in CF airways. Dehydrated mucus and 
inefficient mucus clearance is one of the main problems observed in CF lung disease (Boucher, 
2007) and therefore in vitro models for CF research should ideally provide this feature for 
investigation.  
 
Additionally, this work has shown that HPF promote expression of microvilli and immature cilia 
in the epithelial cells (figure 4.14-4.17). This confirms observations from a previous similar study 
where fibroblasts were located on the undersurface of TWs and it was suggested that the 
promoting effect observed, was either an increase in the number of ciliated cells or prolonged 
survival of ciliated cells (Myerburg et al., 2007). Cilia are part of the innate immune defence of 
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airways in vivo and since ciliary activity is known to be compromised in CF, this is therefore one 
of the essential characteristics to be demonstrated in a valid model of CF airways. 
 
This overall positive influence of fibroblasts on epithelial cell differentiation has been reported 
before. Myerburg et al. has shown for primary bronchial epithelial cells and lung fibroblasts, 
which were seeded on the undersurface of the TWs that this close proximity is necessary for 
promoting certain epithelial cell features. In this culture set up epithelial cells differentiated into 
a polarized ciliated cell layer, when intercellular contacts of epithelial cells and fibroblasts were 
possible but when direct cellular contact was prevented, by seeding fibroblasts at the bottom of 
the well that holds the TW, the epithelial cells differentiated into non-physiological, stratified 
squamous epithelium. This underlines that epithelial cell interactions with fibroblasts are 
important for normal cell differentiation (Myerburg et al., 2007). This study clearly shows that a 
close proximity of fibroblasts and epithelial cells is important for epithelial differentiation. Even 
though fibroblast conditioned media has been shown to enhance cell proliferation similarly to 
fibroblasts, proliferation and differentiation are two different things (Skibinski et al., 2007). 
Again this shows that fibroblast contact with epithelial cells needs to be further investigated and 
it cannot be assumed that based on the fact that proliferation is promoted by conditioned 
medium and fibroblasts to the same extent that this is the same for other cell function and 
developments as shown by Myerburg et al. (2007) for differentiation. The close proximity and 
direct cell contacts are definitely provided in the co-culture models presented in this work as 
fibroblasts were seeded directly into the TW as subepithelial cell layer, rather than on the 
undersurface of the membrane. This gives fibroblasts and epithelial cells chance to communicate 
closely, indeed, they are in direct contact. These co-culture models will be helpful for further 
elucidating these essential communications. 
 
Some other co-culture models have been developed for airway research, which also apply 
fibroblasts into their models. One model for airway wall remodelling was developed by Choe et 
al. (2003). In this model fibroblasts are seeded and cultured in a collagen matrix and the 
epithelial cells are in a separate device that can be put on top of the fibroblasts, which creates a 
certain physical barrier between them but growth factors and other secreted macromolecules 
can diffuse through the model. This group has managed to develop a dynamic cell model for 
mechanical stress in the airways for research of remodelling in asthma (Choe et al., 2006), 
however as mentioned above direct cell contacts between epithelial cells and fibroblasts lead to 
different results in terms of epithelial cell differentiation suggesting that hepatocyte growth 
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factor and other fibroblast secretions are not the only influence on epithelial cell phenotypes 
(Myerburg et al., 2007).  
 
Another model system that was established for CF airway research applied post-mitotic 
fibroblasts in the co-culture system with primary epithelial cells isolated from patients. The 
fibroblasts in these models were included with the main intention to keep primary cultures 
growing for longer based on the promoting effects of fibroblasts, and to establish more cultures 
out of one tissue sample of a patient, as these are limited and not always readily available. Post-
mitotic fibroblasts were generated by mitomycin C treatment, these were then used as feeder 
layers seeded on the undersurface of TWs. Whilst this gives the cells chance to partially interact 
directly through the membrane there is still a physical barrier between them. Even though this 
group has shown that post-mitotic fibroblasts were more efficient in keeping the differentiated 
epithelium growing compared to conditioned medium only (Wiszniewski et al., 2006) there is 
room to criticise this approach at least the intention to use these models for CF research in 
terms of inflammatory responses because mitomycin C has been shown to increase IL-8 
secretion in corneal fibroblasts for example (Chou et al., 2007). As IL-8 is one of the major 
chemokines found in CF airways, this attribute should not be manipulated if the models are to 
retain the most relevant features of the disease. Furthermore it was shown that mitomycin-
treated fibroblasts are still able to express cytokine but whether this is true for ECM components 
for example is not known. These reasons underline the importance for the use of actively 
proliferating fibroblasts and enable to investigate the true pro-inflammatory responses by these 
cells. 
 
The biggest concern when using co-culture models is that the fibroblasts will continue to 
proliferate and eventually overgrow the epithelial cells. However, it has been shown here (figure 
4.12) that the fibroblasts grow subepithelial without overgrowing the epithelium and that co-
cultures are established as two distinct populations of cells. Previous reports demonstrated that 
primary human bronchial fibroblasts expanded by threefold in 10-12 days and therefore had to 
be mitomycin C treated to prevent over-proliferation (Skibinski et al., 2007), here it has been 
shown not to happen with primary human pulmonary fibroblasts. Epithelial cell surface analysis 
using SEM confirms that there are two cell populations and that fibroblasts remain most 
proximal to the TW membrane, as there were no fibroblasts visible on the co-culture surface 
(figures 4.13, 4.16, 4.18, 4.22).  
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All together the epithelial cell features that were analysed in mono-cultures could all be 
identified in co-cultures as well but the addition of fibroblasts creates a model that is more 
relevant to in vivo physiology. As it has been shown before that fibroblasts stimulate epithelial 
cell growth (Skibinski et al., 2007) and epithelial cell differentiation (Myerburg et al., 2007)  
 
The precise component(s) provided by actively proliferating fibroblasts that may support 
epithelial cell differentiation in co-culture models remain to be determined. However, one 
relevant growth factor that is usually secreted by fibroblasts is HGF and this growth factor has 
been shown to support epithelial cell proliferation (Skibinski et al., 2007) and differentiation 
(Myerburg et al., 2007). Furthermore for CF it has been suggested that the increased level of 
HGF found in BAL, is an indicator of actively ongoing repair mechanisms in CF and that this 
increased level of active HGF is responsible for the appearance of a relative normal epithelium 
with limited fibrotic changes (Shute et al., 2003). Fibrotic changes are not very apparent in CF 
but as suggested here, it is because of subepithelial fibroblasts that secrete HGF and therefore 
this fibroblastic support seems to be very important in the disease settings. 
 
Whilst there is abundant evidence for the importance of fibroblasts in a model of the normal 
airways, this is not true for CF airways since almost no significant fibrotic changes are observed 
in CF airways in vivo. There are still other fibroblast functions, such as growth factor secretion, 
which should be taken into account when modelling the disease and it is most likely that these 
cells play a role in inflammatory responses, which will be discussed further on. 
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9.1.4 Inflammatory responses are different in mono-and co-cultures 
Having established promising non-CF and CF mono and co-culture models these were challenged 
with LPS, live bacteria and HIA bacteria to observe their inflammatory responses and to validate 
how these results are in accordance with other existing models. Additionally these models will 
enable further investigation of the fibroblastic influence on inflammatory responses in CF lung 
disease and their impact on epithelial cells.  
Submerged cell mono-cultures were analysed for cell viability and IL-8 induction after the three 
challenges with bacteria (LPS, HIA, live bacteria). The submerged cultures were the simplest cell 
culture models used in this project, and they were found to respond completely differently to 
these challenges compared to cell cultures at ALI. For example C38 responded to B. cepacia LPS 
under submerged conditions but not when cultured at ALI and neither did HPF-C38. As 3D cell 
culture mimics the in vivo cell morphology closely, such as the pseudostratified like appearance, 
it is suggested here that the inflammatory response is more similar in ALI mono- and co-cultures 
compared to in vivo. The fact that submerged cultures respond to bacterial challenges, whereas 
ALI cultures do not is at least partially down to the lack of polarity in these submerged cultures, 
which were undifferentiated mono-layers. These mono-layers do not form a tight epithelial cell 
layer, which has been shown by staining of the tight junction protein ZO-1. In undifferentiated 
submerged cultures ZO-1 is expressed but the typical belt-like staining pattern around the cells is 
lacking (figure 5.4). Therefore a distinct apical and basolateral membrane is not present and no 
apically directed secretions could be retained on the upper side of the cells.  
 
Here it was shown that C38 and IB3-1’s apical secretions only contained MUC5AC after ALI was 
established, suggesting that a protective mucus layer with possibly antibacterial activity is 
secreted and is suggested to prevent LPS from stimulating an inflammatory response in ALI 
cultures as it is likely that the LPS will get entrapped by the mucus layer. For Calu-3 it has been 
shown before that there is significant antibacterial activity in apical secretions of Calu-3 mono-
cultures. The reported data show that P. aeruginosa and E. coli grown in apical secretions were 
killed to a certain extent, depending on the initial bacteria load added to the secretions (Zhang et 
al., 2001b).  
In general it was observed that, following culture at ALI and therefore the formation of a 
polarised, differentiated epithelial cell layer, mono-cultures responded differently compared to 
co-cultures. This is not surprising considering that HPF add more complexity to the model and 
are likely to modulate cell behaviour and pro-inflammatory responses. Of course epithelial cells 
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are able to communicate with HPF and vice versa via signalling molecules such as growth factors, 
for example. 
9.1.5 Fibroblasts respond to infectious stimuli 
Direct cell–cell interactions, as discussed earlier are important in terms of fibroblast-epithelial 
cell communication and were shown to support epithelial cell proliferation (Skibinski et al., 
2007) and differentiation (Myerburg et al., 2007) in different co-culture systems. Other 
important cell-cell communications between fibroblasts and other immune cells have also been 
reported. Alveolar macrophages, for example, secrete TNF-α in response to inflammation. This 
has been reported to induce IL-8 secretion in fibroblasts and therefore it was suggested that an 
initial host response is necessary to stimulate HPF (Rolfe et al., 1991). Data presented here show 
that fibroblasts can respond directly to inflammatory stimuli and secrete IL-8. In the airways, 
fibroblasts would not normally encounter bacteria and other pathogens, being located 
subepithelial, but after injury or bacterial invasion of the epithelium by intact bacteria this could 
be different and lead to direct contact between these pathogens and the fibroblasts. The three 
CF-relevant pathogens used in the current work have all been shown to be able to disrupt tight 
junctions and invade the epithelium (da Silva et al., 2004, Kim et al., 2005b, Azghani, 1996). In 
TW mono-cultures, HPF respond to all live bacteria used in these experiments with IL-8 secretion 
to the apical and basolateral side, suggesting that they will have an influence on the overall 
inflammation found in vivo. Here IL-8 was found in the apical compartment, which is suggested 
to maintain the luminal chemokine concentration that would keep neutrophils at the side of 
infection plus IL-8 was found in the basolateral compartment, where it has been shown before 
that signalling to the underlying tissue cells occurs to recruit neutrophils to the site of infection 
(Conese et al., 2003). 
Another interesting point to note is that live S. aureus decreased cell viability in C38 and IB3-1 
mono-cultures and also in co-cultures but with the difference that IL-8 is only induced in co-
cultures. This underlines that there is a different inflammatory response in mono- and co-
cultures. As already discussed in chapter 7, S. aureus is able to invade epithelial cells and induce 
apoptosis or cause necrosis (Essmann et al., 2003), suggesting that in mono-cultures 
predominantly apoptosis occurs, which does not cause a pro-inflammatory response and that 
this causes the lack of inflammatory response. However, HPF mono-cultures have been shown to 
respond to live S. aureus following the apical and the apical/basolateral challenge and similar 
responses were seen for HPF-C38 (following apical/basolateral) and HPF-IB3-1 (apical, basal), 
which shows that either the fibroblasts respond directly by secreting IL-8,when stimulated from 
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the basolateral side or in case of apical challenge that S. aureus has possibly invaded the 
epithelial cell layer and traverse to the subepithelial cell layer to induce IL-8 secretion.  
Results for live B. cepacia showed that the cell viability was only affected in co-cultures but not 
in mono-cultures of C38 , IB3-1 or HPF. This indicates that co-cultures are more susceptible to 
this bacterium. Whether the decrease in cell viability is down to dying fibroblasts, to dying 
epithelial cells or to both cell types cannot be indentified at this point. HIA B. cepacia is not able 
to decrease viability at all, which indicates that only live B. cepacia causes this damage, perhaps 
via invasion of the epithelium. The invasion of lung tissue with B. cepacia has been shown before 
in tissue samples of CF patients (Sajjan et al., 2001) as well as for epithelial cells (Martin and 
Mohr, 2000). Interestingly it was observed here that HPF-IB3-1 were affected to a higher extent 
compared to HPF-C38 and cell viability was decreased following all three challenges in HPF-IB3-1 
compared to only following the simultaneous challenge from both compartments in HPF-C38. 
This suggests that B. cepacia was able to invade IB3-1 cells in the co-culture model from the 
apical side but was not able to do so in C38 following the apical challenge. It has been shown 
before that several strains of B. cepacia, which express cable-pilus, were able to bind to CF cells 
from human lung sections but not to non-CF ones. The same was observed for mice nasal tissue 
sections (Sajjan et al., 2000a).These findings support what was observed here that HPF-IB3-1 are 
more susceptible to this challenge than HPF-C38. Even though in Sajjan et al. (2000) no binding 
of B. cepacia was seen to non-CF cells at all this is not a direct contrast to the decreased viability 
seen in HPF-C38 following the simultaneous challenge, as they only analysed epithelial cells, 
whereas the cell viability decrease of HPF-C38 could be explained as a result of bacterial binding 
to and/or invading the fibroblasts. A possible receptor that B. cepacia are known to bind to is 
TNFR1 (Sajjan et al., 2008), which is expressed in fibroblasts an could therefore lead to the 
cytotoxicity observed in the co-cultures. 
Comparing pro-inflammatory responses, in terms of IL-8 release, following the challenge with 
HIA B. cepacia and intact B. cepacia it becomes clear that only the viable form of B. cepacia is 
able to induce a pro-inflammatory response in these mono- and co-cultures of HPF, C38 and IB3-
1. This is not surprising considering that HIA bacteria are targeted to the lysosome usually within 
4 h post infection, whereas live B. cepacia have been shown to escape late endosomes and 
lysosomes to enter autophagosomes and replicate afterwards within the endoplasmatic 
reticulum (Sajjan et al., 2006).  
In case of cultures challenged with either live P. aeruginosa or live S. aureus cell viability is 
affected in mono-and co-cultures but to a greater extent in mono-cultures, which is in contrast 
to what was observed following challenges with B. cepacia, after which only the co-cultures 
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showed significant decrease in cell viability. Following P. aeruginosa challenges, the cell viability 
of IB3-1 mono-cultures was reduced by 27 % but was not affected in the co-culture system after 
the basal challenge, suggesting some kind of protection given by the HPF cell layer. This result 
was also observed following the challenge with live S. aureus. Interestingly in a different setting 
it has been shown that fibroblasts can actively support cell survival and it was shown that 
fibroblasts and their secreted ECM components plus growth factors supported cell viability of 
pancreatic islets (Jalili et al., 2010). Further investigation is needed here to get an insight into this 
possible protection by fibroblasts. That this possibly protective layer is not able to defend the co-
cultures against live B. cepacia on the basolateral side indicates the strong virulence of this 
bacterium, especially once it has invaded the cells. B. cepacia are known to be the most invasive 
infection found in CF patients and usually leads to a rapid decline in lung function and often to 
septicaemia (Mahenthiralingam et al., 2005).  
 
In the case of challenges with live P. aeruginosa, basal challenge induced IL-8 secretion by the 
HPF-C38 and HPF-IB3-1 co-cultures but surprisingly none of the mono-cultures of HPF, C38 or 
IB3-1 responded to this challenge by secreting IL-8. Again there were completely different 
responses seen in mono- and co-cultures, which is most likely due to cell-cell communications 
between the epithelial cells and fibroblasts. As the stimulus was given basolaterally it is possible 
a signalling cascade starts with pathogen binding to HPF, which then respond by release of a 
mediator other than IL-8, which is able to stimulate the overlying epithelial cells to apically 
secrete IL-8. It is not clear if HPF respond only to certain bacterial stimuli, for example different 
virulence factors, by secreting IL-8 and whether they respond differently to other virulence 
factors, which might induce different signalling pathways leading to different mediators.  
Even though no underlying mechanism for these differences in IL-8 responses of mono- and co-
cultures can currently be defined, these differences highlight again that fibroblasts and cell-cell 
interactions are important in bacterial induced inflammatory responses. Again this underlines 
the importance of taking fibroblasts into account to further study CF lung pathogenesis and that 
mono-cultures studied only show small part of their contribution to the overall IL-8 driven 
neutrophilic inflammation seen in CF. 
 
Different pro-inflammatory responses were observed for mono- and co-cultures following 
infection with three different CF-relevant organisms. For the challenges with live bacteria it 
needs to be kept in mind that all these bacteria work to a great extent by the regulation of their 
quorum sensing signalling systems and they all secrete different virulence factors (Yarwood and 
Schlievert, 2003, McKeon et al., 2011, Erickson et al., 2002). Furthermore S. aureus is a gram 
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positive bacterium and the other two bacteria are gram negative, which will have an influence of 
the cellular response as different signalling pathways (via, for example, distinct TLRs) will be 
activated by different stimuli to induce IL-8 secretion from epithelial cells (Greene et al., 2005a, 
John et al., 2010). As earlier discussed in this work (chapter six) it was shown that none of these 
cells express TLR4 on their membrane surface but are able to respond to LPS. This mechanism 
has not been fully elucidated yet but it has been reported before that intracellular TLR-4 can be 
located in the Golgi apparatus and there it co-localizes with internalized LPS in intestinal 
epithelial cells for example (Hornef et al., 2002), which could also be a possible control 
mechanism, so that airway epithelial cells do not respond to low levels of LPS or even of the 
bacterial products as these are inhaled constantly but they must be able to respond to a certain 
load of LPS or live bacteria to be able to respond quickly and eliminate the infection. As this is a 
more complex cell-culture model and at least in the case of using live bacteria there are lots of 
pathways involved, such as TLRs (Muir et al., 2004, Greene et al., 2005b) and asialoGM1 
(DiMango et al., 1995, Kube et al., 2001), which can both modulate the interaction with bacteria 
these experiments need future investigation to elucidate the dynamic interactions of epithelial 
cells with fibroblasts and vice versa but also the dynamic interactions of fibroblasts or epithelial 
cells with bacteria. Fibroblasts have not been extensively studied in terms of inflammation in CF 
but as shown here are able to respond to bacterial infections and therefore must have receptors, 
such as TLRs and TNFR1, that initiate a signalling pathway to induce IL-8 expression.  
 
9.1.6 A novel co-culture model mimicking CF 
The overall aim was to establish co-culture systems for non-CF and CF human airways in vitro 
using HPF and one of the epithelial cell lines C38, IB3-1 or Calu-3. As earlier discussed Calu-3 are 
not useful as a control for IB3-1 and will therefore not be taken forward as a suitable non-CF 
model of human airways. In mono-cultures of C38 and IB3-1 it was observed that the TER of IB3-
1 was in general higher compared to C38. However the difference was not significant. When 
these epithelial cells were co-cultured with HPF this changed and the TER was significantly 
higher in the CF model. This is in accordance with other reports that have shown that epithelial 
TER in CF cell is higher based on the dysfunction of CFTR. It was also shown by the same group 
that using the CFTR-inhibitor CFTRinh-172 on normal cells (16HBE) had the same affect in terms of 
increasing TER (Nilsson et al., 2010, Perez et al., 2007). 
 
Furthermore it has been observed here that IB3-1 did not constantly secrete higher IL-8 levels at 
baseline, which is in contrast to what has been shown before (DiMango et al., 1998) , however, 
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the magnitude of IL-8 response is always greater in the CF models. There is an existing area of 
controversy about constitutively increased IL-8 in CF and which leads to one of the outstanding 
questions in CF: What comes first inflammation or infection?  
It has been reported that even without infection in CF infants there was an increased IL-8 
concentration in the BAL fluid in comparison with control subjects. This was also shown for 
neutrophil counts and neutrophil elastase (Khan et al., 1995), which indicates that inflammation 
is present before infection. However there are other reports that show that CF and non-CF cells 
secrete similar amounts of IL-8 (Kube et al., 2001, Scheid et al., 2001) but that CF cells show a 
hyperinflammatory response after exposure to P. aeruginosa, which was appointed to the fact 
that there is increased bacterial adherence to CF cells. These reports are in accordance with the 
hyperinflammatory state found here for challenged IB3-1 cells in mono- and co-cultures.  
In this study here it was observed that IB3-1 cells respond with much higher secretion of IL-8 to 
the live bacteria used. After the challenge with live P. aeruginosa the IL-8 concentration in apical 
supernatants (following apical or apical/basolateral challenges) was about 2.5-fold higher in IB3-
1 samples compared to C38. This difference was even higher after B. cepacia challenges, where 
IL-8 was found to be 3-fold higher for IB3-1 samples. Importantly the typical hyperinflammatory 
state which is reported for CF, is still present in co-cultures. After exposure to live P. aeruginosa, 
the IL-8 concentration in apical supernatants of IB3-1 was still 1.5-fold higher compared to HPF-
C38. For the apical/basolateral challenge it is not possible to make this statement as HPF-IB3-1 
cell viability was reduced by 67 % and this does not allow an accurate comparison to HPF-C38, 
whose cell viability was only decreased by 33 %.  
 
These decreases in cell viabilities, directs to the next CF phenotypic feature presented in this 
model, hypersusceptibility to infection. There were several different approaches that tried to 
find the direct link to why CFTR loss or mutation causes such severe lung disease in most 
patients (depending on the CFTR mutation). CF cells have been closely studied and one receptor 
that has been found to be more numerous on CF cells compared to non-CF cells is asialoGM1 
(DiMango et al., 1995). This receptor is a binding site for P. aeruginosa pili and flagellin, for 
example (Schroeder et al., 2001b) and therefore it was suggested to be involved in the 
hypersusceptibility of CF patients to P. aeruginosa infections by higher adherence of the bacteria 
to CF cells. Although this receptor is more prominent on IB3-1 cells (DiMango et al., 1995), the P. 
aeruginosa strain used here, was isolated from a patient and therefore most likely turned into a 
non-motile bacterium and does not express flagella anymore (de Bentzmann et al., 1996b, de 
Bentzmann et al., 1996a, Mahenthiralingam et al., 1994). However the susceptibility seemed to 
be higher in IB3-1 models compared to C38 models but the precise mechanism remains to be 
 336 
 
determined as there are a variability of other factors that need to be taken into account, such as 
the difference of mucus composition in CF and non-CF (Roussel et al., 1975, Thornton and 
Sheehan, 2004). 
 
These co-culture models display CF phenotypic features and are promising co-culture models for 
further investigations, especially with the integration of actively proliferating fibroblasts, which 
will help to shed more light on the role these cells might play in CF lung disease and the overall 
pro-inflammatory state found in CF. These models are still in their infancies but they show that 
fibroblasts are more than just feeder layers and they will be a useful addition to existing models, 
especially a good addition to the few co-culture models that have been established for CF 
research.  
9.1.7 CF models – aren’t there enough??? 
The answer simply is NO. It is important that new and improved models are developed because 
the investigation of lung pathogenesis has been partially hampered by the necessary but not 
existing models. Novel models will help to further understand CF pathogenesis and in the long 
term help to increase life expectancies and to improve the quality of life for CF patients by 
developing new therapies based on research findings.  
 
In this project novel co-culture models were established for mimicking CF and non-CF human 
bronchial airways in vitro and they have been shown throughout this work to fulfil essential 
characteristic expectations and they have been shown to show CF related differences between 
them. These are promising novel models and they not only look at epithelial cells and how they 
behave but also at subepithelial fibroblasts. These models are more complex compared to the 
standard used mono-cultures systems but they are much simpler compared to whole animal 
models, which gives them the advantage to be easier to control. As one of the future aims is to 
further investigate intercellular communication and investigate the underlying mechanisms, 
these models have the advantage compared to animal models that less variables are present and 
it should be easier to control experimental conditions and that is one reason for the need of 
additional in vitro models.  
 
Even though, many mouse models have been developed for CF research and these show 
dramatic differences to the disease phenotypes compared to what the hallmarks are in human 
CF. As already pointed out in chapter 1 mice show a complete different lung anatomy compared 
to humans (Zollner et al., 2004) and most importantly mice do not express IL-8 and no clear cut 
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IL-8 homolog has been identified despite intensive research (Rovai et al., 1998). Two chemokines 
that are expressed by mice have been referred to as homologous to the human IL-8. One is the 
macrophage inflammatory protein 2-α (MIP-2) and the other one is keratinocyte 
chemoattractant (KC), which have both been shown to recruit neutrophils. These differences 
make it almost impossible to directly and accurately compare results found in human in vitro 
models and in vivo mouse models. The difference of chemokine expression and also the fact that 
humans express two IL-8 receptors and mice only express one KC/MIP receptor, show that 
experimental outcomes have to be taken with care, when these are tried to be related to the 
human disease (Zhang et al., 2001a). In addition it has been shown that the pathophysiology of 
the airway epithelium, which is one of the most affected areas in human lungs with CF, is not 
present in the animal models. Instead the animal models are dominated by the intestinal 
pathology, indeed, this is the main cause of morbidity in CF mice (Davidson and Dorin, 2001). In 
these CF mice no gross pulmonary differences were observed compared to their non-CF 
littermates. There is long list of differences, which have been reviewed extensively but here it 
was important to point out that a direct comparison of results found here for inflammation 
would not be very relevant and would not help in further investigating the inflammatory 
responses, for example, observed here.  
There are some studies, which employ chronic infection of mouse models with P. aeruginosa, for 
example and they have shown that after a three day infection with P. aeruginosa, concentrations 
of the IL-8 homologues MIP-2 and KC in the BAL fluid were significantly increased compared to 
normal littermates (Heeckeren et al., 1997) but as bacteria have been shown to not be retained 
in mouse lungs these have to be embedded in agar beads, for example and therefore represent 
an artifical, exaggerated mode of infection. Hypersecretion of IL-8 in response to infection was 
observed in the mono- and co-culture models presented in this work and the IL-8 secretion of 
IB3-1 in mono-culture is about 3 times as high compared to C38. However, these comparisons 
are better to be made comparing human systems to each other as in vitro experimental settings 
are completely different and there are less variables presented compared to in vivo. As discussed 
earlier on, there is even criticism towards comparing different epithelial cell lines all having 
human origin and maybe originate from different parts of the respiratory system but the 
question arising then is: If human cell systems cannot be compared to each other, how can it be 
valuable to compare results to mouse models that do not even show the same pathophysiology? 
Therefore it is not the intention here to discuss outcomes from other mouse models. 
 338 
 
9.1.8 Future work 
Future work will include additional investigation of the presented model systems in terms of 
paraffin embedded cross-sections. As there is no histology department at Aston University the 
intention is to integrate these techniques into the laboratory. As it has been addressed earlier 
on, immunofluorescence staining on excised TWs, which were then analysed using fluorescent 
microscopy by viewing them from the apical side, is a good method for mono-cultures and 
antibody titrations, for example, but paraffin sections will be more useful in terms of co-culture 
characterisation. These paraffin cross-sections will enable further comparisons of the CF and the 
non-CF model in mono- and co-cultures following staining for different receptors, for example 
TLR expression. Unstimulated submerged cells have been analysed quite well but it is of great 
interest to further investigate the surface expression of different TLRs in response to different 
stimuli and when grown at ALI. This is also very important to further characterise the human 
pulmonary fibroblasts used here as this type of cell has not been extensively studied in the 
setting of CF lung disease. Furthermore goblet cells and mucin expression could be identified in 
this way and most importantly investigate the cultures before and after bacterial infections. 
 
Another future aim is to further investigate mucin expression of these epithelial cell lines. It 
would be interesting to analyse, whether MUC5B is expressed and secreted by these epithelial 
cells. Quantitative analysis of mucus secretion has never been carried out in this laboratory but 
is another future aim to be addressed. This would be very useful as obviously it would be 
interesting to observe if IB3-1 hypersecrete mucus at baseline levels and what direct influence 
bacterial infections have on these cultures. Furthermore the analysis of mucus secretion in co-
cultures of HPF and these epithelial cell lines would be interesting to investigate the 
subepithelial HPF affect on mucus secretion.  
 
Additionally it is important to further investigate the role of HPF in these co-culture models in 
terms of ECM deposition, cytokine (other than IL-8) and growth factor secretion for example. 
ECM deposition by fibroblasts has been shown before (Skibinski et al., 2007) and it would be 
interesting to see if ECM components are accumulated over time in these long-term cultures or 
whether some kind of equilibrium can be established over time between degradation and de 
novo synthesis.  
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In terms of epithelial cell characterisation and functionality there are further possibilities as well 
especially observing differences of mono-and co-cultures as well as observing possible 
differences based on being CF and non-CF. Another close future objective would be to further 
analyse MMPs in these culture models as some MMPs, such as MMP-2 have been shown to be 
increased in CF but in not much research has been carried out to investigate, which role this 
proteolytic enzyme might play in CF. This would include the analysis of MMPs and also the 
analysis of the tissue inhibitors of metalloproteinases (TIMPs). Again this is also an experiment to 
be analysed before and after infection with several CF relevant pathogens. 
Another aspect is the investigation of antimicrobial properties presented in the ASL secretions of 
mono-and co-cultures and further analyse single components, which might be altered down to 
the epithelial difference being CF and non-CF and further what influence HPF have on these 
secretion, for example volume and antibacterial property changes, in the co-culture systems.  
Chemotaxis assays will be carried out to detect if the IL-8 analysed at baseline and following 
infections is biologically active and able to attract neutrophils using a chemotaxis chamber. 
An exposure time of 24 h was used here for the bacterial infections and this only gives a 
snapshot of one time point but it would be nice in terms of TER measurements, for example to 
carry out a time course throughout the infection to see whether there are changes to be noticed 
in between and when changes start to happen in response to certain bacteria. It could also be 
helpful to expose mono- and co-cultures cells to bacteria for different amount of time and then 
follow these developments. These time courses would also be helpful to investigate the cell 
viability changes found here in response to certain bacteria and observe when cells start dying 
(caspase activity) and if the culture can recover after gentamicin treatment. How long would 
these cultures survive in presence of infection?  
Here three CF relevant bacteria were used separately to stimulate the mono- and co-cultures but 
in CF patients, even though P. aeruginosa is the most prominent bacterium, usually 
polymicrobial infections were observed, with new strains often being isolated and bacteria that 
have never been seen before in CF (CF trust). This is an interesting research field and if through 
possible collaborations (Heart of England, for example) new relevant pathogens could be 
received, these could be investigated using these mono- and co-culture models. There is 
different ways of approaching these kinds of experiments depending on what the main interest 
is. Cultures could be exposed to one bacterium first (S. aureus) and then after elimination 
another infection with P. aeruginosa could follow and see whether in these settings S. aureus 
has a promoting affect on P. aeruginosa infection. Furthermore polymicrobial infections of these 
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models could be carried out and investigate whether P. aeruginosa is the leading pathogen in 
these settings and further investigate the establishment of these bacterial communities in CF 
compared to non-CF. 
Another long term aim will be the attempt to expand the established co-culture models by 
adding another dimension to it in terms of an additional cell type, such as endothelial cell or 
macrophages, for example to get another step closer to mimic normal in vivo physiology.  
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